cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
28813,"Tetrafluoroethylene, oxidized, oligomers, reduced, decarboxylated",500-539-6,161075-02-1,Not Classified,Notified C&L,1,Not classified:1
28815,Pentafluorobenzonitrile,212-259-9,773-82-0,Flam. Liq. 3,Notified C&L,61,H226:61;H335:6;H319:7;H312:5;H302:5;H332:5;H315:7;H331:1;H311:1;H301:1
28816,"ethoxyquin (ISO);6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline",202-075-7,91-53-2,Acute Tox. 4,Harmonised C&L,0,H302:0
28821,2-(furfurylthio)ethylamine,253-024-0,36415-21-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
28824,Dimethyl sulphide,200-846-2,75-18-3,Flam. Liq. 2,REACH registration C&L,1759,H225:1563;H301:1349;H335:227;H280:173;H331:175;H332:173;H318:186;H315:211;H319:189;H224:22;H300:22;H330:22;H310:22;H302:13;H317:1;H412:1;Not classified:1
28831,"zoxamide (ISO);(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide",605-037-1,156052-68-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
28833,"2-Propenoic acid, 2-(chloromethyl)-, methyl ester",618-828-1,922-15-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
28835,Heptanoyl chloride,219-775-3,2528-61-2,Met. Corr. 1;Skin Corr. 1B;Acute Tox. 1,REACH registration C&L,135,H314:135;H290:87;H330:128;H318:84;H302:2;H412:1;H226:1;H332:1;H312:1
28837,"Isopropyl (Z,Z)-9,9-dibutyl-2-methyl-4,7,11-trioxo-3,8,10-trioxa-9-stannatetradeca-5,12-dien-14-oate",245-061-6,22535-42-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H319:1;H312:1;H302:1;H412:1;H315:1
28838,5-dimethylaminonaphthalene-1-sulphonyl chloride,210-092-6,605-65-2,Skin Corr. 1B,Notified C&L,52,H314:52;Not classified:1;H290:3;H302:1;H318:2
28839,Tetralead trioxide sulphate,235-380-9,12202-17-4,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,66,H360:66;H410:66;H362:47;H351:47;H400:66;H332:66;H302:66;H372:47;H373:19
28844,1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide,201-091-1,78-18-2,,,0,H314:0;H242:0;H302:0
28846,"Sulfuric acid, mono-C12-16-alkyl esters, compds. with diethanolamine",286-536-8,85252-20-6,Not Classified,Notified C&L,1,Not classified:1
28848,1-(2-Benzylsulfanyl-5-chloro-thiophen-3-yl)-ethanone,926-543-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
28857,1-isopropyl-4-methylcyclohexane,202-790-4,99-82-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2,REACH registration C&L,86,H226:86;H304:74;H315:70;H400:5
28858,"1-(3,4-dichlorophenyl)piperazine",260-652-9,57260-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:39;H319:39;H315:39;H314:7;H302:2;H318:2;H311:1;H312:1
28862,DISPERSE BLACK 4 (C.I. 11220),611-986-2,6054-50-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
28863,"Sodium 6-[(4-amino-3-bromo-9,10-dihydro-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate",229-185-8,6424-75-5,Not Classified,Notified C&L,7,Not classified:7
28867,Pyridinium fluoride,250-889-6,32001-55-1,Acute Tox. 1;Acute Tox. 1;Skin Corr. 1A;Acute Tox. 1,Notified C&L,30,H314:30;H310:28;H300:28;H330:28;H335:1;H319:1;H311:1;H301:1;H225:1
28870,4-(6-methylbenzothiazol-2-yl)aniline,202-150-4,92-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,198,H335:196;H319:196;H315:196;H341:1;H332:1;H373:1;H302:1
28878,2-methyldecanenitrile,273-960-3,69300-15-8,Aquatic Chronic 2,REACH registration C&L,1525,H411:15;Not classified:1510
28882,Methyl 5-mesyl-o-anisate,264-267-7,63484-12-8,Not Classified,REACH registration C&L,11,Not classified:8;H335:2;H319:2;H315:2;H332:1;H302:1;H312:1
28884,"[1R-(1-α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate",426-890-4,77341-67-4,Eye Dam. 1,Harmonised C&L,0,H318:0
28885,"hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate",405-280-1,76508-02-6,Eye Irrit. 2,Harmonised C&L,0,H319:0
28889,Isooctadecyl pivalate,261-521-9,58958-60-4,Not Classified,REACH registration C&L,124,Not classified:124
28893,"3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride (1:1)",601-635-1,119812-29-2,Met. Corr. 1;Acute Tox. 3,Notified C&L,41,H301:38;H290:38;Not classified:2;H302:1;H335:1;H319:1
28896,"Coke (coal), secondary pitch",302-626-2,94113-91-4,Not Classified,Notified C&L,21,Not classified:21
28897,"Coconut oil, hydrogenated",284-283-8,84836-98-6,Not Classified,Notified C&L,38,Not classified:38
28899,"4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[3-bromo-2,5-dimethylphenol] S,S-dioxide",254-780-4,40070-59-5,Not Classified,Notified C&L,1,Not classified:1
28901,"3,5-dimethylcyclohex-3-ene-1-methyl acetate",266-830-2,67634-25-7,Not Classified,Notified C&L,267,Not classified:266;H410:1;H400:1;H317:1;H318:1;H315:1
28902,Lithium bis[4-[(2-chloro-4-nitrophenyl)azo]-2-[[(2-hydroxy-5-nitrophenyl)imino]methyl]phenolato(2-)]chromate(1-),280-930-3,83804-10-8,,Notified C&L,33,Not classified:33
28903,"Chromate(1-), bis[2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-(methylsulfonyl)phenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)]-, hydrogen, compd. with [1R-(1α,4aβ,10aα)]-1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine (1:1)",278-697-8,77496-01-6,Not Classified,Notified C&L,70,Not classified:70
28905,"2,4-dichlorotoluene",202-445-8,95-73-8,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,51,H411:46;H315:6;Not classified:6;H336:1;H361:1;H335:1;H319:1
28911,Disodium D-glucarate,259-013-7,54173-03-4,,Notified C&L,60,H319:60
28913,"turpentine, oil",232-350-7,8006-64-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Asp. Tox. 1;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H312:0;H317:0;H226:0;H302:0;H332:0;H304:0;H411:0;H315:0
28919,"(2-endo,3-exo)-bicyclo[2.2.1]hept-5-ene-2,3-dicarbonyl dichloride",224-967-5,4582-21-2,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H314:38;H332:38;H312:38
28921,Butyl ethyl ether,211-055-7,628-81-9,Flam. Liq. 2;Acute Tox. 4,REACH registration C&L,49,H302:49;H225:49;H332:4;H319:1
28926,"(2-oxo-2-phenylmethoxyethyl) 2-[2-(2,6-dichloroanilino)phenyl]acetate",600-104-1,100499-89-6,Acute Tox. 3;Skin Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:1;H400:1;H317:1;H301:1;H361:1;H302:1
28927,"Benzene, (1-methylethenyl)-, polymer with 2-methyl-2-butene and 1,3-pentadiene",612-976-0,62258-49-5,Not Classified,Notified C&L,1,Not classified:1
28928,"5,9-bis(ethylamino)-10-methylbenzo[a]phenoxazin-7-ium perchlorate",263-682-0,62669-60-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:39;H315:39;H301:1
28932,"3',4'-difluoropropiophenone",245-627-2,23384-72-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
28933,"Fatty acids, C12-18, compds. with diethanolamine",292-918-5,91031-18-4,,Notified C&L,1,H373:1
28938,Ethylenesulphonic acid,214-676-1,1184-84-5,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1;H290:1
28940,"Glycine, N-(2-amino-2-oxoethyl)-N-[2-[bis(carboxymethyl)amino]ethyl]-, N-coco alkyl derivs., trisodium salts",296-986-7,93165-97-0,,Notified C&L,67,Not classified:32;H314:35;H318:28
28943,1H-indazol-6-ol,245-519-5,23244-88-4,Acute Tox. 4,Notified C&L,41,H302:41;H335:1;H319:1;H332:1;H315:1
28944,Spiramycin,232-429-6,8025-81-8,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Aquatic Chronic 2,Notified C&L,8,H334:4;H319:6;H317:4;H411:4;Not classified:2;H335:2;H315:2
28948,1-(benzyl)-3-sulphonatopyridinium,274-098-0,69723-94-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,55,H319:55;H315:55
28950,Didodecyldimethylammonium bromide,221-923-7,3282-73-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44;H302:1
28952,Pentaerythritol octahydrogen tetraphosphate,231-181-6,7440-78-0,Not Classified,Notified C&L,1,Not classified:1
28956,Dimethylthioxostannane,236-266-1,13269-74-4,Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,60,H372:55;H373:56;H361:56;H413:55;H335:4;H319:4;H312:4;H332:4;H302:5;H315:4;H410:1;H400:1;H317:1
28962,"2,6-difluoropyridine",216-152-8,1513-65-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H226:47;H335:46;H319:47;H315:47
28967,formamide,200-842-0,75-12-7,Repr. 1B,Harmonised C&L,0,H360:0
28969,"2,4-dibromobenzoic acid",210-245-7,611-00-7,,Notified C&L,7,H335:6;H319:7;H315:7
28971,"N,N-diethyldodecanamide",222-118-3,3352-87-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H319:45;H315:44
28973,"Phosphoric acid, sodium salt, hydrate (1:2:12)",600-088-6,10039-32-4,Not Classified,Notified C&L,223,Not classified:190;H319:33
28981,2-phenylthioaniline,413-030-8,1134-94-7,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
28985,Ethyl 4-acetylbutyrate,237-776-7,13984-57-1,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H227:1;H315:1
28988,"2-Propenoic acid, 2-methyl-, 2-methylpropyl ester, homopolymer",618-468-5,9011-15-8,Not Classified,Notified C&L,75,Not classified:75
28990,"Butanenitrile, 4-(chlorodimethylsilyl)-, hydrolysis products with silica",271-537-8,68584-38-3,Eye Irrit. 2,Notified C&L,38,H319:38
28993,"Nucleotidyltransferase, deoxyribonucleate",232-741-2,9012-90-2,Not Classified,Notified C&L,61,Not classified:61
28995,Dichloride titanium oxide,237-430-5,13780-39-7,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,172,H314:172;H318:165;H290:81;H335:23;H317:131;H302:83;H330:83
28998,L-alaninamide hydrochloride (1:1),608-843-1,33208-99-0,Not Classified,REACH registration C&L,5,Not classified:5
29008,"3,9-dihydro-1,3,9-trimethyl-1H-purine-2,6-dione",208-267-7,519-32-4,,Notified C&L,2,H302:2
29009,"dibenzo[b,def]chrysene; dibenzo[a,h]pyrene",205-878-0,189-64-0,Muta. 2;Carc. 1B,Harmonised C&L,0,H350:0;H341:0
29013,"2,2,2-trifluoro-N'-[(2Z)-piperazin-2-ylidene]acetohydrazide",616-320-4,763105-70-0,Not Classified,Notified C&L,1,Not classified:1
29015,"Fats and Glyceridic oils, rice bran",618-454-9,90106-37-9,,Notified C&L,1,Not classified:1
29019,Ethyl 2-cyano-3-(4-fluorophenyl)acrylate,242-633-7,18861-57-9,Acute Tox. 4,Notified C&L,38,H302:38
29020,Dimethyl tetradecanedioate,225-711-5,5024-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,11,H335:10;H319:10;H315:10;Not classified:1
29022,POLYAMIDE RESIN,426-580-9,,,Notified C&L,2,Not classified:1;H319:1;H315:1
29024,"Benzothiazole-2(3H)-thione, potassium salt",231-910-8,7778-70-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H314:1;H302:1;H410:1;H400:1
29027,"Schoenocaulon officinale, ext.",283-296-6,84604-18-2,,Notified C&L,1,H301:1;H311:1;H331:1;H225:1
29032,"2,4,6-trichlorophenol",201-795-9,88-06-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H410:0;H351:0;H400:0;H302:0;H315:0
29033,Sodium 2-phenoxyisobutyrate,254-545-6,39617-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
29040,Trisodium N-[5-hydroxy-6-[[5-[[2-(sulphonatooxy)ethyl]sulphonyl]-2-methoxyphenyl]azo]-7-sulphonato-2-naphthyl]succinamate,248-959-6,28316-43-0,Not Classified,Notified C&L,2,Not classified:2
29049,"3,4,5-trimethoxyhydrocinnamic acid",246-706-4,25173-72-2,,Notified C&L,4,H335:4;H319:4;H315:4
29050,neodecanoyl chloride,254-875-0,40292-82-8,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H314:0;H302:0;H330:0
29051,Cadmium bis[benzoate],221-187-7,3026-22-0,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1;H312:1;H332:1;H302:1
29053,Dibutylbis(dodecylthio)stannane,214-688-7,1185-81-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Repr. 1B;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,372,H360:153;H312:133;H410:153;H317:91;H341:175;H372:175;H315:133;Not classified:177;H400:127;H301:42;H302:1
29054,3-chloropropyl chloroformiate,425-770-9,628-11-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H373:0;H317:0;H331:0;H302:0;H318:0;H315:0
29058,Potassium dibutyldithiocarbamate,205-237-5,136-29-8,Skin Sens. 1;STOT RE 2;Aquatic Acute 1,Notified C&L,52,H373:52;H317:52;H400:52
29059,"(6R,7R,14S)-7,8-dihydro-7-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-3,6-O-dimethyl-6,14-ethanomorphine",918-453-6,,Not Classified,Notified C&L,1,Not classified:1
29065,"3-(2,3,4-trimethoxyphenyl)propionic acid",251-389-0,33130-04-0,,Notified C&L,5,H335:5;H319:5;H315:5
29066,4-[[(4-methoxyphenyl)methylene]amino]phenyl acetate,233-993-6,10484-13-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
29073,Potassium 1H-benzotriazolide,256-999-0,51126-65-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,8,H302:8;H412:8;H319:8
29080,2-isopropyl-5-methylhexanal,266-440-2,66656-67-5,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,2,H226:2;H319:2;H317:2;H315:2
29083,"Reaction product of 4-aminophenol with 2-ethyl-6-methylbenzenamine, sodium polysulfide and sodium metabisulfite",600-520-3,1040874-53-0,Eye Irrit. 2,REACH registration C&L,2,H319:2
29085,"1,4-phenylene bismethacrylate",221-262-4,3049-31-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H317:38;H315:38
29087,1-benzyl-4-(o-toluidino)piperidine-4-carbonitrile,213-541-4,972-17-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H318:38;H335:38;H315:38
29088,"1,2,3-trichloro-5-nitrobenzene",243-511-6,20098-48-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,78,H335:43;H319:43;H312:44;H332:44;H302:45;H315:43;Not classified:33
29089,"Propanedioic acid, 2-[(4-hydroxy-3,5-dimethoxyphenyl)methylene]-, 1,3-bis(2-ethylhexyl) ester",610-190-2,444811-29-4,Not Classified,Notified C&L,36,Not classified:36
29092,"2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with eicosyl 2-methyl-2-propenoate, hexadecyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate, octadecyl 2-methyl-2-propenoate, pentadecyl 2-methyl-2-propenoate, tetradecyl 2-methyl-2-propenoate and tridecyl 2-methyl-2-propenoate",613-162-8,63150-07-2,Not Classified,Notified C&L,7,Not classified:7
29096,Titanium dichloride,233-164-9,10049-06-6,Pyr. Liq. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,40,H314:40;H318:40;H250:40
29098,4-ethylpyridine 1-oxide,238-973-0,14906-55-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:38;H318:38;H335:38;H315:38;Not classified:1
29100,"trans,trans-2,3',4',5'-Tetrafluor-4-(4'-propylbicyclohexyl-4 -yl)-biphenyl",606-136-2,188289-44-3,Not Classified,REACH registration C&L,2,Not classified:2
29103,2-(4-methylphenoxy)ethanol,239-209-9,15149-10-7,Acute Tox. 4,Notified C&L,113,H302:103;Not classified:10
29104,"1,4-oxathiane 4,4-dioxide",203-507-7,107-61-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2
29106,"(dimethylstannylene)bis(thioethane-1,2-diyl) bis[(9Z,12Z)-octadeca-9,12-dienoate]",267-412-2,67859-64-7,Not Classified,Notified C&L,57,Not classified:56;H373:1;H410:1;H400:1;H317:1;H302:1;H361:1
29107,"Ethyl 2,6,6-trimethylcyclohexa-2,4-diene-1-carboxylate",252-333-8,35044-57-6,Not Classified,Notified C&L,269,Not classified:243;H412:26;H317:25;H315:1
29108,Chlorosilane,236-705-7,13465-78-6,Flam. Gas 1;Press. Gas (Liq.);Skin Corr. 1B;Acute Tox. 2,Notified C&L,23,H314:23;H220:23;H280:23;H330:23
29114,Bis(2-ethylhexyl) phenyl phosphate,240-424-5,16368-97-1,,Notified C&L,43,Not classified:39;H400:4;H410:3
29115,"6α,9-difluoro-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate",200-150-9,52-70-0,Not Classified,Notified C&L,1,Not classified:1
29116,"2-propenoic acid, 2-ethyl-2-[(-hydroxymethyl)-2-[[(1-oxo-2-propenyl)oxy]methyl]butoxy]methyl-1,3-propanediyl ester",601-375-9,115633-58-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,71,H319:71;H315:71
29117,1-methyl-3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,257-941-7,52474-60-9,Not Classified,Notified C&L,1189,Not classified:1189
29118,Vasicine,228-180-8,6159-55-3,Acute Tox. 4,Notified C&L,38,H302:38
29120,"Nonylphenol, branched, ethoxylated",500-209-1,68412-54-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3346,H400:1622;H410:1818;H319:583;H315:1140;H302:786;H318:882;H317:176;H411:532;H413:83;H412:108;H314:14;Not classified:11;H335:2
29124,"Isobutyl 4-chloro-3,5-diaminobenzoate",251-311-5,32961-44-7,Aquatic Chronic 3,REACH registration C&L,71,H412:33;H302:38;H335:38;H319:38;H315:38;H411:1
29128,"Methyl acetoacetate, monosodium salt",251-918-5,34284-28-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
29135,"1,6-Octadiene, 7-methyl-2-methylene-, reaction products with hydrochloric acid",272-935-4,68921-34-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10,H302:10;H335:10;H319:10;H315:10
29137,3-Bromo-4-chloroanisole,608-086-7,2732-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
29145,"Tetrasodium 3,3'-[carbonylbis(imino-p-phenyleneazo)]bis[4-amino-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate]",261-682-5,59262-64-5,Not Classified,Notified C&L,1,Not classified:1
29146,"(+)-N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutyramide",211-569-1,667-83-4,Not Classified,Notified C&L,45,Not classified:45
29147,"Evernia furfuracea, ext.",289-860-8,90028-67-4,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1438,H319:59;H317:1385;Not classified:2;H411:1372;H335:51;H315:51
29148,"N,N'-(dimethylsilylene)bis[N-ethylacetamide]",279-248-9,79728-78-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,22,H302:22;H318:22
29150,KB 227 Tetralinsalz,613-075-5,6271-86-9,Skin Corr. 1A,Notified C&L,1,H314:1
29152,Ethyl 2-methylpent-4-en-1-oate,258-520-0,53399-81-8,Flam. Liq. 3,Notified C&L,1444,H226:1444
29156,"2,4-dinitrobenzenesulphonic acid",201-876-9,89-02-1,,Notified C&L,5,H314:4;H319:1;H315:1
29157,Veratric acid,202-215-7,93-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,70,H335:55;H319:56;H315:56;H302:10;Not classified:4
29159,Isopentyl lactate,242-966-8,19329-89-6,Not Classified,Notified C&L,90,Not classified:90
29161,"phenyl, [4,[4-(4-hydroxphenyl)-1-piperazinyl]phenyl)carbamate",437-800-8,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
29162,Pyridoxine hydrochloride,200-386-2,58-56-0,Eye Dam. 1,REACH registration C&L,331,H318:158;H319:96;H315:96;Not classified:76;H335:11;H302:1;H360:1;H362:1;H351:1;H411:1
29165,"sodium (2S, 3S)-3-benzyloxy carbonylamino-2-methyl-4-oxo-azetidine-1-sulfonate",601-392-1,115887-91-7,Skin Sens. 1,Notified C&L,1,H317:1
29176,Potassium 5-carboxy-4-hexylcyclohex-2-ene-1-octanoate,269-362-7,68227-50-9,Not Classified,Notified C&L,1,Not classified:1
29177,"Decyl alcohol ethoxylated, phosphate",610-767-9,52019-36-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,33,H319:31;H315:32;H314:1;H318:1
29182,"1,2,3,4-tetrahydro-2,2,4,7-tetramethylquinoline",261-732-6,59388-58-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H319:43;H315:43
29185,3-[[3-(dimethylamino)propyl]amino]propiononitrile,274-159-1,69852-45-5,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,86,H318:86;H315:2;H314:84;H302:84;H412:83
29186,3-methoxypropyne,210-998-1,627-41-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40;H225:40
29188,(E)-m-fluorocinnamic acid,243-902-1,20595-30-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H301:38;H335:45;H319:45;H315:45
29189,2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol,406-080-7,83016-70-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H314:0;H302:0;H412:0
29190,Sodium bis[2-[(2-hydroxy-4-nitrophenyl)azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),279-744-5,81361-02-6,Aquatic Chronic 2,Notified C&L,4,H411:4
29192,"Methyl 2,3-dichloropropionate",222-940-2,3674-09-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,15,H301:7;H335:8;H319:8;H315:8;H314:7;H341:1;H318:1
29193,"[R-(R*,R*)]-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl stearate",240-363-4,16255-48-4,Carc. 2,Notified C&L,38,H351:38
29194,Rhodium trichloride,233-165-4,10049-07-7,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,279,H302:267;H413:184;H335:8;H319:8;H315:8;H290:4;H318:5;H341:4;Not classified:1;H410:1;H400:1
29196,"Ketones, C14",270-614-3,68458-86-6,Not Classified,Notified C&L,88,Not classified:88
29197,"1-[(5α,7α)-4,5-epoxy-3,6-dimethoxy-17-methyl-6,14-ethenomorphinan-7-yl]ethanone",239-393-0,15358-22-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,82,H319:2;H317:3;H332:3;H302:3;H334:3;H315:2;H301:79
29198,"2,2-Dichloro-1-(3-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)ethanone",619-372-6,98730-04-2,Skin Sens. 1;Aquatic Chronic 1,REACH registration C&L,230,H317:192;H410:159;H332:38;H319:33
29200,7-oxoheptyl acetate,608-361-1,29425-54-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
29202,"Terpenes and Terpenoids, limonene fraction, distn. residues",269-829-5,68334-40-7,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H315:1
29205,Ammonium acrylate,234-229-4,10604-69-0,Not Classified,Notified C&L,193,Not classified:108;H400:84;H410:84;H335:1;H319:1;H315:1
29206,"Fatty acids, tall-oil, oxidized, distn. residues",309-337-0,100209-28-7,Not Classified,Notified C&L,63,Not classified:62;H319:1;H315:1
29208,"1,1,2-trimethyl-3-(4-sulphonatobutyl)-1H-benz[e]indolium",263-961-7,63149-24-6,Skin Sens. 1,REACH registration C&L,1,H317:1;H228:1
29209,"2-[2-[4-[(2-chloroethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",222-887-5,3648-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,43,H413:41;H335:41;H319:41;H315:41;Not classified:2
29210,"3,6-dichloropyridine-2-carboxylic acid, compound with 2-aminoethanol (1:1)",260-929-4,57754-85-5,Not Classified,Notified C&L,93,Not classified:55;H318:38
29213,5-chloropentan-2-one,227-565-8,5891-21-4,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,11,H335:9;H319:9;H226:11;H302:10;H315:9
29218,"1-(trans-4-Butyl[trans-1,1-bicyclohexyl]-4-yl)-4-trifluormethoxybenzene",603-930-0,135734-60-0,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
29219,"Slags, ferronickel-manufg.",273-729-7,69012-29-9,Not Classified,REACH registration C&L,2,Not classified:2
29220,"Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;Coal Tar Extract;[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",308-296-6,97926-76-6,Carc. 1B,Harmonised C&L,0,H350:0
29221,2-DIBENZYLAMINO-3-PHENYL-PROPIONIC ACID BENZYL ESTER,619-216-7,96468-81-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H410:38;H400:38
29223,Santalyl acetate,215-349-6,1323-00-8,Not Classified,Notified C&L,234,Not classified:233;H412:1
29225,4-ethyl-4-hexadecylmorpholinium ethyl sulphate,201-094-8,78-21-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,594,H302:594;H318:594;H315:17
29231,C,404-690-8,68132-19-4,Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0;H314:0;H331:0
29233,"Benzo-1,3-dioxole-5-carbonitrile",224-590-6,4421-09-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H332:44;H302:44;H312:44;H301:1;H311:1;H331:1
29234,Buserelin,261-061-9,57982-77-1,Repr. 1A,Notified C&L,3,H360:3;H302:2
29235,"Soybean oil, sulfurized",268-855-4,68152-90-9,Not Classified,Notified C&L,33,Not classified:33
29236,4-[(2-methoxybenzoyl)sulfamoyl]benzoyl chloride,617-251-2,816431-72-8,Eye Dam. 1,Notified C&L,1,H318:1
29240,"Residues (petroleum), steam-cracked naphtha distn.;Cracked gasoil;[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 °C to 300 °C (297 °F to 572 °F) and produces a finished oil having a viscosity of 18cSt at 50 °C.]",295-517-3,92062-04-9,Carc. 1B,Harmonised C&L,0,H350:0
29241,Sodium isobutyrate,213-630-8,996-30-5,Not Classified,Notified C&L,1,Not classified:1
29244,Ammonium dodecyl sulphate,218-793-9,2235-54-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,617,H302:442;H319:481;H318:134;H315:173;H335:13;Not classified:2;H311:1
29245,Monosodium hydrogen 4-chlorophthalate,259-963-2,56047-23-5,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,74,H332:39;H302:39;H319:41;H312:39;Not classified:33;H335:1;H315:2;H331:1;H311:1;H301:1
29250,4-hydroxy-4-methylpentan-2-one;diacetone alcohol,204-626-7,123-42-2,Eye Irrit. 2,Harmonised C&L,0,H319:0
29251,"Phosphoric acid, di-C8-18-alkyl esters, compds. with morpholine",270-199-9,68412-61-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
29253,"Dipotassium [[N,N'-ethylenebis[N-(carboxylatomethyl)glycinato]](4-)-N,N',O,O',ON,ON']zincate(2-)",238-729-3,14689-29-3,Not Classified,REACH registration C&L,90,Not classified:90
29255,Potassium trimethylsilanolate,234-062-7,10519-96-7,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1
29259,"N,N'-diisopropylethylenediamine",223-666-6,4013-94-9,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,47,H226:47;H314:47;H318:1
29262,Methine triacetate,212-422-4,815-68-9,Eye Irrit. 2,Notified C&L,38,H319:38
29263,PM-811,433-570-8,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H317:1;H413:1
29264,"(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate",407-240-9,159604-94-1,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
29272,"(1S,1R)-(5R,5S)-1-Phenyl-2-oxo-3-oxabicyclo[3.1.0]hexane",613-140-8,63106-93-4,Not Classified,REACH registration C&L,6,Not classified:3;H335:2;H319:2;H315:2;H302:1
29275,"Bis(1,1-dimethylethyl) phosphonate",235-996-8,13086-84-5,Flam. Liq. 2;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,43,H314:38;H317:38;H335:5;H319:5;H315:5
29279,2-oxobornane-10-sulphonic acid,221-554-1,3144-16-9,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,66,H314:66;H318:10;H290:6;Not classified:2
29280,3-(2-quinolylmethylene)phthalide,228-857-8,6365-50-0,Not Classified,Notified C&L,1,Not classified:1
29287,benzo[rst]pentaphene,205-877-5,189-55-9,Muta. 2;Carc. 1B,Harmonised C&L,0,H350:0;H341:0
29288,"Quaternary ammonium compounds, (oxydi-2,1-ethanediyl)bis[coco alkyldimethyl, dichlorides",271-761-6,68607-28-3,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,71,H314:71;H302:71;H318:70;H400:71;H335:1;H410:1
29289,Diphenylphosphinic acid,216-948-5,1707-03-5,,Notified C&L,7,H335:5;H319:6;H315:6;Not classified:1
29290,2-bromopropionyl bromide,209-261-7,563-76-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,REACH registration C&L,50,H314:50;H302:46;H317:3;H290:1;H318:1
29294,"2,6-difluorobenzoyl chloride",241-971-2,18063-02-0,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,62,H226:57;H314:62;H304:2;H412:2;H335:1;H319:1;H318:1;H290:1;H317:1
29295,Hexahydro-3H-benzofuran-2-one,227-955-8,6051-03-2,,Notified C&L,1,Not classified:1
29296,o-tolyloxyacetic acid,217-517-4,1878-49-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H319:43;H315:43
29298,Aminoacetonitrile bisulphate,205-794-4,151-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40;H331:1;H311:1;H301:1
29299,"Naphtha (petroleum), unsweetened;Low boiling point naphtha;[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C",272-186-3,68783-12-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
29301,Trichloro(cyclohexylmethyl)silane,242-265-7,18388-16-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H302:38;H318:38
29305,"17,18-dihydrodinaphtho[1',2',3':3,4;3'',2'',1'':9,10]perylo[1,12-efg][1,4]dioxocin-5,10-dione",229-186-3,6424-76-6,Not Classified,REACH registration C&L,13,Not classified:13
29307,"Pine, Pinus palustris, ext",306-895-7,97435-14-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,82,H319:81;H351:81;H317:81;H341:81;H412:82;H315:82
29308,Dicyclohexylphosphine,212-590-9,829-84-5,Flam. Liq. 2;Pyr. Liq. 1;Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3,Notified C&L,53,H319:39;H331:38;H311:38;H301:38;H250:53;H225:38;H314:14;H411:15;H224:1;H335:1;H302:1;H315:1
29311,"Distillates (petroleum), steam-cracked, C",270-738-8,68477-55-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
29321,2-methylnaphthalene,202-078-3,91-57-6,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,1667,H302:1567;H411:126;Not classified:82;H410:25;H400:25;H319:12;H315:11;H335:3;H336:1
29323,Calcitriol,250-963-8,32222-06-3,Acute Tox. 1;Acute Tox. 1;Repr. 2,Notified C&L,90,H310:87;H361:89;H300:90;H330:44;H372:2;H311:1;H413:3;H370:2;H350:1
29324,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate",611-842-9,5949-29-1,Eye Irrit. 2,Notified C&L,1034,H319:852;Not classified:101;H335:141;H315:192;H318:55;H303:11;H313:11;H225:4;H302:1
29325,carbon disulphide,200-843-6,75-15-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Repr. 2,Harmonised C&L,0,H319:0;H225:0;H372:0;H361:0;H315:0
29326,Di(tridecyl) phthalate,204-294-3,119-06-2,Not Classified,Notified C&L,453,Not classified:453
29329,BAL5287,447-970-5,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H318:1;H411:1
29335,Sucrose pentalaurate,303-036-8,94139-21-6,Not Classified,Notified C&L,1,Not classified:1
29341,Orange X-MOb 5330 REG,440-760-4,,Skin Sens. 1;Eye Dam. 1,Notified C&L,37,H318:37;H317:37
29342,Arsenic trichloride,232-059-5,7784-34-1,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,48,H410:48;H400:47;H314:7;H331:48;H301:43;H350:7;H310:39;H300:5;H318:1
29344,Hydroquinidine,215-862-5,1435-55-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H312:38;H301:1;H317:1
29347,Allylestrenol,207-082-9,432-60-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,19,H312:17;H351:17;H332:18;H302:18;H361:18;H373:1
29350,"N-(2,5-dichloropentyl)acetamide",263-759-9,62922-46-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
29351,Magnesium Nitrate Hexahydrate,603-823-9,13446-18-9,Ox. Sol. 3,Notified C&L,208,H272:125;Not classified:79;H335:11;H319:13;H315:12;H271:1
29353,Doxofylline,274-239-6,69975-86-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H302:2;H319:1;H315:1
29356,1-benzyl-4-(ethylamino)piperidine-4-carboxamide,213-839-4,1027-91-4,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H301:38;H319:38
29358,Disodium 5-[[4-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-1-naphthyl]azo]salicylate,222-351-0,3442-21-5,Not Classified,Notified C&L,2,Not classified:2
29368,Methyl 3-aminopyrazinecarboxylate,240-387-5,16298-03-6,Aquatic Chronic 3,REACH registration C&L,9,H412:3;H335:5;H319:6;H315:6
29369,"Methyl 4,5-dimethyl-3-thiophenecarboxylate",604-481-3,14559-13-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H317:1;H411:1
29375,"reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene",426-970-9,94400-98-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
29379,"Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816°C (1500°F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C",270-344-6,68425-29-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
29381,"1,5-diiodopentane",211-054-1,628-77-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:46;H315:46
29387,"Trisodium [[[[2-[(4-chloro-6-methoxy-1,3,5-triazin-2-yl)amino]ethyl]amino]sulphonyl]-29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-)",277-878-9,74449-65-3,Not Classified,Notified C&L,29,Not classified:29
29388,"N-(butoxymethyl)-2-chloro-2',6'-diethylacetanilide",245-477-8,23184-66-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,74,H302:73;H410:38;H400:71;H331:33;H317:33;Not classified:1
29390,"Benzoic Acid acid, 2-hydroxy-,C14-18 alkyl dervis.",605-976-7,182700-89-6,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,21,H400:21;H318:21;H317:21;H410:21
29396,4-propyltoluene,214-044-5,1074-55-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,46,H317:38;H411:38;H225:4;Not classified:3;H226:1;H304:1;H319:1;H315:1
29400,2-chloro-p-xylene,202-444-2,95-72-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H315:39;H226:1
29402,"2,4-dinitro-1-naphthol",210-093-1,605-69-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43;H317:1
29404,3-(3-ethylhexahydro-1-methyl-1H-azepin-3-yl)phenol hydrochloride,261-683-0,59263-76-2,Acute Tox. 4,Notified C&L,40,H302:40
29408,3-chloro-p-toluidine,202-446-3,95-74-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H319:45;H410:41;H400:41;H317:40;H311:39;H301:41;H315:43;H373:4;H300:4;H312:4;H332:6;H331:1;H370:1;H302:1;H372:1;H351:1;H310:2
29409,"7-((E)-(2-((aminocarbonyl)amino)-4-((4-chloro-6-((2-((2- hydroxyalkyl)oxy)alkyl)amino)-1,3,5-triazin-2-yl)amino)phenyl)diazenyl) polycarbocyclo, polysulfonate, sodium salt",406-860-7,,Not Classified,REACH registration C&L,1,Not classified:1
29412,Isopropylquinoline,215-595-4,1333-53-5,Acute Tox. 4;Acute Tox. 3,Notified C&L,88,H302:88;H311:78;H310:10
29415,Isonicotinonitrile 1-oxide,238-974-6,14906-59-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:38;H319:39;H312:39;H332:39;H302:39;H315:39
29416,2-methoxypropionic acid,224-356-3,4324-37-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H302:90;H335:91;H319:90;H315:91;H332:1;H312:1;H318:1
29417,2-methyl-2-(methylsulphonyl)propionaldehyde O-(methylcarbamoyl)oxime,216-710-0,1646-88-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1,Notified C&L,41,H400:38;H310:38;H300:38;H330:38;H301:3
29418,"2-Propen-1-aminium, N,N,N-tri-2-propen-1-yl-, chloride (1:1)",452-170-4,13107-10-3,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,85,H317:85;H411:85
29419,5-Bromo-2-fluorobenzonitrile,605-873-7,179897-89-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H335:46;H319:47;H312:45;H332:45;H302:45;H315:47;H331:3;H311:3;H301:3
29422,Olive oil,617-123-6,8060-29-5,Not Classified,Notified C&L,88,Not classified:88
29424,6-bromo-2-naphthol,239-279-0,15231-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H319:47;H315:47;Not classified:1
29425,"2,2'-[methylenebis(oxymethylene)]bis[2-ethylpropane-1,3-diol]",301-304-9,93983-16-5,,Notified C&L,33,Not classified:33
29426,Butyl thiocyanate,211-056-2,628-83-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
29428,"Tin ores, melting residues, hardhead",283-928-0,84776-04-5,Not Classified,REACH registration C&L,2,Not classified:1;H350:1;H412:1
29429,"3-[(4-nitrophenyl)azo]-5-[(7-sulpho-1-naphthyl)azo]salicylic acid, sodium salt",300-451-6,93940-54-6,Not Classified,Notified C&L,4,Not classified:2;H302:1;H319:2;H317:1
29431,2-(Di-tert-butylphosphino)biphenyl,607-074-9,224311-51-7,Aquatic Chronic 4,Notified C&L,45,H413:40;H335:6;H319:7;H315:7;H302:4
29433,"Trimethylamine, N-oxide",214-675-6,1184-78-7,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,62,H332:3;H302:23;H335:58;H319:59;H315:59
29439,"Borax (Na2(B4O7).10H2O), reaction products with sulfuric acid",271-536-2,68584-31-6,Not Classified,Notified C&L,2,Not classified:2
29443,Benzo[a]carbazole,205-945-4,239-01-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
29444,Arsenic tribromide,232-057-4,7784-33-0,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H400:38;H410:38;H331:38
29445,Gadolinium(3+) acetate,240-204-9,16056-77-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
29446,1-tert-butyl-4-nitrobenzene,221-922-1,3282-56-2,,Notified C&L,4,H332:4;H302:4;H312:4
29448,"2,3',4,4',6-pentahydroxybenzophenone",208-268-2,519-34-6,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H400:38;H319:38
29449,"methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)",403-230-3,77402-05-2,Skin Corr. 1B;Skin Sens. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H314:0;H340:0;H350:0;H317:0
29450,"5-bromo-6-methyl-1,3-benzodioxole",225-712-0,5025-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
29451,(5-bromothiophen-2-yl)-phenylmethanone,608-584-4,31161-46-3,Not Classified,REACH registration C&L,3,Not classified:3
29452,Isopropyl hexanoate,219-000-9,2311-46-8,Flam. Liq. 3,Notified C&L,1448,H226:1314;Not classified:134
29457,4-nitrobenzenediazonium hexafluorophosphate,216-153-3,1514-52-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
29458,"1,1,2,2-tetrabromoethane",201-191-5,79-27-6,Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0;H330:0
29460,"2,4,6-trimethylaniline",201-794-3,88-05-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,REACH registration C&L,129,H335:47;H319:91;H312:49;H302:53;H330:51;H315:89;H373:43;H331:42;H311:44;H301:42;Not classified:36;H341:1;H351:2;H411:2
29464,"2,3,3,3-tetrafluoro-2-[1,1,2,2-tetrafluoro-2-(fluorosulphonyl)ethoxy]propionyl fluoride",223-823-9,4089-57-0,Skin Corr. 1B,Notified C&L,1,H314:1
29465,"Pentasodium 2-[[4-chloro-6-[[8-hydroxy-3,6-disulphonato-7-[(1-sulphonato-2-naphthyl)azo]-1-naphthyl]amino]-1,3,5-triazin-2-yl]amino]-5-sulphonatobenzoate",274-097-5,69723-90-6,Not Classified,Notified C&L,9,Not classified:9
29475,4-acetamidobutyric acid,221-186-1,3025-96-5,Eye Irrit. 2,Notified C&L,43,H319:43;H335:5;H315:5
29480,"Elastins, hydrolyzates",293-509-4,91080-18-1,Not Classified,Notified C&L,18,Not classified:18
29482,"Amylase, fungal",232-742-8,9013-01-8,Resp. Sens. 1,Notified C&L,2,H334:2
29486,"2,4-Diaminopyrimidine 3-N-oxide",616-121-2,74638-76-9,Acute Tox. 4,Notified C&L,1,H302:1
29488,2-acetylthioethyltrimethylammonium chloride,227-953-7,6050-81-3,Eye Dam. 1,Notified C&L,39,H318:39
29491,"2-Naphthalenecarboxylic acid, 4-[2-(5-chloro-2-methylphenyl)diazenyl]-3-hydroxy-",612-135-8,61370-59-0,Not Classified,REACH registration C&L,33,Not classified:33
29492,"1,3,6-Naphthalenetrisulfonic acid, 7-[2-[2-[(aminocarbonyl)amino]-4-[[4-[[5-amino-4-sulfo-2-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-, sodium salt (1:5)",616-587-7,780759-89-9,,Notified C&L,1,H412:1
29504,Dimercury dinitrate,233-886-4,10415-75-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,27,H373:27;H300:27;H410:27;H400:27;H330:27;H310:27;Not classified:1
29508,Cyclopentadec-4-yn-1-one,604-281-6,14224-80-7,Not Classified,REACH registration C&L,1,Not classified:1
29510,"Alcohols, C9-11, ethoxylated",614-482-0,68439-46-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,3429,H302:2933;H318:3353;H400:460;H411:184;H315:281;H319:68;Not classified:7;H412:5
29513,"2,4-dimethylbenzoic acid",210-246-2,611-01-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H319:45;H315:45
29514,p-(trifluoromethyl)benzaldehyde,207-240-7,455-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:50;H319:52;H315:52;H302:8;H312:1;H332:1
29516,"pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate",418-270-7,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
29518,3-bromopropyltrichlorosilane,237-650-1,13883-39-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,40,H226:38;H314:40
29521,Oxatomide,262-320-9,60607-34-3,Acute Tox. 4,Notified C&L,45,H302:45
29527,2-methyl-4-phenylbutyraldehyde,255-022-5,40654-82-8,Skin Sens. 1,Notified C&L,87,H317:77;Not classified:10
29528,Hexachlorodisilane,236-704-1,13465-77-5,Skin Corr. 1A,REACH registration C&L,93,H314:93;H225:26;H318:1;H290:1;H335:1
29531,"Rosin, fumarated, polymer with ethylene glycol and pentaerythritol",614-317-2,68152-57-8,Not Classified,Notified C&L,141,Not classified:88;H319:53;H317:53;H413:51
29535,2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole,448-630-9,3147-77-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
29537,Sucrose stearate,246-705-9,25168-73-4,Not Classified,Notified C&L,42,Not classified:41;H400:1
29539,5-phenylpentan-1-ol,234-064-8,10521-91-2,Eye Dam. 1,Notified C&L,38,H318:38
29540,"7-methoxy-4,4-dimethyl-1H-2-benzopyran-1,3(4H)-dione",611-342-0,55974-25-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H302:2;H412:2;H319:2
29541,Poly(methyl methacrylate),618-466-4,9011-14-7,Not Classified,Notified C&L,523,Not classified:521;H335:2;H319:2;H315:2
29544,"Slags, ferromanganese-manufg.",273-728-1,69012-28-8,Repr. 2,REACH registration C&L,14,H361:7;Not classified:7
29551,"furalaxyl (ISO);methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate",260-875-1,57646-30-7,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
29554,"4,4-Difluorocyclohexane-1-carboxylic acid",602-802-1,122665-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136,H335:134;H319:135;H315:135;H314:1
29557,3-(2-hydroxyethoxy)propiononitrile,246-137-1,24298-26-8,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 1B;Aquatic Chronic 2,Notified C&L,8,H335:8;H225:8;H317:8;H331:8;H311:8;H301:8;H350:8;H318:8;H411:8;H315:8
29561,Trimethyl phosphate,208-144-8,512-56-1,Not Classified,Notified C&L,239,Not classified:121;H319:80;H351:59;H302:98;H340:81;H315:100;H350:22;H318:20;H373:13;H361:13;H341:2;H371:1
29563,"3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole",406-280-4,117584-16-4,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
29564,"1-Propene, 3-[2-(2-methoxypropoxy)propoxy]-",614-247-2,68039-31-6,Skin Sens. 1,Notified C&L,22,H317:22
29567,3-hydroxy-4-[(2-methyl-4-nitrophenyl)azo]-N-(o-tolyl)naphthalene-2-carboxamide,229-102-5,6410-32-8,Not Classified,REACH registration C&L,130,Not classified:124;H317:5;H341:1
29577,"2-[[4-[[4-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulpho-1-anthryl)amino]cyclohexyl]amino]-6-fluoro-1,3,5-triazin-2-yl]amino]benzene-1,4-disulphonic acid, potassium sodium salt",277-179-9,72987-16-7,Not Classified,REACH registration C&L,1,Not classified:1
29578,(benzoato-O)hydroxy(octadecanoato-O)aluminium,269-361-1,68227-49-6,Not Classified,Notified C&L,7,Not classified:7
29580,"Cellulose, methyl ether",619-452-0,99638-59-2,Not Classified,Notified C&L,1,Not classified:1
29582,Chromium dichloride,233-163-3,10049-05-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H302:43;H335:39;H319:39;H315:39;H314:4
29584,"2-nitro-1H-indene-1,3(2H)-dione",222-942-3,3674-33-7,Acute Tox. 4,Notified C&L,38,H302:38
29590,Tosylacetonitrile,227-173-7,5697-44-9,,Notified C&L,7,H335:6;H319:6;H312:5;H332:5;H302:5;H315:6;H301:2;H311:1;H331:1
29591,diethyl N-[3-(trimethoxysilyl)propyl]aspartate,606-274-3,192389-48-3,Acute Tox. 3;Acute Tox. 3,REACH registration C&L,4,H331:4;H311:4
29594,"1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d] pyrimidin-5-yl)phenylsulphonyl]-4-methylpiperazine",918-045-8,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H302:2;H412:2
29595,(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine,425-930-8,151213-39-7,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H314:0;H302:0;H332:0;H411:0
29597,tert-butyl chloroacetate,203-506-1,107-59-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,REACH registration C&L,79,H319:39;H312:79;H226:79;H302:79;H331:77;H315:39;H314:40;H410:29;H400:29;H317:24;H335:5;H332:1
29598,"Ethyl 6,6-dimethyl-2-methylenecyclohex-3-enecarboxylate",252-334-3,35044-58-7,Not Classified,Notified C&L,233,Not classified:233
29599,2-phenyl-2-pyrrolidin-1-ylacetamide,250-803-7,31788-79-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
29601,2-amino-6-chlorobenzoic acid,218-416-8,2148-56-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H335:50;H319:51;H315:51
29605,"Shepherd's-purse, ext.",283-297-1,84604-19-3,Flam. Liq. 3,Notified C&L,2,H226:1;Not classified:1
29607,Zinc methyl phosphate,279-848-0,81907-32-6,Skin Corr. 1B,Notified C&L,13,H314:13
29608,Lynestrenol,200-151-4,52-76-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,18,H360:17;H312:16;H351:18;H332:16;H302:17;H361:1;H341:1
29614,"Benzenamine, N-phenyl-, (tripropenyl) derivs.",614-656-6,68608-79-7,Aquatic Chronic 4,Notified C&L,1,H413:1
29618,"5,6,7,8-tetrahydronaphthalene-1-acetaldehyde",233-994-1,10484-23-8,Not Classified,Notified C&L,88,Not classified:88
29619,4-Pentenoic anhydride,613-244-3,63521-92-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
29624,"6-methoxy-2-methyl-1H-benz[de]isoquinoline-1,3(2H)-dione",221-895-6,3271-05-4,Not Classified,Notified C&L,31,Not classified:31
29625,"1,3 Propanediol 2,2-bis(hydroxymethyl)-polymer with 2-(chloromethyl)oxirane",608-564-5,30973-88-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,90,H319:90;H317:90;H315:90
29626,1-methyl-4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,257-942-2,52475-86-2,Not Classified,Notified C&L,656,Not classified:621;H410:35;H400:10
29627,"methyl 2-(1,3-dioxaindan-5-yl)acetate",608-764-2,326-59-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
29629,Naftidrofuryl,250-572-2,31329-57-4,Acute Tox. 4,REACH registration C&L,2,H302:2
29630,Sodium dibutyldithiocarbamate,205-238-0,136-30-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Aquatic Acute 1,REACH registration C&L,142,H400:141;H317:141;H314:141;H302:141;H311:109;H373:72;H318:65;H335:1;H319:1;H315:1
29633,1-bromo-4-(trans-4-ethylcyclohexyl)benzene,422-030-7,,Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,1,H314:1;H318:1;H335:1
29634,A mixture of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one,609-040-9,34902-57-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,268,H400:210;H410:268;H411:14
29638,p-isopropoxyphenol,231-346-2,7495-77-4,,Notified C&L,1,H335:1;H319:1;H315:1
29639,"1,1',1'',1'''-ethylenedinitrilotetrapropan-2-ol",203-041-4,102-60-3,Eye Irrit. 2,REACH registration C&L,461,H319:309;Not classified:98;H318:33;H315:57;H317:26;H335:23;H351:1;H336:1;H361:1
29640,2-Chlor-3-isothiocyanato-1-propene,604-275-3,14214-31-4,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157,H410:156;H400:156;H314:157;H330:157;H301:156;H318:156;H310:156;H300:1;H317:1
29642,"Reaction mass of N, N'-hexane-1,6-diylbis [12-hydroxyoctadecanamide] and 12-hydroxy-N-[6-[1-oxoalkyl)amino] hexyl ] octadecanamide",469-110-8,,Not Classified,Notified C&L,23,Not classified:23
29645,"Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",269-630-3,68308-10-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H220:0;H350:0
29647,"8-[4-(4-Methylphenyl)-3-cyclohexen-1-yl]-1,4-dioxaspiro[4.5]decane",603-101-3,125962-78-9,Skin Sens. 1B;STOT RE 2,REACH registration C&L,2,H373:2;H317:2
29650,Methyl 2-naphthyl ether,202-213-6,93-04-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1813,H319:70;H411:238;Not classified:1528;H302:80;H361:3;H373:3;H410:1
29651,"4-amino-N,N-diethylaniline;N,N-diethyl-p-phenylendiamine",202-214-1,93-05-0,Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H301:0;H314:0
29653,"Hydroxy[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid",608-364-8,294857-70-8,Not Classified,REACH registration C&L,2,Not classified:2
29659,"Alcohols, C12-14, ethoxylated, sulfates, ammonium salts (1 - 2.5 mol EO)",603-047-0,125301-88-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H412:83;H318:83;H315:83
29660,"estra-4,9-diene-3,17-dione",610-717-6,5173-46-6,Repr. 1A,REACH registration C&L,11,H360:4;Not classified:6;H335:1;H319:1;H351:1;H341:1;H361:1;H315:1
29663,o-(ethoxymethyl)anisole,265-301-3,64988-06-3,Not Classified,Notified C&L,1399,Not classified:1399
29665,"2-Propenoic acid, 1,1'-[(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)]] ester, reaction products with diethylamine",601-101-8,111497-86-0,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,198,H319:131;H317:131;H315:146;Not classified:51;H412:1
29666,"methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate",414-080-3,117291-73-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
29667,"2,4,6-Trimethyl-1,3,5,2,4,6-trioxatriborinane",617-330-1,823-96-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,127,H318:84;H335:84;H315:84;H314:43;H225:43
29668,trans-4-aminocyclohexan-1-ol,248-492-8,27489-62-9,Skin Corr. 1B,REACH registration C&L,75,H314:20;H411:52;H318:2;H335:2;H319:2;H315:2;H301:1
29669,"2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite",418-310-3,126050-54-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
29671,"3 beta,7 alpha,15 alpha-Trihydroxy-5-androsten-17-one",608-385-2,2963-69-1,Repr. 1B;Lact.,REACH registration C&L,3,H362:3;H360:3
29672,"Sodium hydrogen 4,5-dihydroxynaphthalene-2,7-disulphonate",223-430-2,3888-44-6,Not Classified,Notified C&L,2,Not classified:1;H335:1;H319:1;H315:1
29674,Choline hydroxide,204-625-1,123-41-1,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,300,H314:299;H318:191;H372:55;H335:56;H302:8;H319:1;H315:1
29676,4-pentylcyclohexanone,406-670-4,61203-83-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
29679,2-chloroethyl methyl ether,210-999-7,627-42-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,Notified C&L,235,H332:201;H302:235;H225:202;H312:40;H331:33;H319:1;H315:1
29680,Dihydrogen hexabromoplatinate,243-903-7,20596-34-3,,Notified C&L,4,H314:4;H334:4;H317:4
29683,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium [3-[1-(anilinocarbonyl)-2-oxopropyl]azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]hydroxychromate(1-)",304-521-7,94276-36-5,,Notified C&L,1,Not classified:1
29686,"2-fluoro-1,3-dimethylpyridinium tosylate",261-731-0,59387-91-6,Skin Corr. 1B,Notified C&L,38,H314:38
29693,Octadecyl methacrylate,251-013-5,32360-05-7,Not Classified,REACH registration C&L,535,Not classified:153;H335:381;H319:382;H315:382;H317:60;H302:1
29695,"N,N-diethyl-4-hydroxy-3-methoxybenzene-1-carbothioamide",607-324-7,24115-07-9,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
29697,"Ethyl 2,3-dibromopropionate",222-941-8,3674-13-3,,REACH registration C&L,138,H301:138;H311:138;H314:137;H319:1;H315:1;H318:1
29704,"Soybean oil, bisulfited, sodium salt",281-979-3,84082-31-5,Skin Irrit. 2,Notified C&L,31,H315:29;Not classified:2
29708,"3,5,7-Triaza-1-azoniatricyclo[3.3.1.13,7]decane, 1-methyl-, chloride (1:1)",616-409-8,76902-90-4,Not Classified,Notified C&L,5,Not classified:5
29709,"Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;Coal Tar Extract;[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",308-297-1,97926-77-7,Carc. 1B,Harmonised C&L,0,H350:0
29710,"Pyrazine-2,3-dicarboxylic acid",201-875-3,89-01-0,Eye Dam. 1,REACH registration C&L,16,H318:6;H335:10;H319:10;H315:10
29711,Ethylenediamine p-toluenesulphonate,230-728-6,7294-10-2,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1;H228:1
29713,Sulfadiazine sodium,208-919-0,547-32-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,47,H335:42;H319:42;H317:42;H302:45;H334:45;H315:42;H361:4;H351:1;Not classified:1
29715,3-methylpyridine-N-oxide,213-714-4,1003-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:42;H319:44;H315:44
29717,"Phosphoric acid, mixed decyl and Et and octyl esters",270-198-3,68412-60-2,Skin Corr. 1B,Notified C&L,52,H314:52
29718,"Residues (petroleum), thermal cracked vacuum",295-518-9,92062-05-0,Not Classified,REACH registration C&L,21,Not classified:20;H350:1;H412:1
29719,tetrachlorophthalic anhydride,204-171-4,117-08-8,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0;H334:0;H318:0
29720,"Amides, C12-18 and C18-unsatd., N,N-bis(hydroxyethyl)",292-477-9,90622-74-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,7,H412:6;H319:6;H315:7;H318:1;H411:1
29721,Potassium lactate,213-631-3,996-31-6,Not Classified,Notified C&L,40,Not classified:29;H331:10;H319:10;H318:1;H315:1
29723,"Benzonitrile, 4-[(4,6-dichloro-2-pyrimidinyl)amino]-",458-150-1,,Aquatic Chronic 4,REACH registration C&L,2,H413:2
29733,"2,9-bis(p-anisyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",229-187-9,6424-77-7,Not Classified,Notified C&L,9,Not classified:9
29735,"Distillates (petroleum), steam-cracked, C",270-737-2,68477-54-3,Asp. Tox. 1,Harmonised C&L,0,H304:0
29740,[2-[p-(dimethylamino)styryl]ethylpyridinium iodide,223-248-3,3785-01-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
29741,N-(2-chloroethyl)pyrrolidine hydrochloride,230-660-7,7250-67-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,50,H319:50;H411:2;H315:50;H335:47;H332:6;H302:7
29745,"Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine",410-570-6,143747-73-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
29746,Oct-3-en-2-one,216-793-3,1669-44-9,Flam. Liq. 3,Notified C&L,159,H226:149;Not classified:10;H335:4;H319:4;H315:4
29747,1-[(1-methylethyl)thio]propane,225-686-0,5008-73-1,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H335:38;H315:38;H225:38;H226:1
29749,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C10-14 (even numbered)-alkyl ethers, phosphates",614-625-7,68585-36-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,152,H314:131;H318:150;H315:39;Not classified:2
29751,"3,5-dimethyl-1H-pyrazole-1-carboxamidine mononitrate",253-815-0,38184-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
29752,"Sulfonic acids, C14-16-alkane hydroxy and C14-16-alkene, sodium salts",270-407-8,68439-57-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,960,H318:493;H315:758;H302:138;H319:305;H312:126;Not classified:67;H411:62;H311:54;H335:38;H314:1;H317:1;H400:1;H371:1;H412:1
29760,"Fatty acids, olive-oil, mixed esters with glycerol and isodecanol, oxidized, sulfated and sulfonated",307-162-4,97553-08-7,Not Classified,Notified C&L,3,Not classified:3
29768,4-[(3-chloropropanoyl)oxy]benzoic acid,609-278-3,366448-45-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:2;H319:2;H315:2
29769,"2',4'-dihydroxyhexanophenone",221-555-7,3144-54-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:38;H315:38;Not classified:1
29773,"2,6,6-trimethylcyclohexene-1-carbaldehyde",207-081-3,432-25-7,Not Classified,Notified C&L,113,Not classified:63;H335:50;H319:50;H312:43;H332:43;H302:44;H315:50
29774,"Mucins, gastric",282-010-7,84082-64-4,,Notified C&L,1,H334:1;H335:1;H317:1
29779,"Quaternary ammonium compounds, pentamethyltallow alkyltrimethylenedi-, dichlorides",271-762-1,68607-29-4,Acute Tox. 3,Notified C&L,81,H301:58;H335:21;H319:20;H315:21;H302:3;H318:3;H410:4;H400:3;H314:4;H312:1;H225:1;H290:1
29785,"Naphtha (petroleum), catalytic cracked light distd.;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",272-185-8,68783-09-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
29787,"Triisooctyl 2,2',2''-[(octylstannylidyne)tris(thio)]triacetate",247-665-5,26401-86-5,Aquatic Chronic 3,REACH registration C&L,448,H412:2;H302:446;H319:446;H317:446
29791,"1,2,3,6-tetrahydro-4-(4-methylpent-3-enyl)phthalic anhydride",249-870-5,29811-04-9,Acute Tox. 4,Notified C&L,9,H302:9
29794,"2,6-dimethoxybenzoic acid",215-985-4,1466-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,103,H335:97;H319:103;H315:98;H302:42
29795,(2-ethylhexanoato-O)(isodecanoato-O)nickel,284-351-7,84852-39-1,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H410:0;H400:0;H317:0;H334:0;H341:0;H372:0;H350:0
29798,ethyleneimine;aziridine,205-793-9,151-56-4,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Acute Tox. 2;Muta. 1B;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H300:0;H314:0;H340:0;H330:0;H350:0;H310:0;H411:0;H225:0
29800,"Resin acids and Rosin acids, strontium salts",268-854-9,68152-78-3,Not Classified,Notified C&L,126,Not classified:126
29801,Diphenylphosphine,212-591-4,829-85-6,Pyr. Liq. 1;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;STOT SE 3,REACH registration C&L,47,H335:41;H250:47;H319:42;H315:42;H252:4;H314:1
29802,"4,4'-[propane-1,3-diylbis(oxy)]bisbenzene-1,3-diamine tetrahydrochloride",278-022-7,74918-21-1,Skin Sens. 1;Eye Irrit. 2;STOT RE 2,Notified C&L,59,H373:41;H319:46;H317:55;H411:13;H332:4;H335:5;H315:4
29805,"N,N-(dimethylamino)thioacetamide hydrochloride",435-470-1,27366-72-9,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0;H410:0
29811,"Egg yolk, ext.",293-508-9,91080-17-0,Not Classified,Notified C&L,36,Not classified:36
29813,"1-[2-(2,4-dichlorophenyl)-2-oxoethyl]-1H-imidazole mononitrate",246-039-9,24155-29-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2
29814,Methylmagnesium bromide,200-844-1,75-16-1,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,70,H314:70;H318:2;H260:66;H225:27;H224:4;H261:4;H302:4;H336:4
29817,Methyl chlorodifluoroacetate,216-154-9,1514-87-0,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,47,H314:46;H225:47;H335:2;H318:2
29818,5-Chloro-3[[(methoxycarbonyl) methylamino]sulfonyl]-2- thiophenecarboxylic acid methylester,618-611-1,906522-87-0,Aquatic Chronic 3,Notified C&L,1,H412:1
29820,"Indoline-2,3-dione",202-077-8,91-56-5,Skin Sens. 1B,REACH registration C&L,146,H317:1;Not classified:127;H302:12;H319:7;H315:7;H335:4;H312:1
29825,"Hexafluoropropene, oxidized, oligomers, reduced, fluorinated",500-537-5,161075-00-9,Aquatic Chronic 4,REACH registration C&L,2,H413:1;Not classified:1
29828,Pivaloyl chloride,221-921-6,3282-30-2,Flam. Liq. 2;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,326,H314:274;H302:273;H290:206;H330:255;H318:210;H225:273;Not classified:52;H335:21;H410:16;H400:16;H331:18;H336:16;H412:3;H319:2;H224:1
29831,Calcium oxalate,209-260-1,563-72-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,64,H302:64;H312:64
29833,"Esterification reaction of fatty acids, linseed-oil; phenol, 4,4-(1-methylethylidene)bis-, oligomer with (chloromethyl)oxirane and neodecanoic acid, oxiranylmethyl ester",928-726-1,,Skin Sens. 1B;Muta. 2,REACH registration C&L,73,H341:2;H317:2;Not classified:71
29836,"(2,5-dichloropentyl)ammonium chloride",263-758-3,62922-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,42,H335:41;H319:42;H411:2;H315:42
29838,Potassium 4-dodecylbenzenesulphonate,238-608-5,14564-74-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
29840,"Naphthalene-1,4-dicarboxylic acid",210-094-7,605-70-9,Not Classified,REACH registration C&L,47,Not classified:3;H335:43;H319:44;H315:44
29841,"4-ethoxybenzene-1,2-diamine",214-825-0,1197-37-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H312:38;H410:38;H351:38;H400:38;H317:38;H332:38;H302:38;H341:38
29842,"3-piperidinopropane-1,2-diol",225-438-1,4847-93-2,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H300:38;H315:38
29845,"1-(4-NITROBENZYL)-1H-1,2,4-TRIAZOLE",601-587-1,119192-09-5,Acute Tox. 4,Notified C&L,38,H302:38
29847,"1-(3,5-dibromo-4-hydroxyphenyl)ethan-1-one",220-750-4,2887-72-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,40,H314:38;H302:38;H319:2;H315:2;H335:1
29851,Ethyl 2-(m-tert-butyl-p-hydroxyphenoxy)tetradecanoate,250-887-5,31994-60-2,Aquatic Chronic 4,Notified C&L,1,H413:1
29852,N-[3-(trimethoxysilyl)propyl]-N'-(vinylbenzyl)ethylenediamine monohydrochloride,252-297-3,34937-00-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H302:1;H312:1;H225:2;H370:1;H311:1;H330:1;H301:1
29853,"Sorbitan, tridocosanoate",301-037-8,93980-59-7,Not Classified,REACH registration C&L,7,Not classified:7
29855,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, sulfo [[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]sulfonyl derivs., sodium salts",307-555-0,97660-43-0,Not Classified,Notified C&L,17,Not classified:16;H334:1
29856,"2,4,6-Trichlorobenzoic Acid",610-531-5,50-43-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44
29858,"Nonylphenol diethanolamine Mannich base, propylene oxide, ethylene oxide polymer",610-766-3,52019-35-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,149,H302:148;H318:94;H315:94;H319:55;H411:55
29859,Sodium dibutyl phosphate,240-388-0,16298-74-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,33,H318:26;H315:26;Not classified:7
29861,o-toluohydrazide,231-623-8,7658-80-2,,Notified C&L,7,H335:7;H319:7;H315:7;H331:1;H311:1;H301:1
29862,5-isopropyl-2-methylbicyclo[3.1.0]hex-2-ene,220-686-7,2867-05-2,Flam. Liq. 3;Skin Sens. 1,REACH registration C&L,8,H226:8;H317:7;H302:3;H304:3;H411:3;H315:2
29863,"Toxins, botulin, E",297-258-1,93384-47-5,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H310:1;H300:1;H330:1
29864,"Silicate(2-), hexafluoro-, disodium, reaction products with lithium magnesium sodium silicate",285-349-9,85085-18-3,Not Classified,REACH registration C&L,36,Not classified:36
29866,"(S)-3'-[[2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyladenosine dihydrochloride",200-387-8,58-58-2,Acute Tox. 4,Notified C&L,50,H302:50
29867,Dibekacin bis(sulphate),300-960-3,93965-12-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,38,H332:38;H302:38;H360:38;H312:38
29869,(S)-[2-hydroxy-3-(naphthyloxy)propyl]isopropylammonium chloride,224-096-0,4199-10-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H332:38;H302:41;H312:38;H362:3;H360:3;H411:3
29873,C.I. Solvent Orange 59,612-925-2,61969-46-8,Not Classified,Notified C&L,5,Not classified:5
29887,1-(naphthyl)ethan-1-one,215-594-9,1333-52-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,236,H302:236;H412:236;H317:236
29890,"β-d-Glucopyranoside, 5b-[(benzoyloxy)methyl]tetrahydro-5-hydroxy-2-methyl-2,5-methano-1H-3,4-dioxacyclobuta[cd]pentalen-1a(2H)-yl, [1aR-(1aα,2β,3aα,5α,5aα,5bα)]-",245-476-2,23180-57-6,Acute Tox. 4,Notified C&L,1,H302:1
29901,"flocoumafen (ISO);reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin",421-960-0,90035-08-8,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H360:0;H300:0;H410:0;H400:0;H330:0;H372:0;H310:0
29902,4-(2-Chloroethylsulfonyl)butyric Acid,601-771-1,121315-24-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
29907,4-(methylthio)aniline,203-256-3,104-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:38;H319:44;H315:44;H332:6;H302:6;H311:4;H312:2
29911,3-dimethylaminopropan-1-ol,221-659-2,3179-63-3,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,150,H226:150;H302:88;H318:146;H314:89;H312:1;H332:1
29913,"2,7-dimethyloct-5-en-4-one",270-267-8,68419-46-5,Skin Sens. 1,Notified C&L,88,H317:88
29915,1-bromotridecane,212-138-0,765-09-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:38;H318:38;H335:38;H315:39;H319:1
29921,DL-alanine,206-126-4,302-72-7,Not Classified,REACH registration C&L,252,Not classified:251;H335:1;H319:1;H315:1
29922,Meprednisone,214-996-1,1247-42-3,Repr. 1A;STOT RE 1,Notified C&L,26,H372:24;H360:24;Not classified:2
29923,(7L)lithium fluoride,241-438-4,17409-87-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H335:38;H319:38;H315:38
29924,"(±)-trans-1,2-Cyclohexanediamine",601-163-6,1121-22-8,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,50,H314:48;H318:4;H317:6;Not classified:1;H335:1;H319:1;H315:1;H227:1
29928,Sodium 4(or 5)-methyl-1H-benzotriazolide,265-004-9,64665-57-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1192,H314:1003;H302:1102;H318:726;H361:2;H411:96;H335:648;H412:70;H319:100;H315:99;Not classified:6;H301:1;H402:1
29929,N-methylbenzamide,210-362-3,613-93-4,Acute Tox. 4,Notified C&L,44,H302:43;H335:5;H319:5;H315:5;Not classified:1
29930,"4-amino-1-[[3,5-bis(1-cyano-1-methylethyl)phenyl]methyl]-4H-1,2,4-triazolium bromide (1:1)",618-623-7,906813-01-2,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;Carc. 2;Repr. 1B;STOT RE 1;STOT RE 1;Aquatic Chronic 1,Notified C&L,3,H360:3;H319:3;H410:3;H351:3;H331:3;H302:3;H372:3
29931,"1-(2,6-dichlorophenyl)ethan-1-one",218-035-7,2040-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H335:133;H319:134;H315:134
29933,Triallylamine,203-048-2,102-70-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 3;STOT SE 3,REACH registration C&L,59,H335:2;H226:59;H302:59;H314:59;H331:40;H311:20;H318:3;H312:38;H332:18;H412:14
29935,"Oleic acid, compound with (Z)-N-octadec-9-enylpropane-1,3-diamine (2:1)",251-846-4,34140-91-5,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,4,H373:2;H319:2;H400:4;H411:2;H315:2;H314:2;H302:2;H410:2
29936,Barium zirconium trioxide,234-546-8,12009-21-1,Acute Tox. 4,REACH registration C&L,43,H302:43;H332:42
29939,"(9Z,12Z)-N,N-bis(2-hydroxyethyl)octadeca-9,12-dien-1-amide",260-410-2,56863-02-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,89,H319:82;H315:89;H400:7;H318:7
29940,"3-oxatricyclo[3.2.1.02,4]octane",205-995-7,278-74-0,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H228:1
29942,Sodium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-N-(3-methoxypropyl)benzenesulphonamidato(2-)]cobaltate(1-),275-959-3,71735-61-0,Aquatic Chronic 3,REACH registration C&L,2053,H412:6;Not classified:2047
29946,"HEXANAL, 3-METHYL-, (+-)-",606-279-0,19269-28-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1412,H319:1412;H315:1412
29950,Butyl hydrogen phosphonate,240-508-1,16456-56-7,Acute Tox. 4;Skin Corr. 1B,Notified C&L,17,H314:17;H302:17
29952,Diethyl bromomalonate,211-683-1,685-87-0,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1;H290:1
29953,"formic acid, nickel salt",239-946-6,15843-02-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H410:0;H400:0;H317:0;H334:0;H341:0;H372:0;H350:0
29955,3-hydroxy-2-(hydroxymethyl)pyridine hydrochloride,238-021-4,14173-30-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H335:40;H319:41;H312:40;H332:40;H302:40;H315:41
29956,Neostigmine bromide,204-054-8,114-80-7,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,41,H335:39;H319:40;H300:39;H317:39;H334:39;H330:39;H310:39;H315:40;H301:2
29957,magnesium hexafluorosilicate,241-022-2,16949-65-8,Acute Tox. 3,Harmonised C&L,0,H301:0
29962,"Hexadecyl 3,5-bis-tert-butyl-4-hydroxybenzoate",267-342-2,67845-93-6,Not Classified,REACH registration C&L,193,Not classified:96;H411:57;H413:39;H335:1;H319:1;H315:1
29963,"1,2-Benzenedicarboxylic acid, di-C8-10-branched alkyl esters, C9-rich",271-090-9,68515-48-0,Not Classified,REACH registration C&L,502,Not classified:459;H400:39;H361:3;H319:1;H315:1
29965,"6,10-Dodecadien-1-ol, 3,7,11-trimethyl-",610-659-1,51411-24-6,Not Classified,Notified C&L,1,Not classified:1
29966,"glucosidase, β-",232-589-7,9001-22-3,Resp. Sens. 1,Harmonised C&L,0,H334:0
29967,"1,5-dinitronaphthalene",210-095-2,605-71-0,Skin Sens. 1;Eye Dam. 1;Muta. 2;Aquatic Chronic 3,Notified C&L,47,H341:47;H318:38;H317:39;H412:44;H335:7;H319:8;H315:8;H351:2;H301:1;H361:1
29968,"trans-[[N,N'-cyclohexane-1,2-diylbis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)",242-968-9,19332-78-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
29974,Ethyl 2-acetyl-4-oxovalerate,255-582-0,41892-81-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
29975,"Benzenesulfonic acid, C10-16-alkyl derivs., compds. with 2-propanamine",271-531-5,68584-24-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,753,H302:650;H319:633;H315:199;H318:213;H335:20;H314:20;H412:34
29976,"Lubricating oils (petroleum), acid-treated spent",265-125-7,64742-25-2,Asp. Tox. 1,Notified C&L,2,H304:1;Not classified:1
29982,"Disodium 5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonate",274-095-4,69723-86-0,,Notified C&L,9,Not classified:9
29984,"fenpropathrin (ISO);α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate",254-485-0,39515-41-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H312:0;H400:0;H330:0;H301:0
29985,Methyl[2H3]ammonium chloride,238-847-5,14779-52-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
29986,5-ethylnonan-2-one,226-626-6,5440-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,8,H335:3;H319:3;H315:3;Not classified:5
29990,N-(3-chloropropyl)dibutylamine,253-027-7,36421-15-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:3;H315:3;H335:1;H371:1;Not classified:1
30003,"[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonium decyl sulphate",256-903-7,50996-85-5,Resp. Sens. 1,Notified C&L,38,H334:38
30010,Methylenedisalicylic acid,248-497-5,27496-82-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,29,H319:23;H315:23;Not classified:6
30012,Tolfenamic acid,237-264-3,13710-19-5,Acute Tox. 3,Notified C&L,132,H301:129;H302:3
30015,"(E)-1-methoxy-3,7-dimethylocta-2,6-diene",219-896-1,2565-82-4,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,113,H226:113;H319:113;H335:1;H315:1
30019,(Z)-5-decenyl acetate,266-693-9,67446-07-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
30022,"Kaempferia galanga, ext.",296-200-2,92347-13-2,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,78,H304:53;H412:27;H317:28;H226:25;Not classified:25;H411:1
30024,"Phosphoric acid, decyl ester, branched and linear, compd. with diethanolamine",307-234-5,97553-72-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2,Notified C&L,10,H373:10;H313:10;H314:10;H302:10;H318:10
30029,3-(o-chlorophenyl)-3-hydroxy-3-phenylpropiononitrile,252-419-5,35173-29-6,Not Classified,REACH registration C&L,2,Not classified:2
30035,"Methyl 3,3-dimethylpent-4-enoate",264-431-8,63721-05-1,Flam. Liq. 3,Notified C&L,41,H226:41
30040,Lithium dihydrogenorthophosphate,236-633-6,13453-80-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:45;H335:45;H319:45;H315:45
30042,1-(1-bromoethoxy)-4-fluorobenzene,608-848-9,332-48-9,,Notified C&L,6,H335:5;H319:6;H315:6
30043,"Tris(pentane-2,4-dionato-O,O')iridium",239-711-8,15635-87-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,43,H335:40;H319:43;H312:41;H351:39;H332:41;H302:42;H315:42;H413:1;H290:1;H228:1
30047,Ethyl (E)hex-2-enoate,248-681-5,27829-72-7,Not Classified,Notified C&L,171,Not classified:137;H226:34
30049,"1,2-epoxyhexane",215-864-6,1436-34-6,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H225:44;H302:39;H315:44
30054,Propyl heptanoate,231-917-6,7778-87-2,Not Classified,Notified C&L,90,Not classified:90
30055,2-[(methyldithio)methyl]furan,260-773-7,57500-00-2,Acute Tox. 4,Notified C&L,1446,H302:1313;H319:124;H315:124;H335:52
30064,4-ethyl-3-thiosemicarbazide,236-553-1,13431-34-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
30066,Butylammonium chloride,223-369-1,3858-78-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
30067,"2,2-diethoxypropane",204-808-6,126-84-1,Flam. Liq. 2,Notified C&L,41,H225:41
30070,"Phosphonic acid, P-(3-silylpropyl)-, Si,Si,Si-tris(mixed ethoxy and methoxy) derivs., mixed Et and Me diesters",619-721-2,1079258-99-3,Not Classified,REACH registration C&L,84,Not classified:1;H319:83
30071,Calcium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate,226-109-5,5281-04-9,Not Classified,REACH registration C&L,686,Not classified:622;H332:33;H412:30;H373:12;H335:1;H319:1;H315:1;H317:1
30074,2-phenyl-1H-imidazole-1-propiononitrile,245-972-9,23996-12-5,Acute Tox. 4,Notified C&L,26,H302:26;H319:1;H315:1
30080,"Silicic acid, chromium lead salt",234-347-6,11113-70-5,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Carc. 1B;Repr. 1A;STOT RE 2;Aquatic Chronic 1,Notified C&L,23,H373:18;H360:18;H410:18;H400:18;H317:18;H332:18;H302:18;H350:18;Not classified:5
30084,(9S)-6'-methoxycinchonan-9-ol monohydrochloride,216-792-8,1668-99-1,,Notified C&L,1,H302:1;H317:1
30085,"Distillates (petroleum), steam-cracked, C",270-736-7,68477-53-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
30086,"Chive, ext.",289-695-1,89997-59-1,Flam. Liq. 3,Notified C&L,2,H226:2
30091,"1,1':4',1''-Terphenyl, 2',3,4,5-tetrafluoro-4''-propyl-",606-583-3,205806-87-7,,Notified C&L,1,Not classified:1
30092,"Nickel, compound with zirconium (1:2)",235-261-1,12142-92-6,Flam. Sol. 1;Water-react. 1;Skin Sens. 1;Carc. 2;STOT RE 1,Notified C&L,4,H351:4;H317:4;H228:4;H372:4;H260:4
30094,"2-[[2,3,3a,4,7,7a(or 3a,4,5,6,7,7a)-hexahydro-4,7-methano-1H-indenyl]oxy]ethyl methacrylate",271-608-3,68586-19-6,Skin Irrit. 2,Notified C&L,67,H315:59;H335:24;H319:24;H332:21;H411:21;Not classified:7
30099,"3,6-bis(diethylamino)-9-[2-[[[9-(diethylamino)-5H-benzo[a]phenoxazin-5-ylidene]amino]carbonyl]phenyl]xanthylium chloride",239-040-0,14969-56-3,Carc. 2,Notified C&L,42,H351:42;H319:4
30104,"Oxirane, 2-methyl-, polymer with oxirane, dodecyl ether",614-382-7,68238-81-3,Not Classified,Notified C&L,44,Not classified:44
30107,Barium chloroanilinate,236-567-8,13435-46-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H332:39;H302:39;H301:1;H331:1
30115,"Terpineol, acetate",232-357-5,8007-35-0,Aquatic Chronic 2,Notified C&L,288,H411:183;Not classified:105;H315:1
30118,5-bromo-3-indoleacetic acid,254-917-8,40432-84-6,,Notified C&L,6,H335:6;H319:6;H315:6
30119,3-(2-nitrophenyl)propionic acid,217-889-8,2001-32-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
30123,Trimethyl-3-[(1-oxooctadecyl)amino]propylammonium methyl sulphate,242-930-1,19277-88-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H302:37;H318:41;H410:41;H400:37;H315:4
30125,"Sodium tris(1,2-naphthoquinone 1-oximato-O,O')ferrate(1-)",240-299-7,16143-80-9,Not Classified,REACH registration C&L,170,Not classified:81;H413:89
30129,"Caesalpinia digyna, ext.",296-171-6,92346-86-6,Not Classified,Notified C&L,1,Not classified:1
30132,Etebenecid,214-925-4,1213-06-5,Eye Dam. 1,Notified C&L,38,H318:38
30135,α-phenylpyridine-2-acetamide,230-663-3,7251-52-7,Acute Tox. 4,REACH registration C&L,6,H302:5;H319:1;H315:1
30141,"5,6-dimethoxyphthalaldehydic acid",208-261-4,519-05-1,,Notified C&L,4,H335:4;H319:4;H315:4
30142,4-[(2-furylmethyl)thio]-4-methylpentan-2-one,265-249-1,64835-96-7,Acute Tox. 4,Notified C&L,88,H302:88
30143,"N-methyldithiocarbamic acid, compound with methylamine (1:1)",244-252-1,21160-95-2,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1;H400:1;H332:1;H315:1
30148,"4-amino-3,5-diiodobenzoic acid",218-331-6,2122-61-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
30149,"Androsta-1,4-diene-3,17-dione",212-977-2,897-06-3,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 2,REACH registration C&L,19,H362:7;H351:17;H360:7;H411:1;H412:9;H361:10;H373:9;H302:8;H335:1;H319:1;H341:1;H332:1
30151,"Carbonyl(pentane-2,4-dionato-O,O')(triphenylphosphine)rhodium",247-015-0,25470-96-6,Aquatic Chronic 4,REACH registration C&L,92,H413:85;H411:2;H301:83;H319:88;H317:83;H335:5;H315:5
30154,"Tannins, compds. with N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine",606-013-3,183969-60-0,Acute Tox. 4,Notified C&L,2,H302:2
30157,Myristoyl chloride,203-994-6,112-64-1,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,65,H314:65;H290:7;H335:17;H318:3;H302:2;H332:2
30161,"3,5-dimethyl-1,2,4-trithiolane",245-808-6,23654-92-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,114,H335:104;H319:104;H332:104;H302:104;H315:104;Not classified:10
30165,"Chromate(3-), [6-[(4-chloro-2-hydroxy-5-methoxyphenyl)azo]-5-hydroxy-1-naphthalenesulfonato(3-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-1-naphthalenesulfonato(3-)]-, diethanolamine sodium salts",284-678-5,84961-86-4,Eye Dam. 1,Notified C&L,2,H318:2
30166,Bontron E-108,432-820-3,,Aquatic Chronic 1,Notified C&L,1,H410:1
30167,2-acetamidoacetamide,220-058-2,2620-63-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
30168,"Titanium, (butyl phosphate, ethyl alcohol, isopropyl alcohol) complexes",600-894-8,109037-78-7,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,55,H319:55;H411:55;H225:16;H336:8;H228:8
30170,"dicamba (ISO);2,5-dichloro-6-methoxybenzoic acid;3,6-dichloro-2-methoxybenzoic acid",217-635-6,1918-00-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H318:0;H412:0
30171,Ethyl 3-hydroxy-3-methylbutyrate,242-147-5,18267-36-2,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H302:1;H227:1;H315:1
30173,"2,2'-(ethane-1,2-diyldiimino)bisethanol",224-656-4,4439-20-7,Skin Corr. 1B,Notified C&L,40,H314:40;H318:2
30174,2-fluorobiphenyl,206-290-7,321-60-8,Not Classified,Notified C&L,7,Not classified:2;H335:5;H319:4;H315:5;H400:2;H410:1;H302:1;H318:1
30182,"Cedarwood oil, Atlas type",617-018-5,8023-85-6,Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,107,H304:107;H411:69;H400:38
30183,"3,7-dimethyloctanenitrile",403-620-3,40188-41-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H315:0
30184,Hexobarbital,200-264-9,56-29-1,Acute Tox. 4,Notified C&L,41,H302:41;H332:1;H312:1
30192,Triammonium hexafluoroaluminate,232-052-7,7784-19-2,,Notified C&L,5,H301:5;H311:5;H330:4;H331:1
30196,2-phenylpropan-1-ol,214-379-7,1123-85-9,Eye Irrit. 2,REACH registration C&L,273,H319:1;Not classified:267;H302:5
30198,"Hexahydro-2'3a-dimethylspiro[1,3-dithiolo[4,5-b]furan-2,3'(2'H)-furan]",253-884-7,38325-25-6,Acute Tox. 4,Notified C&L,1414,H302:1376;H319:38;H315:38
30200,5-chloro-2-methylbenzoxazole,242-888-4,19219-99-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,40,H314:38;H302:38;H332:38;H312:38;H319:2;H315:2
30206,"3,5-dihydroxy-2,6,6-tris(3-methylbuten-2-yl)-4-(3-methyl-1-oxobutyl)cyclohexa-2,4-dien-1-one",207-405-3,468-28-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,41,H319:3;H312:3;H317:3;H302:3;H315:3;H301:38
30210,2-aminonaphthalene-1-sulphonic acid,201-331-5,81-16-3,Not Classified,Notified C&L,64,Not classified:57;H319:7;H302:2;H315:2
30211,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane and 1,3-diisocyanatomethylbenzene",609-402-6,37312-33-7,Not Classified,Notified C&L,1,Not classified:1
30214,"Sodium 2,4,5-trichlorophenolate",205-239-6,136-32-3,Acute Tox. 4;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H302:1;H311:1
30215,"Octanoic acid, manganese salt",229-437-7,6535-19-9,Not Classified,Notified C&L,41,Not classified:23;H315:18;H335:1;H319:1;H312:1;H332:1;H302:1
30217,Octylsilane,212-817-1,871-92-1,,Notified C&L,1,H226:1;H335:1;H319:1;H315:1
30220,Ethyllithium,212-370-2,811-49-4,Pyr. Sol. 1;Water-react. 2;Skin Corr. 1A,Notified C&L,65,H314:65;H250:65;H261:38;H260:27
30224,(±)-2-hydroxy-2-methylsuccinic acid,209-901-5,597-44-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H319:2;H315:2
30226,2-methylquinoxaline,230-664-9,7251-61-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H319:45;H315:45;Not classified:1
30230,Reactive BrownÂ 10,602-396-6,12225-67-1,Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H318:38;H335:38;H315:38
30231,"Butanal, reaction products with butylamine",270-108-2,68411-19-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,132,H332:132;H302:132;H312:132
30237,reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;bis(N-octadecyl-N'-phenyleneureido)methylene;bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1),406-550-1,,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
30238,"2,2'-[(1-methylethyl)imino]bisethanol",204-509-0,121-93-7,Not Classified,Notified C&L,84,Not classified:83;H302:1;H318:1;H312:1;H315:1
30245,"Hydrocarbons, C10-C14, n-alkanes, <2% aromatics",920-317-6,,Asp. Tox. 1,REACH registration C&L,1,H304:1
30247,Phosphonosuccinic acid,227-294-5,5768-48-9,,Notified C&L,42,Not classified:34;H314:8
30250,"[(2,5-dichlorophenyl)thio]acetic acid",228-468-3,6274-27-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H302:2;H319:2;H315:2;H335:1
30251,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers, reaction products with 2-butanone oxime",500-287-7,103170-26-9,STOT RE 1,REACH registration C&L,196,H372:3;H335:177;H319:177;H317:177;H334:177;H315:177;Not classified:16
30256,"Perylene-3,4,9,10-tetracarboxylic acid",201-343-0,81-32-3,,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
30259,1-chlorobut-2-ene,209-739-5,591-97-9,Flam. Liq. 2;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,238,H317:198;H314:199;H302:238;H290:164;H332:236;H412:198;H225:205;H318:39;H315:39;H319:1
30261,"Lamium album, ext.",281-669-8,84012-23-7,Flam. Liq. 3,Notified C&L,2,H226:1;Not classified:1
30262,Methyl difluoroacetate,207-089-7,433-53-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H335:41;H319:39;H312:42;H226:41;H302:42;H332:42;H315:39;H314:7;H225:6;H318:2
30263,"Sodium 2,4-dichlorophenoxyacetate",220-290-4,2702-72-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,15,H302:15;H318:14;H317:14;H411:14
30265,"Tetrasodium [μ-[[3,3'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4-hydroxy-6-(3-sulphoanilino)naphthalene-2-sulphonato]](8-)]]dicuprate(4-)",277-872-6,74432-30-7,Not Classified,Notified C&L,1,Not classified:1
30266,1-Chloro-4 Trifluromethyl Bisphenol A Epoxy Resin,600-013-7,25085-99-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,150,H319:77;H317:91;H411:91;H315:77;Not classified:59
30267,"Soaps, stocks, herring-oil, acidulated, hydrogenated",296-500-3,92704-65-9,Not Classified,Notified C&L,1,Not classified:1
30270,Heptadecafluoro-1-iodooctane,208-079-5,507-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H335:47;H319:48;H315:48;H413:38;Not classified:6
30271,"4-Ethoxy-2,3-difluorphenylboronic acid",606-729-6,212386-71-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H302:2;H317:2;H411:2;H319:1;H315:1
30272,"4,5-dihydro-2-propyloxazole",225-156-9,4694-80-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
30274,"Tetramethylcyclobutane-1,3-dione",213-269-6,933-52-8,Not Classified,Notified C&L,1,Not classified:1
30276,4-[2-[[3-(p-hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol hydrochloride,256-464-1,49745-95-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,45,H332:43;H302:43;H361:43;H312:43;H410:2;H400:1;H318:1
30281,"Phosphoric acid, C12-14-branched and linear alkyl esters, potassium salts",306-967-8,97468-16-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
30286,Dichlorobis(pyridine)platinum,239-276-4,15227-42-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H319:38;H312:38;H332:38;H302:38;H315:38
30291,Aluminium dicalcium iron pentaoxide,235-094-4,12068-35-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,21,H318:20;H315:20;H319:1
30292,"Slags, ferrochromium-manufg.",273-727-6,69012-27-7,Not Classified,REACH registration C&L,4,Not classified:4
30293,"2-(hydroxymethyl)-2-[[(1-oxooctyl)oxy]methyl]propane-1,3-diyl dioctanoate",261-735-2,59400-09-8,,Notified C&L,1,Not classified:1
30294,3-methoxyacetophenone,209-573-3,586-37-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,18,H319:6;H302:5;H412:2;H411:1;H315:5;Not classified:12;H335:1;H312:1;H332:1
30298,12-methoxyibogamine monohydrochloride,227-687-1,5934-55-4,Acute Tox. 4,Notified C&L,38,H302:38
30300,chlorine dioxide;chlorine dioxide … %,233-162-8,10049-04-4,,,0,H270:0;Not classified:0;H400:0;H314:0;H330:0
30302,"Aromatic hydrocarbons, C",268-618-5,68131-49-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
30303,Zirconium dioxide,215-227-2,1314-23-4,Not Classified,REACH registration C&L,1060,Not classified:989;H319:65;H315:60;H336:4;H220:4;H372:3;H335:12;H373:3
30304,Methyl trifluoromethanesulphonate,206-371-7,333-27-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,58,H226:58;H314:56;H302:4;H318:3;H335:2;H319:1;H315:1;H312:1;H332:2
30306,2-[[]2-[[]bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,613-386-6,6381-92-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,417,H335:138;H319:167;H312:118;H332:193;H302:190;H412:117;H315:141;Not classified:82;H373:73;H320:6;H400:1;H336:1
30307,"4,7,7-trimethyl(2-oxabicyclo[2.2.1]hept-1-yl)carboxylic acid",236-552-6,13429-83-9,,Notified C&L,6,H335:5;H319:6;H315:6
30310,Cupressus oil,616-942-6,8013-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,84,H335:39;H319:39;H315:84;H410:45;H400:45;H317:45;H226:45;H304:45
30311,3-fluorophenyl isothiocyanate,206-967-7,404-72-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,46,H335:41;H312:44;H314:45;H302:44;H332:44;H301:2;H318:1;H331:1;H319:2;H311:1;H330:1;H315:1
30314,(4-fluorophenyl)hydrazine,206-732-9,371-14-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
30315,"Alum, potassium",616-521-7,7784-24-9,,Notified C&L,42,Not classified:42
30318,Potassium vanadium trioxide,237-388-8,13769-43-2,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,95,H319:63;H332:40;H302:6;H372:38;H361:38;H411:38;H335:89;H300:53;H330:57;H310:53;H315:57;H351:32;H400:32;H341:32;H301:32;H318:32;H314:2
30319,4-n-Octyloxybenzoic Acid,607-462-8,2493-84-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
30320,(1R-cis)-2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-ol,218-270-5,2102-59-2,Not Classified,Notified C&L,234,Not classified:233;H335:1;H319:1;H315:1
30324,3-(2-thenoyl)propionic acid,225-089-5,4653-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,199,H335:199;H319:199;H315:199
30325,"(2E)-3-carboxy-N,N-dimethylprop-2-en-1-aminium chloride",617-631-8,848133-35-7,Skin Corr. 1B,Notified C&L,39,H314:36;H335:2;H319:3;H315:3
30327,(4-pyridylthio)acetic acid,233-765-6,10351-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43;H331:1;H311:1;H301:1
30336,"1,4,7,10,13-pentaoxa-16-azacyclooctadecane",251-751-8,33941-15-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
30337,Hexaphenylcyclotrisiloxane,208-145-3,512-63-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H319:39;H315:39;Not classified:1
30342,"Oxirane, 2-methyl-, polymer with α-butyl-ω-hydroxypoly(oxy-1,2-ethanediyl) and oxirane",614-520-6,68459-87-0,Not Classified,Notified C&L,59,Not classified:59
30343,1-Methoxy-2-methyl-2-propanol,609-188-4,3587-64-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H226:43;H335:39;H319:39;H315:39;H302:1
30350,dibenzoyl peroxide,202-327-6,94-36-0,Org. Perox. B;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H241:0;H317:0
30354,"reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile);2,2’-dimethyl-2,2’-azoheptanenitrile;2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile);2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)",429-710-2,,Self-react. D;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H242:0;H411:0;H302:0
30358,Dicesium oxalate,213-950-8,1068-63-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H312:38
30359,"3-butylpentane-2,4-dione",216-274-1,1540-36-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H317:1;H315:1
30360,Sodium bis[2-[[5-(aminosulphonyl)-2-hydroxyphenyl]azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),276-701-2,72496-88-9,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,22,H412:11;H317:11;Not classified:6;H319:5;H315:5;H335:2
30365,4-Heptylbenzoic acid-(4-cyano-3-fluorphenylester),617-919-3,86776-54-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
30367,"Hydrocarbons, C8-11",271-391-5,68553-14-0,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,8,H226:8;H304:8
30368,(3-phenoxyphenyl)glycolonitrile,254-486-6,39515-47-4,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 3,Notified C&L,144,H226:144;H314:144;H331:144;H301:144;H318:144;H310:144
30371,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-amino-4,6-dinitrophenol, diazotized 4-nitrobenzenamine and resorcinol",275-120-1,71010-82-7,Not Classified,Notified C&L,6,Not classified:6
30373,"1,2-Ethanediamine, N,N,N',N'-tetramethyl-, polymer with 1,1'-oxybis(2-chloroethane)",608-578-1,31075-24-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 1,Notified C&L,26,H332:26;H302:22;H410:26;H400:5;H335:1;H319:1;H315:1
30374,Ursodeoxycholic acid,204-879-3,128-13-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,98,H319:95;H315:95;Not classified:3;H302:1;H335:1
30376,"N-cyano-N',N''-bis(hydroxymethyl)guanidine",254-782-5,40074-04-2,Not Classified,Notified C&L,1,Not classified:1
30378,"Carbamic acid, [1,3-phenylenebis[methyleneiminocarbonylimino(methyl-3,1-phenylene)]]bis-, diisotridecyl ester",617-879-7,865536-03-4,Not Classified,REACH registration C&L,4,Not classified:4
30379,"Hydrocarbons, C14-C19, isoalkanes, cyclics, <2% aromatics",920-114-2,,Asp. Tox. 1,REACH registration C&L,445,H304:445
30380,"Benzene, C14-30-alkyl derivs.",272-472-8,68855-24-3,Not Classified,Notified C&L,531,Not classified:462;H413:65;H400:2;H410:2;H319:2;H315:2
30381,"2,2,2-trichloro-2,2-dihydro-1,3,2-benzodioxaphosphole",217-913-7,2007-97-8,,Notified C&L,4,H314:4
30383,3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride,427-780-9,114565-70-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H318:0;H410:0;H400:0
30384,4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide,229-105-1,6410-39-5,Not Classified,Notified C&L,2,Not classified:2
30385,Flurbiprofen,225-827-6,5104-49-4,Acute Tox. 3,Notified C&L,55,H301:54;H335:9;H319:8;H315:7;H361:4;H360:1;H341:1;H372:1;H302:1
30393,"Fatty acids, C6-19-branched, iron salts",269-635-0,68308-20-3,Skin Irrit. 2,Notified C&L,13,H315:11;H413:2
30400,2-bromoethyldimethylammonium bromide,220-680-4,2862-39-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:40;H335:40;H319:40;H315:40
30403,2-Aminobenzeneboronic acid,611-303-8,5570-18-3,,Notified C&L,6,H335:6;H319:6;H315:6
30404,Di-''isodecyl'' phthalate,247-977-1,26761-40-0,Not Classified,Notified C&L,289,Not classified:155;H411:71;H400:62;H410:40;H319:1;H315:1
30405,"Averrhoa carambola, ext.",307-626-6,97675-54-2,Not Classified,Notified C&L,37,Not classified:37
30406,O-(tert-butyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine,276-260-6,71989-33-8,,Notified C&L,4,H332:2;H302:2;H312:2;Not classified:1;H317:1;H413:1
30408,"(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] diacrylate",225-144-3,4687-94-9,Skin Sens. 1,Notified C&L,43,H317:43;H319:1;H315:1
30409,Ethyl N-formylglycinate,221-596-0,3154-51-6,Flam. Liq. 3,Notified C&L,1,H226:1
30411,4-methoxy-1-naphthol,201-566-3,84-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
30413,3-ethyl-5-[(1-methyl-2-pyrrolidinylidene)ethylidene]-2-thioxooxazolidin-4-one,255-417-2,41504-26-1,Not Classified,Notified C&L,1,Not classified:1
30414,Benzohydrazide,210-363-9,613-94-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H301:41;H335:42;H319:44;H315:44;H351:6;H302:2;H312:1;H332:1;H331:1;H311:1;H334:1;H341:1;H413:1
30415,"Resin acids and Rosin acids, fumarated, decyl esters",275-288-6,71243-68-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
30419,"4-chlorobenzene-1,3-disulphonyl dichloride",220-759-3,2891-17-0,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H302:1;H335:1
30422,"1,6-dichlorohexane",218-491-7,2163-00-0,Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,141,H304:85;H411:98;H315:137;H335:38;H319:39;H412:4
30423,Nitronium tetrafluoroborate,237-533-5,13826-86-3,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,45,H314:45;H334:38;H317:38;H335:1;H318:1
30424,Cyclooctene,213-245-5,931-88-4,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,39,H226:39;H304:38
30426,toluene,203-625-9,108-88-3,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;STOT RE 2;Repr. 2,Harmonised C&L,0,H373:0;H225:0;H336:0;H304:0;H361:0;H315:0
30427,3-hydroxypropanesulphonic acid,240-051-8,15909-83-8,Skin Corr. 1A,Notified C&L,52,H314:52;H290:14
30432,4-(5-Propyl-tetrahydropyran-2-yl)-phenol,919-949-5,,Not Classified,REACH registration C&L,2,Not classified:2
30434,"5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",266-769-1,67604-48-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H335:200;H319:200;H315:200
30435,3-cyclopentylpropionyl chloride,203-257-9,104-97-2,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,47,H314:47;H318:4;H335:4
30439,"(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-hydroxy-2-methyl-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate",616-626-8,78439-06-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,62,H334:61;H317:62;H400:3;H332:1
30442,"2,3-dihydroindol-2-one",200-429-5,59-48-3,Acute Tox. 4,Notified C&L,145,H302:145;H335:1;H319:1;H312:1;H332:1;H315:1
30457,N-(4-acetylaminophenyl)-3-hydroxynaphthalene-2-carboxamide,255-419-3,41506-62-1,Not Classified,REACH registration C&L,34,Not classified:1;H413:33
30459,"(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride",607-518-1,250611-13-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
30462,"1-(2,4,5-trimethylphenyl)ethan-1-one",218-036-2,2040-07-5,Flam. Liq. 3,Notified C&L,38,H226:38
30465,(Bromomethyl)trimethylsilane,605-967-8,18243-41-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,39,H314:39;H225:39;H318:1
30469,3-(p-methoxyphenyl)-2-methylpropionaldehyde,226-749-5,5462-06-6,Skin Sens. 1B,REACH registration C&L,1678,H317:1675;H412:1564;H319:1291;Not classified:4
30471,"α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω-(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]",413-420-8,144736-29-8,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H317:0;H411:0
30472,"Estra-1,3,5(10)-triene-3,17-diol, 3-(hydrogen sulfate), monosodium salt, (17α)-",259-966-9,56050-04-5,Repr. 2,Notified C&L,41,H361:41;H351:16;H360:16
30474,Methyl 3-(4-bromomethyl)cinnamate,619-059-4,946-99-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
30477,Tetrakis[2-(2-methoxyethoxy)ethyl] orthosilicate,246-406-3,24685-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,23,H335:23;H319:23;H315:23
30480,"trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate",427-710-7,215612-56-9,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H317:0
30482,Barium tin trioxide,234-545-2,12009-18-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,171,H332:171;H302:171
30484,"(±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol",411-580-3,107898-54-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H315:0
30486,Acetonyltriphenylphosphonium bromide,218-796-5,2236-01-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
30487,"4,4'-Isopropylidenediphenol bis(2,3-epoxypropyl) ether, oligomers, esters with acrylic acid",500-127-6,54847-34-6,Not Classified,Notified C&L,8,Not classified:6;H335:2;H319:2;H315:2
30494,Sucrose hexalaurate,303-037-3,94139-22-7,Not Classified,Notified C&L,1,Not classified:1
30495,"Myrtus communis, ext.",282-012-8,84082-67-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1606,H317:1605;H226:1604;H304:1603;H411:7;H315:1604;H410:1413;H400:1368;H319:286;H351:308;H341:289
30498,Tin monoxide,244-499-5,21651-19-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT RE 1;STOT RE 2,REACH registration C&L,33,H373:6;H319:7;H317:7;H302:7;H372:7;Not classified:26
30499,3-(chloromethyl)pyridinium chloride,230-150-4,6959-48-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,49,H314:46;H302:49;H312:4;H351:4;H317:4;H341:4;H290:1;H318:1
30502,Mofebutazone,218-641-1,2210-63-1,Acute Tox. 4,Notified C&L,39,H302:39
30504,2-[(o-nitrophenyl)azo]-p-cresol,215-863-0,1435-71-8,Not Classified,Notified C&L,84,Not classified:84;H413:1
30506,Tetralithium orthosilicate,236-634-1,13453-84-4,Acute Tox. 4,Notified C&L,196,H302:196
30507,"4-[2-(4-hydroxyphenyl)propan-2-yl]phenol, reaction product with diphenyl carbonate",926-571-4,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Muta. 2;Repr. 1B;STOT RE 2,REACH registration C&L,1,H373:1;H360:1;H317:1;H314:1;H331:1;H341:1;H311:1;H301:1;H361:1
30508,"Dichloro[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]silicon",242-969-4,19333-10-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H315:39
30512,"Rosin, maleated, esterified with sorbitol",925-698-2,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,2,H319:2;H317:2;H413:2
30515,"Benzenamine, 4,4'-methylenebis-, reaction products with Bu glycidyl ether",272-470-7,68855-22-1,Not Classified,Notified C&L,22,Not classified:22
30518,"α-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",254-484-5,39515-40-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H302:156;H410:156;H400:141;H332:14;H370:13;H372:13
30523,"Fatty acids, C18-unsatd., dimers, 2-ethylhexyl esters",500-204-4,68334-05-4,Not Classified,REACH registration C&L,543,Not classified:541;H413:2
30525,Triethoxyoxovanadium,216-870-1,1686-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
30526,[2H6]methylammonium chloride,238-848-0,14779-55-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
30528,"2,2'-[1,4-phenylenebis(1,3,4-oxadiazole-5,2-diyl)]bis[1-aminoanthraquinone]",258-090-4,52671-38-2,Not Classified,Notified C&L,15,Not classified:15
30533,2-propyl-1H-imidazole,256-902-1,50995-95-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,232,H302:187;H318:187;H315:227;H335:39;H319:40;Not classified:5
30535,Tripropylamine,203-047-7,102-69-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1110,H335:1003;H226:1104;H332:1045;H314:1104;H311:1023;H301:1092;H412:160;H318:959;H312:81;H331:53;H300:10;Not classified:7;H330:4;H302:2;H319:1
30537,"1,1'-(dodecylimino)dipropan-2-ol",216-276-2,1541-66-8,Aquatic Chronic 2,Notified C&L,34,H411:34;H314:1
30549,Tetraamminepalladium(2+) diacetate,262-819-1,61495-96-3,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40,H319:40;H410:2;H400:2;H317:2;H302:2;H335:38;H315:38
30551,Hexanoic acid,205-550-7,142-62-1,Skin Corr. 1C,REACH registration C&L,2002,H314:2000;H318:1514;H311:340;H302:50;H331:40;H332:7;Not classified:4;H312:2;H290:1;H317:1;H412:1
30556,Chloromethylphosphonic acid,219-895-6,2565-58-4,,Notified C&L,1,H314:1;H302:1;H312:1
30559,L-p-menth-3-yloxyacetic acid,254-857-2,40248-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40
30562,"Ammonium O,O-bis(methylphenyl) dithiophosphate",261-229-1,58373-83-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,14,H314:14;H302:14;H311:14;H410:14
30564,"N,N-diethyl-1,1,1-trimethylsilylamine",213-637-6,996-50-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,69,H314:68;H225:69;H335:2;H319:1;H315:1;H318:2;H312:1;H410:1;H400:1;H332:1;H302:1;H411:1
30566,[No public or meaningful name is available],485-360-0,120144-90-3,Flam. Sol. 2;Pyr. Sol. 1;Self-heat. 2,Notified C&L,2,H252:2;H250:2;H228:2
30569,nickel telluride,235-260-6,12142-88-0,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H400:0;H317:0;H372:0;H350:0
30571,[No public or meaningful name is available],,,,Notified C&L,1,Not classified:1
30573,Propyl cinnamate,231-916-0,7778-83-8,Flam. Liq. 3,Notified C&L,1412,H226:1286;Not classified:88;H411:38
30582,(2H)chloroform,212-742-4,865-49-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2;Repr. 2;STOT RE 1,REACH registration C&L,97,H319:49;H351:61;H331:49;H302:57;H336:12;H372:50;H361:50;H315:60;Not classified:36;H373:11;H300:4;H370:1;H314:1;H341:1;H318:1;H411:1
30588,nickel titanium oxide,235-752-0,12653-76-8,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H372:0;H350:0;H317:0
30589,[[4-(trifluoromethoxy)phenyl]hydrazono]malononitrile,206-730-8,370-86-5,Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,129,H301:129;H317:127;H413:127;H319:1;H331:1;H311:1;H330:1;H315:1
30592,"3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carbonyl chloride",224-723-8,4462-55-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,22,H319:8;H315:7;H314:14;H317:1
30594,"1-[1,6-dimethyl-4-(4-methylpent-3-enyl)-3-cyclohexen-1-yl]ethan-1-one",260-772-1,57499-57-7,Not Classified,REACH registration C&L,3,Not classified:3
30599,"1-[1,1'-biphenyl]-4-yl-2-phenylethan-1-one",217-888-2,2001-23-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
30603,"Naphtha (petroleum), catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",273-271-8,68955-35-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
30604,2-undecyl-1H-imidazole-1-propiononitrile,245-973-4,23996-16-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H319:1;H331:1;H311:1;H301:1;H315:1
30605,Isopentyl p-methoxycinnamate,275-702-5,71617-10-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,39,H400:39;H410:17
30611,"Oxalic acid, niobium salt",244-341-5,21348-59-4,,Notified C&L,5,H302:5;H312:5;H314:1
30612,"N,3-dimethyl-L-valinamide",431-420-6,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
30614,BUTAMINE HCl,453-190-6,,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2,H302:2;H412:2;H319:2
30615,"2,4-dimethylhexan-3-ol",236-554-7,13432-25-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
30619,5-dodecyl-2-hydroxybenzaldehyde oxime,278-736-9,77635-32-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,22,H319:22;H410:22;H317:22;H302:22;H315:22
30622,Sodium 3-(2-propyn-1-yloxy)-1-propanesulfonate,608-454-7,30290-53-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H302:1;H318:1;H412:1;H315:1
30623,2-(2-Methoxyphenoxy)ethanamine,606-000-2,1836-62-0,Not Classified,REACH registration C&L,54,Not classified:3;H302:40;H318:39;H314:10;H319:4;H315:4;H335:2;H312:1;H332:2
30628,nickel hydroxide,234-348-1,11113-74-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H410:0;H400:0;H317:0;H332:0;H302:0;H334:0;H341:0;H372:0;H350:0;H315:0
30630,Strontium sulphate,231-850-2,7759-02-6,Not Classified,REACH registration C&L,47,Not classified:41;H413:4;H412:2
30631,3-hydroxy-p-toluic acid,209-571-2,586-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:46;H319:49;H315:47;H412:3;H302:1;H318:1
30633,Rhenium trioxide,215-228-8,1314-28-9,Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39
30634,"2,6-dibromoaniline",210-158-4,608-30-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H319:47;H317:38;H315:47;H332:8;H302:8;H311:5;H373:1;H312:3;H371:1
30635,"α,α,4-trimethylcyclohexylmethyl acetate",201-264-1,80-25-1,Not Classified,Notified C&L,312,Not classified:217;H411:95;H319:52;H317:52;H226:38;H304:38
30639,"2,5-dihydro-3-methyl-1-phenyl-1H-phosphole 1-oxide",231-463-9,7564-51-4,Not Classified,Notified C&L,3,Not classified:1;H335:2;H319:2;H315:2;H312:1;H332:1;H302:1
30640,Hyoscyamine hydrochloride,227-686-6,5934-50-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H301:1;H311:1;H331:1
30641,"bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium",410-500-4,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
30647,"4-amino-3,5,6-trichloropyridine-2-carboxylic acid",217-636-1,1918-02-1,Aquatic Chronic 3,Notified C&L,191,H412:90;H400:56;H410:59;H319:42;H335:4;H411:3;Not classified:3;H332:1;H302:1;H350:1;H312:1
30648,Tetraethylammonium cyanide,236-566-2,13435-20-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H410:38;H400:38;H330:38;H310:38
30651,BLEU REACTIF TZ 3926,415-530-1,,Not Classified,Notified C&L,1,Not classified:1
30655,4-[(o-tolyl)azo]-o-toluidinium chloride,218-945-4,2298-13-7,Carc. 2,Notified C&L,1,H351:1
30656,Valerian root oil,616-930-0,8008-88-6,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,59,H319:58;H410:56;H400:56;H317:59;H226:57;H304:59;H411:2
30659,"2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-",603-355-5,129722-12-9,Acute Tox. 3,Notified C&L,109,H301:93;H302:15;H413:7;H361:7;H331:1;H332:3;H412:1;H312:2;H360:3;H410:3;H362:4;H351:4;H372:3;H350:2;H370:1;H373:3;H335:1;H319:1;H315:1;H336:1;H400:1;H317:1;H341:1
30662,"3-((3,4-dicyanophenyl)sulfonyl)-N-(2-hydroxypropyl)propane-1-sulfonamide",611-431-4,569316-81-0,Not Classified,REACH registration C&L,1,Not classified:1
30667,"Waxes and waxy substances, palm",232-420-7,8021-56-5,Not Classified,Notified C&L,3,Not classified:3
30672,"Benzenesulfonic acid, mono-C15-36-branched alkyl derivs., calcium salts",290-660-8,90194-49-3,Skin Sens. 1B,Notified C&L,33,H317:33
30673,"(±)-N-(2,6-dimethylphenyl)-2-(ethylpropylamino)butyramide monohydrochloride",253-144-3,36637-19-1,Acute Tox. 3,Notified C&L,5,H301:3;H302:2
30674,Tetradecyne,212-139-6,765-10-6,Not Classified,Notified C&L,2,Not classified:1;H304:1
30675,"Distillates (petroleum), polymd. steam-cracked petroleum distillates, C",270-735-1,68477-50-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
30679,Methyl linoleate,203-993-0,112-63-0,Not Classified,Notified C&L,1448,Not classified:1448
30683,"2-(diethylamino)-N-(2,4,6-trimethylphenyl)acetamide monohydrochloride",213-836-8,1027-14-1,Acute Tox. 4,Notified C&L,1,H302:1
30684,"Phosphoric acid, octadecyl ester, compd. with 2,2'-iminobis[ethanol]",284-594-9,84930-14-3,Not Classified,Notified C&L,1,Not classified:1
30685,Ethyl 1-naphthylacetate,218-332-1,2122-70-5,,Notified C&L,2,H302:1;H412:1
30687,Dosulepin hydrochloride,212-978-8,897-15-4,Acute Tox. 4,Notified C&L,41,H302:40;H301:1;H370:1;H332:1;H361:1
30688,"2,2-diisopropyl-1,3-dioxolane",224-591-1,4421-10-7,Eye Irrit. 2,Notified C&L,43,H319:38;H226:5
30693,"Benzoic acid, 3,5-diamino-2-[2-(2-sulfophenyl)diazenyl]-, sodium salt (1:2), reaction products with diazotized 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate, sodium salts",610-409-1,481066-69-7,Not Classified,Notified C&L,1,Not classified:1
30694,4-[(2-hydroxy-1-naphthyl)azo]naphthalenesulphonic acid,242-148-0,18268-54-7,Not Classified,Notified C&L,2,Not classified:2
30695,"Barosma crenata, ext.",296-170-0,92346-85-5,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,138,H317:112;H302:138;H304:111;H411:111;H315:110;H341:1;H351:1
30697,"1,1,3,3-tetramethyl-1,3-diphenyldisiloxane",200-265-4,56-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H319:39;H315:39;H332:1;H302:1;H312:1
30699,Sodium phenylpyruvate,204-053-2,114-76-1,Not Classified,Notified C&L,1,Not classified:1
30702,Zinc bis(p-nonylphenolate),277-783-2,74230-03-8,Not Classified,Notified C&L,1,Not classified:1
30704,"Carbonic acid, dimethyl ester, polymer with 1,6-hexanediol",500-286-1,101325-00-2,Not Classified,Notified C&L,74,Not classified:74
30707,(4-hydroxyphenyl) 3-pyridyl ketone,252-796-6,35926-15-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
30708,4-bromothiophene-2-carbaldehyde,242-577-3,18791-75-8,,Notified C&L,6,H335:6;H319:6;H315:6;H312:1;H332:1;H302:1
30709,"Hieracium pilosella, ext.",281-668-2,84012-22-6,Flam. Liq. 3,Notified C&L,3,H226:3;H319:1
30711,"Carbamic acid, [3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl]methyl-, ethyl ester",605-285-0,16234-88-1,Not Classified,Notified C&L,1,Not classified:1
30712,"Perylene-3,4:9,10-tetracarboxydiimide",201-344-6,81-33-4,Not Classified,REACH registration C&L,150,Not classified:150
30713,"3,6,9-trioxaundecamethylene bis(2-ethylhexanoate)",242-149-6,18268-70-7,Not Classified,REACH registration C&L,454,Not classified:449;H302:5;H319:5;H315:5
30714,"(Z,E)-tetradeca-9,12-dienyl acetate",608-490-3,30507-70-1,Skin Irrit. 2,Notified C&L,5,H315:5
30722,Choline dihydrogen phosphate,281-072-2,83846-92-8,Not Classified,Notified C&L,2,Not classified:1;H335:1;H319:1;H315:1
30725,4-trans-(4-trans-Propylcyclohexyl)-cyclohexancarbonic acid,613-782-9,65355-32-0,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:2;H410:3
30727,Sodium 3-hydroxy-4-(2-hydroxy-1-naphthylazo)-1-naphthalenesulphonate,219-810-2,2538-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:39;H319:50;H315:49;Not classified:1
30729,"β-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]",612-110-1,61276-17-3,Not Classified,Notified C&L,2,Not classified:2
30741,Trazodone,243-317-1,19794-93-5,Acute Tox. 4,REACH registration C&L,3,H302:3
30743,C.I. Acid Yellow 246,400-910-1,,Aquatic Chronic 3,REACH registration C&L,5,H412:5
30746,"4,6-dinitroresorcinol",210-489-4,616-74-0,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1;H228:1
30748,Methylheptenol,215-619-3,1335-09-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,234,H319:234;H315:234
30753,"Isocyanic acid, polymethylenepolyphenylene ester",618-498-9,9016-87-9,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,1776,H373:1392;H335:1652;H319:1656;H334:1524;H330:569;H315:1656;H351:899;H317:1051;H332:901;H410:85;H312:59;H314:59;H302:97;H411:59;H341:54;Not classified:7
30758,trans-4-phenylcyclohexan-1-ol,227-295-0,5769-13-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H332:1;H302:1;H315:1
30760,Aluminium fluoride,232-051-1,7784-18-1,,REACH registration C&L,294,Not classified:279;H335:11;H319:11;H315:11;H301:5;H314:4;H302:5;H331:1
30761,Potassium thiocyanate,206-370-1,333-20-0,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,267,H312:266;H332:266;H302:267;H412:217;H318:70;H319:74;H410:22;H400:22;H413:10;H373:6
30762,"3-((1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-phenylamino)-methyl)-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester Diacetate",925-312-2,,,REACH registration C&L,2,Not classified:2
30765,"2,5-dichlorobenzene-1,4-diamine",243-512-1,20103-09-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,78,H302:45;H335:44;H319:45;H315:45;Not classified:33;H312:5;H332:5
30769,2-hydroxy-6-nitro-4-sulphonaphthalene-1-diazonium,256-582-3,50412-00-5,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,92,H314:8;H318:8;Not classified:84
30770,"Residues (petroleum), steam-cracked, resinous;Heavy Fuel oil;[A complex residuum from the distillation of steam-cracked petroleum residues.]",273-272-3,68955-36-2,Carc. 1B,Harmonised C&L,0,H350:0
30771,Vinyl trifluoroacetate,207-088-1,433-28-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,43,H312:39;H314:43;H302:39;H332:39;H225:43;H351:4;H335:4;H341:1;H318:1
30773,"2,3-bis((2-mercaptoethyl)thio)-1-propanethiol",411-290-7,131538-00-6,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H373:0;H400:0
30776,"Disodium 7-hydroxynaphthalene-1,3-disulphonate",212-674-5,842-19-3,Eye Irrit. 2,REACH registration C&L,2,H319:2
30778,"Gibbane-1,10-dicarboxylic acid, 2,4a-dihydroxy-1-methyl-8-methylene-, 1,4a-lactone, (1α,2β,4aα,4bβ,10β)-",207-406-9,468-44-0,Skin Sens. 1,Notified C&L,2,H317:1;Not classified:1
30779,"Pentasodium 2-[[8-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulphonato-2-naphthyl]azo]naphthalene-1,5-disulphonate",278-674-2,77365-64-1,Not Classified,REACH registration C&L,97,Not classified:87;H334:7;H318:4;H319:2;H332:1;H302:1;H312:1;H317:1
30782,"Dioleic acid, diester with decaglycerol",251-750-2,33940-99-7,Not Classified,Notified C&L,8,Not classified:8
30793,"2,2-dichloro-1-methylcyclopropanecarboxylic acid",215-901-6,1447-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
30794,Aluminum gallium magnesium oxide,261-969-5,59871-73-7,Aquatic Chronic 3,Notified C&L,7,H412:7
30795,"2,3,5,6-tetrachloropyridine-4-thiol",233-764-0,10351-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
30799,"5,6,11,12-tetrahydrodibenz[b,f]azocinium chloride",279-577-8,80866-74-6,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
30801,"2,4,7,9-tetramethyldec-5-yne-4,7-diol",204-809-1,126-86-3,Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1887,H402:13;H318:817;H317:585;H412:1434;H319:1033;H400:52;H410:66;Not classified:37;H335:28;H315:28;H373:15;H413:2;H411:2;H302:1
30804,"cis-3,5,5-trimethylcyclohexan-1-ol",213-268-0,933-48-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,130,H412:3;H319:129;H315:130;H318:1
30806,6-nitrobenzoxazol-2(3H)-one,225-157-4,4694-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:45;H319:45;H315:45;H312:1;H332:1;H302:1
30807,Domiphen bromide,208-702-0,538-71-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:40;H319:42;H315:42;H302:7;H312:2;H332:2
30808,bis(piperidinothiocarbonyl) disulphide,202-328-1,94-37-1,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H335:0;H319:0;H317:0;H315:0
30813,1-Hexylpyridinium chloride,612-956-1,6220-15-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:1;H319:1;H315:1;Not classified:1
30814,Lead diformate,212-371-8,811-54-1,,Notified C&L,4,H373:4;H360:4;H410:4;H400:4;H332:4;H302:4
30815,"Antimony(3+) potassium [R-(R*,R*)]-monotartrate",229-436-1,6535-15-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H332:1;H302:1;H411:1
30820,"Butanal, reaction products with aniline",270-109-8,68411-20-1,Skin Sens. 1B;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,146,H373:5;H317:4;H411:4;H319:140;H315:3;Not classified:1
30823,Bromoterephthalic acid,209-572-8,586-35-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H301:38;H335:43;H319:44;H315:44;H314:1
30824,"N-allyl-1,1,1-trimethyl-N-(trimethylsilyl)silylamine",231-699-2,7688-51-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H335:39;H319:39;H315:39
30830,C.I. 74190 Direct Blue 199,602-190-6,12222-04-7,Eye Irrit. 2,Notified C&L,166,H319:85;H302:50;H373:50;H411:50;Not classified:31
30833,Spinflam MF 83 PP-25,442-080-3,,Eye Irrit. 2,Notified C&L,32,H319:32
30834,3-nitrobenzoic acid,204-508-5,121-92-6,Eye Irrit. 2,REACH registration C&L,99,H319:98;H335:84;H302:94;H412:50;H315:54;H341:5;H314:2;Not classified:1
30838,"2-ethylhexyl 4,4-dibutyl-10-ethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate",234-186-1,10584-98-2,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Muta. 2;STOT SE 1;STOT RE 1;Aquatic Acute 1,REACH registration C&L,401,H370:37;H319:327;H410:167;H400:152;H317:252;H331:37;H302:327;H341:176;H311:37;H372:247;H315:200;H360:299;Not classified:74;H373:56;H312:79;H335:23;H413:3
30840,4-fluorophenyl isocyanate,206-966-1,404-71-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H335:44;H319:44;H312:38;H226:44;H302:38;H332:38;H315:44;H334:6;H330:4;H301:6;H311:1;H331:1
30844,"4-[(2,5-dichlorophenyl)azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide",229-104-6,6410-38-4,Skin Sens. 1,REACH registration C&L,46,H317:3;Not classified:43
30845,Fyroflex SOL-DP,479-310-7,,Not Classified,Notified C&L,1,Not classified:1
30847,Cobalt sulfide,235-751-5,12653-56-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,25,H400:15;H317:25;H410:25
30849,p-[2-(methylamino)ethyl]phenol,206-731-3,370-98-9,,Notified C&L,1,H314:1;H302:1;H335:1
30854,5-cyanoisophthalic acid,245-594-4,23341-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
30855,Sodium 2-methylpropan-2-olate,212-741-9,865-48-5,Flam. Sol. 1;Self-heat. 1;Skin Corr. 1B,REACH registration C&L,782,H314:782;H251:311;H228:140;H318:529;H335:444;Not classified:1;H302:1
30859,rhodiola rosea extract,927-596-3,,,Notified C&L,1,H302:1
30867,Raffinose,208-146-9,512-69-6,Not Classified,Notified C&L,33,Not classified:33
30873,Potassium neodecanoate,247-978-7,26761-42-2,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,39,H318:12;H315:15;H319:15;Not classified:10
30875,"Hydrocarbon waxes (petroleum), clay-treated, microcryst., oxidized, potassium salts",275-287-0,71243-66-8,Not Classified,Notified C&L,4,Not classified:4
30876,4-chloro-2-nitro-N-phenylaniline,240-660-9,16611-15-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
30878,"Hexanedioic acid, polymer with 1,4-butanediol and 1,2-ethanediol",607-961-0,26570-73-0,Not Classified,Notified C&L,63,Not classified:63
30880,"[2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulphophenyl)-1H-pyrazol-4-yl]azo]benzoato(3-)]chromium",276-702-8,72496-90-3,Not Classified,Notified C&L,8,Not classified:8
30884,N-ethyl-p-methoxy-α-methylphenethylamine,238-339-3,14367-46-5,Acute Tox. 3;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,56,H301:55;H318:44;H314:53;H317:54;H335:44;H311:43;H310:9;H319:2;H315:2;H332:1;H361:1;H228:1
30885,"N,N-bis-(2-hydroxyethyl)-p-toluidine",600-470-2,103671-44-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,231,H302:231;H318:211;H317:32;H341:32;H412:32;H315:32;H319:20
30888,"Rhubarb, Rheum palmatum, ext.",290-249-3,90106-27-7,Flam. Liq. 3,Notified C&L,27,H226:26;Not classified:1
30891,DL-3-methylcyclopentanone,217-148-9,1757-42-2,Flam. Liq. 3,Notified C&L,42,H226:42
30893,Diiodomethane,200-841-5,75-11-6,Not Classified,REACH registration C&L,70,Not classified:5;H302:58;H318:49;H335:64;H315:64;H319:16;H312:10;H332:11;H311:5;H301:6;H314:1;H331:1
30894,methylcyclohexane,203-624-3,108-87-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H225:0;H336:0;H304:0;H411:0;H315:0
30897,"Linseed oil, cobalt manganese salt",271-392-0,68553-15-1,Not Classified,Notified C&L,64,Not classified:35;H319:29;H315:29
30900,"Succinic acid, ammonium salt",239-631-3,15574-09-1,,Notified C&L,44,Not classified:33;H335:11;H319:11;H315:11
30905,"N,N-dimethyl-p-toluenesulphonamide",209-971-7,599-69-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
30908,"(1α,2β,3aα,4β,7β,7aα)-1,2,4,5,6,7,8,8-octachloro-2,3,3a,4,7,7a-hexahydro-4,7-methano-1H-indene",225-826-0,5103-74-2,Acute Tox. 4;Carc. 2;Aquatic Acute 1,Notified C&L,45,H302:44;H351:40;H400:42;H335:2;H319:2;H312:2;H332:2;H315:2;Not classified:1
30909,4-aminophenylacetic acid,214-828-7,1197-55-3,,Notified C&L,7,H335:6;H319:7;H315:7
30910,"1H-Pyrrole-2-acetamide, 1-[(2-chlorophenyl)methyl]-N,N-bis(1-methylpropyl)-.alpha.-oxo-",918-617-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H335:1;H319:1;H315:1
30911,2-Aminoadenosine,606-677-4,2096-10-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
30913,4-chloro-3-phenyl-L-alanine,238-023-5,14173-39-8,Acute Tox. 3;Skin Sens. 1,Notified C&L,39,H301:39;H317:39
30914,4-benzyloxy-2-nitro-beta-pyrrolidinostyrene,619-437-9,99474-22-3,Not Classified,REACH registration C&L,4,Not classified:4
30919,"1,4-bis(vinyloxy)butane",223-437-0,3891-33-6,Flam. Liq. 3;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,122,H226:84;H317:84;H411:84;H335:38;H319:38;H315:38
30921,3-(4-aminophenyl)-2-cyano-2-propenoic acid,417-480-6,252977-62-1,Skin Sens. 1,Harmonised C&L,0,H317:0
30922,"5-Amino-2,4-dichloroanisole",619-345-9,98446-49-2,,Notified C&L,6,H335:4;H319:5;H312:5;H332:5;H302:5;H315:5;H301:1;H311:1;H331:1
30931,4-methyl-1-oxaspiro[5.5]undecene,269-401-8,68228-06-8,Not Classified,Notified C&L,89,Not classified:79;H412:10;H315:10
30932,Araucaria angustifolia,307-625-0,97675-53-1,Not Classified,Notified C&L,1,Not classified:1
30934,"2-(2H-1,2,3-benzotriazol-2-yl)-6-(2-phenylpropan-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol",422-600-5,,Not Classified,REACH registration C&L,92,Not classified:92
30936,"2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal",221-597-6,3155-71-3,Skin Sens. 1,Notified C&L,129,H317:128;H319:51;H411:50;H315:26;H410:1;H400:1
30938,2-acetoxymethyl-4-benzyloxybut-1-yl acetate,407-140-5,131266-10-9,Aquatic Chronic 3,Harmonised C&L,0,H412:0
30939,"(E,Z) 4-[3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl] morpholine",600-969-5,110488-70-5,Aquatic Chronic 1,Notified C&L,195,H411:195
30940,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-isopropyl-L-threonine,276-261-1,71989-35-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H400:39;H410:39;H332:2;H302:2;H312:2;Not classified:1;H317:1;H413:1
30943,"4(or 5)-methyl-1H-benzotriazole, potassium salt",265-002-8,64665-53-8,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,31,H301:21;H332:21;H412:26;H319:22;H302:9;H318:6;H314:4;H315:1;H411:1
30944,N-ethyl-N-methylaniline,210-364-4,613-97-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H301:38;H311:38;H331:38
30946,"1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene acetaldehyde",201-565-8,84-83-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H301:41;H335:42;H319:42;H315:42
30947,"tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-.sc.dl.sc.-aspartate",429-270-1,136210-30-5,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
30948,C.I. REACTIVE RED 221; KAYACELON REACT RED CN-3B,404-280-9,,Skin Sens. 1,Notified C&L,10,H317:8;Not classified:2
30950,Dodecyldimethylphosphine oxide,212-818-7,871-95-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
30951,"4,6-Dichloro-2-phenylpyrimidine",609-426-7,3740-92-9,Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,196,H332:196;H410:156;H317:195;H400:156;H318:39;H319:1;H315:1
30952,"Benzenemethanesulfonic acid, α,4-dihydroxy-, sodium salt (1:1)",611-295-6,55620-40-1,Not Classified,Notified C&L,1,Not classified:1
30954,Hexafluoroantimonyic acid,241-023-8,16950-06-4,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1A;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,42,H300:38;H314:38;H330:38;H310:38;H411:42;H332:4;H302:4
30958,N-chlorosuccinimide,204-878-8,128-09-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,112,H335:42;H410:8;H400:8;H314:71;H302:105;H290:8;H318:11;H319:34;H412:33;Not classified:7;H315:2;H332:1;H312:1
30960,"Reaction mass of methyl 3-(4,8-dimethylnona-3,7-dienyl)-3-methyl-oxirane-2-carboxylate and ethyl 3-(4,8-dimethylnona-3,7-dienyl)-3-methyl-oxirane-2-carboxylate and (5Z)-6,10-dimethylundeca-5,9-dien-2-one and (5E)-6,10-dimethylundeca-5,9-dien-2-one",917-606-4,,Not Classified,Notified C&L,1,Not classified:1
30963,2-methyleneundecanal,607-068-6,22414-68-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H410:1;H315:1
30966,tert-Butyldimethylsilyl (S)-(+)-glycidyl ether,602-924-5,123237-62-7,Acute Tox. 4,Notified C&L,50,H302:49;H319:12
30970,4-chlorobenzenesulphonamide,202-689-5,98-64-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H319:45;H315:45;Not classified:1
30973,p-anisidine;4-methoxyaniline,203-254-2,104-94-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H373:0;H300:0;H400:0;H330:0;H310:0
30974,N-tosyl-L-aspartic acid,225-391-7,4816-82-4,Acute Tox. 4,Notified C&L,11,H302:11
30976,"Formic acid, compound with N,N-dimethylcyclohexylamine (1:1)",270-618-5,68459-80-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,25,H301:25;H311:25;H331:25
30981,"4'-tert-butyl-2',6'-dimethylacetophenone",218-037-8,2040-10-0,Acute Tox. 3;Acute Tox. 4,Notified C&L,1581,H301:1581;H312:1581
30982,"1,1-bis(vinyloxy)butane",203-046-1,102-68-1,Not Classified,Notified C&L,5,Not classified:5
30985,"Sulfuric acid, aluminum ammonium salt (2:1:1), dodecahydrate",616-522-2,7784-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H335:51;H319:52;H315:51;H412:1
30986,4-(4-bromophenyl)piperidin-4-ol,261-065-0,57988-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:39;H319:40;H315:40;H302:2;H318:1;H317:1
30987,"L-Glutamic acid, N,N-bis(carboxymethyl)-, monosodium salt",608-180-8,282524-66-7,Not Classified,Notified C&L,2,Not classified:2
30988,"4-methoxy-6-methyl-1,3,5-triazin-2-amine",216-790-7,1668-54-8,Acute Tox. 4,Notified C&L,143,H302:143;H335:39;H319:41;H315:41;H331:13;H336:13;H373:13
30994,"Ethyl 1,3-dithiane-2-carboxylate",243-838-4,20462-00-4,Flam. Liq. 3,Notified C&L,43,H226:43
30995,"1,1,2,3,4,4-hexafluorobuta-1,3-diene",211-681-0,685-63-2,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,122,H373:2;H280:122;H331:122;H220:122;H412:2
30998,4-(dimethylamino)-2-phenylbutyronitrile,256-642-9,50599-78-5,Eye Irrit. 2,Notified C&L,38,H319:38
31000,"Propane, 1,1,1,2,2,3,3-heptafluoro-3-methoxy-",609-440-3,375-03-1,Not Classified,Notified C&L,4,Not classified:4
31001,"3,5-Diiod-O-(4-methoxyphenyl)-L-tyrosine",619-013-3,94345-95-6,STOT RE 2,Notified C&L,1,H373:1
31002,3-amino-N-butyl-4-methoxybenzenesulphonamide,201-261-5,80-22-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H332:38;H302:38;H351:38;H312:38
31003,1-azabicyclo[2.2.1]heptane,205-997-8,279-27-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;STOT RE 2,Notified C&L,1,H373:1;H312:1;H314:1;H302:1;H225:1
31004,"21-Acetoxy-16 alpha-methyl-4-pregnene-3,20-dione",609-765-0,39987-85-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
31005,"Silane, trimethoxyoctyl-, hydrolysis products with silica",296-597-2,92797-60-9,Not Classified,Notified C&L,157,Not classified:157
31008,Chlorantraniliprole,610-489-8,500008-45-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,225,H400:186;H410:186;H335:39;H319:39
31010,".sc.d.sc.-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate",432-960-5,124655-09-0,Acute Tox. 4,Harmonised C&L,0,H302:0
31012,N-benzoyl-4-piperidone,246-407-9,24686-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
31014,"2,6-dimethyl-4-pyrone",213-719-1,1004-36-0,Acute Tox. 4,Notified C&L,46,H302:46;H332:1;H312:1
31015,Clidinium bromide,222-471-3,3485-62-9,Acute Tox. 4,Notified C&L,41,H302:39;H332:2;H312:2
31024,"Fatty acids, C16-18, triesters with 3,3'-oxybis[1,2-propanediol]",293-033-7,91050-86-1,Not Classified,Notified C&L,6,Not classified:6
31025,"Distillates (petroleum), chemically neutralized heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-127-8,64742-27-4,Carc. 1A,Harmonised C&L,0,H350:0
31028,4-phenylsemicarbazide. hydrochloride,226-628-7,5441-14-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
31029,"Cashew, nutshell liq.",232-355-4,8007-24-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1,Notified C&L,185,H302:109;H318:140;H317:144;H315:147;Not classified:38;H312:42;H412:4;H335:5;H319:7;H334:3;H332:1
31031,"7(S)-hydroxy-16(R)-methyl-10-phenyl-24-oxa[14]cytochalasa-6(12),13(E),21(E)-triene-1,20,23-trione",237-964-9,14110-64-6,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Repr. 2,Notified C&L,39,H310:39;H361:39;H300:39;H330:39
31034,2-methylbutene,247-975-0,26760-64-5,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 2,REACH registration C&L,27,H225:26;H351:2;H336:2;H302:27;H341:2;H304:2;H411:2;H315:2;H224:1
31037,"1,1'-iminodianthraquinone",201-405-7,82-22-4,Eye Irrit. 2,Notified C&L,39,H319:39
31038,"(1-Methyl-2-(1,2,2-trimethylbicyclo[3.1.0]-hex-3-ylmethyl)cyclopropyl)methanol",606-389-9,198404-98-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,218,H400:178;H410:218
31039,"Benzenesulfonic acid, C10-16-alkyl derivs., magnesium salts",271-533-6,68584-26-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H302:1;H318:1;H315:1
31041,"7,8-dihydroxy-2-phenyl-4-benzopyrone",253-812-4,38183-03-8,Acute Tox. 4,Notified C&L,38,H302:38
31042,(ethylsulphonyl)benzene,209-972-2,599-70-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
31045,"Estra-1,3,5(10),7-tetraene-3,17-diol, 3-(hydrogen sulfate), monosodium salt, (17α)-",259-967-4,56050-05-6,Repr. 2,Notified C&L,41,H360:40;H361:25;H351:16
31052,"Octahydro-4,7-methano-1H-indene-2-carboxylic acid",254-858-8,40252-86-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
31053,"Sodium 1-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]-2-methylpropane-2-sulphonate",261-226-5,58370-37-9,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,37,H412:37;H319:37
31058,1-[[(2-hydroxyphenyl)imino]methyl]-2-naphthol,212-975-1,894-93-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,123,H400:85;H410:85;H317:38
31060,"Phosphoric acid, decyl ester, branched and linear, compd. with triethanolamine",307-236-6,97553-74-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
31064,potassium ferrite,430-010-4,12160-44-0,Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H314:0;H317:0
31065,Methyl 2-hydroxycyclohexanecarboxylate,218-797-0,2236-11-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:39;H318:39;H335:39;H315:39
31067,"2-ethyl-2-[[(1-oxodecyl)oxy]methyl]-1,3-propanediyl didecanoate",201-090-6,78-17-1,Not Classified,Notified C&L,1,Not classified:1
31068,o-aminophenethyl alcohol,226-275-9,5339-85-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,130,H302:89;H319:129;H335:39;H315:40;Not classified:1
31072,"2-Pyrazineethanol, α-phenyl-",609-310-6,36914-69-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
31073,4-(isopropyl)cyclohexadiene-1-ethyl formate,272-066-0,68683-20-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,265,H319:265;H317:265;H315:265
31075,"3',4',5'-trifluorobiphenyl-2-amine",619-905-2,915416-45-4,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,117,H319:84;H317:84;H410:84;H411:33
31078,3-chloro-4-(dimethylamino)benzenediazonium hexafluorophosphate,270-033-5,68400-43-1,Not Classified,Notified C&L,3,Not classified:2;H332:1;H302:1;H312:1;H228:1
31079,"Benzo-1,3-dioxole-5-methylamine",220-056-1,2620-50-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:43;H319:43;H315:43;H314:6;H318:2;Not classified:1
31080,Potassium sulfate,231-915-5,7778-80-5,Not Classified,Notified C&L,532,Not classified:475;H318:59;H319:5;H315:1
31084,Cefotetan,274-093-3,69712-56-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H334:3;H317:3
31086,Allyl tetraethyldiamidophosphate,278-141-4,75219-49-7,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,4,H314:4;H302:4;H335:4
31090,4-ethoxymethylene-2-phenyl-2-oxazoline-5-one,239-713-9,15646-46-5,Skin Sens. 1,Notified C&L,42,H317:42;H335:4;H319:4;H315:4
31091,"Myristica fragrans, ext.",282-013-3,84082-68-8,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Muta. 2;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,1493,H317:1454;H226:1454;H341:1451;H350:1450;H304:1452;H411:87;H410:1366;H400:1357;H315:1358;Not classified:37;H351:4;H319:5;H335:1;H302:1;H412:2
31097,Thalidomide,200-031-1,50-35-1,Acute Tox. 4;Repr. 1A,Notified C&L,135,H302:128;H360:131;H301:5;H361:4;H312:4;H400:1;H372:1
31098,"N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate",258-997-5,54143-56-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,45,H335:44;H360:43;H319:44;H302:45;H315:43;H334:1;H361:2;H372:1;H411:1
31099,[No public or meaningful name is available],929-637-0,,Skin Corr. 1B,Notified C&L,1,H314:1
31104,Calcium myristate,239-328-6,15284-51-2,Not Classified,Notified C&L,3,Not classified:3
31110,17-α-methyloestradiol-17-beta,206-128-5,302-76-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,16,H312:16;H351:16;H332:16;H302:16;H361:16
31112,(pyridin-3-yl)methyl acetate,600-124-0,10072-09-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
31117,nickel sulfide,234-349-7,11113-75-0,Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H400:0;H317:0;H341:0;H372:0;H350:0
31120,"oils, palm, propoxylated",610-641-3,512802-65-2,Not Classified,REACH registration C&L,22,Not classified:22
31121,"2,4-dimethyl-4-phenyltetrahydrofuran",279-967-8,82461-14-1,Aquatic Chronic 3,REACH registration C&L,1658,H412:1323;H315:335;Not classified:1
31124,"(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)triethylene tris[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]",251-844-3,34137-09-2,Not Classified,Notified C&L,127,Not classified:127
31127,(2-hydroxyethyl)ammonium dihydrogen orthoborate,271-606-2,68586-07-2,Not Classified,Notified C&L,46,Not classified:27;H319:19;H315:19
31129,Haematoporphyrin,238-450-7,14459-29-1,Not Classified,Notified C&L,1,Not classified:1
31130,"Sodium 4,4'-bis(p-hydroxyphenylazo)-2,2'-vinylenedibenzenesulphonate",221-267-1,3051-11-4,Not Classified,Notified C&L,1,Not classified:1
31132,potassium (oxido-,613-953-8,66603-10-9,Flam. Sol. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H228:0;H301:0;H318:0;H411:0;H315:0
31133,Sodium phenylacetate,204-052-7,114-70-5,Eye Irrit. 2,REACH registration C&L,3,H319:2;H318:1
31134,N-(trimethylsilyl)acetamide,236-565-7,13435-12-6,,Notified C&L,44,Not classified:38;H335:4;H319:4;H315:4;H228:2
31140,"Sulfuric acid, mono-C8-16-alkyl esters, ammonium salts",306-734-0,97392-96-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
31142,"trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol",419-050-3,79944-37-9,Skin Sens. 1,Harmonised C&L,0,H317:0
31148,Isophthalic acid,204-506-4,121-91-5,Not Classified,REACH registration C&L,661,Not classified:601;H319:60;H315:5;H335:2
31153,4-amino-N-[4-(aminocarbonyl)phenyl]benzamide,277-874-7,74441-06-8,Not Classified,REACH registration C&L,37,Not classified:36;H319:1;H315:1
31156,"Alkenes, C11-13, C12-rich",271-215-7,68526-58-9,Asp. Tox. 1,Notified C&L,4,H304:4
31157,Alizarine Brilliant Sky Blue,612-608-9,61901-16-4,Aquatic Chronic 3,Notified C&L,3,H412:3
31161,1-methyl-2-[(2-methyl-1-oxoallyl)oxy]ethyl hydrogen phthalate,265-951-8,65859-45-2,Not Classified,Notified C&L,61,Not classified:61
31164,"2-Propanamine, N-(1-methylethyl)-, 4-methylbenzenesulfonate (1:1)",603-703-6,133080-79-2,Not Classified,Notified C&L,83,Not classified:83
31168,Magnesium acrylate,227-177-9,5698-98-6,Not Classified,REACH registration C&L,14,Not classified:10;H335:4;H319:4;H411:4;H315:4
31169,2'-deoxy-N-(2-methyl-1-oxopropyl)guanosine 3'-benzoate,264-386-4,63660-23-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,38,H301:38;H319:38;H331:38;H315:38
31170,Methyl N-[4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulphonyl]carbamate,244-254-2,21165-77-5,,Notified C&L,1,H302:1
31172,"(S)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose",240-429-2,16376-36-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:39;H312:38
31179,Benzyl(purin-6-yl)amine,214-927-5,1214-39-7,Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,156,H302:110;H411:89;H361:92;H400:92;H335:48;H319:49;H315:49;H412:7;Not classified:3;H332:1
31180,"1,3-Dioxol-2-one, 4-[(formyloxy)methyl]-5-methyl-",618-762-3,91526-17-9,Not Classified,Notified C&L,1,Not classified:1
31181,Dithallium carbonate,229-434-0,6533-73-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,44,H373:44;H300:44;H330:44;H310:38;H411:44
31182,"Formic acid, 2,2-dimethyl-6-methylene-cyclohexyl-, methyl ester",617-257-5,81752-87-6,Skin Irrit. 2,Notified C&L,113,H315:89;Not classified:24
31183,α-2-pyridylpyridine-2-methanol,252-338-5,35047-29-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
31191,2-pyridylmethylamine,223-090-5,3731-51-9,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,209,H314:209;H302:5;H318:6;H335:158;H319:158;H312:2
31193,Potassium metaborate,237-262-2,13709-94-9,Repr. 2,REACH registration C&L,92,H361:42;H319:90
31195,"Chromate(3-), bis[3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-1-naphthalenesulfonato(3-)]-, trihydrogen, nitro derivs.",271-881-9,68610-93-5,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
31196,2-(methylamino)isobutyric acid,219-898-2,2566-34-9,Eye Irrit. 2,Notified C&L,39,H319:39
31198,Palmitoyl chloride,203-996-7,112-67-4,Met. Corr. 1;Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,171,H290:93;H317:95;H315:95;H314:75;H335:27;H318:1;H319:1;Not classified:1
31200,"2-[[4,5-dihydro-3-methyl-5-oxo-1-[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]-1H-pyrazol-4-yl]azo]naphthalene-1,5-disulphonic acid, potassium sodium salt",288-950-4,85940-63-2,Not Classified,REACH registration C&L,2047,Not classified:2046;H319:1
31201,"1,2,3,4,5,6,7,8-octahydro-8,8-dimethyl-2-naphthaldehyde",273-661-8,68991-97-9,Aquatic Chronic 3,Notified C&L,1537,H412:1286;Not classified:226;H317:25;H411:1
31203,"Peptones, beef",293-426-3,91079-38-8,Not Classified,REACH registration C&L,9,Not classified:9
31204,"2,3-difluorobenzonitrile",244-418-3,21524-39-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,203,H302:201;H312:201;H335:44;H319:46;H332:45;H315:47;H331:1;H311:1;H301:2;H318:1
31205,Diallyl terephthalate,213-835-2,1026-92-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
31207,"3-ethyl-2-[7-(3-ethyl-3H-benzothiazol-2-ylidene)hepta-1,3,5-trienyl]benzothiazolium iodide",221-342-9,3071-70-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H335:39;H319:40;H312:39;H332:39;H302:39;H315:40
31208,Calcium bis(4-hydroxybenzoate),274-235-4,69959-44-0,Not Classified,Notified C&L,3,Not classified:3
31211,"N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide",425-650-6,171887-03-9,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H318:0;H317:0;H412:0
31213,"17-hydroxy-19-norpregn-4-ene-3,20-dione 17-acetate",250-882-8,31981-44-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,21,H360:19;H312:16;H351:19;H332:16;H302:16;H361:2;H362:3
31214,Dithallium trioxide,215-229-3,1314-32-5,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,69,H373:69;H411:69;H300:69;H330:69
31215,4-bromo-1-naphthylamine,218-944-9,2298-07-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H319:41;H315:41;H341:1
31216,"Potassium alloy, nonbase, K,Na",601-078-4,11135-81-2,Water-react. 1;Skin Corr. 1B,Notified C&L,1,H314:1;H260:1
31217,"1,2-di(2-pyridyl)ethylene",215-866-7,1437-15-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H315:39
31221,"4-chloro-2,6-xylenol",214-376-0,1123-63-3,,Notified C&L,6,H335:6;H319:6;H315:6
31223,"Phosphorodithioic acid, mixed O,O-bis(sec-Bu and isooctyl) esters, zinc salts",601-275-5,113706-15-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H315:1
31224,4-amino-5-(ethylsulphonyl)-o-anisic acid,275-833-8,71675-87-1,Not Classified,REACH registration C&L,18,Not classified:16;H302:1;H335:1;H319:1;H315:1
31226,"1,4-diamino-2,3-diphenoxyanthraquinone",229-066-0,6408-72-6,Not Classified,REACH registration C&L,2285,Not classified:2280;H319:4;H317:1
31227,"5-(phenylazo)toluene-3,4-diamine monohydrochloride",224-654-3,4438-16-8,Not Classified,Notified C&L,1,Not classified:1
31228,"Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;Petroleum gas;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]",273-270-2,68955-34-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H220:0;H350:0
31230,4-(4-Brom-5-ethyl-tetrahydropyran-2-yl)-phenol,919-822-4,,Not Classified,REACH registration C&L,2,Not classified:2
31232,"(±)-N,α-dimethylphenethylamine",225-433-4,4846-07-5,Eye Irrit. 2,REACH registration C&L,40,H319:40
31233,Lithium metaborate,236-631-5,13453-69-5,Acute Tox. 4;Eye Dam. 1;Repr. 2,REACH registration C&L,45,H302:33;H318:6;H361:6;Not classified:9;H335:3;H319:3;H315:3
31236,"chlorthiamid (ISO);2,6-dichloro (thiobenzamide)",217-637-7,1918-13-4,Acute Tox. 4,Harmonised C&L,0,H302:0
31237,cyclopentyl(thiophen-2-yl)methanone,619-401-2,99186-05-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
31239,"[R-(R*,R*)]-α-[1-(methylamino)ethyl]benzyl alcohol",206-292-8,321-97-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,40,H314:1;H302:40;H318:1;H317:1;H335:38;H319:39;H312:39;H332:39;H315:39;H371:1
31246,Aluminium iodide,232-054-8,7784-23-8,Skin Corr. 1B;Skin Sens. 1,Notified C&L,45,H314:45;H317:38
31247,"Reaction mass ofPyrrolo[3,4-c]pyrrole-1,4-dione, 3,6-bis(4-chlorophenyl)-2,5-dihydro-,Pyrrolo[3,4-c]pyrrole-1,4-dione, 3-(4-chlorophenyl)-2,5-dihydro-6-phenyl-, monosulfo deriv., monosodium saltandBenzenesulfonic acid, 4,4'-(2,3,5,6-tetrahydro-3,6-dioxopyrrolo[3,4-c]pyrrole-1,4-diyl)bis-, sodium salt (1:2)",460-020-4,,Eye Irrit. 2,Notified C&L,83,H319:83
31249,1-tert-Butoxypropan-2-ol,611-448-7,57018-52-7,Flam. Liq. 3;Eye Dam. 1,Notified C&L,41,H226:41;H318:40
31253,"S-[5-[(ethoxycarbonyl)amino]-1,3,4-thiadiazol-2-yl] O-ethyl thiocarbonate",244-417-8,21521-73-3,Skin Sens. 1,Notified C&L,1,H317:1
31254,"Formaldehyde, reaction products with N,N-dimethylbenzenamine and N-ethyl-2-methylbenzenamine, oxidized, acetates",281-503-4,83968-26-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,85,H319:83;H410:83;H400:83;H317:83;H301:83;H315:83;Not classified:2
31256,(2-butylbenzofuran-3-yl) (4-methoxyphenyl) ketone,280-851-4,83790-87-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2
31260,Lauroyl anhydride,211-449-9,645-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H335:40;H319:61;H315:61
31264,"Cellulose, 6-carboxy",618-529-6,9032-53-5,Not Classified,Notified C&L,1,Not classified:1
31269,"picolinafen (ISO); N-(4-fluorophenyl)-6-[3-(trifluoromethyl)phenoxy]pyridine-2-carboxamide; 4′-fluoro-6-[(α,α,α-trifluoro-m-tolyl)oxy]picolinanilide",604-030-0,137641-05-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,306,H400:306;H410:306
31270,Triethylsilanol,209-903-6,597-52-4,Flam. Liq. 3,Notified C&L,45,H226:45;H335:1;H319:1;H315:1
31271,"rac-5-Amino-N-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamic acid",601-093-6,111453-32-8,Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
31272,"N,N'-(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)bisacetamide",229-435-6,6534-28-7,Aquatic Acute 1,Notified C&L,38,H400:38
31276,Diethyl acetamidomalonate,213-952-9,1068-90-2,Acute Tox. 2,REACH registration C&L,21,H302:10;Not classified:7;H335:2;H319:4;H315:2
31277,Chlorodimethylphosphine,212-372-3,811-62-1,,Notified C&L,1,H252:1;H302:1;H332:1;H310:1;H250:1;H225:1
31279,"Octa-1,7-diyne",212-815-0,871-84-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:45;H335:43;H319:40;H315:44;H304:5
31280,4-Nitrobenzyl Acetoacetate,612-114-3,61312-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H319:1;H315:1;H341:1
31283,LZ-Z 1,400-180-4,,Eye Irrit. 2,Notified C&L,571,H319:571
31287,2-ethyl-4-methyl-1H-imidazole-1-propiononitrile,245-975-5,23996-25-0,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,138,H301:48;H318:61;H335:53;H315:92;H302:76;H412:45;H319:76;H317:6;H331:6;H311:6;H312:1;Not classified:1
31293,O-benzoylecgonine,208-263-5,519-09-5,Acute Tox. 3,Notified C&L,39,H301:39
31295,hydrazinecarboximidamide dimethanesulfonate,918-488-7,676353-80-3,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H317:2
31299,"2-ethylhexanol, ethoxylated, phosphated, potassium salt",614-383-2,68238-84-6,,Notified C&L,65,Not classified:32;H318:32;H411:29;H315:33;H319:1
31300,"p-(2,2-dimethoxyethyl)toluene",255-976-2,42866-91-1,Not Classified,Notified C&L,126,Not classified:88;H302:38;H335:38;H319:38;H315:38
31301,Carbonic acid potassium zirconium salt,245-747-5,23570-56-1,Eye Irrit. 2,Notified C&L,37,H319:28;Not classified:9
31302,"1-Ethyl-4-[2-(4-trans-propyl-[1,1-bicyclohexyl]-4-trans-yl)-ethyl]-benzene",601-786-3,121553-94-4,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
31303,"Hydrocarbons, C11-C14, n-alkanes, <2% aromatics",924-803-9,,Asp. Tox. 1,REACH registration C&L,7,H304:7
31317,"Soaps, stocks, lard-oil, acidulated, hydrogenated",296-502-4,92704-67-1,Not Classified,Notified C&L,1,Not classified:1
31318,Phytomenadione,201-564-2,84-80-0,Aquatic Chronic 4,Notified C&L,50,H413:32;Not classified:17;H335:1;H319:1;H315:1
31319,Octyl isocyanate,221-598-1,3158-26-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H335:44;H319:44;H302:44;H334:44;H315:44;H332:4
31320,Inosine 5'-monophosphate disodium salt hydrate,225-146-4,4691-65-0,Not Classified,Notified C&L,107,Not classified:106;H373:1;H361:1
31321,perfluorononan-1-oic acid,206-801-3,375-95-1,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Repr. 1B,Harmonised C&L,0,H360:0;H362:0;H351:0;H332:0;H302:0;H372:0;H318:0
31325,Mineral spirits,613-601-3,64475-85-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,69,H226:68;H319:64;H315:64;H304:4;H336:4;Not classified:1
31326,"Slags, aluminium-vanadium",273-725-5,69012-25-5,Not Classified,Notified C&L,1,Not classified:1
31328,"2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one",607-088-5,224785-90-4,Not Classified,Notified C&L,2,Not classified:1;H301:1;H373:1;H413:1
31331,Pyrrolidine-1-valeronitrile,276-146-6,71888-57-8,Acute Tox. 3,Notified C&L,38,H301:38
31332,"iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts",417-850-7,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
31333,Capsaicin,206-969-8,404-86-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1752,H302:1383;H318:1705;H315:1747;H301:368;H335:46;H319:46;H317:43;H334:43;H312:5;H332:3;H300:1;H311:2;H331:1
31336,Potassium myristate,236-550-5,13429-27-1,Not Classified,Notified C&L,7,Not classified:7
31337,(Z)-cyclooctene,213-243-4,931-87-3,Flam. Liq. 3,Notified C&L,68,H226:68;H304:30;H410:26;H400:25;H411:4
31340,"4,6-dinitro-m-xylene",210-488-9,616-72-8,Acute Tox. 4,Notified C&L,38,H302:38
31341,"3,6-Octadien-1-yne, 3,7-dimethyl-",613-620-7,64547-65-5,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,1,H226:1;H304:1
31342,Propantheline bromide,200-030-6,50-34-0,Acute Tox. 4,Notified C&L,92,H302:91;H400:1
31343,"Benzene-1,3,5-tricarbonyl trichloride",224-594-8,4422-95-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,81,H314:81;H302:39;H318:35;H290:34
31346,"1,5-Dimethoxypentane",601-135-3,111-89-7,Flam. Liq. 3,Notified C&L,40,H226:40
31347,"Cobaltate(3-), bis[4-[4-[[4-[4-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, trisodium",278-140-9,75214-72-1,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,39,H412:4;H318:4;Not classified:35
31351,4-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-3-hydroxy-7-nitronaphthalene-1-sulphonic acid,204-203-7,117-69-1,Not Classified,Notified C&L,1,Not classified:1
31356,Diacerein,237-310-2,13739-02-1,Not Classified,REACH registration C&L,59,Not classified:2;H335:56;H319:57;H315:57
31357,Sodium 2-[(2-hydroxynaphthyl)azo]naphthalenesulphonate,214-998-2,1248-18-6,Not Classified,Notified C&L,1,Not classified:1
31362,"tert-Butyl [(7R,9R)-9-(cyanomethyl)-6,10-dioxaspiro[4.5]dec-7-yl]acetate",920-979-6,,Not Classified,REACH registration C&L,1,Not classified:1
31368,"4-chloro-2,5-dimethoxyaniline",228-782-0,6358-64-1,Acute Tox. 4,Notified C&L,78,H302:75;H373:38;H411:31;H410:2;H400:2;H331:2;H311:2;H301:2;Not classified:1
31369,"1,1'-(1,1,3-trimethylpropane-1,3-diyl)bis(cyclohexane)",254-227-7,38970-72-8,Skin Sens. 1B,REACH registration C&L,46,H317:3;H335:42;H319:42;H315:43
31378,"Biphenyl-2,2'-dicarboxylic anhydride",227-950-0,6050-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44
31381,4-tert-butylphenyl salicylate,201-728-3,87-18-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
31384,"Estra-1,3,5(10)-triene-3,16α,17β-triol tripropionate",218-798-6,2236-31-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,16,H312:16;H351:16;H332:16;H302:16;H361:16
31386,Benzyl methyl ether,208-705-7,538-86-3,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1417,H226:1417;H319:1321;H335:1;H315:1
31388,2-(trifluoromethyl)benzenesulfonamide,700-280-0,1869-24-5,Acute Tox. 4,REACH registration C&L,119,H302:1;Not classified:117;H335:1;H319:1;H315:1
31389,Antimony oxide,215-474-6,1327-33-9,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,205,H332:205;H302:205;H411:205
31392,"Disodium 8-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-1-[(2-chlorophenyl)amino]-9-hydroxy-2-methyl-1H-naphth[1,2-d]imidazole-7-sulphonate",276-703-3,72496-91-4,Not Classified,Notified C&L,1,Not classified:1
31393,3-acetamido-5-amino-4-hydroxybenzenesulphonic acid,254-879-2,40306-75-0,Not Classified,REACH registration C&L,49,Not classified:10;H317:1;H335:38;H319:38;H315:38
31397,2-(Ethenyloxy)-2-methyl-propane,618-860-6,926-02-3,Flam. Liq. 2;Skin Irrit. 2,Notified C&L,44,H315:40;H225:44;H412:4
31399,"3-ethylpentane-2,4-dione",216-272-0,1540-34-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40
31400,"chlozolinate (ISO);ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate",282-714-4,84332-86-5,Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H351:0;H411:0
31402,"(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol",617-901-5,866607-35-4,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,1,H317:1;H413:1
31403,3-(N-methylanilino)propiononitrile,202-325-5,94-34-8,Acute Tox. 4,Notified C&L,14,H302:14;H312:5;H319:1;H332:1;H315:1
31407,"2-Butyne-1,4-diol, ethers with epichlorohydrin, hydrolyzed",270-106-1,68411-16-5,Acute Tox. 3;Acute Tox. 4;Acute Tox. 3,Notified C&L,1,H301:1;H331:1;H312:1
31414,1-tert-butyl-4-piperidone,215-982-8,1465-76-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H319:1;H315:1;H314:1
31417,Iron oxalate,239-948-7,15843-42-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H312:2
31422,4-ethylcyclohexanone,226-629-2,5441-51-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H227:1
31430,"1-ethoxy-2,2,2-trifluoroethanol",207-087-6,433-27-2,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,47,H226:46;H319:47;H302:9;H315:7;H360:1;H336:1;H340:1;H225:1;H301:1;H335:1;H312:1;H332:1
31432,Sumilizer GP,442-450-4,,Not Classified,Notified C&L,1,Not classified:1
31435,Potassium tert-butanolate,212-740-3,865-47-4,Flam. Sol. 1;Self-heat. 2;Skin Corr. 1A,REACH registration C&L,666,H252:295;H314:666;H228:584;H251:12;H302:326;H318:167;H225:1;Not classified:1;H261:2
31436,5-bromoquinolin-8-ol,214-829-2,1198-14-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
31439,"(1α,2α,3aα,4β,7β,7aα)-1,2,4,5,6,7,8,8-octachloro-2,3,3a,4,7,7a-hexahydro-4,7-methano-1H-indene",225-825-5,5103-71-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H335:40;H319:40;H410:38;H400:42;H332:40;H302:42;H311:40;H315:40;H224:2;H301:2;Not classified:1
31441,"2,2-dimethyl-1,3-propanediyl dioctanoate",250-575-9,31335-74-7,Not Classified,REACH registration C&L,48,Not classified:48
31442,Oxotripropoxyvanadium,216-871-7,1686-23-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
31445,[2-(cyclohexyloxy)ethyl]benzene,279-576-2,80858-47-5,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,80,H400:2;H317:2;H410:2;H315:2;Not classified:78
31449,1-bromo-4-fluoro-2-nitrobenzene,207-160-2,446-09-3,,Notified C&L,7,H335:6;H319:7;H312:6;H332:6;H302:6;H315:7
31451,"Dodecanedioic acid, compound with 2-aminoethanol and 2,2',2''-nitrilotriethanol",282-286-9,84145-59-5,Not Classified,Notified C&L,1,Not classified:1
31452,"(E)-6,10-dimethylundeca-5,9-dien-2-yl acetate",221-803-4,3239-35-8,Not Classified,Notified C&L,1401,Not classified:1401
31454,"Methane, bis(methoxymethoxy)-Trioxymethylene dimethyl etherBis(methoxymethyl)OME/DMM 3RD_CLP_2,4,6,8-Tetraoxanonane_13353-03-2_V01_20171214_TS",818-232-3,13353-03-2,Flam. Liq. 3,Notified C&L,1,H226:1
31455,Ethyl 5-methyl-1H-pyrazole-3-carboxylate,223-702-0,4027-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H319:3;H315:3;H312:1;H332:1;H302:1
31460,4-hydroxy-3-methylbutan-2-one,222-238-6,3393-64-4,,Notified C&L,37,Not classified:33;H335:4;H319:4;H315:4
31465,Scandium trinitrate,236-701-5,13465-60-6,Ox. Sol. 2;Carc. 1B,Notified C&L,45,H350:38;H272:44;H335:6;H319:6;H315:6;Not classified:1
31466,4-(Oxiran-2-ylmethoxy)-9H-carbazole,610-764-2,51997-51-4,Skin Sens. 1B;Eye Irrit. 2;Muta. 2,REACH registration C&L,56,H341:50;H319:14;H317:50;Not classified:1;H302:2;H335:3;H315:4;H312:1;H332:1;H412:1
31467,"Beeswax, synthetic",275-286-5,71243-51-1,Not Classified,Notified C&L,24,Not classified:24
31468,Ammonium tetrafluoroborate,237-531-4,13826-83-0,,REACH registration C&L,78,H314:46;H319:34;H315:34;H290:39;H335:32;H302:5;H318:2
31469,O-(tert-butyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine,276-262-7,71989-38-3,Not Classified,Notified C&L,5,Not classified:4;H332:1;H302:1;H335:1;H312:1
31471,"diazinon (ISO);O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate",206-373-8,333-41-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
31472,Pizotifen,239-632-9,15574-96-6,Acute Tox. 4;Repr. 2,Notified C&L,39,H302:39;H361:39
31475,"(-)-3,7-dimethyloct-6-enyl acetate",266-767-0,67601-05-2,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H315:4
31480,N-(p-tolylsulphonyl)-L-glutamic acid,225-390-1,4816-80-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:2
31485,Uronium hydrogen sulphate,244-343-6,21351-39-3,Met. Corr. 1;Eye Dam. 1,REACH registration C&L,58,H318:44;H290:5;H314:13;H302:1;H319:1
31487,Pancreatic Enzymatic Digest Hydrolysate of Casein (Bovine),924-561-4,,Not Classified,Notified C&L,2,Not classified:2
31488,"Benzenesulfonic acid, C10-16-alkyl derivs., compds. with triethanolamine",271-532-0,68584-25-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,147,H302:60;H319:99;H315:146;H318:48;H411:1;H314:1;H412:1
31490,ALUMINIUM NITRATE,616-523-8,7784-27-2,Eye Dam. 1,Notified C&L,243,H318:172;H272:138;H319:68;H315:68;Not classified:2;H271:1;H350:1
31491,"Pyrazolo[5,1-b]quinazolin-9(1H)-one, 2-methyl-",616-079-5,74336-55-3,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,106,H317:106;H411:106
31492,"Propanesulfonic acid, 3,3'-[methylenebis(thio)]bis- (9CI)",616-131-7,747355-34-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
31495,Sodium zirconium lactate,239-570-2,15529-67-6,Not Classified,REACH registration C&L,32,Not classified:28;H226:4;H319:4;H315:4
31505,N-(2-hydroxyethyl)phthalimide,223-434-4,3891-07-4,Eye Irrit. 2B,REACH registration C&L,42,H320:2;H335:39;H319:40;H315:40
31507,3-methyloctan-3-ol,226-276-4,5340-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H319:43;H315:43
31508,3-amino-4-hydroxy-N-methylbenzenesulphonamide,201-262-0,80-23-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H302:2;H319:2;H315:2;H335:1;H332:1
31510,"Pyridine, 2-chloro-5-(trichloromethyl)-",614-911-1,69045-78-9,,Notified C&L,1,H335:1;H319:1;H332:1;H302:1;H315:1
31511,"2,2',2'',4,4'-pentamethoxytrityl alcohol",217-146-8,1755-51-7,Not Classified,Notified C&L,1,Not classified:1
31512,"1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, hydrochloride (1:1)",609-093-8,352211-11-1,Not Classified,Notified C&L,1,Not classified:1
31513,"Formaldehyde, oligomeric reaction products with diethylenetriamine and phenol",500-129-7,55552-95-9,Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,24,H314:24;H400:1;H317:24;H410:1;H301:1;H312:1
31514,Barium diniobate,234-543-1,12009-14-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:42;H302:42
31517,"Fatty acids, animal, Bu esters",309-163-5,100085-23-2,Not Classified,Notified C&L,1,Not classified:1
31518,"1,4-epoxycyclohexane",205-998-3,279-49-2,Flam. Liq. 2,Notified C&L,44,H225:44
31524,"Capsicum chinense, ext.",307-469-3,97659-63-7,Not Classified,Notified C&L,1,Not classified:1
31528,Silver(1+) neodecanoate,272-065-5,68683-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H319:41;H315:42;H228:1;H410:1;H400:1
31529,propachlor (ISO);2-chloro-N-isopropylacetanilide;α-chloro-N-isopropylacetanilide,217-638-2,1918-16-7,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H410:0;H400:0;H317:0;H302:0
31530,"Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, esters with C16-22 fatty acids",603-046-5,125301-84-0,Not Classified,REACH registration C&L,1,Not classified:1
31532,Quinoline-2-carbonitrile,215-865-1,1436-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H335:43;H319:44;H312:40;H332:40;H302:44;H315:44
31537,"2H-Benzimidazol-2-one, 1,3-dihydro-1-methyl-5-nitro-",613-897-4,66108-85-8,Not Classified,Notified C&L,31,Not classified:31
31538,(R)-1-(1-Naphthyl)ethylamine (R)-Mandelate,600-816-2,1073144-62-3,Not Classified,REACH registration C&L,2,Not classified:2
31539,"1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich",271-091-4,68515-49-1,Not Classified,REACH registration C&L,591,Not classified:549;H319:42;H315:30
31542,nickel dichromate,239-646-5,15586-38-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H410:0;H400:0;H317:0;H334:0;H341:0;H372:0;H350:0
31547,Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate,254-482-4,39514-19-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H317:1;H302:1;H315:1
31550,"2,3,6,7-tetrahydro-8-hydroxy-1H,5H-benzo[ij]quinolizine-9-carboxaldehyde",263-966-4,63149-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
31552,4-bromophenyl methyl sulphide,203-255-8,104-95-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,51,H302:42;H319:13;H335:9;H315:10;H312:1;H332:1
31553,5-Iodo-2-Methylbenzoic acid,611-200-8,54811-38-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,6,H335:5;H319:6;H315:6
31556,"4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile",480-420-2,,Not Classified,REACH registration C&L,2,Not classified:2
31558,"1-[2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-3-(2,6-difluorobenzoyl)urea",600-387-1,103055-07-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H400:195;H317:195;H410:195
31559,"2-(3-methoxypropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",613-987-3,667917-13-7,Acute Tox. 4,Notified C&L,1,H302:1
31560,"2-ethylhexanoic acid, iron salt",243-169-8,19583-54-1,Acute Tox. 4;Repr. 2,REACH registration C&L,32,H302:13;H361:13;Not classified:14;H315:3;H413:2;H319:1;H411:1
31562,Benzenesulphonohydroxamic acid,209-973-8,599-71-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
31564,"5-Amino-N,N'-bis(2,3-dihydroxypropyl)-1,3-phthaldiamidehydrochloride",421-690-3,,Not Classified,REACH registration C&L,7,Not classified:7
31568,"2,5,7,10-tetraoxaundecane",224-631-8,4431-83-8,Not Classified,REACH registration C&L,179,Not classified:179
31570,"9β,11β-epoxy-6α-fluoro-17,21-dihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate)",276-705-4,72498-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Chronic 3,REACH registration C&L,1,H335:1;H319:1;H412:1;H361:1;H315:1
31571,2-chlorophenothiazine,202-152-5,92-39-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,66,H319:65;H317:21;H411:20;H335:44;H315:45;H341:9;H302:1
31574,Diammonium propylenebis(dithiocarbamate),282-716-5,84332-87-6,Aquatic Chronic 2,REACH registration C&L,1,H410:1
31576,"Chimaphila umbellata, ext.",289-692-5,89997-56-8,Not Classified,Notified C&L,88,Not classified:88
31577,"3,5-dichloropentan-2-one",261-227-0,58371-98-5,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 2;Muta. 2,Notified C&L,35,H302:34;H341:33;H319:33;H330:33;H314:1;H318:2;H335:2;H312:1;H332:1;H227:1;H315:1
31578,"1-Ethoxy-2,3-difluor-4-(4-propyl-1-cyclohexen-1-yl)-benzen",922-707-1,,Not Classified,REACH registration C&L,2,Not classified:2
31580,"[1-ethyl-1-phenyl-2-(3,4,5-trimethoxybenzoyloxy)ethyl]dimethylammonium hydrogen maleate",251-845-9,34140-59-5,Not Classified,Notified C&L,10,Not classified:4;H335:2;H319:2;H315:2;H302:1;H361:3
31587,N-1-naphthylacetamide,209-380-4,575-36-0,Acute Tox. 4,Notified C&L,1,H302:1
31588,"7-[3-[[2-(3,5-dihydroxyphenyl)-2-oxoethyl](phenylmethyl)amino]propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrochloride",254-859-3,40254-73-7,,Notified C&L,1,Not classified:1
31589,"N,N-dimethylisopropylamine",213-635-5,996-35-0,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,147,H335:90;H314:147;H302:146;H331:130;H318:92;H411:146;H225:147;H332:16
31591,"7-methoxy-3,7-dimethyloct-1-ene",258-750-1,53767-86-5,Not Classified,REACH registration C&L,93,Not classified:93
31593,Di[(2H3)methyl]ammonium chloride,258-409-7,53170-19-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:39;H335:39;H319:39;H315:39
31596,"N,N',N'',N'''-tetraisopropyldiphosphoramide",208-149-5,513-00-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H310:38;H300:38;H330:38
31602,"2,2'-[[3-chloro-4-[(4-nitrophenyl)azo]phenyl]imino]bisethanol",224-889-1,4540-00-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
31605,"N-(5-chloro-2,4-dimethoxyphenyl)-4-[[5-[(diethylamino)sulphonyl]-2-methoxyphenyl]azo]-3-hydroxynaphthalene-2-carboxamide",229-107-2,6410-41-9,Not Classified,REACH registration C&L,321,Not classified:317;H317:4
31606,4-methylpent-2-ene,224-721-7,4461-48-7,Flam. Liq. 2,Notified C&L,39,H225:39;H304:1
31610,"1,1'-Biphenyl, 4-bromo-4'-chloro-2-fluoro-",603-808-7,134316-79-3,Not Classified,Notified C&L,2,Not classified:2
31611,C.I. Acid Red 283,612-736-5,61931-20-2,Not Classified,Notified C&L,2,Not classified:2
31612,3M (TM) SPECIALTY GAS PFG-3480,440-180-1,,Not Classified,Notified C&L,1,Not classified:1
31614,"2-Propenoic acid, polymer with 2-propenal, sodium salt",610-819-0,52286-11-0,Not Classified,Notified C&L,2,Not classified:2
31616,"reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate",411-890-9,108936-08-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H318:0;H412:0
31617,CLOVE LEAF OIL,616-772-2,8000-34-8,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2,Notified C&L,345,H226:178;H304:294;H319:333;H317:294;H315:132;H335:40;Not classified:11;H302:2;H312:1
31619,Methyl phenyl disulphide,238-020-9,14173-25-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,87,H226:87;H302:77
31621,Tetraethylammonium chloride,200-267-5,56-34-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,70,H319:70;H315:70;H335:65;H302:25
31622,Lithium tetrahydroborate,241-021-7,16949-15-8,Water-react. 1;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,134,H301:132;H314:134;H260:80;H261:53;H331:103;H311:103;H318:3;Not classified:1;H335:1;H319:1;H351:1;H225:1
31623,2-methyl-4-phenylpentanol,402-770-7,92585-24-5,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
31626,Cocaine,200-032-7,50-36-2,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3,Notified C&L,41,H301:39;H311:38;H317:38;H331:38;Not classified:1;H360:1;H319:1;H372:1;H332:1;H400:1
31628,"Distillates (petroleum), chemically neutralized light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-128-3,64742-28-5,Carc. 1A,Harmonised C&L,0,H350:0
31629,Diethylthiocarbamoyl chloride,201-799-0,88-11-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:38
31637,"N,N,N',N'-tetramethyl-N''-[3-(trimethoxysilyl)propyl]guanidine",274-092-8,69709-01-9,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,6,H314:5;H318:5;Not classified:1
31641,Gold(3+) pentasodium tetrasulphite,267-418-5,67859-69-2,,Notified C&L,2,H319:2;H315:2
31643,"Pentasodium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]chromate(5-)",279-318-9,79828-44-7,Not Classified,Notified C&L,2,Not classified:2
31645,2-nitroisophthalic acid,244-253-7,21161-11-5,Acute Tox. 4,Notified C&L,40,H302:38;H319:2;H315:2;H335:1
31649,(R)-(+)-3-Chlorostyrene oxide,613-060-3,62600-71-9,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Muta. 2;Aquatic Chronic 2,Notified C&L,121,H314:83;H341:83;H301:83;H318:83;H411:83;H335:38;H319:38;H317:38;H315:38
31650,"Protein hydrolyzates, trachea",293-504-7,91080-13-6,Not Classified,Notified C&L,1,Not classified:1
31652,1-(benzyloxy)-4-[2-(cyclopropylmethoxy)ethyl]benzene,613-308-0,63659-15-4,Acute Tox. 4;Repr. 2,REACH registration C&L,2,H302:2;H361:2
31656,Allyl isothiocyanate,200-309-2,57-06-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1465,H410:1455;H400:1456;H317:82;H226:1460;H302:13;H314:13;H334:53;H311:15;H330:1414;H318:17;H319:1443;H301:1447;H310:1445;H315:1411;H331:42;H335:123;Not classified:5;H373:3
31664,Cyclohexyl p-toluenesulphonate,213-468-8,953-91-3,,Notified C&L,4,H335:4;H319:4;H315:4
31669,3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]-N-(o-tolyl)naphthalene-2-carboxamide,229-681-4,6655-84-1,Not Classified,Notified C&L,7,Not classified:7
31674,"2,4,4-trimethylhexamethylene-1,6-di-isocyanate",239-714-4,15646-96-5,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H335:0;H319:0;H331:0;H334:0;H315:0
31676,"5-(trans-4-propylcyclohexyl)-2-trans-(3,4,5-trifluorophenyl)-1,3-dioxane",442-740-0,181943-57-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
31677,"Pyridinium, 1-(2-hydroxyethyl)-4-methyl-, sulfate (2:1)",605-071-7,156738-24-8,Not Classified,Notified C&L,1,Not classified:1
31679,"2,5-Furandione, polymer with ethenylbenzene, methyloxirane polymer with oxirane 2-aminopropyl methyl ether and methyloxirane polymer with oxirane monomethyl ether, 3-(dimethylamino)propyl amide",607-103-5,225367-02-2,Not Classified,Notified C&L,68,Not classified:68
31682,"3,4-(methylenedioxy)phenylacetonitrile",224-655-9,4439-02-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H332:44;H302:46;H312:40;H311:4;H319:3;H315:3;H335:1
31687,"3,5,5-trimethylhexanoic acid, iron(2+) iron(3+) salt",269-241-9,68201-82-1,,Notified C&L,1,H302:1;H319:1;H315:1
31689,"4-Amino-5-chloro-2,1,3-benzothiadiazole",608-495-0,30536-19-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
31693,Tacrine,206-291-2,321-64-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3;Carc. 2,Notified C&L,1,H335:1;H319:1;H351:1;H331:1;H311:1;H301:1;H315:1
31694,Barium bis(nonylphenolate),249-359-7,28987-17-9,Acute Tox. 4,Notified C&L,113,H302:105;H332:19;H400:6;H410:6;Not classified:2
31698,"1-[4-[[2-(isopropoxy)ethoxy]methyl]phenoxy]-2,3-epoxypropane",613-981-0,66722-57-4,Not Classified,REACH registration C&L,6,Not classified:3;H351:1;H317:2;H332:1;H302:2;H341:2;H315:1
31701,"N-[4-(aminocarbonyl)phenyl]-4-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]benzamide",277-873-1,74441-05-7,Not Classified,REACH registration C&L,56,Not classified:56
31703,3-nitrobenzoyl chloride,204-505-9,121-90-4,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,45,H314:45;H318:39;H311:41;H312:4;H290:1;H301:1;H331:1
31713,Potassium 1-(β-D-glucopyranosylthio)but-3-enylideneaminooxysulphonate,223-545-8,3952-98-5,Not Classified,Notified C&L,3,Not classified:2;H335:1;H319:1;H315:1
31716,4'-chloro-2-nitrobiphenyl,613-073-4,6271-80-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H302:3;H410:2;H400:2;H411:1
31718,"lufenuron (ISO);N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide",410-690-9,103055-07-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
31720,3-isopropenyl-1-methyl-2-methylenecyclopentan-1-ol,256-465-7,49748-25-6,Not Classified,Notified C&L,25,Not classified:25
31723,Norgestrel,229-433-5,6533-00-2,Carc. 2;Repr. 1A;Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,26,H360:24;H410:24;H362:24;H351:25;H400:24;H373:1;H335:2;H319:2;H413:1;H315:2
31725,2-chloroacetanilide,209-604-0,587-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:38;H315:38;H314:1
31728,3-(trifluoromethyl)cinnamic acid,212-301-6,779-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H319:48;H315:48
31731,Tripropylaluminium,203-045-6,102-67-0,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,38,H314:38;H250:38;H260:38
31734,2'-hydroxychalcone,214-928-0,1214-47-7,Acute Tox. 4,REACH registration C&L,49,H302:4;H335:43;H319:44;H315:44;Not classified:1
31738,"3-ethyldihydro-3-methylfuran-2,5-dione",256-641-3,50598-33-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
31739,"21-Hydroxy-16 alpha-methyl-4-pregnene-3,20-dione",609-766-6,39987-86-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
31741,"1,3-Benzenedisulfonic acid, 4,4'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]bis[6-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]-, hexasodium salt",273-662-3,68991-98-0,Not Classified,REACH registration C&L,53,Not classified:52;H412:1;H317:1
31747,1-phenylethyl hydroperoxide,221-341-3,3071-32-7,Not Classified,Notified C&L,1,Not classified:1
31748,"Alkenes, C8-10-branched, C9-rich",307-301-9,97593-01-6,Not Classified,REACH registration C&L,9,Not classified:7;H304:2;H410:2;H400:2;H225:2
31750,"2,2,2-trifluoro-N-methyl-N-(trifluoroacetyl)acetamide",211-680-5,685-27-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,41,H226:41;H314:41;H318:1
31751,"Fatty acids, castor-oil, triesters with trimethylolpropane",294-970-4,91771-76-5,Not Classified,Notified C&L,2,Not classified:2
31755,Dodecyl acetate,203-995-1,112-66-3,Not Classified,Notified C&L,1590,Not classified:1552;H413:38
31756,"(Z)-3,7-dimethylocta-2,6-dienenitrile",250-883-3,31983-27-4,Muta. 2;Aquatic Chronic 2,Notified C&L,10,H341:10;H411:10
31758,"1,3,5-triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",213-834-7,1025-15-6,Acute Tox. 4;Acute Tox. 4;STOT RE 2,REACH registration C&L,335,H302:325;H373:118;H312:62;Not classified:10;H411:10
31759,Sulphur diterbium dioxide,235-262-7,12143-18-9,Not Classified,Notified C&L,1,Not classified:1
31762,Sodium 4-hydroxybenzoate,204-051-1,114-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,85,H335:81;H319:82;H315:82;Not classified:3
31763,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-2-[[2-(trifluoromethyl)phenyl]azo]butyramide",268-734-6,68134-22-5,Not Classified,REACH registration C&L,833,Not classified:392;H319:441
31764,"Hydrocarbons, C7-C9, isoalkanes",921-728-3,64741-66-8,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,31,H225:30;H336:30;H304:31;H411:29;H315:30;H350:1;H340:1;H319:1;H410:1;H400:1
31769,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with tall-oil fatty acids and tetraethylenepentamine",500-289-8,103758-98-1,Not Classified,Notified C&L,34,Not classified:33;H319:1;H317:1;H315:1
31770,4-sec-butylaniline,250-108-9,30273-11-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:49;H319:50;H315:50;H331:1;H311:1;H301:1
31776,"Disodium 4,4'-[(1,4-diamino-9,10-dihydro-9,10-dioxo-2,3-anthrylene)bis(oxy)]bis[benzenesulphonate]",229-067-6,6408-73-7,Not Classified,Notified C&L,5,Not classified:5
31777,Urethane-formation and allophanate-formation product of diphenyl methane diisocyanate and butyldiglycol,927-666-3,,Not Classified,Notified C&L,71,Not classified:71
31779,"5,11-dimethyl-6H-pyrido[4,3-b]carbazole",208-264-0,519-23-3,Acute Tox. 3,Notified C&L,38,H301:38
31783,"Naphthalene-1,8:4,5-tetracarboxylic dianhydride",201-342-5,81-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:46;H315:46
31787,"Slags, ilmenite electrothermal smelting",293-671-6,91081-64-0,Not Classified,REACH registration C&L,14,Not classified:14
31789,"Fatty acids, C18-unsatd, dimers, hydrogenated, diisopropyl esters",500-288-2,103213-20-3,Not Classified,REACH registration C&L,35,Not classified:35
31790,"[2-[4-(dihexylamino)-2-methylbenzylidene]benzo[b]thien-3(2H)-ylidene]malononitrile S,S-dioxide",277-785-3,74239-96-6,Skin Sens. 1,REACH registration C&L,2062,H317:2;Not classified:2060
31792,aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate,422-150-1,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
31793,Aluminium trihydride,232-053-2,7784-21-6,Water-react. 1;Skin Corr. 1B,Notified C&L,38,H314:38;H260:38
31795,"Dodecanedioic acid, compound with 2-aminoethanol",282-287-4,84145-60-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
31801,"2,6-dibutyl-4-(2-methylpropyl)-2H-1,2,6-thiadiazine-3,5(4H,6H)-dione 1,1-dioxide",280-850-9,83789-26-8,Not Classified,Notified C&L,1,Not classified:1
31805,"Soaps, stocks, lard-oil, acidulated",296-501-9,92704-66-0,Not Classified,Notified C&L,2,Not classified:2
31812,"1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptane-1-sulphonic acid",206-800-8,375-92-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H314:1;H302:1;H332:1;H312:1
31813,3-ethylpentan-3-ol,209-902-0,597-49-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:38;H226:43;H302:38;H318:38;H315:38
31822,"Amines, N-(3-aminopropyl)-N'-coco alkyltrimethylenedi-, monoacrylated",294-702-6,91745-32-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,1,H314:1;H302:1;H410:1
31823,3'5'-anhydro thymidine,425-810-5,38313-48-3,Aquatic Chronic 3,Harmonised C&L,0,H412:0
31825,2-Acetoxypropionyl Chloride,609-599-9,38939-83-2,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1;H290:1
31827,Methacholine bromide,206-372-2,333-31-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H319:40;H315:40;H302:5
31828,"4-amino-1,3,5-triazin-2-one",213-242-9,931-86-2,Acute Tox. 4,Notified C&L,42,H302:41;H335:1;H319:1;H332:1;H315:1;Not classified:1
31838,"Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;Redistillates;[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220°C to 230°C (428°F to 446°F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]",295-329-1,91995-66-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
31841,"Dipotassium 7-hydroxynaphthalene-1,3-disulphonate",212-672-4,842-18-2,Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:38;H319:39;Not classified:2
31843,"Tris[2-[[2,4,8,10-tetra-tert-butyldibenzo[d,f][1,3,2]dioxaphosphepin-6-yl]oxy]ethyl]amine",279-459-6,80410-33-9,Not Classified,REACH registration C&L,89,Not classified:88;H302:1
31845,"1-Pentyl-4-[2-(4-trans-propyl-[1,1-bicyclohexyl]-4-trans-yl)-ethyl]-benzene",601-787-9,121553-95-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
31846,4-anilino-2-methoxybenzenediazonium hydrogen sulphate,252-959-1,36305-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:39;H319:42;H315:42;H301:1
31853,"1,3-dichloro-4-fluorobenzene",406-160-1,1435-48-9,Acute Tox. 4;Skin Irrit. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H373:0;H411:0;H315:0
31855,2-ethylhex-2-enal,211-448-3,645-62-5,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,686,H412:560;H317:611;H315:683;H335:71;H319:71;H411:71;H318:39;H226:13;Not classified:3
31858,4-methoxybenzyl azidoformate,247-017-1,25474-85-5,Ox. Sol. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H272:38;H312:38
31859,1-benzyl-4-(methylamino)piperidine-4-carbonitrile,213-467-2,953-79-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
31861,styrene-4-sulfonyl chloride,404-770-2,2633-67-2,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0;H315:0
31862,"2,6-dichloro-4-nitroanisole",403-350-6,17742-69-7,Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H411:0
31865,"3-[(2,5-dihydro-2-methyl-3-furyl)thio]tetrahydro-2-methylfuran-3-thiol",253-883-1,38325-24-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
31866,4-trans-Propylcyclohexancarbonic acid-(4-butoxyphenyl)ester,614-086-8,67589-41-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
31867,2-mercapto-2-methylpropionic acid,225-159-5,4695-31-2,Eye Dam. 1,Notified C&L,39,H318:39;H335:1;H315:1
31872,Piperazine-1-dithiocarboxylic acid,202-720-2,99-00-3,Not Classified,Notified C&L,1,Not classified:1
31873,"2-hydroxy-3-(3-methylbut-2-enyl)-1,4-naphthoquinone",201-563-7,84-79-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:39;H319:39;H312:39;H332:39;H302:39;H315:39
31875,Indium(3+) neodecanoate,269-709-2,68310-35-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
31877,5-pentadecylresorcinol,221-599-7,3158-56-3,Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H318:38;H317:38
31878,"2-Butyne-1,4-diol, ethers with bis(2-chloroethyl) ether, sulfonated",270-107-7,68411-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H319:2;H315:2
31879,2-butoxyethyl acrylate,230-665-4,7251-90-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H311:38;H319:38;H315:38
31882,2-methyl-3-phenylpropanol,230-961-3,7384-80-7,Eye Irrit. 2,Notified C&L,2,H319:2
31887,"Camphor tree, ext.",295-980-1,92201-50-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1486,H319:14;H317:1485;H226:1470;H304:1468;H411:13;H315:1486;H410:1471;H400:1434;H412:2
31889,Fenfluramine hydrochloride,206-968-2,404-82-0,Acute Tox. 2,Notified C&L,2,H300:1;H302:1
31893,2-methyl-1H-imidazole-1-propiononitrile,245-976-0,23996-55-6,Acute Tox. 4,Notified C&L,32,H302:30;H351:3;H335:2;H319:3;H312:1;H332:1;H318:1;H315:3;H331:2;H311:2;H301:2
31894,diethylcarbamoyl chloride,201-798-5,88-10-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Harmonised C&L,0,H335:0;H319:0;H351:0;H332:0;H302:0;H315:0
31897,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(hexadecyloxy)-, ammonium salt (1:1)",611-878-5,59764-60-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H318:6;H315:6
31902,"Peppermint, ext.",282-015-4,84082-70-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1805,H412:1457;H319:180;H317:448;H315:1739;H411:110;Not classified:52;H318:4;H304:5;H226:2;H401:2;H303:2;H227:1;H302:2;H334:1;H335:1;H320:2;H312:1;H332:1
31903,3-[(4-methylphenyl)thio]propionic acid,237-311-8,13739-35-0,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H301:39;H318:39;H335:39;H315:39
31905,1-fluoro-4-(methylthio)benzene,206-733-4,371-15-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H319:44;H315:44
31906,"4-[(2,5-dichlorophenyl)azo]-N-(2,5-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide",229-106-7,6410-40-8,Not Classified,Notified C&L,31,Not classified:31
31909,2-hexylthiophene,242-579-4,18794-77-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1412,H335:1287;H319:1412;H312:1286;H332:1286;H302:1325;H315:1373;H413:38
31910,Potassium dihydrogenorthophosphate,231-913-4,7778-77-0,Not Classified,REACH registration C&L,783,Not classified:716;H314:22;H318:18;H335:13;H319:29;H315:21;H302:11;H332:1
31912,(2-nitrophenyl)boronic acid,611-304-3,5570-19-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H302:42;H335:43;H319:45;H315:45;H332:2;H312:2
31919,1H-purine-6-carboxylic acid,219-120-1,2365-43-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H302:2;H335:2;H319:2;H315:2
31922,"1,3-bis(dimethylamino)propan-2-ol",227-754-5,5966-51-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:39;H315:39;H314:1;H302:2;H318:1;H311:1
31923,"Fatty acids, C16-18 and C18-unsatd., Me esters, epoxidized, reaction products with ethylene glycol",606-712-3,211450-54-3,Skin Sens. 1B,REACH registration C&L,89,H317:89
31925,Dilithium salicylate,254-228-2,38970-76-2,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,3,H314:2;H302:2;H318:2;Not classified:1
31926,2-(dipropylamino)ethanol,221-802-9,3238-75-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
31931,4-fluoro-2-nitrotoluene,207-161-8,446-10-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H302:46;H335:44;H319:45;H315:45;H312:7;H332:7
31932,2-amino-1H-pteridin-4-one,218-799-1,2236-60-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
31935,"1,8-dichlorooctane",218-490-1,2162-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H319:43;H315:43
31937,Aluminatesilicate,215-475-1,1327-36-2,Not Classified,REACH registration C&L,252,Not classified:230;H319:21;H315:21;H335:1
31939,"Trisodium 5-[[2,4-dihydroxy-5-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]phenyl]azo]-8-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]naphthalenesulphonate",276-704-9,72496-92-5,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,26,H412:10;H319:10;Not classified:16
31943,4-bromo-2-chlorofluorobenzene,405-580-2,60811-21-4,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0;H315:0
31944,nickel dichloride,231-743-0,7718-54-9,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H410:0;H400:0;H317:0;H331:0;H334:0;H341:0;H372:0;H301:0;H350:0;H315:0
31950,"3,3,4,4,5,5,6,6,7,7,8,8,9,10,10,10-hexadecafluoro-9-(trifluoromethyl)decyl acrylate",239-633-4,15577-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
31960,4-methylpyridine;4-picoline,203-626-4,108-89-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H335:0;H319:0;H226:0;H302:0;H332:0;H311:0;H315:0
31962,"Oils, chicken",297-182-9,93348-40-4,Not Classified,Notified C&L,11,Not classified:11
31963,N-2-aminoethyl-1-naphthylamine dihydrochloride,215-981-2,1465-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H335:51;H319:56;H315:56;H412:1;H341:1;H302:1
31966,"1,4-bis(trifluoromethyl)benzene",207-086-0,433-19-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44;H225:44
31969,[(o-methoxyphenoxy)methyl]oxirane,218-644-8,2210-74-4,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,10,H317:3;H315:6;Not classified:3;H302:1;H341:3;H335:2;H319:3
31970,"Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt, hydrate (1:1:1:4)",612-063-7,6100-16-9,Not Classified,Notified C&L,3,Not classified:3
31972,Allylmalonic acid,219-958-8,2583-25-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
31977,Diiron trimolybdenum dodecaoxide,237-389-3,13769-81-8,Not Classified,REACH registration C&L,47,Not classified:47
31979,"Fatty acids, C6-19-branched, copper(2+) salts",269-634-5,68308-19-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,41,H302:39;H411:1;H400:3;H413:2;H410:2
31984,"Fatty acids, C10-20-neo-",285-549-6,85116-96-7,Aquatic Chronic 3,Notified C&L,508,H412:450;Not classified:55;H302:4;H317:3;H411:3
31986,"2-methyl-4-phenyl-1,3-dioxolane",251-752-3,33941-99-0,Not Classified,REACH registration C&L,91,Not classified:80;H412:11
31987,"1,4-diazabicyclooctane",205-999-9,280-57-9,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,786,H302:760;H318:313;H315:765;H228:563;H319:402;H332:58;H335:159;H412:144;Not classified:8;H290:4;H314:4;H334:2;H312:2;H373:2;H361:1
31988,Methyl cholate,215-903-7,1448-36-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H302:3;H319:3;H315:3;Not classified:1
31989,Hexahydrophthalic acid,216-872-2,1687-30-5,Acute Tox. 4,Notified C&L,8,H302:7;H334:1;H318:1;H317:1
31991,ethyl (Z)-α-(hydroxyimino)-2-(tritylamino)thiazol-4-acetate hydrochloride,266-321-5,66339-00-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
31993,dicyclohexylcarbodiimide,208-704-1,538-75-0,Acute Tox. 4;Acute Tox. 3;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H302:0;H318:0;H311:0;H317:0
31994,Isobutyl salicylate,201-729-9,87-19-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1687,H302:1687;H410:33;H411:33;H400:33;H319:1;H315:1
31995,1-(3-(1-ethoxyethoxy)but-1-yn-1-yl)-6-isopropyl-3-methylcyclohex-2-enol,618-235-8,89079-91-4,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,1,H226:1;H315:1
31997,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 2-piperazin-1-ylethylamine",500-206-5,68391-18-4,Not Classified,Notified C&L,101,Not classified:79;H317:22;H312:6;H314:6;H302:5;H412:4;H411:2
31999,(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide,605-756-0,175481-36-4,Acute Tox. 3;Eye Irrit. 2,Notified C&L,65,H301:61;H319:61;H302:1;H360:1;Not classified:1;H332:2;H311:1;H361:1;H312:1
32001,Reactive Blue 198,602-995-2,124448-55-1,Skin Sens. 1,Notified C&L,5,H317:4;Not classified:1
32002,"3-propylpentane-2,4-dione",216-273-6,1540-35-8,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H312:1;H317:1;H332:1;H302:1;H413:1
32008,"4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone",408-220-2,141420-50-0,Aquatic Chronic 4,Harmonised C&L,0,H413:0
32011,N-(dodecylphenyl)naphthalen-1-amine,265-000-7,64654-05-3,Aquatic Chronic 4,Notified C&L,17,H413:17
32016,N-methyl-N-nitrosoaniline,210-366-5,614-00-6,Acute Tox. 3;Acute Tox. 3,Notified C&L,3,H301:3;H311:1;H351:2;H319:2
32018,Bis[2-(acryloyloxy)ethyl] hydrogen phosphate,254-783-0,40074-34-8,Skin Corr. 1B,Notified C&L,168,H314:83;H319:72;H318:13;H317:13;H315:14
32023,3-ethylpentane,210-529-0,617-78-7,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H225:0;H400:0;H336:0;H304:0;H315:0
32025,2-({2-[(3-aminobenzoyl)amino]ethyl}sulfonyl)ethyl hydrogen sulfate,601-770-6,121315-20-6,Not Classified,Notified C&L,1,Not classified:1
32026,"1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one",239-399-3,15362-40-0,Acute Tox. 4,REACH registration C&L,65,H302:10;H335:53;H319:53;H315:53;Not classified:2
32030,Bromocarbonylbis(triphenylphosphine)rhodium,237-897-5,14056-79-2,,Notified C&L,4,H335:4;H319:4;H315:4
32033,Dodecyl myristate,218-039-9,2040-64-4,Eye Irrit. 2,REACH registration C&L,3,H319:2;Not classified:1
32034,"Phenol, 4-[2-(cyclopropylmethoxy)ethyl]-",613-309-6,63659-16-5,,Notified C&L,1,H302:1
32036,Xylenol orange,216-553-8,1611-35-4,Not Classified,Notified C&L,3,Not classified:2;H335:1;H319:1;H315:1
32037,"6,8-dichloro-2H-3,1-benzoxazine-2,4(1H)-dione",225-149-0,4693-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
32040,sodium bis[4-[[5-chloro-2-(hydroxy-.kappa.O)phenyl]azo-.kappa.N1]-3-(hydroxy-.kappa.O)-N-phenyl-2-naphthalenecarboxamidato(2-)]ferrate(III),470-700-2,,Not Classified,Notified C&L,1,Not classified:1
32042,"Pentasodium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]chromate(5-)",279-317-3,79828-43-6,Skin Sens. 1,REACH registration C&L,29,H317:24;Not classified:5
32044,2'-(trifluoromethyl)acetophenone,241-434-2,17408-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:46;H315:46;H227:1
32045,(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate,603-261-4,128173-53-5,Not Classified,REACH registration C&L,2,Not classified:2
32047,5-methylbenzimidazole,210-401-4,614-97-1,Not Classified,Notified C&L,40,Not classified:33;H335:4;H319:4;H315:4;H302:3
32052,Triphenylpropylphosphonium,240-056-5,15912-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32053,"3-(1-ethoxyethoxy)-3,7-dimethylocta-1,6-diene",255-138-6,40910-49-4,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1599,H412:1322;H315:1322;H226:224;Not classified:53;H317:25
32056,"N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotriazole-1-methylamine",279-503-4,80584-90-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1152,H317:1127;H411:1101;H315:1089;H319:38;H412:25;Not classified:25;H400:1
32057,3-butoxypropiononitrile,230-153-0,6959-71-3,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,41,H226:2;H318:2;H315:40;H335:38;H319:39
32059,Lysergide,200-033-2,50-37-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 2,Notified C&L,41,H351:40;H310:40;H300:40;H330:40;H360:2;H400:1
32060,"1,1-dimethoxy-2-(2-methoxyethoxy)ethane",303-115-7,94158-44-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
32063,Zinc cyanide,209-162-9,557-21-1,Acute Tox. 4;Acute Tox. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,123,H410:71;H400:122;H303:3;H310:71;H361:3;H300:68;H330:68;Not classified:1
32066,propargite (ISO);2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite,219-006-1,2312-35-8,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H351:0;H400:0;H331:0;H318:0;H315:0
32069,"Dodecanedioic acid, compound with 2,2'-iminodiethanol",282-322-3,84176-56-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
32072,"Aniline, 2,4-difluoro-6-nitro-",609-244-8,364-30-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H312:1;H332:1;H302:1
32074,"N-(4-chloro-2,5-dimethoxyphenyl)-2-[(4-nitrophenyl)azo]-3-oxobutyramide",253-968-3,38489-19-9,Not Classified,Notified C&L,39,Not classified:39
32076,"1,3,2-benzodioxaborole",205-991-5,274-07-7,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,45,H314:45;H225:41;H373:4;H224:4;H336:4;H361:4;H318:1;H335:1;H351:1;H302:1
32079,N-ACRYLOYLPIPERIDINE,600-093-3,10043-37-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
32082,Hexamethyldisiloxane,203-492-7,107-46-0,Flam. Liq. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,3655,H400:3349;H411:2566;H225:3613;H410:672;H351:121;Not classified:5;H319:4;H228:1;H260:1;H315:2;H226:1;H304:1;H336:1;H372:1
32088,Sodium 2-naphthyl hydrogen phosphate,238-452-8,14463-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
32089,"Aluminoxanes, iso-Bu Me, branched, cyclic and linear",604-547-1,146905-79-5,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,24,H314:22;H318:4;H250:24;H260:22;H252:2;H228:2
32091,"[S-(R*,R*)]-4-[2-[2-carboxy-5-(β-D-glucopyranosyloxy)-2,3-dihydro-6-hydroxy-1H-indol-1-yl]vinyl]-2,3-dihydropyridine-2,6-dicarboxylic acid",231-628-5,7659-95-2,Not Classified,Notified C&L,5,Not classified:5
32093,2-[N-ethyl-p-[(6-methoxybenzothiazol-2-yl)azo]anilino]ethanol,236-797-9,13486-43-6,Not Classified,Notified C&L,2,Not classified:2
32094,"Stearic acid, compound with ethane-1,2-diamine",246-401-6,24682-74-4,Not Classified,Notified C&L,442,Not classified:442
32096,N-4-aminobenzoyl-L-glutamic acid,224-261-7,4271-30-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,3,H334:1;H317:1;H302:1;H335:1;H319:1;H315:1
32100,silver nitrate,231-853-9,7761-88-8,Ox. Sol. 2;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H400:0;H272:0;H410:0
32104,"Diethyl 2-vinylcyclopropane-1,1-dicarboxylate",231-695-0,7686-78-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
32108,"Sulfonic acids, C13-17-alkane, sodium salts",297-913-1,93763-92-9,Not Classified,Notified C&L,2,Not classified:2
32110,tert-butyl 2-hydroxyisobutyrate,252-952-3,36293-63-7,Flam. Liq. 3,REACH registration C&L,41,H226:41
32111,"1,1'-(3-bromopropylidene)bisbenzene",243-467-8,20017-68-9,Skin Corr. 1B,Notified C&L,2,H314:1;H319:1;H315:1
32112,Oxalyl bromide,239-271-7,15219-34-8,Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,39,H314:39;H332:39;H318:39
32113,"1,3-Benzenedisulfonic acid, 4,4'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]bis[6-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]-",300-622-5,93942-67-7,Not Classified,Notified C&L,2,Not classified:2
32114,Tiapride,256-907-9,51012-32-9,Not Classified,REACH registration C&L,5,Not classified:5
32116,2-Amino-5-nitrobenzamide,605-314-7,16313-65-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H317:38
32118,"Hydrocarbons, C",309-987-5,101896-28-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
32120,Ethyl N-phenylglycinate,218-702-2,2216-92-4,Not Classified,Notified C&L,1,Not classified:1
32121,3-diethylaminopropan-1-ol,210-759-1,622-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40;H302:1
32124,"[(1,2,5,6-η)-cycloocta-1,5-diene]diiodoplatinum",235-538-7,12266-72-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
32125,"1,1,1-trifluoro-2-methylpropan-2-ol",208-075-3,507-52-8,Flam. Liq. 2,Notified C&L,45,H225:45;H335:6;H319:6;H315:6
32126,"reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid",411-660-8,147027-04-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H302:0;H318:0;H317:0;H315:0
32127,4-chlorophenylarsonic acid,226-622-4,5440-04-0,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H400:38;H410:38;H331:38
32128,C.I. Acid Brown 97,612-611-5,61901-18-6,Not Classified,Notified C&L,2,Not classified:2
32129,"5,6-diaminouracil",221-809-7,3240-72-0,Acute Tox. 4,Notified C&L,38,H302:38
32135,"3,4-dihydroxyanthraquinon-2-ylmethyliminodi(acetic acid)",223-544-2,3952-78-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
32136,N-Methylsulfamoyl chloride,600-562-2,10438-96-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2;Carc. 2,Notified C&L,40,H312:40;H351:38;H314:40;H302:40;H330:38;H332:2
32138,"Disodium 4,4'-[(4,6-diamino-1,3-phenylene)bis(azo)]bisnaphthalene-1-sulphonate",227-443-4,5850-05-5,Not Classified,Notified C&L,3,Not classified:3
32144,"1,4-dioxane-2,3-diol",225-431-3,4845-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H319:44;H315:40;H302:1
32145,"1,1,1,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluoro-8-iodo-2-(trifluoromethyl)octane",212-747-1,865-77-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
32146,Heptacosafluorotetradecanoic acid,206-803-4,376-06-7,,Notified C&L,8,H314:5;Not classified:3
32147,"(4,4-difluorocyclohexyl)methanamine",617-193-8,810659-05-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,39,H318:38;H315:38;H314:1;H227:1
32149,"Sodium 1-amino-9,10-dioxo-4-phenylaminoanthracene-2-sulphonate",229-068-1,6408-78-2,Aquatic Chronic 3,REACH registration C&L,195,H412:97;H335:45;H319:71;H315:66;Not classified:29
32150,2-(decyloxy)ethanol,245-512-7,23238-40-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
32151,"Fatty acids, soya, reaction products with polyethylenepolyamines",293-110-5,91051-56-8,,Notified C&L,8,H302:8;H318:8;H317:8;H315:8
32154,(Z)-cyclodecene,213-301-9,935-31-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32156,"(6R,7R)-7-amino-3-{[(furan-2-ylcarbonyl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",617-065-1,80370-59-8,Skin Sens. 1B;Resp. Sens. 1,REACH registration C&L,1,H334:1;H317:1
32157,Dysprosium trihydroxide,215-163-5,1308-85-6,Not Classified,Notified C&L,2,Not classified:2
32158,"5-[3-(5-cyano-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridyl)allylidene]-1-ethyl-1,2,5,6-tetrahydro-4-methyl-2,6-dioxopyridine-3-carbonitrile, compound with triethylamine (1:1)",289-457-7,88969-31-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H319:38;H312:38;H332:38;H302:38;H315:38
32173,"3-[(2-aminoethyl)amino]propiononitrile, N-(2-aminoethyl) derivative",265-639-1,65216-94-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,4,H314:4;H302:4;H317:4;H312:4
32175,cis-2-methylcyclohexanol,231-187-9,7443-70-1,Acute Tox. 4,Harmonised C&L,0,H332:0
32179,"Peptones, casein",293-428-4,91079-40-2,Not Classified,REACH registration C&L,61,Not classified:61
32181,Dimethylammonium bromide,230-019-1,6912-12-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
32183,(4-pyridylmethyl)amine,223-092-6,3731-53-1,Skin Corr. 1B,Notified C&L,49,H314:49;H318:2;H302:1
32184,Methyl 2-Chloro-5-nitrobenzoate,613-139-2,6307-82-0,,Notified C&L,5,H335:4;H319:5;H315:4
32185,"Resin acids and Rosin acids, potassium salts",263-142-4,61790-50-9,Eye Irrit. 2,REACH registration C&L,426,H319:271;Not classified:155
32186,tetramethylthiuram monosulphide,202-605-7,97-74-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H317:0;H411:0
32189,2-nitropyridin-3-amine,236-260-9,13269-19-7,,Notified C&L,6,H302:5;H335:5;H319:6;H315:6
32191,boric acid,234-343-4,11113-50-1,Repr. 1B,Harmonised C&L,0,H360:0
32193,"(6ALPHA,11BETA,16ALPHA,17ALPHA)-6,9-DIFLUORO-11-HYDRO XY-16-METHYL-3-OXO-17- (1-OXOPROPOXY)ANDROSTA-1,4-DIENE-CARBOTHIOIC ACID",617-084-5,80474-45-9,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3,H412:1;H319:3;H317:3
32195,"Tetrasodium [μ-[[4,4'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-)",235-414-2,12222-00-3,Not Classified,REACH registration C&L,58,Not classified:54;H412:4
32201,"1,3,5-Triazin-2-amine, 4-methoxy-N,6-dimethyl-",610-849-4,5248-39-5,Acute Tox. 4;Acute Tox. 4;STOT SE 3;STOT RE 2,Notified C&L,38,H302:38;H335:38;H373:38;H312:38
32202,Picrotoxin,204-716-6,124-87-8,Acute Tox. 2,Notified C&L,43,H300:43
32208,POLY[DIMETHYLSILOXANE-CO-METHYL(3-HYDROXYPROPYL)SILOXANE]-GRAFT-POLY(ETHYLENE GLYCOL) METHYL ETHER,601-468-4,117272-76-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,90,H319:90;H411:89;H302:1;H315:1
32210,"1,1'-Bi-2-naphthol bis(trifluoromethanesulfonate)",603-283-4,128575-34-8,Skin Corr. 1B,Notified C&L,38,H314:38
32211,"Phenol, 2,2'-methylenebis(4-amino-, dihydrochloride",608-082-5,27311-52-0,Acute Tox. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,14,H400:13;H319:14;H300:13;H410:13;H335:1;H312:1;H332:1;H302:1;H315:1
32217,Methoxyacetaldehyde-diethylacetal,225-393-8,4819-75-4,Flam. Liq. 3,Notified C&L,38,H226:38
32219,"5,5-dimethylcyclohexane-1,3-dione",204-804-4,126-81-8,Not Classified,REACH registration C&L,7,Not classified:5;H335:2;H319:2;H315:2
32222,Hex-3-yne,213-173-4,928-49-4,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H225:43;H304:44;H315:44
32223,"2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile",225-085-3,4651-91-6,,Notified C&L,7,H302:6;H335:7;H319:7;H315:7;H312:1;H332:1;H301:1
32224,"(,5E)-2,6-dimethyl-3,5-octadien-2-ol",242-493-7,18675-17-7,Not Classified,Notified C&L,233,Not classified:233
32233,4-trans-Pentylcyclohexancarbonic acid-(4-trans-propylcyclohexyl)ester,615-942-3,73255-65-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,Not classified:1;H302:1;H413:1
32235,Vanadium trichloride,231-744-6,7718-98-1,Skin Corr. 1C;Aquatic Chronic 3,REACH registration C&L,46,H314:46;H412:2;H302:40;H300:4;H411:1
32240,N-vinylphthalimide,222-473-4,3485-84-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:46;H315:46
32243,Hexamethylene bis(chloroformate),220-840-3,2916-20-3,,REACH registration C&L,0,No data
32244,4-[3-(stearoylamino)propyl]morpholinium lactate,259-860-2,55852-14-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
32246,"Sulfonic acids, C8-24-branched and linear alkane, potassium salts",309-219-9,100085-76-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
32249,3-[(aminoiminomethyl)amino]-L-alanine monohydrochloride,216-044-0,1482-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32251,N-(n-Butyl)thiophosphoramide,619-010-7,94317-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:42;H319:42;H315:42;H318:4;H361:4
32252,"2,6-dimethyloct-7-en-2-yl acetate",258-751-7,53767-93-4,Aquatic Chronic 2,REACH registration C&L,1518,H411:1288;Not classified:230
32262,1-benzylcycloheptan-1-ol,223-660-3,4006-73-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;STOT SE 3;Repr. 2;STOT RE 2,REACH registration C&L,2,H373:2;H335:2;H225:2;H336:2;H304:2;H361:2;H315:2
32263,Chromium trioleate,244-256-3,21178-63-2,Aquatic Chronic 4,Notified C&L,84,H413:84
32268,"2,2-dimethylbutan-1-ol",214-681-9,1185-33-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H319:1;H315:1
32271,reaction mass of: 2-(hexylthio)ethylamine hydrochloride;sodium propionate,405-720-2,,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H318:0;H317:0;H411:0
32272,Salazosulfapyridine,209-974-3,599-79-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,72,H334:46;H317:46;H360:25;H351:2;H362:1;H361:1;H413:1
32277,Caesium hydroxide,244-344-1,21351-79-1,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Repr. 2;STOT RE 2,REACH registration C&L,123,H373:47;H314:122;H302:118;H318:47;H361:47
32281,(Z)-hex-3-enyl benzoate,246-669-4,25152-85-6,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1644,H317:11;H411:11;Not classified:1594;H335:38;H319:38;H315:39
32282,"Alkenes, C9-11, C10-rich",271-213-6,68526-56-7,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Carc. 2;Repr. 2;STOT RE 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,115,H373:1;H335:60;H319:60;H410:5;H351:3;H400:5;H226:60;H302:60;H332:5;H336:5;H340:5;H350:5;H372:5;H304:60;H361:5;H315:60;H331:55;H411:55
32285,3-ethoxypropane-1-ol,203-861-2,111-35-3,Flam. Liq. 3;Eye Irrit. 2;Acute Tox. 4,Notified C&L,38,H226:38;H332:38;H319:38
32286,"1,5-bis(4-methylphenyl)amino]anthraquinone",201-403-6,82-20-2,Not Classified,Notified C&L,1,Not classified:1
32289,"Tung oil, polymd.",614-236-2,68038-50-6,Not Classified,Notified C&L,1,Not classified:1
32291,[No public or meaningful name is available],680-295-6,99817-36-4,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H410:4;H400:4;H317:4;H301:4;H318:4
32292,4-chlorobenzenesulphonyl chloride,202-685-3,98-60-2,Skin Corr. 1B;STOT SE 3,REACH registration C&L,90,H314:90;H335:9;H318:1;H290:1
32294,Bis(tributyltin) oxide,200-268-0,56-35-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,363,H360:4;H319:358;H312:347;H410:358;H400:358;H372:182;H301:358;H315:358;H373:176;H331:177;H335:6;H311:11;Not classified:5;H361:1
32300,Potassium trifluorozincate,237-537-7,13827-02-6,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 2;STOT RE 1;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,1,H319:1;H410:1;H302:1;H330:1;H372:1
32307,2-(3-Fluoro-3’-methoxybiphenyl-4-lycarbamoyl)-cyclopent-1-enecarboxylic acid,615-418-4,717824-30-1,Acute Tox. 4;Repr. 1A;Aquatic Chronic 4,Notified C&L,2,H302:2;H360:2;H413:2
32309,"3-chloro-1H-1,2,4-triazole",229-892-1,6818-99-1,Acute Tox. 4,Notified C&L,46,H302:40;H335:6;H319:7;H315:7;H312:1;H332:1
32311,"Octahydro-4,7-methano-1H-indene-1,2-diol",225-229-5,4728-34-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
32317,"Poly(oxy-1,2-ethanediyl), α,α',α''-(nitrilotri-2,1-ethanediyl)tris[ω-hydroxy-, polymer with 2,4-diisocyanato-1-methylbenzene",615-178-0,70833-62-4,Not Classified,Notified C&L,31,Not classified:31
32318,Clonixin,241-730-1,17737-65-4,Acute Tox. 4,Notified C&L,47,H302:47;H332:9;H312:9;H319:1;H315:1
32320,Reaction products of acetic acid and acetylferrocene and butan-1-ol and 2-methylpropan-1-ol and propan-1-ol and propan-2-ol,700-283-7,,Flam. Liq. 3,Notified C&L,1,H226:1
32322,"hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate",418-550-9,168689-49-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
32323,"Naphthalene-1,7-diol",209-383-0,575-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H319:45;H315:45
32324,(Chloromethyl)dimethoxymethylsilane,606-938-2,2212-11-5,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,40,H226:40;H319:39;H302:1;H412:1;H315:1
32326,Methyl stearate,203-990-4,112-61-8,Not Classified,REACH registration C&L,186,Not classified:186
32330,"Benzoic acid, 2,3-dichloro-, methyl ester",608-309-8,2905-54-6,,Notified C&L,1,H335:1;H319:1;H315:1
32333,"[dimethylamino(triazolo[4,5-b]pyridin-3-yloxy)methylidene]-dimethylazanium; hexafluorophosphate",604-662-7,148893-10-1,Skin Sens. 1,Notified C&L,180,H317:119;H335:61;H319:62;H315:62;H228:49;H334:2
32338,"Fatty acids, C14-18 and C16-18 unsatd., Me esters, mixed with hydrogenated fish oil, sulfurized",309-165-6,100085-25-4,Not Classified,Notified C&L,1,Not classified:1
32339,"Mandarin orange, Satsuma, ext.",308-594-6,98106-71-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H400:2;H317:2;H226:2;H304:2;H315:2
32340,"Trisodium 4-amino-5-hydroxy-3-[[4'-[[4-hydroxy-2-[(o-tolyl)amino]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-6-[(4-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",228-784-1,6358-80-1,Not Classified,Notified C&L,1,Not classified:1
32341,Dehydrocholic acid,201-335-7,81-23-2,Not Classified,Notified C&L,3,Not classified:2;H335:1;H319:1;H315:1
32346,"1,5-diamino-4,8-dihydroxy-2-(4-hydroxyphenyl)anthraquinone",237-269-0,13716-91-1,Not Classified,Notified C&L,25,Not classified:25
32355,4-(methylamino)benzenesulphonic acid,246-256-9,24447-99-2,,Notified C&L,4,H335:4;H319:4;H315:4
32360,"2-aminonaphthalene-1,5-disulphonic acid",204-201-6,117-62-4,Eye Irrit. 2,REACH registration C&L,56,H319:43;H318:9;Not classified:4
32362,"1,3-Diiodo-5,5-dimethyl-imidazolidine-2,4-dione",480-280-2,,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H314:3;H302:3;H311:3;H411:3
32363,"[1,1'-bicyclohexyl]-4,4'-diol",243-908-4,20601-38-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H315:39
32365,"Glycerides, coco mono- and di-, acetates",295-192-8,91845-20-4,Not Classified,Notified C&L,8,Not classified:8
32369,tert-pentyl 2-ethylperoxyhexanoate,211-687-3,686-31-7,Org. Perox. D;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,253,H242:182;H410:80;H317:182;H400:80;Not classified:71
32370,Ethylenediaminetetraacetonitrile,227-290-3,5766-67-6,Not Classified,REACH registration C&L,40,Not classified:2;H302:38
32371,Thiamine,200-425-3,59-43-8,Not Classified,Notified C&L,6,Not classified:6
32372,"(2R-(2α,3Z,5α))-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 1:1 salt with 2,4,4-Trimethylpentan-2-amine",613-879-6,66069-32-7,Flam. Sol. 2;Acute Tox. 4;Skin Sens. 1B;Resp. Sens. 1,Notified C&L,1,H302:1;H334:1;H317:1;H228:1
32373,10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dimalonate,238-842-8,14777-25-4,,Notified C&L,2,H302:2
32379,"Poly(oxy-1,2-ethanediyl), α-butyl-ω-butoxy-",608-675-9,31885-97-9,Not Classified,Notified C&L,31,Not classified:31
32382,4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane,401-130-4,71526-07-3,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
32383,(cyclopropylmethyl)ammonium chloride,230-668-0,7252-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H319:44;H315:44
32384,1-ethyl-2-[3-(1-ethyl-2(1H)-quinolylidene)prop-1-enyl]quinolinium iodide,210-099-4,605-91-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,43,H301:43;H311:43;H331:39;H330:4;H319:1;H315:1
32385,"1,3-(dicyclohexyl)thiourea",214-920-7,1212-29-9,Aquatic Chronic 4,Notified C&L,44,H413:38;H302:5;H335:1;H319:1;H315:1
32388,"Calcium hydroxide (Ca(OH)2), reaction products with magnesium hydroxide and silicic acid (H4SiO4) zirconium salt (1:1)",270-104-0,68411-14-3,,Notified C&L,1,H318:1;H312:1
32393,(E)-2-methylpent-2-en-1-oic acid,241-026-4,16957-70-3,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,683,H314:683;H318:470;Not classified:1;H290:1
32395,2-methylpropylenediamine,212-374-4,811-93-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,95,H226:95;H302:56;H318:56;H314:95;H317:1;H412:1
32406,Methyl mercaptoacetate,219-121-7,2365-48-2,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,97,H335:95;H319:97;H226:72;H332:81;H301:87;H315:97;H312:26;H317:25;H302:10;H331:10
32409,"bis[2-hydroxy-N,N-bis(2-hydroxyethyl)ethanaminium] 3-[(2-{[2-(carboxylatomethyl)octadecanoyl]oxy}ethoxy)carbonyl]icosanoate",459-060-5,,Eye Dam. 1,Notified C&L,446,H318:446
32411,5-amino-2-methoxyphenol,216-873-8,1687-53-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:44;H319:45;H312:44;H332:44;H302:44;H315:45
32412,"Tetrasodium 2,2''-diamino-8,8''-dihydroxy-4',4'''-{4-[bis(2-hydroxyethyl)amino]-1,3,5-triazine-2,6-diyldiimino}bis(naphthalene-1-azobenzene-2',6-disulfonate)",442-680-5,443688-20-8,Eye Dam. 1,REACH registration C&L,7,H318:7;H412:6
32413,METHYL 2-CYANO-2-(3-THIENYL) ACETATE,617-224-5,81344-59-4,Acute Tox. 4,Notified C&L,1,H302:1
32418,Perfluorophenyl isothiocyanate,252-791-9,35923-79-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H335:39;H319:39;H312:42;H317:38;H302:42;H332:42;H334:38;H315:39;H314:5;H331:1;H311:2;H301:2;H330:1
32422,"2-[2,4-bis(tert-pentyl)phenoxy]butyric acid",236-495-7,13403-01-5,Not Classified,Notified C&L,1,Not classified:1
32427,"1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2,3-dicarbonitrile",201-347-2,81-41-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
32435,"Naphthenic acids, vanadyl complexes",271-395-7,68553-60-6,Not Classified,Notified C&L,10,Not classified:5;H301:4;H330:4;H335:1;H319:1;H317:1;H315:1
32438,Octadecyl D-glucoside,248-686-2,27836-65-3,Not Classified,Notified C&L,29,Not classified:29
32440,3-fluorobenzonitrile,206-963-5,403-54-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H302:45;H318:39;H335:44;H315:45;H319:6;H332:5;H311:6;H331:2;H301:2;H312:1
32442,(4-methylphenyl)mesitylene sulfonate,407-530-5,67811-06-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
32445,Dispers Gelb F06-0246,473-150-1,,Not Classified,REACH registration C&L,1,Not classified:1
32448,"4,6,10-Dodecatrien-3-one, 7,11-dimethyl-, cyclized, by-products from, fractionation residues",273-062-1,68937-31-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,25,H317:25;H411:25
32453,Platinum dioxide,215-223-0,1314-15-4,Ox. Sol. 1,REACH registration C&L,222,H271:125;H272:58;H319:52;Not classified:39;H318:1;H315:1;H412:1
32456,(1R)-1-Phenylpropan-1-amine,608-544-6,3082-64-2,Acute Tox. 3;Skin Corr. 1A;Eye Irrit. 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,128,H319:1;H314:128;H401:1;H301:84;H411:88;H318:83;H302:44
32457,Copper di(acetate),205-553-3,142-71-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,553,H400:184;H314:133;H302:360;H318:142;H411:107;H301:120;H412:120;H311:120;Not classified:73;H335:43;H319:46;H410:81;H315:46;H332:2;H312:1
32459,Tetramethylenediammonium dichloride,206-375-9,333-93-7,Skin Irrit. 2;STOT SE 3,Notified C&L,176,H335:174;H315:175;H319:59;H314:1;H302:1;H311:1;H330:1;H318:1
32461,4-bromocumene,209-577-5,586-61-8,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,43,H302:39;H411:43;H319:5;H315:5
32463,2-octyldodecyl isooctadecanoate,298-361-4,93803-87-3,Not Classified,REACH registration C&L,24,Not classified:24
32464,"Sodium hydrogen 4-[[4-(ethylamino)-m-tolyl][4-(ethylimino)-3-methylcyclohexa-2,5-dien-1-ylidene]methyl]-6-hydroxybenzene-1,3-disulphonate",224-728-5,4463-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:51;H319:51;H315:51
32468,"Rosin, polymer with phenol and tall-oil rosin",614-689-6,68648-57-7,Not Classified,Notified C&L,2,Not classified:2
32472,Cerium phosphate,236-637-8,13454-71-2,Not Classified,Notified C&L,1,Not classified:1
32474,"Propanenitrile, 3-[[3-(isodecyloxy)propyl]amino]-",919-218-0,72162-47-1,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,33,H314:33;H400:33;H410:33
32476,"Wastewater, zinc sulfate electrolytic, acid",273-723-4,69012-24-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,34,H302:34;H318:34;H410:34;H400:34;H373:16;H360:16;H314:16;H341:16;H350:16;H315:16
32478,"Hydrocarbons, C",308-290-3,97926-71-1,Carc. 1B,Harmonised C&L,0,H350:0
32484,Zinc dimyristate,240-369-7,16260-27-8,Not Classified,REACH registration C&L,4,Not classified:4
32486,"Ethyl 2-[[[2,4(or3,5)-dimethyl-3-cyclohexen-1-yl]methyl]amino]benzoate",269-404-4,68228-09-1,Not Classified,Notified C&L,88,Not classified:88
32492,"2-{4-[2-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)propan-2-yl]phenyl}ethyl 4-methylbenzenesulfonate",606-467-2,202189-76-2,Muta. 2,REACH registration C&L,4,H341:4;H335:1;H319:1;H351:1;H302:1;H413:1;H361:1;H315:1
32493,N-(4-cyanophenyl)acetamide,252-685-2,35704-19-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H335:42;H319:42;H312:38;H332:38;H302:42;H315:42
32495,Quinoline-6-carboxylic acid,233-761-4,10349-57-2,,Notified C&L,6,H335:5;H319:6;H315:6
32497,3-acetoxyindole,210-154-2,608-08-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H302:41;H335:40;H319:40;H315:40;H332:1;H312:1
32502,"Hexanedioic acid, polymer with 1,6-hexanediol and 1,1'-methylenebis[4-isocyanatobenzene]",608-577-6,31075-20-4,Eye Irrit. 2,Notified C&L,12,H319:8;Not classified:4
32504,"Gases (petroleum), extractive, C3-5, butene-isobutylene-rich",270-732-5,68477-42-9,Flam. Gas 1;Press. Gas (Liq.);Muta. 1B;Carc. 1A,REACH registration C&L,3,H340:3;H350:3;H220:3;H280:3
32506,N-phenylpyridin-4-amine,245-352-8,22961-45-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
32508,2-pentyl-3-phenylprop-2-en-1-ol,202-982-8,101-85-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,316,H319:303;H317:278;H315:277
32512,4-phenylthiazole-2(3H)-thione,218-274-7,2103-88-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,42,H302:38;H318:38;H335:4;H319:4;H315:4
32513,Sodium (6R-trans)-3-(acetoxymethyl)-7-(cyanoacetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,245-513-2,23239-41-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H335:1;H319:1;H317:1;H334:1;H315:1
32514,Manganese bis(2-ethylhexanoate),236-562-0,13434-24-7,Eye Irrit. 2,Notified C&L,708,H319:582;H361:147;H373:141;H411:128;Not classified:73;H315:44;H226:6;H304:5;H413:2
32515,"1,3-diphenyl-5-pyrazolone",225-430-8,4845-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32516,8-octanelactam,213-300-3,935-30-8,,Notified C&L,5,H335:4;H319:5;H315:5
32526,"methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate",445-990-9,376588-17-9,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
32528,"Siloxanes and Silicones, ethoxy Pr, ethoxy vinyl, ethoxy-terminated",606-447-3,201615-10-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,14,H413:14;H319:14;H315:14
32533,"Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with bentonite",275-124-3,71011-24-0,Not Classified,Notified C&L,521,Not classified:488;H319:20;H315:20;H411:13
32536,3'-chloroacetophenone,202-721-8,99-02-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:47;H319:49;H315:49;H302:8;H312:1;H332:1;H301:1;H311:1;H330:2
32538,Potassium carbamoylcarbamate,247-728-7,26479-35-6,Not Classified,REACH registration C&L,1,Not classified:1
32540,"Hydrogen [[[(2-ethylhexyl)amino]sulphonyl][[(3-methoxypropyl)amino]sulphonyl]-29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-), compound with N,N'-di(o-tolyl)guanidine (1:1)",276-657-4,72428-99-0,Not Classified,REACH registration C&L,2079,Not classified:2079
32541,"5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol",609-737-8,3967-32-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,REACH registration C&L,3,H335:3;H319:2;H301:2;H361:2;H315:3;H317:1;H302:1;H411:1
32550,thioacetamide,200-541-4,62-55-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H302:0;H350:0;H412:0;H315:0
32552,3-Bromo-5-chlorobenzonitrile,608-484-0,304854-55-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H319:1;H331:1;H311:1;H301:1;H315:1
32554,"2-ethylhexanoic acid, iron(2+) iron(3+) salt",269-240-3,68201-81-0,Not Classified,Notified C&L,88,Not classified:88
32555,2-(1-methylpropyl)-4-tert-butylphenol,421-740-4,51390-14-8,Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H411:0
32558,Dibutyl maleate,203-328-4,105-76-0,Skin Sens. 1;STOT RE 2;Aquatic Acute 1,REACH registration C&L,1148,H373:236;H317:420;H400:40;Not classified:551;H335:177;H319:178;H315:248;H411:112
32562,"p-(1,2,3,4-thiatriazol-5-ylamino)phenol",245-745-4,23567-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32563,"Hexane-3,4-dione",224-651-7,4437-51-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1598,H226:1598;H319:1555;H331:1555;H315:1555
32565,"Benzenesulfonic acid, mono-C10-13-branched alkyl derivs., compds. with butylamine",290-663-4,90194-52-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H315:1
32566,"(E)-3,7-dimethylocta-1,3,6-triene",223-241-5,3779-61-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,104,H226:90;H335:90;H319:90;H315:104;H302:13;H304:13;H400:1;H411:1
32567,"3-hydroxy-4,5-dimethoxybenzoic acid",217-630-9,1916-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
32569,1-METHYLPYRIDINIUM IODIDE,632-664-8,930-73-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
32570,(R)-Ethyl piperidine-3-carboxylate,607-565-8,25137-01-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:40;H335:40;H315:41;H319:1
32572,5-iodouridine,213-833-1,1024-99-3,Not Classified,Notified C&L,1,Not classified:1
32573,"Fatty acids, C18-unsatd., reaction products with acrylic acid and polyethylenepolyamines",287-820-4,85586-18-1,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,4,H412:3;H317:3;H373:2;Not classified:1
32574,"Phosphoric acid, C8-10-alkyl esters",308-806-7,98653-76-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,458,H318:449;H411:6;H315:6;H290:442;H314:9;Not classified:1
32585,"Methane, 1,1'-thiobis[1-(methylthio)-",613-792-3,6540-86-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,120,H302:115;H335:119;H319:119;H315:119;Not classified:1
32587,cyclohexylamine,203-629-0,108-91-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Repr. 2,Harmonised C&L,0,H312:0;H226:0;H302:0;H314:0;H361:0
32589,(E)-2-chloro-N-[4-chloro-2-[(hydroxyimino)phenylmethyl]phenyl]acetamide,220-755-1,2888-63-3,Not Classified,REACH registration C&L,2,Not classified:2
32590,"9-Octadecenoic acid, 12-hydroxy-, 2-hydroxyethyl ester, (R-(Z))-",618-404-6,9004-97-1,Not Classified,Notified C&L,2,Not classified:2
32593,"1-Hexadecanol, phosphate, compd. with 2,2'-iminobis[ethanol] (1:1)",273-968-7,69331-39-1,Eye Dam. 1,Notified C&L,2,H318:1;H319:1
32596,"1,2-Benzenedicarboxylic acid, heptyl nonyl ester, branched and linear",601-082-6,111381-89-6,,Notified C&L,1,Not classified:1
32597,"Oils, fish, bisulfited, oxidized",309-451-0,100298-97-3,Not Classified,Notified C&L,5,Not classified:5
32599,Sodium methylarsonate,218-495-9,2163-80-6,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H301:38;H400:38;H410:38;H331:38;H302:4
32600,(S)-3-hydroxy-α-[(methylamino)methyl]benzyl alcohol,210-367-0,614-03-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
32604,Amisulpride,275-831-7,71675-85-9,Acute Tox. 4,Notified C&L,60,H302:53;H335:12;H319:12;H312:9;H332:9;H315:6;Not classified:2
32605,Chloro(triethylphosphine)gold,239-572-3,15529-90-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,41,H335:39;H319:39;H331:39;H311:39;H301:41;H315:39;H228:1;H413:1
32607,"Disodium 2,2'-[(2,4-dihydroxy-1,3-phenylene)bis(azo-4,1-phenyleneimino)]bis(5-nitrobenzenesulphonate)",276-027-9,71799-43-4,Aquatic Chronic 3,Notified C&L,62,H412:36;Not classified:14;H319:12
32610,Hex-3-enyl isobutyrate,260-993-3,57859-47-9,Not Classified,Notified C&L,1,Not classified:1
32613,5-decyn-1-ol,269-529-4,68274-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H319:43;H315:43
32619,(dimethylphosphinyl)methanol,227-442-9,5850-00-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
32622,Protheobromine,200-034-8,50-39-5,,Notified C&L,1,H400:1
32623,ethyl cyclopent-2-en-1-ylacetate,605-150-6,15848-49-4,Skin Irrit. 2,REACH registration C&L,2,H315:2;H335:1;H319:1;H227:1
32626,Butyl vinyl ether,203-860-7,111-34-2,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,143,H317:98;H315:103;H225:143;H412:9;H335:4;H319:6
32629,Hexyl lactate,243-676-4,20279-51-0,Not Classified,Notified C&L,2,Not classified:2
32631,Picolamine,223-091-0,3731-52-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,152,H314:152;H318:90;H290:12;H319:3;H302:1;H332:1;H312:1;H335:1
32633,(E)-1-(trans-4-Ethenylcyclohexyl)-2-[trans-4-(4-methylphenyl)-cyclohexyl]-ethene,606-409-6,199433-38-0,Aquatic Chronic 4,Notified C&L,2,Not classified:2;H413:2
32636,PI stabilized,618-362-9,9003-31-0,Not Classified,Notified C&L,267,Not classified:225;H334:32;H317:32;H412:9;H319:1;H315:1
32637,2-iodomesitylene,223-709-9,4028-63-1,Not Classified,Notified C&L,2,Not classified:1;H335:1;H319:1;H315:1
32645,CATALYST SG1,456-840-7,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Carc. 2,Notified C&L,1,H351:1;H317:1;H226:1;H302:1;H318:1;H315:1
32646,2-ethylhexyl diphenyl phosphite,239-716-5,15647-08-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,87,H319:52;H315:52;Not classified:32;H361:1;H373:1;H332:1;H302:1;H317:2;H411:1
32648,Olaflur,229-891-6,6818-37-7,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
32650,"Benzyl 2,2,2-Trichloroacetimidate",617-271-1,81927-55-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H302:38;H335:42;H319:43;H315:43
32654,7-nitro-1H-indole-2-carboxylic acid,230-154-6,6960-45-8,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,43,H334:38;H319:43;H335:5;H315:5
32655,"7-amino-1H-triazolo[4,5-d]pyrimidine",214-375-5,1123-54-2,Not Classified,Notified C&L,1,Not classified:1
32656,"N,N-bis(2-ethylhexyl)-ar-methyl-1H-benzotriazole-1-methanamine",619-007-0,94270-86-7,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,277,H317:269;H411:269;H315:272;H400:76;H319:28;Not classified:5
32659,"2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester",448-260-8,379268-96-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
32662,L-arginine L-glutamate,224-350-0,4320-30-3,Not Classified,Notified C&L,5,Not classified:5
32663,disodium octaborate anhydrous;disodium octaborate tetrahydrate,234-541-0,12008-41-2,Repr. 1B,Harmonised C&L,0,H360:0
32664,"1,3-benzodioxolane",205-992-0,274-09-9,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,84,H226:41;H302:84;H332:40;H335:5;H319:6;H315:6;H312:1;H314:1
32666,"Sulfite liquors and Cooking liquors, white",268-615-9,68131-33-9,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,318,H312:159;H314:318;H302:265;H290:318;H318:318;H400:106;H311:53
32668,2-isobutyl-3-methoxypyrazine,246-402-1,24683-00-9,Not Classified,Notified C&L,287,Not classified:240;H335:43;H319:47;H315:47
32670,α-methylcyclohexylmethyl acetate,236-798-4,13487-27-9,Not Classified,REACH registration C&L,234,Not classified:234
32674,Fenhexamid,603-167-3,126833-17-8,Aquatic Chronic 2,Notified C&L,38,H411:38
32676,"Propylidynetrimethanol, propoxylated, esters with acrylic acid",500-123-4,53879-54-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,145,H319:145;H315:129;H335:57;H317:17
32681,"1,2,4,9-Tetrahydrocarbazol-3-one",610-619-3,51145-61-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H317:1;H411:1
32685,"2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one",243-751-1,20348-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H319:43;H315:43
32694,p-[(diiodomethyl)sulphonyl]toluene,243-468-3,20018-09-1,Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1,Notified C&L,304,H331:276;H400:276;H318:298;H410:120;H315:47;H330:22;H373:23;H317:29;Not classified:5
32696,Tretinoin,206-129-0,302-79-4,Skin Irrit. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,320,H400:244;H360:271;H410:244;H315:271;H302:53;H335:28;H319:30;H411:29;H361:7;H312:2;H341:2
32700,"5,6-diamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione",226-621-9,5440-00-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
32701,Ethyl 2-hydroxy-4-methylvalerate,233-760-9,10348-47-7,Not Classified,Notified C&L,100,Not classified:62;H412:38;H319:38
32702,Maleamic acid,209-163-4,557-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H315:39
32703,"N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide",255-137-0,40908-37-0,Eye Dam. 1,REACH registration C&L,40,H318:2;H335:38;H319:38;H315:38
32704,"Octahydro-6,7a-dihydroxy-4-methyl-7-[4-methyl-7-(tetrahydro-5-oxo-2-furyl)-1-heptenyl]-3-(phenylmethyl)-1H-isoindol-1-one",237-965-4,14110-71-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H310:38;H300:38;H330:38
32706,"[2R[2R*(4R*,8R*)]]-3,4-dihydro-2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",204-299-0,119-13-1,Not Classified,REACH registration C&L,49,Not classified:48;H332:1;H302:1;H312:1
32707,2-methylquinuclidin-3-ol,223-543-7,3952-61-2,Skin Corr. 1B,Notified C&L,38,H314:38
32710,"Methanone, [2-[5-(aminomethyl)-2-methyl-1H-imidazol-1-yl]-5-chlorophenyl](2-fluorophenyl)-, dihydrochloride",611-832-4,59468-73-4,Acute Tox. 4,REACH registration C&L,2,H302:2
32711,"Rosin, fumarated, oligomeric reaction products with paraformaldehyde",500-200-2,68201-58-1,Not Classified,Notified C&L,7,Not classified:7
32715,"Disodium 1-amino-9,10-dihydro-4-[(4-methyl-2-sulphonatophenyl)amino]-9,10-dioxoanthracene-2-sulphonate",229-069-7,6408-80-6,Not Classified,Notified C&L,5,Not classified:5
32716,dicyclohexylamine,202-980-7,101-83-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H302:0;H410:0;H400:0
32717,1-phenylcyclopropanemethylamine,213-302-4,935-42-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H301:91;H335:91;H319:90;H315:91;H318:1
32721,"sodium salt of DNOC;sodium 4,6-dinitro-o-cresolate",219-007-7,2312-76-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0;H331:0;H311:0;H301:0
32723,Calcium di(acetate),200-540-9,62-54-4,Not Classified,REACH registration C&L,495,Not classified:451;H335:39;H319:43;H315:43;H318:2;H302:1
32726,"2,2,3-trimethylpentane",209-266-4,564-02-3,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H225:0;H400:0;H336:0;H304:0;H315:0
32731,"Hexa-1,5-diene-3,4-diol",213-955-5,1069-23-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H301:38;H311:40;H331:38;H302:2;H319:1;H315:1
32732,brucine sulphate,225-432-9,4845-99-2,Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H300:0;H330:0
32733,3-[(2-ethylhexyl)oxy]propiononitrile,233-519-8,10213-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H335:22;H319:22;H315:22
32736,Strontium tin trioxide,235-264-8,12143-34-9,,Notified C&L,4,H335:4;H319:4;H315:4
32739,"diphenylmethyl (6R,7R)-3-[(methylsulfonyl)oxy]-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",618-817-1,92096-37-2,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H334:1;H317:1
32740,Dimethoxymethyloctylsilane,288-374-3,85712-15-8,Not Classified,Notified C&L,3,Not classified:1;H411:1;H319:1;H315:1
32741,Di-tert-butyl sulphide,203-493-2,107-47-1,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,538,H226:501;H319:479;H335:63;H315:70
32744,Pontacyl Violet 6R,611-675-1,5850-63-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
32751,"1,4-bis(bromomethyl)-2,3,5,6-tetramethylbenzene",252-414-8,35168-64-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
32756,3-chloro-2-methylpropyl(dimethyl)amine,245-598-6,23349-86-2,Not Classified,REACH registration C&L,6,Not classified:6
32761,"(,5Z)-2,6-dimethylocta-3,5-dien-2-ol",242-492-1,18675-16-6,Not Classified,Notified C&L,233,Not classified:233
32767,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, reaction products with methylated 4-[(4-aminophenyl)azo]benzenesulfonic acid monosodium salt",235-415-8,12222-37-6,Not Classified,Notified C&L,23,Not classified:20;H319:2;H315:1
32771,"2,2-dimethylvaleric acid",214-682-4,1185-39-3,Skin Corr. 1B,Notified C&L,41,H314:41;H318:1;H290:1
32773,2-(2-aminoethyl)pyridine,220-295-1,2706-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:39;H319:39;H315:39;H314:7;H318:2
32774,"6-nitrophenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid",207-499-6,475-80-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 2,Notified C&L,2,H351:2;H331:2;H341:2;H311:2;H301:2
32778,Barium molybdate,232-111-7,7787-37-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:42;H302:42
32779,"Bis(2-ethylhexyl) 2,2'-thiobisacetate",246-131-9,24293-43-4,Skin Sens. 1,REACH registration C&L,34,H317:34
32783,4-fluorobenzoyl chloride,206-961-4,403-43-0,Skin Corr. 1B,Notified C&L,62,H314:62;H318:1;H290:1;H335:1;H319:1
32785,2-pentylcyclopentan-1-one,225-392-2,4819-67-4,Not Classified,REACH registration C&L,1592,Not classified:1554;H319:38
32788,"Fuels, diesel;Gasoil - unspecified;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",269-822-7,68334-30-5,Carc. 2,Harmonised C&L,0,H351:0
32789,Tosyl chloride,202-684-8,98-59-9,Met. Corr. 1;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,893,H318:763;H290:72;H317:160;H315:267;H314:573;H335:491;H412:99;Not classified:56;H272:20;H319:1;H312:1;H302:1;H332:1
32790,5-Hexyl-2-methyl pyridine,414-530-9,710-40-7,Skin Sens. 1B,Notified C&L,25,H317:25
32792,"6-{[4-dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy]-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one hydrochloride",928-754-4,,Not Classified,REACH registration C&L,2,Not classified:2
32794,"Ulexite (CaNaH12(BO3)5.2H2O), calcined",296-662-5,92908-33-3,Eye Irrit. 2;Repr. 1A,Notified C&L,22,H360:20;H319:20;Not classified:2
32795,"2,4,7,9-TETRAMETHYL-4,7-DECANEDIOL",605-849-6,17913-76-7,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,124,H412:70;H319:70;Not classified:54
32797,Dipotassium tetrabromoplatinate,237-536-1,13826-94-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
32798,"(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-[(triphenylmethoxy)imino]acetyl]amino]-3-[(E)-[(3'R)-1'-[(1,1-dimethylethoxy)carbonyl]-2-oxo-[1,3'-bipyrrolidin]-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester",609-463-9,376653-41-7,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H302:1;H317:1;H334:1
32804,"Chromate(3-), bis[3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-1-naphthalenesulfonato(3-)]-, diethanolamine sodium salts",284-675-9,84961-84-2,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
32807,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl formate",272-067-6,68683-22-7,Not Classified,Notified C&L,88,Not classified:88
32808,(RS)-5-ethyl-2-(4-isopropyl-4-methyl-4-oxo-2-imidazolin-2-yl) nicotinic acid,617-222-4,81335-77-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,176,H400:173;H410:173;Not classified:3;H332:1
32809,Chlorcyclizine hydrochloride,238-335-1,14362-31-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H335:38;H319:38;H315:38
32811,"5-acetamido-4-hydroxy-3-[[2-methoxy-5-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic acid, potassium sodium salt",288-955-1,85940-67-6,Not Classified,Notified C&L,1,Not classified:1
32820,4-(methylthio)benzoic acid,236-171-5,13205-48-6,,Notified C&L,5,H335:4;H319:5;H315:5
32823,5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine,604-948-1,154361-50-9,Muta. 2;Carc. 1B;Repr. 1B,Notified C&L,49,H350:44;H341:41;H360:49;H319:7;H351:2;H411:3;H315:7;H410:1;H400:1
32825,D-camphoric acid,204-715-0,124-83-4,Not Classified,REACH registration C&L,43,Not classified:2;H302:39;H319:2;H315:2;H335:1
32826,"Benzoic acid, 2-[(dioctadecylamino)carbonyl]-",618-070-1,87787-81-3,Not Classified,Notified C&L,1,Not classified:1
32831,"Alkenes, C8-10, C9-rich",271-212-0,68526-55-6,Flam. Liq. 3;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,469,H226:469;H304:469;H410:469;H400:469
32833,"Oils, fish, mixed with vegetable oils, Me esters, sulfurized",273-640-3,68991-30-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,29,H319:29;H315:29
32837,"Reaction Products of 3-(2,3-epoxypropoxy)propyltrimethoxysilane and triacetoxy(vinyl)silane",604-964-9,154518-41-9,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;STOT RE 2,REACH registration C&L,24,H373:24;H335:2;H317:24;H318:24;H315:2;H226:22
32838,"Naphthalenesulfonic acids, reaction products with formaldehyde, sodium salts",293-351-6,91078-68-1,Not Classified,Notified C&L,169,Not classified:165;H319:4
32844,Tributyltin acetate,200-269-6,56-36-0,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H319:42;H312:42;H410:42;H400:42;H372:42;H301:42;H315:42
32848,"N,N-diethyl-4-[(4-nitrophenyl)azo]aniline",221-180-9,3025-52-3,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
32852,3-oxoandrost-4-ene-17-ß-carboxylic acid,414-990-0,302-97-6,Aquatic Chronic 4;Repr. 2,Harmonised C&L,0,H361:0;H413:0
32857,DEHYMULS FCE,403-420-6,,Not Classified,Notified C&L,83,Not classified:83
32861,Urea Ammonium Nitrate,605-190-4,15978-77-5,Eye Irrit. 2,Notified C&L,16,H319:16
32863,"Oxirane, methyl-, polymer with oxirane, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), 2-propenoate",601-566-7,118800-30-9,Aquatic Chronic 2,Notified C&L,166,H411:83;H319:83
32875,"Sodium [[α,α'-(ethylenediimino)bis[2-hydroxybenzene-1-acetato]](4-)]ferrate(1-)",240-505-5,16455-61-1,Not Classified,REACH registration C&L,95,Not classified:92;H302:3;H335:3;H319:3;H315:3
32876,N-[{2-Chloro-3-[(phenylimino)methyl]-2-cyclohexen-1-ylidene}methyl]aniline hydrochloride,613-390-8,63857-00-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H319:39;H315:38;H312:1;H351:1;H317:1;H332:1;H302:1;H341:1;H372:1;Not classified:1
32886,"Fatty acids, C16-18 and C16-18-unsatd., reaction products with 2-[(2-aminoethyl)amino]ethanol, diethanolamine, polyethylenepolyamines and triethanolamine",309-166-1,100085-26-5,Not Classified,Notified C&L,1,Not classified:1
32888,"Zeolite, synthetic, crystalline, non fibrous, silica and titanium based",930-993-4,,Not Classified,REACH registration C&L,85,Not classified:85
32890,Copper chromite,235-000-1,12053-18-8,Ox. Sol. 2;STOT SE 3,Notified C&L,75,H335:38;H272:43;Not classified:32;H319:5
32891,"Valerian, ext.",232-501-7,8057-49-6,Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1427,H319:1297;H410:1295;H400:1294;H317:1423;H304:1422;H411:128;H315:14;H226:7;H312:2;H302:2;H332:2;Not classified:2
32893,"1,2:5,6-diepoxyhexahydro-4,7-methanoindan",201-334-1,81-21-0,Acute Tox. 3;Eye Irrit. 2,Notified C&L,44,H301:44;H319:40
32904,[1-(4-bromobenzyl)-2-butyl-4-chloro-1H-imidazol-5-yl]methanol,604-770-4,151012-31-6,Eye Irrit. 2,REACH registration C&L,37,H319:37;H335:1;H332:1;H302:1;H315:1
32906,"[2,4-bis(1,1-dimethylpropyl)phenoxy]acetic acid",236-494-1,13402-96-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
32907,"Centaurea cyanus, ext.",281-664-0,84012-18-0,Not Classified,Notified C&L,4,Not classified:4
32908,Adrafinil,264-303-1,63547-13-7,Acute Tox. 4,Notified C&L,40,H302:40;H332:1;H334:1
32909,"Prosopis spicigera, ext.",296-953-7,93165-66-3,Not Classified,Notified C&L,88,Not classified:88
32912,Ammonium gold(1+) sulphite,275-798-9,71662-32-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
32914,"1,4-diamino-2,3-dichloroanthraquinone",201-348-8,81-42-5,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,113,H302:95;H319:95;Not classified:18
32915,"4,5-dichloro-N-ethyl-2-nitroaniline",263-826-2,63059-56-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32916,"3-Acetoxy-17,17-(2,2-dimethyltrimethylenedioxy)androst-3,5-diene",927-431-5,,Aquatic Chronic 4,Notified C&L,1,H413:1
32919,2-phenyl-2-piperidinoacetonitrile,227-291-9,5766-79-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
32925,"Glycerides, C16-18 and C18-hydroxy mono- and di-",295-191-2,91845-19-1,Not Classified,Notified C&L,8,Not classified:8
32928,"4,6-di-tert-butyl-o-cresol",210-485-2,616-55-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,72,H335:71;H319:71;H302:71;H315:71;H413:71;H400:1;H410:1
32929,Phenylephrine,200-424-8,59-42-7,Acute Tox. 4,Notified C&L,87,H302:87;H317:1;H412:1;H319:1
32930,"Octadecanoic acid, chlorinated",271-888-7,68611-20-1,Not Classified,Notified C&L,1,Not classified:1
32931,(3R)-(+)-3-(tert-Butoxycarbonylamino)pyrrolidine,602-787-1,122536-77-0,,Notified C&L,11,H314:5;H335:5;H319:6;H315:6
32937,[No public or meaningful name is available],608-399-9,29694-85-7,Not Classified,Notified C&L,96,Not classified:76;H319:20;H317:20;H411:20;H315:20
32942,"Michelia alba, ext.",296-299-2,92457-18-6,Skin Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,1349,H351:1332;H341:1332;H412:1332;H315:1349;H226:41;H304:48;H319:9;H411:2
32945,"Formaldehyde, polymer with methylphenol",618-497-3,9016-83-5,Not Classified,Notified C&L,80,Not classified:64;H319:16;H411:16
32949,"Trisodium 8-hydroxypyrene-1,3,6-trisulphonate",228-783-6,6358-69-6,Not Classified,REACH registration C&L,2273,Not classified:2191;H335:82;H319:82;H315:82
32951,Salicylanilide,201-727-8,87-17-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,585,H400:486;H335:543;H319:544;H315:544;Not classified:42;H411:2
32952,"1-ethoxy-2,3-difluorobenzene",441-000-4,121219-07-6,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
32958,5-Fluoro-2-nitrobenzotrifluoride,609-643-7,393-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:40;H319:46;H315:46;H332:7;H302:7;H311:4;H312:3
32966,5-methoxyindole-3-carbaldehyde,234-220-5,10601-19-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H319:47;H315:47
32970,"2,2'-iminobisethanol, compound with sulphur dioxide",263-968-5,63149-47-3,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H312:1;H315:1
32973,Methyl 2-[4-[2-piperidinoethoxy]benzoyl]benzoate hydrochloride,214-999-8,1248-42-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,7,H335:3;H319:3;H315:3;H302:3;H361:2;Not classified:1
32974,"Diethyl 4,4'-carbonylbis(hydrogen phthalate), compound with p,p'-methylenedianiline (1:1)",265-882-3,65701-06-6,Not Classified,Notified C&L,14,Not classified:14
32977,"3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide",406-200-8,117827-06-2,Skin Sens. 1,Harmonised C&L,0,H317:0
32981,"Extract residues (coal), benzole fraction alk., acid ext.;Light Oil Extract Residues, low boiling;[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90°C to 160°C (194°F to 320°F). It consists predominantly of benzene, toluene and xylenes.]",295-323-9,91995-61-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
32982,Dodecyl D-glucoside,248-685-7,27836-64-2,Not Classified,Notified C&L,52,Not classified:52
32987,Ethyldimethyl[3-[(1-oxoisooctadecyl)amino]propyl]ammonium ethyl sulphate,266-778-0,67633-63-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,141,H302:139;H318:140;H315:140;Not classified:1
32990,"1,1,1,2,3,3,3-heptafluoro-2-(trifluoromethyl)propane",206-571-4,354-92-7,Press. Gas (Comp.);Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H280:1;H315:1
32991,"METHYL (1R,2R,4S)-2-[HEX-5-EN-1-YL(METHYL)CARBAMOYL]-4-({7-METHOXY-8-METHYL-2-[4-(PROPAN-2-YL)-1,3-THIAZOL-2-YL]QUINOLIN-4-YL}OXY)CYCLOPENTANECARBOXYLATE",922-147-8,,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,1,H302:1;H413:1
32992,"N,N-diethyl-1,2,2-trichlorovinylamine",211-686-8,686-10-2,Skin Corr. 1B,Notified C&L,38,H314:38
32994,Magnesium di(acetate),205-554-9,142-72-3,Not Classified,REACH registration C&L,2439,Not classified:2397;H226:42;H332:32;H312:32;H318:10;H314:10
32998,Methyl acetimidate hydrochloride,238-843-3,14777-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
32999,reaction mass of isomers of: dibenzylbenzene;dibenzyl(methyl)benzene;dibenzyl(dimethyl)benzene;dibenzyl(trimethyl)benzene,405-570-8,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
33002,"Distillates (petroleum), acid-treated light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-121-5,64742-21-8,Carc. 1A,Harmonised C&L,0,H350:0
33016,Methyl 4-(hydroxymethyl)benzoate,230-017-0,6908-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
33017,"Disodium 4-formylbenzene-1,3-disulphonate",251-551-0,33513-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,55,H335:53;H319:55;H315:55
33019,3-amino-4-fluorobenzoic acid,219-122-2,2365-85-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
33020,"1,1'-[(6-phenyl-1,3,5-triazine-2,4-diyl)diimino]bisanthraquinone",223-912-2,4118-16-5,Not Classified,REACH registration C&L,2205,Not classified:2205
33023,Bis(acetato-O)phenyliodine,221-808-1,3240-34-4,,Notified C&L,50,Not classified:33;H302:8;H335:16;H319:17;H315:17;H312:3
33026,"(5R,5aR,8aR,9S)-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one",613-823-0,6559-91-7,Muta. 1B,Notified C&L,3,H340:1;H319:1;H315:1;H350:1;H360:1
33029,"Boswellia carterii, ext.",289-620-2,89957-98-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1440,H317:1440;H411:1305;H315:1437;H410:135;H400:95;H226:136;H304:148;H335:1;H319:3;H334:1;H401:1;H332:1;H228:1;H351:1;H341:1;H302:1;H361:1
33033,"(R*,S*)-4-hydroxy-α-[1-[[2-(4-hydroxyphenyl)ethyl]amino]ethyl]benzyl alcohol hydrochloride",245-514-8,23239-51-2,Acute Tox. 4,Notified C&L,41,H302:41;H361:1;H360:1
33038,Cyclen tetrahydrochloride,600-097-5,10045-25-7,Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H314:4;H302:8;H335:43;H319:44;H315:40;H410:4;H400:4
33039,"2-Propenoic acid, γ-ω-perfluoro-C8-14-alkyl esters",288-003-5,85631-54-5,Not Classified,REACH registration C&L,38,Not classified:38
33041,"1,4-Benzenediamine, N1-(4-aminophenyl)-N1-phenyl-",609-895-8,4117-90-2,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H302:33;H410:33;H317:33;H400:33
33042,Diphenyl ether,202-981-2,101-84-8,Eye Irrit. 2A;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2208,H400:203;H412:71;H319:1790;H411:1961;H410:186;Not classified:69;H315:52;H318:9;H317:7;H335:7;H312:3;H302:5
33043,N2-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-N6-(trifluoroacetyl)-L-lysyl-L-proline,405-650-2,,Not Classified,Notified C&L,3,Not classified:3
33052,"Mimosa, ext.",297-646-0,93685-96-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1352,H332:1288;H302:1288;H412:1298;Not classified:53;H361:10;H226:1
33057,Strontium peroxide,215-224-6,1314-18-7,Ox. Sol. 2,REACH registration C&L,52,H272:52;H318:47;H335:47;H315:47
33058,"1-(2,6-dimethylphenyl)-3-[imino(methylamino)methyl]uronium chloride",265-307-6,65009-35-0,Acute Tox. 3,Notified C&L,1,H301:1
33059,Indoline-2-carboxylic acid,278-899-6,78348-24-0,Skin Sens. 1;Repr. 2,Notified C&L,44,H361:44;H317:44;H373:4
33061,chlorobenzene,203-628-5,108-90-7,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H226:0;H332:0;H411:0;H315:0
33062,"Equisetum arvense, ext.",275-123-8,71011-23-9,Not Classified,Notified C&L,98,Not classified:95;H226:3;H319:1
33065,Sodium 2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-1H-benzimidazolesulphonate,274-520-3,70267-73-1,Not Classified,Notified C&L,61,Not classified:60;H317:1
33070,"5-Amino-1,3-dimethylpyrazole",609-103-0,3524-32-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H319:44;H315:44
33072,"Poly(oxy-1,2-ethanediyl), α-isodecyl-ω-hydroxy-",612-519-5,61827-42-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,2496,H302:2185;H318:2320;H315:247;H319:97;Not classified:61;H412:2
33073,"Vaccinium vitis-idaea, ext.",290-400-3,90131-85-4,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,2,H226:2;H319:2
33078,"N-(2,4-dinitrophenyl)benzene-1,4-diamine",228-919-4,6373-73-5,Skin Sens. 1,Notified C&L,2,H317:2
33081,"3-(1-pyrrolidinyl)propane-1,2-diol",286-772-1,85391-19-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H319:2;H315:2
33082,"[(2,4-dichlorophenyl)methyl]triphenylphosphonium chloride",219-659-2,2492-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H315:39
33084,N-amidinosarcosine,200-306-6,57-00-1,Not Classified,REACH registration C&L,100,Not classified:44;H335:56;H319:56;H315:56;H302:1
33086,Prazosin,242-885-8,19216-56-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
33087,(p-toluenesulphonyl)methyl isocyanide,253-140-1,36635-61-7,Acute Tox. 3;Acute Tox. 3;Resp. Sens. 1;Repr. 2,REACH registration C&L,216,H301:209;H334:8;H361:6;H331:211;H311:207;H300:6;H319:3;H315:3;Not classified:3;H310:2;H330:3;H335:1
33088,5-butyl-5-ethyldihydrofuran-2(3H)-one,269-171-9,68188-98-7,Not Classified,Notified C&L,88,Not classified:88
33090,"Dihydrogen [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']nickelate(2-)",247-019-2,25481-21-4,Not Classified,REACH registration C&L,15,Not classified:8;H317:7;H411:2;H302:2;H351:1
33091,2-(5-methoxyindol-3-yl)ethylamine,210-153-7,608-07-1,Acute Tox. 4,Notified C&L,47,H302:45;H314:3;H335:1;H319:1;H315:1;Not classified:1
33094,"3,3-dimethyl-2-oxopentanoic acid",609-041-4,34906-91-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
33097,Uniconazol-P,617-481-3,83657-17-4,Acute Tox. 4,Notified C&L,50,H302:50;H411:12
33099,"Ethane, 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)-",609-858-6,406-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,7,H335:4;H319:6;H315:6;H225:1;H336:2
33101,11-bromoundecanol,216-554-3,1611-56-9,Not Classified,REACH registration C&L,5,Not classified:5
33104,"Sodium O,O-bis(methylphenyl) dithiophosphate",263-223-4,61792-48-1,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,15,H314:15;H412:14;H318:14;H302:1;H330:1
33107,"[(2S,3S,4R,5R)-2-(acetyloxymethyl)-2-[(2R,3R,4S,5R,6R)-6-(acetyloxymethyl)-3,4,5-tris(2-methylpropanoyloxy)oxan-2-yl]oxy-4-(2-methylpropanoyloxy)-5-(2-methylpropanoyloxymethyl)oxolan-3-yl] 2-methylpropanoate",608-058-4,27216-37-1,Not Classified,Notified C&L,22,Not classified:18;H413:4
33108,bis(2-methylpropyl) perylene-dicarboxylate,616-749-7,79869-59-3,Aquatic Chronic 4,REACH registration C&L,85,H413:85
33110,"(2,4,6-trioxotriazine-1,3,5(2H,4H,6H)-triyl)tris(hexamethylene) isocyanate",223-242-0,3779-63-3,Skin Sens. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,184,H332:1;H335:1;H317:178;Not classified:6
33111,6-methylcoumarin,202-158-8,92-48-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1608,H302:1608;H319:1564;H317:38;H334:38;H335:4;H315:4
33122,"Citrus medica vulgaris, ext.",296-175-8,92346-90-2,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,40,H319:39;H410:27;H400:27;H317:27;H226:27;H304:27;H315:27;H225:13
33131,6-AMINO-4-CHLORO-2-IMINO-2H-PYRIMIDIN-1-OL,609-047-7,34960-71-9,Acute Tox. 4,Notified C&L,1,H302:1
33133,2-methylnonane,212-814-5,871-83-0,Flam. Liq. 3,Notified C&L,47,H226:43;H304:9
33139,"Ethene, hydroformylation products, by-products from, distn. residues",606-536-7,203588-71-0,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,14,H332:14;H319:14;H315:14
33142,"Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium, 6,7-dihydro-, chloride (1:1)",611-948-5,6020-18-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT RE 2,Notified C&L,2,H301:2;H373:2;H311:2;H330:2
33144,Hydroxy(6-methyl-2-pyridyl)methyl 6-methyl-2-pyridyl ketone,230-667-5,7252-50-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H335:38;H319:38;H315:38
33145,(+/-)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol,613-310-1,63659-18-7,Acute Tox. 4;Repr. 2;Aquatic Chronic 3,Notified C&L,1,H302:1;H412:1;H361:1
33146,4-amino-5-(ethylthio)-o-anisic acid,275-832-2,71675-86-0,Not Classified,REACH registration C&L,2,Not classified:2
33147,"7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-benzo-1,4-diazepin-2-one 4-oxide",220-756-7,2888-64-4,Not Classified,REACH registration C&L,2,Not classified:2
33148,1-phenylbutan-1-ol,210-368-6,614-14-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
33152,3'-aminoacetophenone,202-722-3,99-03-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,49,H302:49;H412:2;H319:44
33153,2-benzyl-1H-benzimidazole monohydrochloride,214-921-2,1212-48-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
33155,Aluminium sodium tetrachloride,232-050-6,7784-16-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H314:44;H318:39
33160,"Charcoal, bone",232-421-2,8021-99-6,,Notified C&L,46,Not classified:45;H335:1;H319:1;H315:1
33162,Triamcinolone,204-718-7,124-94-7,Carc. 2,Notified C&L,59,H351:38;H361:18;H302:4;H334:1;H332:1;H312:1;H372:1;H360:1
33169,"Poly(oxy-1,2-ethanediyl), α-(2-ethyl-1-oxohexyl)-ω-hydroxy-",607-850-7,26027-36-1,Not Classified,Notified C&L,33,Not classified:33
33170,"2,2'-[[(5-methyl-1H-benzotriazol-1-yl)methyl]imino]bisethanol",279-501-3,80584-88-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,609,H302:609;H318:608;H317:609;H315:455;H412:154;H314:1
33173,Decyl methacrylate,221-657-1,3179-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,505,H335:61;H319:502;H315:502;H410:3;H317:442
33175,"2,2,6,6-tetramethyl-4-piperidinyl stearate",605-462-2,167078-06-0,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56,H400:55;H318:55;H317:55;H410:55;Not classified:1
33178,3β-hydroxyandrost-5-en-17-one heptanoate,245-970-8,23983-43-9,Repr. 2;Lact.;Aquatic Chronic 4,Notified C&L,24,H362:24;H360:24;H361:24;H413:24
33179,"Phosphoric acid, 2-chloro-1-methylethyl bis(2-chloropropyl) ester",616-366-5,76649-15-5,,Notified C&L,33,Not classified:33
33184,"N,N'-ethylenedi(diacetamide)",212-811-9,871-78-3,Not Classified,Notified C&L,37,Not classified:33;H335:4;H319:4;H315:4
33188,"1,1,1,2,3,3,4,4,5,5,6,6-dodecafluoro-6-iodo-2-(trifluoromethyl)hexane",222-475-5,3486-08-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
33189,DL-ornithine monohydrochloride,213-956-0,1069-31-4,Not Classified,Notified C&L,3,Not classified:3
33192,1H-indole-6-carboxylic acid,605-464-3,1670-82-2,,Notified C&L,10,H335:8;H319:9;H315:9;H312:2;H332:2;H302:3;Not classified:1
33193,1-L-alanyl-L-proline,236-795-8,13485-59-1,Not Classified,Notified C&L,12,Not classified:12
33195,"Formic acid, compd. with N,N-diethyl-2-propyn-1-amine (1:1)",610-297-4,463931-04-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H332:1;H302:1;H412:1;H312:1
33196,Thallium hydroxide,234-708-8,12026-06-1,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,38,H373:38;H411:38;H300:38;H330:38
33199,"Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide",246-403-7,24683-26-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,46,H332:2;H302:3;H312:1;H331:41;H335:1;H319:1;H315:1;H301:1;H372:1;H361:1
33200,Azulene,205-993-6,275-51-4,Aquatic Chronic 2,Notified C&L,42,H411:38;Not classified:4
33202,(-)-Gallocatechin,608-899-7,3371-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H319:41;H315:41
33203,Egg white,618-431-3,9006-50-2,Not Classified,Notified C&L,31,Not classified:31
33209,"N,N'-bis{}{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt",419-500-9,171599-85-2,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
33210,Benzyl phenyl carbonate,608-171-9,28170-07-2,Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H318:38;H317:38
33212,2-(dodecyloxy)ethanol,224-886-5,4536-30-5,Not Classified,Notified C&L,1,Not classified:1
33214,4-Fluor-2-Methylphenylmagnesiumbromide,608-550-9,30897-90-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,26,H314:26;H225:26
33215,"Soybean oil, Me ester, sulfated, sodium salt",272-864-9,68918-47-8,Eye Dam. 1,Notified C&L,20,H318:20
33216,"2,3-dichloroaniline",210-157-9,608-27-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,239,H410:239;H317:1;H331:204;H372:1;H341:1;H311:238;H301:238;H350:1;H318:1;H315:193;H373:237;H400:236;H330:35;H319:1;H300:1;H310:1
33217,"4-[(4-Aminophenyl)-(4-methyliminocyclohexa-2,5-dien-1-ylidene)methyl]aniline",603-635-7,1325-82-2,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,160,H400:154;H318:120;H410:154;H319:34;Not classified:6
33223,Tetra[carbonato(2-)]dihydroxypentamagnesium,231-851-8,7760-50-1,Not Classified,Notified C&L,59,Not classified:45;H319:14
33227,"Trisodium 3-[[4-[[4-[(2,5,6-trichloropyrimidin-4-yl)amino]phenyl]azo]phenyl]azo]naphthalene-1,5,7-trisulphonate",243-469-9,20025-74-5,Aquatic Chronic 3,Notified C&L,31,H412:31
33229,Benzyltris(dimethylaminato)phosphorus(1+) chloride,253-141-7,36636-04-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3,H412:2;H319:2;H301:1;H311:1;H331:1
33232,"L-Glutamic acid, N-[(4-methoxyphenyl)sulfonyl]-",619-418-5,99289-76-6,Not Classified,Notified C&L,1,Not classified:1
33242,"2,2,2-trichloro-1-phenylethanol",217-887-7,2000-43-3,,Notified C&L,4,H319:4;H315:4
33243,Ethyl hydrogen suberate,237-968-0,14113-01-0,,Notified C&L,4,H319:4;H315:4
33245,"Turpentine, Venice",232-359-6,8007-41-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H226:2;H302:2;H332:2;H312:2
33246,"3-aminomethyl-3,5,5-trimethylcyclohexan-1-ol",239-717-0,15647-11-7,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,39,H314:1;H318:1;H317:1;H335:38;H319:38;H315:38
33247,"Urea, reaction products with formaldehyde, glyoxal and methanol",296-665-1,92908-36-6,Not Classified,REACH registration C&L,137,Not classified:125;H350:12;H317:8
33251,"Trisodium bis[2-[[2,4-dihydroxy-3-[(2-methyl-4-sulphophenyl)azo]phenyl]azo]benzoato(3-)]chromate(3-)",278-145-6,75234-41-2,Not Classified,REACH registration C&L,126,Not classified:124;H319:2
33252,Tricopper nitride,215-161-4,1308-80-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,68,H319:42;H315:42;H314:26;H412:26
33257,2-[ethyl[(heptadecafluorooctyl)sulphonyl]amino]ethyl methacrylate,206-805-5,376-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33261,Ethyl 4-(bromomethyl)benzoate,607-949-5,26496-94-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,15,H410:15;H400:15;H317:11;H314:15;H302:11
33262,N-(tert-butyl)hydroxylamine hydrochloride,260-771-6,57497-39-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
33263,Chromium Picolinate,477-680-4,14639-25-9,Skin Sens. 1,Notified C&L,11,H317:11
33268,4-nitrophenethyl bromide,226-271-7,5339-26-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:46;H317:39;H315:46
33270,4-(diphenylmethoxy)piperidinium chloride,265-637-0,65214-86-0,,Notified C&L,1,H302:1
33275,"Syrups, corn, dehydrated",268-616-4,68131-37-3,Not Classified,Notified C&L,122,Not classified:122
33276,"Opopanax chironium, ext.",297-649-7,93686-00-1,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H304:1;H317:1;H315:1
33278,"1,6-dimethylnaphthalene",209-385-1,575-43-9,Not Classified,Notified C&L,3,Not classified:3
33280,(-)-pin-2-ene-10-ol,208-193-5,515-00-4,Acute Tox. 4,Notified C&L,1401,H302:1401
33285,α-methylbicyclo[2.2.1]heptane-2-methanol,236-329-3,13305-29-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
33293,4-(trans-4-Ethylcyclohexyl)-4'-fluorbiphenyl,617-261-7,81793-57-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
33296,N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,604-045-2,137862-53-4,Repr. 2,REACH registration C&L,91,H361:81;H412:74;H360:5;H413:4;H335:3;H319:3;H315:3;H402:1;H411:1
33299,4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride,402-190-4,113674-95-6,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0;H317:0;H302:0;H372:0;H318:0
33303,"Hexane-1,5-diol",213-171-3,928-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H335:70;H319:70;H315:70
33306,6-fluoro-2-methylquinolin-4-ol,240-054-4,15912-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33312,Clomifen dihydrogen citrate,200-035-3,50-41-9,Repr. 2,Notified C&L,47,H361:43;H360:4;H400:1;H335:1;H319:1;H351:2;H317:1;H334:1;H341:2;H315:1;H302:2
33313,"Oils, salmon",273-641-9,68991-43-5,Not Classified,Notified C&L,12,Not classified:12
33315,2-pyrrolidone,210-483-1,616-45-5,Eye Irrit. 2,REACH registration C&L,587,H319:402;H360:185;Not classified:114;H302:49;H318:64;H335:67;H315:94;H301:21;H311:5;H336:3;H312:1;H412:2;H361:1
33317,"Boric acid, potassium salt",603-184-6,12712-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H335:22;H319:42;H315:42;H360:14
33318,"2-Aminoethanol reaction products with cyclohexane and peroxidized N-butyl-2,2,6,6-tetramethyl-4-piperidinamine-2,4,6-trichloro-1,3,5-triazine reaction products",426-650-9,,Not Classified,REACH registration C&L,84,Not classified:84
33319,2-[2-(2-hydroxyethoxy)-4-nitroanilino]ethanol,611-897-9,59820-43-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,9,H302:9;H319:8;H335:1
33324,"A mixture of: cis-1,3-cyclohexanedicarboxylic acid; trans-1,3-cyclohexanedicarboxylicacid",432-490-0,3971-31-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
33327,"9-Octadecenoic acid (Z)-, reaction products with diethylenetriamine, di-Me sulfate-quaternized",308-415-1,97953-16-7,Skin Irrit. 2;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H317:2;H410:2;H315:2
33328,2-aminoethyldiisopropylamine,204-447-4,121-05-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,135,H226:134;H302:88;H318:88;H314:95;H335:41;H331:1;H311:1;H412:1;H225:1;H315:40
33331,"Hydrocarbons, C",309-870-9,101316-66-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
33335,"2,2-Bis(4-aminophenyl)hexafluoropropane",600-922-9,1095-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H319:41;H315:41
33336,4-methyl-8-methylenetricyclo[3.3.1.1,406-330-5,122760-84-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H315:0
33337,"Zinc 3,5-bis(α-methylbenzyl)salicylate",258-753-8,53770-52-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,4,H302:1;H318:1;H412:1;H319:3;H315:3
33338,"(3R,4S,5S)-5-azido-4-acetylamino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester",433-320-8,,Not Classified,REACH registration C&L,2,Not classified:2
33340,"1-(acetoxy)pyrrolidine-2,5-dione",238-454-9,14464-29-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,41,H302:38;H319:41;H317:38;H315:3;H335:2
33343,1-acetylpiperazine,237-659-0,13889-98-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H319:59;H315:59;H335:7
33349,"(7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride",260-990-7,57852-57-0,Acute Tox. 2;Carc. 2;Repr. 1B,Notified C&L,124,H351:122;H360:123;H300:124;H341:31;H331:1;H340:3;H311:1;H350:2;H312:1;H332:1;H361:1
33352,"2,2'-(dodecylimino)bisethanol",216-277-8,1541-67-9,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,214,H317:176;H411:176;Not classified:33;H314:4;H302:4;H318:4;H400:4;H319:1;H315:1
33354,6-ethoxy-1-methyl-2-(3-nitrostyryl)quinolinium methyl sulphate,247-336-6,25910-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H335:38;H319:39;H315:39;Not classified:33
33357,"7-Hydroxy-3,4-dihydroquinolin-2(1H)-one",606-966-5,22246-18-0,Acute Tox. 4;Skin Sens. 1,Notified C&L,50,H302:42;H317:41;H335:6;H319:7;H315:6;Not classified:1;H412:1;H402:1
33358,"Fatty acids, montan-wax, calcium salts",269-637-1,68308-22-5,Not Classified,Notified C&L,47,Not classified:47
33360,"trans-4-ethyl-4'-(4-pentylcyclohexyl)-1,1'-biphenyl",279-240-5,79709-85-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
33361,Vinyl neodecanoate,256-905-8,51000-52-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,238,H400:156;H410:156;Not classified:69;H412:13;H335:1;H319:1;H361:1
33368,Tris(p-tert-pentylphenyl) phosphite,212-731-4,864-56-2,Skin Irrit. 2,Notified C&L,1,H315:1
33369,"Alcohols, C12-18, ethoxylated",500-201-8,68213-23-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,2467,H302:1537;H318:2324;H411:446;H400:234;H412:247;H410:53;H319:43;H315:34;Not classified:17
33370,Aluminium antimonide,246-667-3,25152-52-7,,Notified C&L,5,H332:5;H302:5;H411:5
33372,"3,4-dimethoxysalicylaldehyde",242-936-4,19283-70-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H317:38;H302:38;H315:38
33375,"Antimony, compound with lead (1:1)",235-536-6,12266-38-5,,Notified C&L,4,H373:4;H360:4;H410:4;H400:4;H332:4;H302:4
33376,N-[[4-[2-[4-(benzoxazol-2-yl)phenyl]vinyl]benzoyl]oxy]acetamidine,273-358-0,68957-66-4,Not Classified,Notified C&L,31,Not classified:31
33382,Pentaamminechlororhodium sulphate,244-346-2,21360-80-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33383,Ethyl(2-(methylamino)ethyl)amine,203-863-3,111-37-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H335:1;H315:1
33387,"3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol",407-920-5,6390-69-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
33389,2-Chloro-5-cyanopyridine,608-851-5,33252-28-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H319:48;H312:41;H302:46;H315:48;H332:8;H311:7;H331:2;H301:2
33391,3-(4-methylcyclohex-3-enyl)but-3-enyl acetate,229-894-2,6819-19-8,Not Classified,Notified C&L,88,Not classified:88
33392,Tetramethylgermanium,212-745-0,865-52-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,43,H319:38;H312:42;H332:42;H302:42;H225:43
33395,Strontium bis(dihydrogen phosphate),242-141-2,18266-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H319:2;H315:2
33398,Allylchlorodimethylsilane,223-706-2,4028-23-3,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,43,H314:43;H225:43;H318:1;H290:1
33399,"Hydroperoxide, 1,1'-[[]1,4-phenylenebis(1-methylethylidene)]bis-",608-649-7,3159-98-6,Org. Perox. C;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H242:1;H319:1;H302:1;H315:1
33401,1-(1-hydroxycyclohexyl)ethan-1-one,214-372-9,1123-27-9,Not Classified,Notified C&L,127,Not classified:88;H301:38;H335:1;H319:1;H315:1
33406,Dipotassium tetrabromopalladate(2-),237-535-6,13826-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
33409,ALKYLSILAN TA 01946,404-020-4,,Aquatic Chronic 2,Notified C&L,2,H411:2
33416,"17-methyl-5α-androstane-3β,17β-diol",211-377-8,641-83-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1A,Notified C&L,1,H335:1;H360:1;H319:1;H312:1;H332:1;H302:1;H315:1
33417,1-methylbarbituric acid,219-894-0,2565-47-1,Acute Tox. 4,Notified C&L,38,H302:38
33419,"5-(acetamido)-4-hydroxy-3-[[4-[[[3-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]amino]carbonyl]phenyl]azo]naphthalene-2,7-disulphonic acid, sodium salt",288-954-6,85940-66-5,Not Classified,Notified C&L,18,Not classified:18
33420,Methyl oleate,203-992-5,112-62-9,Not Classified,Notified C&L,1027,Not classified:585;H319:442
33423,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with polymethylenepolyphenylene polyisocyanate",500-126-0,54323-23-8,Not Classified,Notified C&L,55,Not classified:55
33425,"3,3'-pyridine-2,4-diylbis[5,6-diphenyl-1,2,4-triazine]",252-417-4,35171-26-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33428,piperazine dihydrochloride,205-551-2,142-64-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H319:0;H317:0;H334:0;H412:0;H361:0;H315:0
33430,"Sulfonic acids, petroleum, barium salts",263-140-3,61790-48-5,Skin Sens. 1B,REACH registration C&L,143,H317:50;H332:123;H302:122;H413:25;H315:51;H319:26;H411:25;Not classified:8;H301:2;H312:1;H412:1
33433,"(1R,5aR,10R,11aS)-1-acetyl-10-[4-(dimethylamino)phenyl]-5a-hydroxy-11a-methyl-3,3a,3b,4,5,6,8,9,10,11-decahydro-2H-spiro[cyclopenta[a]phenanthrene-7,2'-[1,3]dioxolan]-1-yl acetate",615-905-1,730962-28-4,Acute Tox. 4;Repr. 1A,REACH registration C&L,3,H302:3;H360:3;H413:1
33434,disulfiram;tetraethylthiuramdisulfide,202-607-8,97-77-8,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0;H317:0;H302:0
33435,"Tris(1,1-dimethylethyl)phosphine",237-266-4,13716-12-6,Pyr. Sol. 1;Skin Corr. 1B,Notified C&L,47,H314:46;H250:46;H252:4;H318:1;H225:2;H312:1;H302:1;H290:1;H413:1;H319:1;H341:1;H361:1;H315:1
33437,"3,6,9,12-Tetraoxatetradeca-1,13-diene",616-344-5,765-12-8,Not Classified,Notified C&L,13,Not classified:12;H319:1;H317:1;H411:1;H315:1
33439,"Oils, vegetable, winterized",269-821-1,68334-29-2,Not Classified,Notified C&L,1,Not classified:1
33444,Potassium methyl malonate,253-886-8,38330-80-2,Eye Irrit. 2,Notified C&L,43,H319:43;H335:3;H315:4
33445,1-(3-sulphonatopropyl)pyridinium,239-491-3,15471-17-7,Not Classified,REACH registration C&L,18,Not classified:13;H335:4;H319:5;H315:5
33452,Tetrasodium 7-amino-4-hydroxy-3-[(2-methoxy-5-methyl-4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-8-[(2-sulfonato-4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2-sulfonate,610-522-6,503155-49-5,Not Classified,REACH registration C&L,58,Not classified:27;H334:31;H319:31;H317:31;H315:31
33453,"4-(2-naphthyl)-1,3-thiazol-2-amine",606-740-6,21331-43-1,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,7,H400:1;H317:2;H411:1;H335:6;H319:6;H315:6;H301:1
33454,[No public or meaningful name is available],457-390-4,,Not Classified,Notified C&L,1,Not classified:1
33455,"Glycine, N-[2-[(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)-, disodium salt",612-943-0,62099-15-4,Skin Corr. 1;Eye Dam. 1,Notified C&L,28,H314:27;H318:27;Not classified:1
33459,BENZYL TRIMETHYL AMMONIUM DICHLOROIODIDE,601-338-7,114971-52-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:45;H319:46;H315:46;H300:1;H400:2;H314:2;H331:2;H311:2;H410:1;H301:1;H318:1
33462,Di-sec-butyl sulphide,210-938-4,626-26-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H335:39;H319:38;H315:39;H318:1
33463,"Methyl 2-[[[[(4,6-dimethyl-2-pyrimidinyl)amino]carbonyl]amino]sulphonyl]benzoate",277-780-6,74222-97-2,Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,226,H332:156;H410:185;H319:156;H400:223;Not classified:3
33464,Dimethyl 4-methoxyisophthalate,245-350-7,22955-73-3,Eye Irrit. 2,Notified C&L,38,H319:38
33467,1-phenyl-3-pyrazolidone,202-155-1,92-43-3,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
33477,"2,2',4,4',6,6'-hexachlorobiphenyl",251-773-8,33979-03-2,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H373:38;H410:38;H400:38;Not classified:3
33478,"Dimethylammonium 2,4-dichlorophenoxyacetate",217-915-8,2008-39-1,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,256,H302:256;H318:256;H317:256;H411:185;H410:71;H312:33;H332:33
33479,"Sodium N-(3-α,7-α,12-α-trihydroxy-24-oxocholan-24-yl)glycinate",212-730-9,863-57-0,Not Classified,Notified C&L,5,Not classified:5
33481,Mephenesin,200-427-4,59-47-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,47,H302:47;H319:40;H317:2
33487,"Fatty acids, C14-18, compds. with triethanolamine",275-122-2,71011-16-0,Not Classified,Notified C&L,8,Not classified:8
33489,2-(benzoyloxy)ethyl methacrylate,238-844-9,14778-47-3,Acute Tox. 4,Notified C&L,1,H332:1
33490,"N,N-diethylacetamide",211-685-2,685-91-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:39;H319:44;H312:39;H332:39;H302:44;H315:44;Not classified:1;H227:1
33492,3-mercaptoisobutyric acid,247-726-6,26473-47-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:39;H315:39;H318:1;H361:1
33495,4-[(4-ethoxyphenyl)azo]naphthol,229-439-8,6535-42-8,Not Classified,Notified C&L,3417,Not classified:3417
33497,Ferro Phosfophorus,921-086-4,8049-19-2,Acute Tox. 1;Skin Corr. 1A;Eye Irrit. 2,Notified C&L,1,H301:1;H320:1;H303:1;H315:1
33499,"2-(1,2-dichloro-1,2,2-trifluoroethoxy)-1,1,2,2-tetrafluoroethanesulfonyl fluoride",604-439-4,144728-59-6,Not Classified,Notified C&L,1,Not classified:1
33500,"2,2-dimethyl-1,3-dioxolane",220-842-4,2916-31-6,Flam. Liq. 2,Notified C&L,46,H225:46
33503,"Boron, triethyl(1,3-propanediamine-.kappa.N)-, (T-4)-",604-654-3,148861-07-8,Acute Tox. 4;Skin Corr. 1A,Notified C&L,85,H314:85;H312:85;H318:1;H317:1
33505,Chroman-4-ol,216-041-4,1481-93-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
33507,"Bis-(4,4'-dodecylphenyl)-iodoniumhexafluorphoshat",610-377-9,477602-76-9,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H317:1;H315:1
33509,4-nitrophenyl phenyl sulphide,213-462-5,952-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H319:43;H315:43
33512,"2,4,6-trichloroborazine",213-267-5,933-18-6,Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H335:1
33515,3-[3-(Trifluoromethyl)phenyl]propanal,606-717-0,21172-41-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H319:1;H315:1
33516,Diniconazole-M,617-482-9,83657-18-5,Acute Tox. 4;Repr. 2;STOT SE 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,12,H370:12;H373:12;H410:12;H400:12;H302:12;H361:12
33526,tert-butyl (triphenylphosphoranylidene) acetate,412-880-7,35000-38-5,Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H319:0;H317:0;H301:0;H411:0
33529,Allyl 3-cyclohexylpropionate,220-292-5,2705-87-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1885,H312:1848;H410:1546;H400:1545;H317:1546;H332:1584;H302:1885;H315:261;H314:2
33531,"flumioxazin (ISO);2-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione",600-425-7,103361-09-7,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0;H410:0
33533,"Benzenesulfonic acid, mono-C10-13-branched alkyl derivs., compds. with N,N-dimethyl-1,3-propanediamine",290-665-5,90194-53-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,16,H318:16;H411:16;H315:16
33535,1-methylimidazole,210-484-7,616-47-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H314:0;H302:0;H312:0
33536,"Naphtha (petroleum), chemically neutralized heavy;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-122-0,64742-22-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
33539,Acetyl-2-thiourea,209-699-9,591-08-2,Acute Tox. 2,Notified C&L,55,H300:55;H341:1
33540,"N,N',N'',N'''-tetramethylethylenediylidenetetraamine",213-638-1,996-70-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,41,H226:40;H314:41;H318:2
33542,"Phosphonic acid, [1-hydroxy-2-(3-pyridinyl)ethylidene]bis-,monosodium salt hemi-pentahydrate",601-362-8,115436-72-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:39;H302:41;H312:38;H319:3;H318:1;H335:3;H315:3;H362:2;H373:1;H361:2
33543,"2,2,2-trifluoro-N-phenylacetamide",206-965-6,404-24-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H335:2;H319:2;H312:2;H332:2;H302:2;H315:2
33544,"3-[4-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonamide",299-651-3,93893-61-9,Not Classified,Notified C&L,83,Not classified:83
33545,1-chloro-4-[(2-chloroethyl)thio]benzene,238-338-8,14366-73-5,Acute Tox. 4,Notified C&L,38,H302:38
33546,"propene, hydroformylation products, by-products from, distillation residues",606-535-1,203588-70-9,Skin Irrit. 2;STOT SE 3;Repr. 2;Aquatic Chronic 3,Notified C&L,14,H412:14;H335:14;H361:14;H315:14
33547,"Wastewater, cadmium sulfate electrolytic, acid",273-721-3,69012-21-1,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H360:3;H410:3;H400:3;H317:3;H372:3;H334:3;H340:3;H330:3;H301:3;H350:3;H318:3
33555,(S)-1-(2-Naphthyl)ethylamine,608-543-0,3082-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,44,H335:39;H319:40;H411:39;H315:40;H314:4;H302:4;H312:4
33556,3-methylveratrole,224-726-4,4463-33-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:48;H319:48;H315:48
33557,4-hydroxynaphthalene-1-sulphonic acid,201-568-4,84-87-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,5,H319:3;H315:3;Not classified:2;H335:1
33561,"Hop, Humulus lupulus, ext.",232-504-3,8060-28-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1439,H319:7;H317:1303;H315:7;H412:1372;H226:99;H304:63;Not classified:33;H302:1
33562,Carnitine hydrochloride,200-305-0,56-99-5,Not Classified,Notified C&L,1,Not classified:1
33563,Sodium 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetate,252-687-3,35711-34-3,Acute Tox. 4,Notified C&L,1,H302:1
33565,POLYETHYLENE GLYCOL STEARATE,618-405-1,9004-99-3,Not Classified,Notified C&L,444,Not classified:345;H335:91;H319:41;H315:40;H400:5;H412:6
33566,"6,13-dihydrodibenzo[b,i]phenazine",233-763-5,10350-06-8,Aquatic Acute 1,Notified C&L,38,H400:38
33567,2-nitro-m-xylene,201-333-6,81-20-9,Aquatic Chronic 2,Notified C&L,48,H411:44;H332:4;H312:4;Not classified:3;H301:1;H311:1;H331:1;H310:1;H300:1;H330:1
33570,Pentylbenzene,208-701-5,538-68-1,Aquatic Chronic 3,Notified C&L,35,H412:22;H411:10;Not classified:4;H304:1
33574,nickel dicyanide,209-160-8,557-19-7,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H400:0;H317:0;H334:0;H372:0;H350:0
33576,4-cyclohexylaniline,228-918-9,6373-50-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H319:38;H315:38;H302:4;H312:4
33577,7-chloro-2-methylquinoline,440-600-3,,Not Classified,Notified C&L,1,Not classified:1
33578,"N,N,N',N'-tetrakis(2,3-epoxypropyl)-m-xylene-α,α'-diamine",264-438-6,63738-22-7,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,104,H302:103;H315:104;H319:74;H312:86;H317:89;H412:72;H331:13;H341:12;H318:15;H340:1;H411:2;H335:1
33582,"Phosphoric acid, 2-ethylhexyl ester, compd. with 2,2',2''-nitrilotris[ethanol]",269-172-4,68189-01-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,20,H318:15;H315:19;H319:5
33585,Oxazolam,246-032-0,24143-17-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,38,H301:38;H319:38;H331:38;H315:38
33586,Dicesium oxide,243-679-0,20281-00-9,Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,153,H314:88;H318:83;H411:88;Not classified:34;H319:26;H315:26;H400:5;H410:5;H361:1
33592,N-(indazol-6-yl)-4-aminobenzenesulphonamide,237-314-4,13744-68-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33595,Isopropylmethoxypyrazine,299-837-4,93905-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33598,"1-ethyl-4,5-dihydro-1-(2-hydroxyethyl)-2-isoheptadecyl-1H-imidazolium ethyl sulphate",266-775-4,67633-57-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,129,H318:128;H315:129;H410:2;H400:2;H302:3;H319:1
33605,"α,α,α',α'-tetramethyl-m-xylene-α,α'-diol",217-886-1,1999-85-5,Not Classified,REACH registration C&L,43,Not classified:2;H302:41;H335:39;H319:40;H315:40;H336:1
33607,Betaine,203-490-6,107-43-7,Not Classified,REACH registration C&L,269,Not classified:240;H319:29;H315:29;H335:1
33614,"3,7,8-trihydroxy-3-methyl-10-oxo-1,3,4,10-tetrahydropyrano[4,3-b]chromene-9-carboxylic acid",610-395-7,479-66-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,6,H332:6;H302:6;H312:6
33617,"3,4,4a,5,8,8a(or 3,4,4a,7,8,8a)-hexahydro-3,3,6,7-tetramethyl-1H-2-benzopyran",276-659-5,72429-08-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,125,H319:125;H315:125;H302:1
33618,"Butane-1,4-diylbis[diphenylphosphine]",231-698-7,7688-25-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,221,H335:180;H319:220;H315:220;H413:39;H410:16;H400:14;H317:14;H302:14
33620,thiourea;thiocarbamide,200-543-5,62-56-6,Acute Tox. 4;Carc. 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H302:0;H351:0;H361:0;H411:0
33623,"1,1,1,2,2,3,4,5,5, 5-Decafluoropentane",604-080-3,138495-42-8,Aquatic Chronic 3,Notified C&L,127,H412:125;H335:34;H319:34;H315:34
33628,"Trisodium [5-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-3-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]naphthalene-2,7-disulphonato(5-)]nickelate(3-)",279-314-7,79817-91-7,Not Classified,Notified C&L,2039,Not classified:2039
33632,m-toluic acid,202-723-9,99-04-7,Eye Dam. 1,REACH registration C&L,121,H318:37;H302:48;Not classified:32;H335:8;H319:12;H315:10;H332:1;H312:1
33635,1-fluorobutane,219-123-8,2366-52-1,Not Classified,Notified C&L,3,Not classified:1;H224:1;H335:1;H319:1;H315:1;H226:1
33636,Blue Cypress,605-885-2,180287-43-8,,Notified C&L,3,H319:3;H315:3
33638,5-methylhex-5-en-2-one,221-807-6,3240-09-3,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H226:38;H302:38;H318:38
33639,"bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;red squill;scilliroside",208-077-4,507-60-8,Acute Tox. 2,Harmonised C&L,0,H300:0
33640,"3,3'-dichloro[1,1'-biphenyl]-4,4'-bis(diazonium) dichloride",256-462-0,49744-39-0,Self-react. B,Notified C&L,83,H241:83
33641,dilauroyl peroxide,203-326-3,105-74-8,Org. Perox. D,Harmonised C&L,0,H242:0
33644,6-ethyl-m-cresol,216-875-9,1687-61-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
33645,"2-Propenoic acid, polymer with 2,5-furandione",607-984-6,26677-99-6,,Notified C&L,1,H314:1;H317:1
33649,"Disodium 5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(4-methoxyphenyl)azo]naphthalene-2,7-disulphonate",277-870-5,74432-27-2,Not Classified,Notified C&L,1,Not classified:1
33650,"2,8-dimethylnaphtho[3,2,1-kl]xanthene",201-345-1,81-37-8,Not Classified,Notified C&L,2,Not classified:2
33652,"Hazel, Corylus avellana, ext.",281-667-7,84012-21-5,Flam. Liq. 3,Notified C&L,1379,H226:1288;Not classified:90;H319:1;H225:1
33653,Diethylammonium bromide,228-466-2,6274-12-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:43;H319:45;H315:45;Not classified:1
33654,"Titanium, acetylacetone iso-Pr alc. triethanolamine complexes",288-004-0,85631-55-6,Not Classified,Notified C&L,7,Not classified:7
33657,"Sodium 2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanesulphonate",252-563-9,35441-13-5,Not Classified,REACH registration C&L,39,Not classified:39
33658,O-ethylhydroxylamine,402-030-3,624-86-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H319:0;H400:0;H317:0;H331:0;H372:0;H311:0;H301:0;H225:0
33660,"Diethyl 4,4'-carbonylbis(hydrogen phthalate), compound with benzene-m-diamine",265-883-9,65701-07-7,Not Classified,Notified C&L,11,Not classified:11
33661,Orthosulfamuron,606-744-8,213464-77-8,Aquatic Acute 1,Notified C&L,2,H400:2
33665,"Oils, rice bran",271-397-8,68553-81-1,Not Classified,Notified C&L,64,Not classified:63;H319:1;H315:1
33668,"2-vinyl-1,3-dioxane",227-689-2,5935-25-1,Flam. Liq. 3;Acute Tox. 3,Notified C&L,1,H226:1;H301:1
33671,"Tris[4,4,4-trifluoro-1-(2-thienyl)butane-1,3-dionato-O,O']europium",237-892-8,14054-87-6,,Notified C&L,6,H335:5;H319:5;H315:5;Not classified:1
33679,"Citrus medica limonum, ext.",296-174-2,92346-89-9,Not Classified,Notified C&L,122,Not classified:109;H226:11;H304:10;H319:2
33680,Thorium dioxide,215-225-1,1314-20-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 1B,Notified C&L,244,H301:211;H350:243;H311:211;H331:211;H373:71;H351:1
33684,"heptachlor epoxide;2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane",213-831-0,1024-57-3,Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H351:0;H400:0;H301:0
33688,Benzoylacetonitrile,210-369-1,614-16-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H335:46;H319:47;H312:41;H332:41;H302:46;H315:47
33689,Methyl 5-chlorosalicylate,223-778-5,4068-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:42;H315:42;Not classified:1
33691,Cycluron,218-493-8,2163-69-1,Acute Tox. 4,Notified C&L,38,H302:38
33692,"Glycerides, mixed hydrogenated palm kernel-oil stearin and hydrogenated palm-oil",309-453-1,100298-99-5,Not Classified,Notified C&L,1,Not classified:1
33693,3-nitrostyrene,209-575-4,586-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H319:42;H315:42;H312:4;H332:4;H302:4
33694,5-aminopyrazole-4-carbonitrile,240-665-6,16617-46-2,,Notified C&L,11,H302:8;H335:6;H319:10;H315:10;H312:3;H332:2;H331:1;H311:1;H301:1
33699,"2,4,7,9-Tetraoxadecane",611-501-4,5732-48-9,Not Classified,Notified C&L,1,Not classified:1
33700,"Dinonylnaphthalene-1-sulphonic acid, compound with N-(2-aminoethyl)ethane-1,2-diamine (5:2)",288-089-4,85650-80-2,Not Classified,Notified C&L,5,Not classified:5
33701,"4-[(4-oxocyclohexa-2,5-dien-1-yl)imino]phenyl acetate",231-852-3,7761-80-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
33705,Methyl 5-bromosalicylate,223-776-4,4068-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H319:41;H315:41
33707,"Soaps, stocks, marine-oil, acidulated",308-741-4,98219-72-8,Not Classified,Notified C&L,1,Not classified:1
33711,Calcium bis(dinonylnaphthalenesulphonate),260-991-2,57855-77-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1080,H319:1027;H317:967;H315:1036;Not classified:29;H334:15;H413:9;H318:8;H400:1;H410:1
33715,"N-(α,α,α-trifluoro-3-tolyl)piperazine",239-574-4,15532-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H319:38;H315:38;H314:5
33716,Deaminase,232-959-8,9067-84-9,Resp. Sens. 1,Notified C&L,25,H334:25
33717,"Cuprate(3-), [μ-[4-[[3,3'-dihydroxy-4'-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo][1,1'-biphenyl]-4-yl]azo]-3-hydroxy-2,7-naphthalenedisulfonato(7-)]]di-, trihydrogen, compd. with 2,2'-iminobis[ethanol] (1:3)",277-010-9,72906-64-0,Not Classified,Notified C&L,39,Not classified:39
33720,(9Z)-N-[2-(2-hydroxyethoxy)ethyl]octadec-9-enamide,607-851-2,26027-37-2,Eye Irrit. 2,Notified C&L,670,H319:506;H315:118;H411:30;Not classified:8;H318:9;H400:2
33721,"1,3-dichloro-1,1,2,2,3-pentafluoropropane",208-076-9,507-55-1,Not Classified,Notified C&L,8,Not classified:6;H332:2;H319:2;H315:2;H059:1
33723,"(4S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",616-407-7,7689-03-4,Acute Tox. 3,Notified C&L,206,H301:205;H340:10;H302:1;H335:1;H319:1;H372:1;H315:1
33724,2-hydroxyoctanoic acid,210-524-3,617-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44
33725,"Cyclohexanamine, N-[3-(dimethoxymethylsilyl)propyl]-",601-684-9,120218-28-2,Not Classified,Notified C&L,3,Not classified:3
33726,6-Fluorochromane-2-carboxylic acid,619-405-4,99199-60-7,Not Classified,REACH registration C&L,6,Not classified:2;H302:2;H319:2;H315:2;H335:1
33728,ethyl (2E)-3-methyl-4-oxobut-2-enoate,690-663-8,62054-49-3,Not Classified,REACH registration C&L,2,Not classified:2
33729,N-Butylmaleimide,608-406-5,2973-09-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H335:38;H319:38;H302:38;H334:38;H315:38
33732,"Formaldehyde, reaction products with N,N-dimethylbenzenamine and N-methylbenzenamine, oxidized, hydrochlorides",281-506-0,83968-28-9,Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,51,H400:2;H318:46;H335:49;H410:1;H315:47;H319:3;H332:3;H302:3;H336:1;H413:1;Not classified:2
33733,"1,2,4-triazole-3-thiol",221-656-6,3179-31-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,84,H319:74;H410:2;H400:2;H317:4;H302:75;Not classified:6;H315:3;H335:1
33734,"Oils, mustard",232-358-0,8007-40-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,45,H319:31;H226:33;H302:28;H330:33;H310:26;H411:26;H315:31;Not classified:12;H335:5;H410:7;H400:6;H311:7;H301:5;H317:2;H314:2;H334:2;H318:1
33740,4-methylpyrimidine-2-thiol hydrochloride,230-152-5,6959-66-6,,Notified C&L,6,H335:5;H319:5;H315:5;H302:1;Not classified:1
33741,"1,2-epoxy-3-methylbutane",215-869-3,1438-14-8,,Notified C&L,4,H335:4;H319:4;H315:4;H225:4
33744,"Urea, reaction products with formaldehyde and glyoxal",296-664-6,92908-35-5,Not Classified,REACH registration C&L,139,Not classified:131;H350:6;H341:2;H317:6;H319:2;H315:2
33746,[No public or meaningful name is available],639-963-2,5099-13-8,Acute Tox. 4,Notified C&L,33,H312:33
33751,Moroxydine,223-093-1,3731-59-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
33755,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers",500-125-5,53880-05-0,Skin Sens. 1,Notified C&L,521,H317:515;H334:182;H335:101;Not classified:6;H332:5;H315:5;H226:2;H336:2;H411:2
33756,"Oils, lard, sulfurized",263-141-9,61790-49-6,Eye Irrit. 2,Notified C&L,525,H319:443;Not classified:82
33758,5-Ethyluracil,622-736-7,4212-49-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:50;H319:50;H315:50
33762,"Petrolatum (petroleum), oxidized, zinc salt",272-865-4,68918-69-4,Skin Irrit. 2,Notified C&L,33,H315:33;H319:4
33765,"Tetracyclo[2.2.1.02,6.03,5]heptane",205-994-1,278-06-8,Flam. Liq. 2;Acute Tox. 2,Notified C&L,38,H330:38;H225:38
33769,2-chloro-m-cresol,210-156-3,608-26-4,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,Notified C&L,34,H312:33;H400:33;H317:33;H302:33;H318:33;H314:1
33770,5-ethylsulphonyl-o-anisidine,226-272-2,5339-62-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H319:38;H312:38;H332:38;H302:38;H315:38
33772,"Tangelo, ext.",297-916-8,93763-95-2,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1364,H410:1288;H400:1287;H317:1288;H226:1288;H304:1339;H315:1313
33774,5-methylindole,210-400-9,614-96-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H319:45;H315:45;Not classified:1
33775,"1-ethyl-1,2-dihydro-5H-tetrazole-5-thione",239-270-1,15217-53-5,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H318:1;H312:1
33779,2-methylbenzoxazole,202-399-9,95-21-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,133,H335:132;H319:90;H312:80;H226:89;H302:133;H332:80;H315:133;H318:43;H331:10;H311:10
33782,"Hexanedioic acid, polymer with 1,6-hexanediol",607-641-0,25212-06-0,Not Classified,Notified C&L,2,Not classified:2
33784,"Alkanes, C14-17, arom.-free desulfurized",273-642-4,68991-50-4,Not Classified,Notified C&L,2,Not classified:1;H362:1;H400:1;H410:1
33785,"2,2'-[[(4-methyl-1H-benzotriazol-1-yl)methyl]imino]bisethanol",279-502-9,80584-89-0,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,147,H302:147;H318:147;H317:147;H412:147;H315:1
33786,7-oxooctanoic acid,237-967-5,14112-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33788,diethylzinc,209-161-3,557-20-0,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H314:0;H250:0;H260:0
33790,Sodium 3-chloro-2-hydroxypropanesulphonate,204-807-0,126-83-0,Not Classified,REACH registration C&L,135,Not classified:17;H318:55;H335:110;H315:110;H319:63
33796,1-phenylcyclopropanecarbonitrile,213-304-5,935-44-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:42;H302:42;H312:41;H319:3;H315:3;H335:1
33798,"Amyris balsamifera, ext.",291-076-6,90320-49-3,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1418,H317:14;H411:14;H315:15;Not classified:1400;H412:3;H302:1
33800,6-hydroxypicolinic acid,417-690-8,19621-92-2,Skin Sens. 1,Notified C&L,2,H317:1;H319:1;H315:1
33802,"2,6-dimethyloct-7-yne-2,6-diol",249-510-7,29210-76-2,Not Classified,REACH registration C&L,2,Not classified:2
33803,"Soaps, stocks, marine-oil",308-912-3,98999-22-5,Not Classified,Notified C&L,1,Not classified:1
33804,3-aminobenzoic acid,202-724-4,99-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,205,H335:203;H319:204;H315:204;H302:39
33806,Chromium (III) oxide,215-160-9,1308-38-9,Not Classified,REACH registration C&L,1818,Not classified:998;H302:458;H319:463;H317:520;H360:278;H334:55;H413:19;H410:4;H400:4;H332:13;H335:10;H315:7;H373:3;H340:3;H412:1;H350:3;H312:2;H411:2;H318:1;H361:1
33810,Vanadium dichloride oxide,233-517-7,10213-09-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38
33811,"1-amino-4-(4-amino-2-sulphoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",242-574-7,18791-01-0,Skin Sens. 1,Notified C&L,1,H317:1
33812,"N,N-dimethyl(vinylbenzyl)amine",256-875-6,50976-17-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
33814,"Hydrogen (benzyl)[4-[[4-[benzylethylamino]phenyl](2,4-disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)ammonium, sodium salt",222-476-0,3486-30-4,Not Classified,REACH registration C&L,48,Not classified:44;H412:2;H335:3;H319:3;H315:3;H341:1
33819,Sodium 2-(3-benzoylphenyl)propionate,260-770-0,57495-14-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Lact.,Notified C&L,2,H335:2;H319:2;H362:1;H331:1;H311:1;H301:2;H315:2
33822,"1,3-dimethylnaphthalene",209-384-6,575-41-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:39;H410:39;Not classified:3
33823,endo nortropine base,700-286-3,538-09-0,Acute Tox. 4,REACH registration C&L,5,H302:3;H319:1;H303:1
33826,"4,6-bis[2-(4-hydroxyphenyl)isopropylidene]resorcinol",432-380-2,147504-92-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H411:1
33827,"Benzene, 1,1'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[4-methyl-",600-921-3,1095-77-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
33828,Nitrile hydratase recombinant from E.coli,617-328-0,82391-37-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H334:38;H317:38;Not classified:1
33830,"1,1,3,3-tetramethylbutylamine",203-491-1,107-45-9,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,150,H226:137;H302:110;H290:96;H314:150;H412:12;H318:95;H411:96;H301:40
33833,2-ethyl-2-methylhexanoic acid,214-680-3,1185-29-1,Eye Irrit. 2,Notified C&L,39,H319:39
33834,"reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate",445-280-9,371921-40-3,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H317:0
33840,Hexadecyl acrylate,236-492-0,13402-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,138,H335:137;H319:138;H411:137;H315:138;H317:93
33842,"(8α,9R)-10,11-dihydro-6'-methoxycinchonan-9-ol monohydrobromide",285-797-5,85153-19-1,,Notified C&L,1,H302:1;H317:1
33844,"Fatty acids, C10-16 and C12-20-unsatd.",307-837-3,97765-81-6,Not Classified,Notified C&L,1,Not classified:1
33849,Iron hydroxide,234-346-0,11113-66-9,Not Classified,Notified C&L,5,Not classified:5
33860,"Bis(pentane-2,4-dionato-O,O')lead",239-323-9,15282-88-9,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H360:42;H410:42;H400:42;H332:42;H302:42
33861,"1-cyano-2,3-dimethylisothiourea",227-440-8,5848-24-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H302:39;H312:39
33863,Butyl isocyanate,203-862-8,111-36-4,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,77,H335:15;H317:7;H314:73;H302:76;H330:73;H412:6;H318:23;H225:57;H334:69;H311:42;H224:16;Not classified:1
33867,Adiphenine hydrochloride,200-036-9,50-42-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H332:39;H302:40;H312:39;H400:1
33868,N-1-naphthylbenzamide,211-208-8,634-42-4,Aquatic Chronic 2,Notified C&L,38,H411:38
33869,3-methylthiophene,210-482-6,616-44-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,186,H335:116;H319:116;H312:113;H225:185;H302:183;H332:180;H315:116;H226:1
33870,Barium selenate,232-113-8,7787-41-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,42,H302:2;H319:2;H411:2;H315:2;H373:40;H410:40;H400:40;H331:40;H301:40
33872,"trans,trans-2,4-decadien-1-al",246-668-9,25152-84-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,247,H319:244;H312:201;H315:246;H335:38;Not classified:1
33873,p-iodobenzenesulphonyl chloride,202-686-9,98-61-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H314:44;H318:40;H290:1
33874,2-amino-4-chlorobenzonitrile,253-967-8,38487-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H319:45;H315:45;H332:5;H311:5;H301:5;H312:1;H302:1;H331:1
33878,"Formaldehyde, polymers with 1,3-benzenedimethanamine, bisphenol A, diethylenetriamine-glycidyl Ph ether reaction products, epichlorohydrin, propylene oxide and triethylenetetramine, reaction products with glycidyl o-tolyl ether, sulfamates (salts)",607-272-5,238080-05-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,22,H302:22;H318:22
33879,(Z)-2-phenylhex-2-enenitrile,613-754-6,6519-09-1,Not Classified,REACH registration C&L,2,Not classified:2
33880,"2,2,4,6-tetramethylpiperidine",228-550-9,6292-82-6,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,Notified C&L,1,H226:1;H302:1;H290:1;H314:1;H331:1;H318:1
33881,Bi(glutathion-S-yl),248-170-7,27025-41-8,Not Classified,Notified C&L,8,Not classified:6;H319:2;H315:2;H335:1
33884,"4,4-dimethylpiperidine-2,6-dione",214-373-4,1123-40-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H317:38;H302:38;H315:43
33885,"reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate",401-520-4,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
33886,"Hydrocarbons, C",309-871-4,101316-67-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
33887,"Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz[b,f][1,4]oxazepine (1:1)",248-682-0,27833-64-3,Acute Tox. 3;Eye Irrit. 2,Notified C&L,7,H301:6;H319:5;Not classified:2
33893,5α-pregnane,211-378-3,641-85-0,Aquatic Chronic 4,Notified C&L,38,H413:38
33898,Carbomer,618-435-5,9007-20-9,Not Classified,Notified C&L,12,Not classified:12
33899,acetalization product between glucose and C16-18(even numbered)- alcohol,927-870-2,,Not Classified,Notified C&L,1,Not classified:1
33905,Fluoroacetonitrile,610-523-1,503-20-8,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H335:38;H319:39;H225:40;H331:39;H311:40;H301:40;H315:39
33907,"4-hydroxy-3-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic acid, potassium sodium salt",288-953-0,85940-65-4,Not Classified,Notified C&L,1,Not classified:1
33909,Ethyl 4-hydroxypiperidine-1-carboxylate,265-636-5,65214-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H319:2;H315:2;H302:1
33912,Oxycodone hydrochloride,204-717-1,124-90-3,Acute Tox. 4,Notified C&L,62,H302:59;H317:16;H334:16;H332:7;H362:3;H318:3;H331:1;H336:1;H301:3;H361:1
33915,"(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide",609-299-8,368421-58-3,STOT SE 2,Notified C&L,1,H371:1
33920,4-dodecylmorpholine,216-278-3,1541-81-7,Not Classified,Notified C&L,11,Not classified:11
33921,3-acetamidobenzoic acid,209-600-9,587-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44
33924,"(1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl) diacrylate",246-253-2,24447-78-7,Not Classified,Notified C&L,5,Not classified:5
33925,4-[2-(2-pyridyl)ethyl]morpholine,261-807-3,59566-50-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
33926,"2,2',2''-nitrilotriethanol",203-049-8,102-71-6,Not Classified,REACH registration C&L,6166,Not classified:4818;H318:226;H361:57;H319:1113;H315:403;H302:164;H373:168;H335:41;H317:25;H290:4;H312:2;H332:2;H314:1;H334:1
33927,4-(2-aminopropyl)morpholine,256-904-2,50998-05-5,,Notified C&L,3,H332:1;H302:2;H312:1;H335:2;H319:1;H315:2;H318:1
33928,Diethyl ethoxymethylenemalonate,201-725-7,87-13-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,114,H302:113;H335:51;H319:58;H315:58;H400:1;H317:65;H411:1;H314:55;H318:55;H334:9
33929,3-[[2-(2-cyanoethoxy)ethyl][4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile,274-407-9,70210-10-5,Acute Tox. 4,REACH registration C&L,22,H302:19;Not classified:3;H319:2;H312:2;H332:2;H315:2
33931,"Bis(cyclohexyl)ammonium(2S)-2-{[(benzyloxy)carbonyl]amino}-3,3-dimethylbutanoate",478-250-9,,Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,Notified C&L,1,H372:1;H302:1;H412:1
33934,"reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt",442-290-5,457624-86-1,Eye Dam. 1,Harmonised C&L,0,H318:0
33940,"Castor oil, oligomeric reaction products with maleic anhydride",500-202-3,68308-83-8,Skin Sens. 1,REACH registration C&L,6,H317:2;Not classified:4
33947,p-tert-butylbenzohydrazide,256-090-9,43100-38-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H335:42;H319:43;H312:38;H332:38;H302:38;H315:43
33950,3-methylhexan-2-ol,219-009-8,2313-65-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
33951,Ytterbium trinitrate,237-384-6,13768-67-7,,Notified C&L,8,H335:5;H319:5;H272:6;H302:4;H315:6;H318:2;H411:1;Not classified:1;H400:1;H410:1
33954,4-chlorosalicylic acid,225-829-7,5106-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:46;H315:46;H302:6
33957,"Chromate(1-), [2,4-dihydro-4-[(2-hydroxy-5-methyl-3-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-[4-[[5-(2,2-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonamidato(2-)]-, hydrogen",277-097-3,72928-87-1,Not Classified,REACH registration C&L,2,Not classified:2
33958,Iodo(2H3)methane,212-744-5,865-50-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Carc. 2;STOT SE 2,Notified C&L,41,H335:41;H312:41;H351:41;H317:38;H331:41;H334:38;H371:38;H301:41;H315:41
33960,Norflurane,212-377-0,811-97-2,Press. Gas (Liq.),REACH registration C&L,526,H280:414;Not classified:112;H370:5;H371:1
33962,2'-phenylacetohydrazide,204-055-3,114-83-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,763,H335:640;H319:643;H317:638;H301:760;H315:643;H351:28;H312:3;H302:3;H332:3;H410:4;H400:4;H311:4;H336:1
33965,Tetrahydropyran,205-552-8,142-68-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:41;H319:42;H315:42;H225:50
33972,Diethyl fluoromalonate,211-684-7,685-88-1,Acute Tox. 2;Acute Tox. 3;Skin Corr. 1C;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,48,H300:1;H410:1;H400:1;H314:48;H331:1;H311:2;H412:1;H301:1;H330:1;H318:1
33975,Perfluoro(methylcyclohexane),206-573-5,355-02-2,Not Classified,Notified C&L,23,Not classified:23
33976,Dioleamide,276-974-8,72901-31-6,Not Classified,REACH registration C&L,3,Not classified:3
33982,1-Butyl-3-nitroguanidine,611-171-1,5458-83-3,Flam. Sol. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H228:38;H301:38;H315:38
33985,Sodium trivanadium octaoxide,234-709-3,12026-08-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2,Notified C&L,1,H335:1;H319:1;H332:1;H302:1;H341:1;H315:1
33987,N-lauroylsarcosine,202-608-3,97-78-9,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,67,H318:23;H330:5;H315:50;H335:38;H319:44
33990,Dysprosium triiodide,239-493-4,15474-63-2,Skin Sens. 1;Repr. 2,Notified C&L,46,H361:38;H317:45;H334:7;Not classified:1
33995,Disodium 2-amino-5-[(4-sulphonatophenyl)azo]benzenesulphonate,220-293-0,2706-28-7,Eye Irrit. 2,REACH registration C&L,138,H319:41;Not classified:97;H335:38;H315:38
33997,"1-Ethoxy-2,3-difluor-4-(4-pentyl-1-cyclohexen-1-yl)-benzen",603-125-4,126163-36-8,Not Classified,REACH registration C&L,2,Not classified:2
33998,"Oils, vegetable, hydrogenated",269-820-6,68334-28-1,Not Classified,Notified C&L,286,Not classified:286
33999,"ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate",429-680-0,122665-86-5,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
34000,"5,5'-Bis-1H-tetrazole diammonium salt",485-290-0,,Flam. Sol. 1,REACH registration C&L,2,H228:2
34001,Diethyl trimethylsilyl phosphite,237-268-5,13716-45-5,Flam. Liq. 3,Notified C&L,38,H226:38
34003,"1,1,2-triethoxyethane",225-394-3,4819-77-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H319:1;H315:1
34008,"2,3,4-trimethoxybenzaldehyde",218-271-0,2103-57-3,,Notified C&L,11,H335:5;H319:6;H315:6;Not classified:5
34009,di-sec-butylamine,210-937-9,626-23-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H226:0;H302:0;H332:0;H312:0
34011,"3-methyl-6-(p-toluidino)-3H-dibenz[f,ij]isoquinoline-2,7-dione",201-346-7,81-39-0,Not Classified,REACH registration C&L,217,Not classified:217
34012,"2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanol",252-562-3,35441-12-4,Not Classified,REACH registration C&L,3,Not classified:3
34013,Disodium L-tyrosinate,274-152-3,69847-45-6,Eye Dam. 1,REACH registration C&L,114,H318:15;H319:98;H315:98;H335:42;Not classified:1
34015,"Elecampane, ext.",281-666-1,84012-20-4,Flam. Liq. 3,Notified C&L,1,H226:1
34019,Procaine,200-426-9,59-46-1,Acute Tox. 4,Notified C&L,1,H302:1
34020,4-(trimethoxysilyl)aniline,251-772-2,33976-43-1,,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
34021,"Lanthanum oxide sulfide (La2O2S), europium-doped",271-886-6,68611-12-1,Not Classified,Notified C&L,8,Not classified:8
34024,Butylate,217-916-3,2008-41-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,41,H332:40;H411:38;H312:2;Not classified:1
34025,2-methoxycyclohexanone,231-071-8,7429-44-9,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H227:1;H315:1
34027,Acetylurea,209-698-3,591-07-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
34031,decanoic acid,206-376-4,334-48-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0;H315:0
34032,p-tolylguanidinium nitrate,279-190-4,79574-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34035,4-trans-Propylcyclohexancarbonic acid-(4-trans-propylcyclohexyl)ester,615-941-8,73255-62-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
34036,Cyclohexyl 2-hydroxybenzoate,607-733-0,25485-88-5,Aquatic Chronic 2,Notified C&L,105,H411:97;H400:8;H410:8
34039,Dilithium sulphite,236-636-2,13453-87-7,,Notified C&L,1,H335:1
34045,Zinc bis(tetrafluoroborate),237-534-0,13826-88-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,41,H332:38;H302:38;H314:38;H312:38;H319:3;H315:3
34050,"1,3-Benzenedicarboxylic acid, polymer with 1,4-benzenedicarboxylic acid, 1,4-butanediol and hexanedioic acid",613-871-2,66027-02-9,Not Classified,Notified C&L,2,Not classified:2
34052,1-methylcyclohexanecarbonyl chloride,608-291-1,2890-61-1,Acute Tox. 4,Notified C&L,39,H302:39;H314:1;H330:1
34053,Ethyl 4-nitrocinnamate,213-463-0,953-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
34057,METH SANDALORE KETONE,607-379-7,244614-20-8,Aquatic Chronic 2,Notified C&L,11,H411:10;Not classified:1
34059,Glucose pentaacetate,223-439-1,3891-59-6,Not Classified,Notified C&L,88,Not classified:88
34062,"Naphthalene-2,3-diol",202-156-7,92-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H319:42;H315:46;H302:5;H318:4
34063,"Tetrasodium [29H,31H-phthalocyaninetetrasulphonato(6-)-N29,N30,N31,N32]zincate(4-)",248-683-6,27836-01-7,Aquatic Chronic 2,Notified C&L,119,H411:119
34065,"Poly(oxy-1,2-ethanediyl), α-[bis(1-phenylethyl)phenyl]-ω-hydroxy-",618-669-8,9086-52-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H319:2;H411:2;H315:2
34068,"Benzenesulfonic acid, mono-C10-13-branched alkyl derivs., compds. with 2-propanamine",290-666-0,90194-54-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,44,H318:44;H411:41;H315:44
34069,"Hexadecanol, branched and linear",291-392-4,90388-13-9,Not Classified,Notified C&L,25,Not classified:25
34071,"Sulfonyl chlorides, C16-34-alkane, chloro",293-744-2,91082-32-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
34073,"Naphtha (petroleum), chemically neutralized light;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-123-6,64742-23-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
34078,2-chloro-4-methylquinoline,211-209-3,634-47-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
34081,"Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione",224-597-4,4424-06-0,Not Classified,REACH registration C&L,269,Not classified:268;H341:1
34084,3-fluoro-DL-tyrosine,206-964-0,403-90-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:38;H302:42;H312:38
34087,"N,N-diethyloctanamide",213-639-7,996-97-4,Skin Irrit. 2,Notified C&L,1374,H315:1296;Not classified:78
34088,2-(2-thienyl)ethyl toluene-p-sulphonate,254-911-5,40412-06-4,Aquatic Chronic 2,REACH registration C&L,4,H411:2;Not classified:2
34090,Sulphanilyl fluoride,202-687-4,98-62-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:38;H302:1;H332:1;H312:1
34091,m-phenoxybenzaldehyde,254-487-1,39515-51-0,Acute Tox. 4;Acute Tox. 2;Aquatic Chronic 1,REACH registration C&L,260,H302:260;H410:4;H330:255;H312:55;H400:40;H411:4;H332:1
34092,"hexahydro[1,3]oxazolo[2,3-c][1,4]oxazine",618-973-0,937717-10-7,Repr. 1B,REACH registration C&L,2,H360:2
34094,N-methylbenzothiazol-2-amine,241-025-9,16954-69-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
34095,4-aminonaphthalene-1-sulphonic acid,201-567-9,84-86-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,46,H319:3;H315:3;H314:43
34096,Telajet Black E-AS VP 2115,434-980-1,,Eye Dam. 1,Notified C&L,31,H318:31
34097,"(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone",410-440-9,164058-20-2,Aquatic Chronic 2,Harmonised C&L,0,H411:0
34099,trans-4-phenyl-L-proline,416-020-1,96314-26-0,Skin Sens. 1;Repr. 2,Harmonised C&L,0,H361:0;H317:0
34101,"2-bromo-1,1-dimethoxyethane",230-669-6,7252-83-7,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,48,H226:48;H319:46;H335:6;H330:6;H301:6;H315:7;H302:2;H314:1
34104,(2H5)pyridine,230-720-2,7291-22-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,50,H319:38;H312:50;H225:50;H332:49;H302:50;H315:38;Not classified:1;H331:1
34105,Petitgrain lemon,617-086-6,8048-51-9,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,147,H410:147;H400:86;H317:147;H304:147;H315:122;H319:57;H351:31;H226:26
34106,"A mixture of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate",604-258-0,141880-36-6,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,26,H412:17;H317:17;Not classified:9
34112,"α,α,2,6-tetrachlorotoluene",201-332-0,81-19-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 1,REACH registration C&L,43,H335:4;H319:4;H410:1;H302:1;H315:1;H314:39;H400:38;H318:1
34113,Oleyl methanesulphonate,252-686-8,35709-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34114,(S)-N-ethyl-α-methyl-m-(trifluoromethyl)phenethylamine hydrochloride,221-806-0,3239-45-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H301:39;H311:38;H331:38
34115,Dibutyl fumarate,203-327-9,105-75-9,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,177,H373:38;H410:167;H317:167;H400:166;Not classified:7;H319:2;H315:2
34117,"Dibutyl 2,2'-thiobisacetate",223-914-3,4121-12-4,,Notified C&L,33,Not classified:33
34118,"1,1',1''-[propylidynetris(oxy)]tributane",263-389-8,62042-45-9,Not Classified,Notified C&L,2,Not classified:2
34119,"N,N,N',N'-tetrabutylmethylenediamine",243-678-5,20280-10-8,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,59,H319:59;H312:59;H302:59;H332:59;H301:59;H315:59
34120,Gonadorelin,251-553-1,33515-09-2,Repr. 1A,Notified C&L,2,H360:2
34125,"Ocimum sanctum, ext.",295-208-3,91845-35-1,Skin Irrit. 2,Notified C&L,29,H315:26;H304:3;H319:3;H317:3;H351:1;H341:1
34126,"Sodium 2,5-dihydroxy-4-(1-methylheptadecyl)benzenesulphonate",263-828-3,63059-59-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H335:1;H319:1;H317:1;H302:1;H411:1;H315:1
34128,Sorbitan tristearate,247-891-4,26658-19-5,Not Classified,REACH registration C&L,159,Not classified:155;H315:4
34130,"2,3-dibromopropionyl chloride",242-575-2,18791-02-1,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,45,H314:45;H302:44;H335:39;H332:4;H290:1;H318:1
34131,"1-t-Butyl-3-(2,6-diisopropyl-4-phenoxyphenyl)thiourea",616-885-7,80060-09-9,Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H331:156;H373:156;H410:156;H400:156;H332:38
34136,"Benzidine-2,2'-disulphonic acid",204-200-0,117-61-3,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,57,H319:8;H317:2;H351:38;Not classified:11;H335:4;H315:6;H312:2;H332:2;H302:2
34137,"[3aR-(3aα,5aβ,9aα,9bβ)]decahydro-3a,6,6,9a-tetramethylnaphth[2,1-b]furan-2(1H)-one",209-269-0,564-20-5,Not Classified,REACH registration C&L,1580,Not classified:1558;H319:22
34140,"Paraffin oils, reaction products with aluminum stearate",271-398-3,68553-92-4,Not Classified,Notified C&L,7,Not classified:7
34141,"N-phenyl-1,1,3,3-tetramethylbutylnaphthalen-1-amine",269-527-3,68259-36-9,Aquatic Chronic 3,Notified C&L,573,H412:452;Not classified:120;H413:1
34150,Zinc peroxide,215-226-7,1314-22-3,Ox. Sol. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,99,H271:93;H319:94;H315:94;H335:4;H272:5;H332:4;H400:2;H410:2;Not classified:1
34156,"Oil shale, thermal processing waste",297-648-1,93685-99-5,Not Classified,REACH registration C&L,41,Not classified:8;H372:16;H373:21;H318:25;H335:25
34157,4-benzyloxyaniline,228-917-3,6373-46-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H319:2;H315:2
34158,"Sodium bis[3-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonamidato(2-)]ferrate(1-)",276-700-7,72496-87-8,Not Classified,Notified C&L,2,Not classified:2
34159,"4-(4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxo-2-anthryl)phenyl ethyl carbonate",240-666-1,16618-09-0,Not Classified,Notified C&L,1,Not classified:1
34160,"Bis[benzyl[2-(3,5-dihydroxyphenyl)-2-oxoethyl]isopropylammonium] sulphate",302-501-2,94109-60-1,,Notified C&L,1,Not classified:1
34161,"Oils, fish, Me esters, glycerol-free",309-452-6,100298-98-4,Not Classified,Notified C&L,1,Not classified:1
34164,3-amino-4-hydroxyphenylarsonic acid,218-494-3,2163-77-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H400:38;H410:38;H331:38
34167,"(3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxobenzo[e]thiazin-4-one",615-253-8,71125-38-7,Acute Tox. 3;Repr. 1A;Aquatic Chronic 3,Notified C&L,114,H301:110;H412:64;H360:59;H335:5;H319:6;H315:5;H302:2;H370:2;H362:1;H331:1;H372:2;H311:1;H361:3;H332:1;H312:1;Not classified:1;H413:1;H300:1
34170,"Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, tungstatephosphate",276-024-2,71798-70-4,Not Classified,Notified C&L,12,Not classified:12
34173,Trimedoxime bromide,200-304-5,56-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34175,"2,5,6-trimethylbenzoxazole",242-887-9,19219-98-8,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1
34176,"8-isopropyl-1,3-dimethyltricyclo[4.4.0.02,7]dec-3-ene",223-364-4,3856-25-5,Asp. Tox. 1,Notified C&L,1,H304:1
34177,"[hydroxyacetato(2-)-O1,O2]bis(methacrylato-O)titanium",264-437-0,63735-11-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H335:1;H319:1;H315:1
34178,2-methylresorcinol,210-155-8,608-25-3,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,158,H301:148;H400:39;H318:85;H317:76;H335:111;H319:71;H315:106;H302:9;Not classified:1
34185,"3,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone",244-414-1,21511-25-1,Not Classified,Notified C&L,1,Not classified:1
34190,"disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate",419-460-2,120029-06-3,Aquatic Chronic 3,Harmonised C&L,0,H412:0
34192,"metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one",255-349-3,41394-05-2,Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H302:0;H400:0
34200,Trititanium tetrakis(phosphate),239-641-8,15578-51-5,Not Classified,Notified C&L,25,Not classified:25
34206,"Polysulfides, diallyl",615-862-9,72869-75-1,Not Classified,Notified C&L,89,Not classified:89
34207,Methyl 2-(4-nitrophenyl)propionate,256-584-4,50415-69-5,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H319:2
34211,Isopropyl 2-cyanoacrylate,234-188-2,10586-17-1,Not Classified,Notified C&L,1,Not classified:1
34212,2-chloro-5-chloromethylthiazole,429-830-5,105827-91-6,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H314:0;H302:0;H311:0;H411:0
34214,(2S)-6-fluoro-2-[(2S)-oxiran-2-yl]chromane,603-314-1,129050-23-3,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H411:3;H319:1;H225:1;H302:1;H341:1;H315:1
34215,"[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]nickel",237-893-3,14055-02-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,42,H332:38;H302:38;H350:38;H312:38;H335:4;H319:4;H351:4;H317:4;H315:4
34216,1-benzyl-4-(ethylamino)piperidine-4-carbonitrile,213-830-5,1024-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34218,(3-cyanophenyl)boronic acid,604-729-0,150255-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:48;H319:49;H315:49;H302:11;H312:2;H332:2;H331:1;H311:1;H301:1
34220,Mephentermine sulphate,214-923-3,1212-72-2,Acute Tox. 3,Notified C&L,40,H301:38;H336:1;H302:1
34222,"Trihydrogen bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonato(3-)]ferrate(3-)",279-313-1,79817-90-6,Not Classified,Notified C&L,1,Not classified:1
34223,m-anisic acid,209-574-9,586-38-9,Acute Tox. 4,Notified C&L,41,H302:39;H319:3;H315:3;H335:2
34225,(Z)-hex-2-ene,231-697-1,7688-21-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,74,H335:70;H319:70;H315:66;H225:74;H314:4;H304:2
34228,"2-methyl-1,4-oxathiane 4,4-dioxide",247-727-1,26475-39-8,Eye Dam. 1;STOT SE 3,REACH registration C&L,34,H318:34;H335:34
34230,2-acetamido-6-chlorobenzoic acid,243-040-6,19407-42-2,,Notified C&L,5,H335:5;H319:5;H315:5
34231,2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulphonyl)phenyl]propyl chloroacetate,284-235-6,84824-83-9,Not Classified,REACH registration C&L,2,Not classified:2
34232,"Octanoic acid, iron salt",229-438-2,6535-20-2,Not Classified,Notified C&L,9,Not classified:9
34233,Canola oil,601-748-6,120962-03-0,Not Classified,Notified C&L,532,Not classified:532
34240,2-methoxyethyl cyanoacetate,233-597-3,10258-54-5,Not Classified,REACH registration C&L,92,Not classified:27;H335:65;H319:65;H315:65
34242,2-acryloyloxyethyl hydrogen phthalate,250-301-8,30697-40-6,Not Classified,Notified C&L,21,Not classified:13;H319:7;H315:7;H335:4;H302:1;H318:1;H317:2;H312:1;H311:1
34243,"3,5-Dihydroxy-4-methylbenzoic Acid",608-159-3,28026-96-2,,Notified C&L,5,H335:4;H319:5;H315:5
34245,Lifibrate,244-839-2,22204-91-7,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38,H301:38;H413:38
34248,PM14943,416-300-3,,Not Classified,Notified C&L,1,Not classified:1
34255,"Oils, chamomile, German",926-224-7,8002-66-2,Not Classified,Notified C&L,29,Not classified:25;H412:4
34256,5-sulphoisophthalic acid,244-912-9,22326-31-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:1;H319:1;H315:1;Not classified:1
34259,Glycerol palmitate,247-887-2,26657-96-5,Not Classified,Notified C&L,44,Not classified:44
34260,"6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-5-hydroxy-3-oxo-, 1,1-dimethylethyl ester, (6E)-",609-442-4,375846-25-6,Not Classified,REACH registration C&L,2,Not classified:2
34263,Oxamic acid,207-443-0,471-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44
34269,1-isocyanatonaphthalene,610-028-0,4242-18-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:4;H335:2;H302:1;H318:1
34270,"ethyl (2E)-4,4,4-trifluorobut-2-enoate",607-752-4,25597-16-4,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H226:46;H335:45;H319:46;H315:7
34271,"granulated copper; [particle length: from 0,9 mm to 6,0 mm; par­ticle width: from 0,494 to 0,949 mm]",231-159-6,7440-50-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
34281,Hexasodium hydrogen bis[4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]-6-[(sulphomethyl)amino]naphthalene-2-sulphonato(5-)]chromate(7-),229-050-3,6408-22-6,,Notified C&L,147,H412:122;Not classified:25
34285,(+)-α-(1-aminoethyl)benzyl alcohol hydrochloride,205-826-7,154-41-6,Acute Tox. 4,Notified C&L,137,H302:133;H332:2;H319:4;H315:3;H335:2;H301:1;H362:1;H361:1
34287,7H-benzo[c]carbazole,205-909-8,205-25-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
34289,2-Bromo-6-fluoroaniline,464-930-2,65896-11-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
34290,"(3β,5β)-3-[(2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide",211-140-9,630-64-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H310:38;H300:38;H330:38
34293,TOX,433-670-1,,Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H228:1
34295,"Esterase, aryl",232-884-0,9032-73-9,Resp. Sens. 1,REACH registration C&L,42,H334:42
34300,"Natural gas condensates;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",272-896-3,68919-39-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
34301,Ethyl(methyl)amine,210-862-1,624-78-2,Flam. Liq. 1;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;STOT SE 3,REACH registration C&L,206,H224:165;H335:158;H314:206;H301:3;H318:160;H302:197;H332:197;H311:156;H312:41;H225:41
34302,"Stearic acid, compound with 2-aminoethanol (1:1)",218-347-3,2129-99-9,Eye Dam. 1,Notified C&L,60,H318:58;Not classified:2
34303,"2,4,4-trimethylpent-1-ene",203-486-4,107-39-1,Flam. Liq. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H225:0
34305,"4,4'-(4,5,6,7-tetrabromo-3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dichlorophenol] S,S-dioxide",262-578-2,61053-97-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
34306,"Methyl 2,3-dibromopropionate",217-044-3,1729-67-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,52,H302:4;H319:51;H312:3;H315:5;H335:47;H410:1;H400:1;H317:1;H314:1
34308,Chloro[p-[(2-hydroxy-1-naphthyl)azo]phenyl]mercury,221-358-6,3076-91-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H300:38;H410:38;H400:38;H330:38;H310:38
34309,"3,3-diphenylpropionic acid",210-125-4,606-83-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H335:5;H319:6;H315:6
34310,"Benzoic acid, 3-methyl-5-nitro-4-[(1-oxobutyl)amino]-, methyl ester",604-865-0,152628-01-8,,Notified C&L,1,H332:1;H302:1;H312:1
34311,"Fatty acids, vegetable-oil, reaction products with pentaethylenehexamine",297-455-2,93572-25-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:1;H317:2;H315:1;H314:1;H410:1
34315,piperazine;[liquid];[solid],203-808-3,110-85-0,,,0,H314:0;H334:0;H361:0;H317:0
34317,Cobalt selenide,215-155-1,1307-99-9,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H410:42;H400:42;H331:42;H301:42
34318,"1,4-dioxacyclohexadecane-5,16-dione",259-423-6,54982-83-1,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1801,H400:1759;H412:175;H410:264;H302:24;Not classified:1
34319,Sodium propanesulphonate,238-564-7,14533-63-2,Not Classified,Notified C&L,1,Not classified:1
34320,"reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)",430-970-4,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
34322,2-(vinyloxy)ethanol,212-124-4,764-48-7,Flam. Liq. 3,Notified C&L,56,H226:50;Not classified:6
34323,"2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5-triazine",426-040-2,,Not Classified,REACH registration C&L,44,Not classified:44
34329,cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine,425-080-8,104860-26-6,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H312:0;H410:0;H400:0;H302:0;H318:0
34333,Iodofenphos,242-069-1,18181-70-9,Acute Tox. 3;Aquatic Acute 1,Notified C&L,41,H400:38;H311:38;H332:3;H302:3;H312:3
34338,"1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one",260-709-8,57378-68-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1628,H410:1586;H400:1577;H317:1628;H302:1584;H315:1584;Not classified:1;H411:1;H319:1
34341,"1,5-diphenylpenta-1,4-dien-3-one",208-697-5,538-58-9,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,159,H400:156;H317:156;H410:156;H335:2;H319:3;H315:3;H332:1;H312:1
34343,"Fatty acids, coco, esters with propylene glycol",267-056-8,67784-83-2,Not Classified,Notified C&L,5,Not classified:5
34352,Dimetridazole,209-001-2,551-92-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:46;H319:47;H315:47;H341:5;H302:1
34354,Diisopentyl disulphide,218-113-0,2051-04-9,Eye Irrit. 2,Notified C&L,38,H319:38
34355,COAGULANT 122,417-040-3,,Not Classified,REACH registration C&L,2,Not classified:2
34359,"N,N-dimethyl-3-(octadecyloxy)propylamine",241-516-8,17517-01-0,Met. Corr. 1;Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H410:6;H400:6;H314:6;H290:6;H318:6
34362,Methyl D-glucopyranoside,221-581-9,3149-68-6,Not Classified,REACH registration C&L,3,Not classified:3
34364,"4,4'-(4,5,6,7-tetrabromo-3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromophenol] S,S-dioxide",224-622-9,4430-25-5,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,38,H412:36;H318:37;H319:1;H315:1
34368,"Isooctadecanoic acid, compound with 1-aminopropan-2-ol (1:1)",259-782-9,55738-53-9,Not Classified,Notified C&L,6,Not classified:6
34369,4'-anilinotoluene-4-sulphonanilide,202-902-1,100-93-6,Skin Sens. 1,REACH registration C&L,57,H317:2;H272:2;H280:2;H261:2;H302:38;Not classified:17
34370,"1,3-dihydro-5,6-diamino-2H-benzimidazol-2-one",259-728-4,55621-49-3,Not Classified,REACH registration C&L,42,Not classified:2;H319:39;H315:1;H332:1;H302:1;H312:1
34371,"2,5-thiophenediylbis(5-tert-butyl-1,3-benzoxazole)",230-426-4,7128-64-5,Not Classified,REACH registration C&L,3550,Not classified:336;H413:3141;H411:71;H412:2
34375,3-(dimethoxymethylsilyl)propylamine,222-919-8,3663-44-3,Skin Corr. 1B,Notified C&L,24,H314:18;Not classified:5;H319:1;H315:1;H318:2;H335:1
34378,Isomenthone,207-727-4,491-07-6,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1620,H317:1412;H315:1413;H412:119;Not classified:87;H302:1;H319:1
34381,bis(4-methylbenzoyl)peroxide,407-950-9,895-85-2,Org. Perox. B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H241:0;H410:0
34382,"4-(2,6-Dichloro-4-pyrimidyl)morpholine",610-785-7,52127-83-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
34383,"(1R,2S,3R,6S)-1,2-dimethyl-3,6-epoxycyclohexane-1,2-dicarboxylic anhydride",200-263-3,56-25-7,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:43;H319:44;H300:46;H315:44;H310:3;H330:3
34385,benazolin-ethyl;ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate,246-591-0,25059-80-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
34388,nickel boride,235-723-2,12619-90-8,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H400:0;H317:0;H372:0;H350:0
34389,N-methylnaphthalene-1-methylamine,238-497-3,14489-75-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,9,H319:8;H401:3;H301:4;H411:4;H315:8;H335:3;H314:1;H302:1;H412:1
34392,"2,4-difluorobenzonitrile",223-523-8,3939-09-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H335:46;H319:48;H312:46;H332:46;H302:47;H315:48;H331:1;H311:1;H301:1
34396,"2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one",434-820-9,106461-41-0,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0
34402,Buphenine hydrochloride,212-701-0,849-55-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H332:39;H312:39;H302:1
34403,4-hydroxybenzenesulphonic acid,202-691-6,98-67-9,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,201,H314:144;H318:104;H290:138;H335:84;H302:85;Not classified:57;H341:1
34405,"1,1'-(2,2,2-trichloroethylidene)dibenzene",221-007-7,2971-22-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H410:38;H319:38;H400:38
34409,"2-heptyl-1,3-dioxolane",224-438-9,4359-57-3,Not Classified,Notified C&L,88,Not classified:88
34410,Decyl mercaptoacetate,256-198-6,45163-99-3,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
34414,Diisopropyl-m-cresol,250-549-7,31291-59-5,Not Classified,Notified C&L,33,Not classified:33
34415,"Pyridine-2,6-dicarboxylic acid",207-894-3,499-83-2,Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,219,H314:13;H318:28;H335:218;H319:193;H315:206;Not classified:1
34418,reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol,415-990-3,67739-11-1,Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0
34421,dimethyltin dichloride,212-039-2,753-73-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;STOT RE 1;Repr. 2,Harmonised C&L,0,H372:0;H314:0;H311:0;H330:0;H301:0;H361:0
34425,"ferrocene, [4-(dimethylsilyl)butyl]-",600-343-1,102744-79-6,Acute Tox. 4,REACH registration C&L,2,H302:2
34429,Trisodium hydrogen ethylenediaminetetraacetate,205-758-8,150-38-9,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT RE 2,REACH registration C&L,88,H332:18;H302:66;H318:22;H373:23;H319:51;H335:6;H315:6;Not classified:2
34434,"Poly[2,2´-(m-phenylene)]5,5´-bibenzimidazole",607-830-8,25928-81-8,Skin Irrit. 2,Notified C&L,1,H315:1
34435,"α,α,α',α'-tetramethylxylene-α,α-diol",248-256-4,27138-01-8,Not Classified,REACH registration C&L,3,Not classified:2;H302:1;H319:1;H315:1
34440,"9,10-o-benzeno-9,10-dihydroanthracene",207-519-3,477-75-8,Not Classified,Notified C&L,1,Not classified:1
34441,"Alcohols, C13-15, reaction products with N-[3-(dimethoxymethylsilyl)-2-methylpropyl]- 1,2-ethanediamine, glycidol and hydroxyterminated di-Me siloxanes",607-267-8,237753-63-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,34,H319:34;H315:34
34444,"1-(3,4-dichlorophenyl)ethan-1-one",220-146-0,2642-63-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,96,H302:94;H335:95;H319:96;H315:96;H301:1;H300:1
34445,"Sorbitan, di-9-octadecenoate, (Z,Z)-",249-448-0,29116-98-1,Not Classified,Notified C&L,3,Not classified:3
34448,"α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)",404-920-7,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H302:0;H411:0;H312:0
34449,"2,5-OXAZOLIDINEDIONE, 4-[(4-HYDROXYPHENYL)METHYL]-, (4S)-",608-948-2,3415-08-5,Skin Sens. 1;Eye Irrit. 2,Notified C&L,40,H319:38;H317:38;H318:2;H335:2;H315:2
34450,Tris(o-methoxyphenyl)phosphine,225-235-8,4731-65-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,46,H413:39;H335:45;H319:46;H315:46;H302:2;H312:1;H332:1
34455,"Fatty acids, tall-oil, compds. with diethylenetriamine-tall-oil fatty acid reaction products",271-205-2,68526-44-3,,Notified C&L,10,Not classified:6;H319:3;H315:3;H314:1;H302:1;H317:1;H411:1
34458,"Bis(pentane-2,4-dionato-O,O')(propane-1,3-diolato-O,O')titanium",253-245-2,36870-02-7,Not Classified,Notified C&L,5,Not classified:5
34459,"3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, 3-(4-methylbenzenesulfonate), (3S,4R)-",608-663-3,317323-77-6,,Notified C&L,1,H335:1;H319:1;H332:1;H302:1;H315:1
34466,Quinoline-2-thiol,220-132-4,2637-37-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39;H302:1
34471,"Acetic acid, esters with lanolin alcs.",262-980-8,61788-49-6,Not Classified,REACH registration C&L,52,Not classified:52
34473,Perhydroazocine,214-342-5,1121-92-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,40,H226:40;H314:40;H318:1
34474,"α,α-bis(p-dimethylaminophenyl)benzyl alcohol",208-109-7,510-13-4,Acute Tox. 4,Notified C&L,42,H302:41;H410:2;H400:2;H318:2;H361:2;Not classified:1
34475,"Copper, C5-23-branched carboxylate naphthenate octanoate complexes",295-913-6,92200-87-8,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H400:1
34477,"Veratrum album, ext.",290-407-1,90131-91-2,,Notified C&L,1,H332:1;H302:1;H312:1;H225:1
34479,Halazone,201-253-1,80-13-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
34480,"2,4,6-trimethylpiperidine",244-690-3,21974-48-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H312:1;H314:1;H302:1;H332:1
34481,Ammonium nitrate,229-347-8,6484-52-2,Ox. Sol. 3;Eye Irrit. 2,REACH registration C&L,1206,H272:1110;H319:1158;H335:112;H315:91;Not classified:25;H370:8;H271:18;H312:1;H302:1;H332:1;H300:1
34482,7-benzamido-4-hydroxynaphthalene-2-sulphonic acid,205-080-2,132-87-6,Skin Sens. 1,REACH registration C&L,4,H317:2;H302:1;H319:1;H315:1;Not classified:1
34485,2-[2-(3-aminopropoxy)ethoxy]ethanol,203-960-0,112-33-4,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,108,H314:99;H318:98;Not classified:7;H400:2;H410:2
34489,"Amines, dimethyltallow alkyl",272-339-4,68814-69-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,71,H314:71;H302:71;H400:71;H318:32
34490,L-proline,205-702-2,147-85-3,Not Classified,REACH registration C&L,296,Not classified:292;H335:3;H319:4;H315:3;H333:1;H303:1;H316:1;H302:1
34493,"Gasoline, straight-run, topping-plant;Low boiling point naphtha;[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36.1°C to 193.3°C (97°F to 380°F).]",271-727-0,68606-11-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
34495,"Fatty acids, C14-18 and C16-22-unsatd., lithium salts",292-817-6,91001-47-7,Not Classified,Notified C&L,5,Not classified:5
34497,(S)-2-[p-bromo-α-[2-(dimethylamino)ethyl]benzyl]pyridinium (Z)-maleate (1:1),219-236-2,2391-03-9,Acute Tox. 3,Notified C&L,48,H301:48;H317:10;H314:10;H332:10;H318:10
34498,"2-chloro-4,6-dinitroaniline",222-564-9,3531-19-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H373:42;H300:38;H330:38;H310:38;H411:42;H319:5;H302:4;H311:5;H315:5;H331:1;H341:1;H301:1;H412:1
34499,tetrasodium ethylene diamine tetraacetate,200-573-9,64-02-8,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H302:0;H318:0
34501,Dibutylbis(octadec-9(Z)-enoyloxy)stannane,236-359-7,13323-62-1,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,310,H373:183;H360:252;H410:259;H400:259;H341:252;H372:76;Not classified:51;H319:7;H312:7;H302:7;H315:7;H370:1;H317:1;H314:1
34504,"1,1-diphenylpropane",216-222-8,1530-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
34505,Hexacosafluorododecane,206-204-8,307-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
34506,Methyl 2-hexenoate,607-296-6,2396-77-2,Flam. Liq. 3,Notified C&L,154,H226:154
34507,Furfuryl valerate,253-160-0,36701-01-6,Acute Tox. 4,Notified C&L,1374,H302:1364;H301:10
34508,Bendazol,210-703-6,621-72-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H335:38;H319:38;H315:38
34511,"Mercaptoacetic acid, monoester with propane-1,2,3-triol",250-264-8,30618-84-9,Acute Tox. 3;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,40,H301:39;H412:3;H317:40;H312:37;H302:1
34512,2-nitro-N-(2-nitrophenyl)aniline,242-138-6,18264-71-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34513,"Amines, C14-18 and C16-18-unsatd. alkyl, reaction products with 1,1'-methylenebis[4-isocyanatobenzene]",610-753-2,519142-82-6,Not Classified,Notified C&L,1,Not classified:1
34514,Polyamide wax,434-430-9,,Skin Sens. 1B;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,180,H373:2;H317:179;H413:179;Not classified:1
34517,Sodium dimethyldithiocarbamate,204-876-7,128-04-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,326,H400:266;H410:142;H332:69;H335:33;H302:72;H318:33;H411:65;H315:34;H319:3;H370:1
34520,"Gasoline, pyrolysis, debutanizer bottoms;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C",271-726-5,68606-10-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
34525,Furazolidone,200-653-3,67-45-8,Repr. 2,Notified C&L,51,H361:43;H341:5;Not classified:2;H319:1;H410:1;H317:2;H350:1;H315:1;H351:1
34526,"Deca-1,5,9-triene",236-474-2,13393-64-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43,H226:43;H314:38;H335:4;H319:5;H315:5;H304:1
34529,"4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)",407-560-9,107934-68-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
34530,p-fluorobenzyl isothiocyanate,220-368-8,2740-88-7,,Notified C&L,5,H314:4;H302:5;H332:5;H312:5;H335:1;H319:1;H315:1
34541,"1-Butanamine, N-butyl-, reaction products with polyethylene glycol monoacrylate ether with trimethylolpropane (3:1) (1-2.5EO)",606-330-7,195008-76-5,Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,106,H319:106;H317:84;H411:83;H335:22;H315:22
34543,"4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one",420-220-4,92771-56-7,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
34544,"Disodium 2,2'-[(4-oxo-2-phenyl-4H-1-benzopyran-5,7-diyl)bis(oxy)]bisacetate",236-409-8,13358-62-8,Not Classified,Notified C&L,1,Not classified:1
34546,Diammonium succinate,218-759-3,2226-88-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,30,H335:14;H319:27;H317:14;H315:27;Not classified:3
34550,"2,4-Hexadienal",617-079-8,80466-34-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1,Notified C&L,88,H317:88;H226:88;H302:88;H311:88;H315:88
34551,(2-methylphenyl)boronic acid,605-351-9,16419-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,203,H335:201;H319:202;H315:202;H332:1;H302:3;H312:1
34552,"5-(benzoylamino)-4-hydroxy-3-[[1-sulpho-6-[[2-(sulphooxy)ethyl]sulphonyl]-2-naphthyl]azo]naphthalene-2,7-disulphonic acid",270-006-8,68400-00-0,Not Classified,Notified C&L,2,Not classified:2
34555,"5-[[4-[benzylmethylamino]phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium trichlorozincate(1-)",254-149-3,38845-47-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,68,H302:64;H412:58;H319:50;H318:17;H411:9;Not classified:1
34556,"2-Propanol, 1,1'-[[(2-hydroxypropyl)imino]bis(3,1-propanediylimino)]bis-, N-tallow alkyl derivs.",307-286-9,97592-88-6,,Notified C&L,1,H314:1;H302:1;H410:1
34557,"1,4,5,8-tetraaminoanthraquinone;C.I. Disperse Blue 1",219-603-7,2475-45-8,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Carc. 1B,Harmonised C&L,0,H350:0;H318:0;H317:0;H315:0
34559,Trioctylphosphine,225-234-2,4731-53-7,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,84,H314:63;H318:5;H335:21;H319:21;H315:21;H312:1;H302:1;H332:1;H400:1;H410:1
34560,"3',4'-dichloropropiophenone",229-511-9,6582-42-9,,Notified C&L,6,H335:5;H319:6;H315:6
34561,Copper wolframate,237-022-7,13587-35-4,,Notified C&L,5,H335:4;H319:4;H332:4;H302:4;H315:4;Not classified:1
34566,"4-(4-Chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile",601-308-3,114369-43-6,Aquatic Chronic 1,Notified C&L,195,H410:195;H400:39;H373:1
34569,Aluminium diformate,257-721-0,52186-48-8,Not Classified,Notified C&L,47,Not classified:47
34573,"1-(2-Chloro-acetyl)-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester",929-125-7,,Not Classified,REACH registration C&L,2,Not classified:2
34574,"N,N,N',N'-tetramethylbenzene-1,3-diamine",244-998-8,22440-93-3,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H317:38;H301:38;H315:38
34576,Disodium diisononylnaphthalenedisulphonate,265-783-5,65451-61-8,,Notified C&L,1,Not classified:1
34581,"DNOC (ISO);4,6-dinitro-o-cresol",208-601-1,534-52-1,Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 2;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H410:0;H400:0;H317:0;H341:0;H330:0;H318:0;H310:0;H315:0
34582,Dilithium oxide,235-019-5,12057-24-8,Skin Corr. 1B,Notified C&L,402,H314:309;H412:83;H318:83;Not classified:74;H413:19;H290:1
34583,"Disodium 5-[[2,4-dihydroxy-5-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]naphthalene-2,7-disulphonate",268-975-7,68155-63-5,Eye Irrit. 2,REACH registration C&L,38,H319:4;H412:31;Not classified:2;H317:1
34586,3-bromo-4-methoxybenzoic acid,202-768-4,99-58-1,,Notified C&L,7,H335:6;H319:7;H315:7
34593,o-[1-(4-hydroxyphenyl)-1-methylethyl]phenol,212-650-4,837-08-1,Not Classified,Notified C&L,71,Not classified:71
34598,2-butoxyethyl hydrogensulphate,213-167-1,927-96-8,Skin Corr. 1B,Notified C&L,1,H314:1
34604,"3-[[4-[[5-cyano-6-[(2-hydroxyethyl)amino]-4-methyl-2-[[2-(4-sulphophenyl)ethyl]amino]-3-pyridyl]azo]-2,5-xylyl]azo]benzenesulphonic acid, sodium salt",305-803-2,95027-07-9,Not Classified,Notified C&L,39,Not classified:39
34605,Lithium 2-aminobenzothiazole-6-sulphonate,265-367-3,65072-36-8,Not Classified,Notified C&L,2,Not classified:2
34611,3-methylbenzothiazolium iodide,220-505-1,2786-31-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
34614,diisooctyl phthalate,248-523-5,27554-26-3,Repr. 1B,Harmonised C&L,0,H360:0
34615,Dichloro(mesitylene)ruthenium (II) dimer,610-845-2,52462-31-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H315:1
34619,"Benzenesulfonic acid, 2,3(or 3,4)-dimethyl-, mono-C10-14-branched alkyl derivs., sodium salts",290-708-8,90218-34-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,57,H319:57;H411:57;H315:57
34621,3-methyl-2-butenyl 3-methyl-2-butenoate,276-828-3,72779-06-7,Not Classified,Notified C&L,88,Not classified:88
34623,"2,2'-(phenylimino)bisethyl diacetate",242-918-6,19249-34-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
34625,"2-Propenoic acid, polymer with 4-(1,1-dimethylethyl)phenol, formaldehyde, 2,5-furandione, 2-methyloxirane, 4-nonylphenol and oxirane",603-367-0,129828-31-5,Not Classified,Notified C&L,2,Not classified:2
34626,Strychnine hydrochloride,215-826-9,1421-86-9,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H400:40;H410:39;H300:41;H330:41;H310:2;H411:2
34627,Magnesium 2-ethylhexanoate,239-685-8,15602-15-0,Eye Dam. 1;Repr. 2,REACH registration C&L,26,H318:9;H361:11;Not classified:13;H314:3
34630,"titanium, dichloro(η5-2,4-cyclopentadien-1-yl)[p,p,p-tris(1,1-dimethylethyl)phosphine imidato-κn]-",606-876-6,219792-35-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H302:5;H335:4;H319:4;H315:4
34632,4-methylaminopiperidine dihydrobromide,919-497-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
34633,Diethoxy(methyl)(vinyl)silane,226-850-4,5507-44-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H335:42;H319:43;H225:43;H334:38;H315:43
34634,PROBIMIDE 733,416-890-2,,Aquatic Chronic 4,Notified C&L,1,H413:1
34636,"2,4-di-sec-butylphenol",217-434-3,1849-18-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H335:38;H319:38;H302:38;H315:38;H413:38
34637,"Fatty acids, C12-20, esters with triethanolamine",292-941-0,91031-39-9,Not Classified,Notified C&L,111,Not classified:111
34641,2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol,286-397-3,85232-76-4,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,88,H319:88;H411:88
34642,Synthon B,467-680-2,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
34650,Parapropamol,216-894-2,1693-37-4,Acute Tox. 4,Notified C&L,40,H302:40
34652,"5'-Uridylic acid, 2'-deoxy-, disodium salt",255-687-1,42155-08-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:38;H335:38;H319:38;H315:38;Not classified:1
34653,Lactic acid,200-018-0,50-21-5,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2838,H318:2601;H315:2616;H314:201;H319:122;H335:65;H290:26;H400:17;Not classified:5;H331:5;H281:1
34654,"2,2'-(propane-1,3-diyldiimino)bis[2-(hydroxymethyl)propane-1,3-diol]",264-899-3,64431-96-5,Not Classified,Notified C&L,7,Not classified:3;H335:4;H319:4;H315:4
34656,phosphorous acid,233-663-1,10294-56-1,Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H314:0;H302:0
34663,"2-bromo-1,1,1-triphenylethane",209-884-4,596-43-0,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1;H290:1
34665,"1-tert-butyl 2-ethyl (2R)-5-oxopyrrolidine-1,2-dicarboxylate",480-250-9,,Not Classified,REACH registration C&L,4,Not classified:4
34668,3-nitrobutan-2-ol,228-447-9,6270-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34673,"1,4-dibromo-2-nitrobenzene",222-404-8,3460-18-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,44,H335:43;H319:44;H400:38;H302:39;H315:44;H312:1;H332:1;H341:1
34674,2'-aminoacetophenone,209-002-8,551-93-9,Not Classified,REACH registration C&L,134,Not classified:79;H335:40;H319:45;H315:45;H302:17;H332:1
34675,"trans-1,4-dimethylcyclohexane",218-622-8,2207-04-7,Flam. Liq. 2;Acute Tox. 4,Notified C&L,39,H302:38;H225:39
34676,"gon-5-ene-3,11,17-trione, 13-ethyl-, cyclic 3,17-bis(1,2-ethanediyl acetal)",600-023-1,100071-89-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1,H312:1;H351:1;H332:1;H302:1;H361:1
34678,"4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one",610-555-6,50650-75-4,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,34,H302:34;H411:34
34685,Caesium bromide,232-130-0,7787-69-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H335:39;H319:39;H315:39;Not classified:26;H302:5;H361:1
34686,"Oils, fish, stearins",296-483-2,92704-50-2,Not Classified,Notified C&L,1,Not classified:1
34689,hexamethylphosphoric triamide;hexamethylphosphoramide,211-653-8,680-31-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
34692,"6,7,8,14-tetradehydro-4,5α-epoxy-3,6-dimethoxy-17-methylmorphinan hydrogen [R-(R*,R*)]-tartrate",305-572-8,94713-28-7,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,2,H301:2;H318:2
34695,glyphosate-trimesium;glyphosate-trimethylsulfonium,617-243-9,81591-81-3,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
34699,Bicyclo[2.2.1]hept-5-ene-2-carbonitrile,202-391-5,95-11-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:38;H319:39;H312:39;H332:39;H302:39;H315:39
34700,Tetrabromo-p-benzoquinone,207-679-4,488-48-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
34702,"1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)",272-574-2,68890-66-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,318,H412:213;H318:317;H315:318;H335:90;H410:80;H400:85;H411:13;H319:2;H317:1;H332:1;H302:1;H334:1
34703,Prednisolone 21-(3-sodium-sulphobenzoate),211-141-4,630-67-1,Repr. 2;STOT RE 2,Notified C&L,5,H373:3;H361:2;Not classified:2;H312:1;H351:1;H332:1;H302:1
34704,γ-(1-methylethoxy)benzenebutyronitrile,274-540-2,70289-00-8,Acute Tox. 4,Notified C&L,38,H302:38
34712,bromine,231-778-1,7726-95-6,Skin Corr. 1A;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H314:0;H400:0;H330:0
34713,"Disodium tetracarbonylferrate(2-), compound with 1,4-dioxane (2:3)",261-892-7,59733-73-2,Pyr. Sol. 1;Water-react. 2;Acute Tox. 3;Carc. 2,Notified C&L,42,H331:38;H351:42;H250:42;H261:38;H252:4;H311:4;H330:4;H301:4
34718,3-amino-2-benzopyrone,216-659-4,1635-31-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
34722,"Bis(2,3,4,5,6-pentafluorophenyl) sulphide",213-874-5,1043-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H400:39;H335:39;H319:39;H315:39
34726,Tetraterbium heptaoxide,234-856-3,12037-01-3,Not Classified,REACH registration C&L,16,Not classified:16
34727,"Gases (petroleum), catalytic reformer, C1-4-rich;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]",270-760-8,68477-79-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H220:0;H350:0
34735,"ketoconazole;1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",265-667-4,65277-42-1,Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H373:0;H360:0;H410:0;H400:0;H301:0
34736,Orcein,215-750-6,1400-62-0,Acute Tox. 4,Notified C&L,43,H302:39;Not classified:3;H319:2;H315:2
34737,Tetraethyltin,209-906-2,597-64-8,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H300:43;H410:43;H400:43;H226:39;H330:43;H310:43
34738,"α,α,α-trifluoro-m-toluonitrile",206-711-4,368-77-4,,Notified C&L,8,H319:6;H312:5;H332:5;H302:5;H315:6;H331:2;H311:3;H301:3;H330:1
34740,(R)-α-cyclohexanemethylamine,227-634-2,5913-13-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,43,H226:43;H302:38;H314:43;H312:38;H318:1
34741,"Neodecanoic acid, zinc salt, basic",282-780-4,84418-68-8,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,17,H400:10;H411:14;H315:4;Not classified:2;H412:1
34744,"Cuprate(3-), [[]5-amino-3-[[]2-[[]3-chloro-2-(hydroxy-[?]O)-5-sulfophenyl]diazenyl-[?]N1]-4-(hydroxy-[?]O)-2,7-naphthalenedisulfonato(5-)]-, sodium (1:3)",615-164-4,70776-13-5,Not Classified,REACH registration C&L,2,Not classified:2
34746,4-Acetamidobenzyl chloride,611-197-3,54777-65-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H319:2;H315:3;H302:1;H318:1
34747,4-bromo-alpha-methylbenzyl alcohol,226-389-9,5391-88-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H335:43;H319:45;H312:41;H332:40;H302:41;H315:45
34748,2-[(4-bromophenyl)phenylmethoxy]ethyl(dimethyl)ammonium chloride,217-310-9,1808-12-4,,Notified C&L,1,H301:1;H361:1
34750,"Sodium [[6'-[(2,4-dimethylphenyl)amino]spiro[3H-2,1-benzoxathiole-3,9'-[9H]xanthene]-3'-yl]amino]xylenesulphonate S,S-dioxide",276-362-0,72139-04-9,Not Classified,Notified C&L,1,Not classified:1
34751,Pyridine-3-sulphonic acid,211-265-9,636-73-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,122,H335:70;H319:69;H315:69;H314:53;H318:3;H290:1;Not classified:1;H302:1;H332:1;H312:1
34753,Didecyl maleate,256-226-7,45298-06-4,Not Classified,Notified C&L,1,Not classified:1
34760,Potassium 2-methylbutan-2-olate,255-272-5,41233-93-6,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT SE 3,REACH registration C&L,136,H335:87;H312:87;H314:136;H302:87;H332:87;H228:130;H318:124;H251:8;H410:4;H400:4;H336:4;H225:4
34767,"N,N-diethylmethanesulphonamide",219-155-2,2374-61-0,Acute Tox. 3,Notified C&L,38,H301:38
34769,"resorcinol diglycidyl ether;m-bis(2,3-epoxypro­poxy)benzene; resorcinol diglycidyl ether;1,3-bis(2,3-epoxypropoxy)benzene",202-987-5,101-90-6,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Muta. 2;Carc. 1B;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H317:0;H302:0;H341:0;H412:0;H311:0;H350:0;H315:0
34771,Methyl fluoroacetate,207-218-7,453-18-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H226:56;H335:55;H319:55;H315:55;H400:33;H300:34;H301:2;H311:2;H314:3;H330:2;H331:1;H318:1;H310:1
34773,"m-xylene-2,α,α'-triol",220-919-2,2937-59-9,Not Classified,Notified C&L,33,Not classified:33
34776,scyllo-Inositol,610-437-4,488-59-5,Not Classified,Notified C&L,12,Not classified:12
34777,Allyltrichlorosilane,203-485-9,107-37-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,43,H314:43;H225:42;H312:1;H302:1;H332:1;H318:1
34779,"3,6-nonadien-1-ol",278-518-3,76649-25-7,Not Classified,Notified C&L,92,Not classified:88;H319:4;H315:4
34782,"N,N-dimethyl-3-oxobutyramide",218-059-8,2044-64-6,Not Classified,REACH registration C&L,94,Not classified:71;H319:23;H315:21;H316:1
34786,Glycerol dipalmitate,247-886-7,26657-95-4,Aquatic Chronic 2,Notified C&L,20,H411:18;Not classified:2
34787,"2,3-dihydroimidazo[2,1-b]benzothiazol-6-amine",278-892-8,78291-99-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H302:2;H335:2;H319:2;H315:2
34788,Oxamide,207-442-5,471-46-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H302:42;H319:43;H315:43;H335:4
34795,"Oils, tallow, calcium salts",265-037-9,64741-37-3,Not Classified,Notified C&L,1,Not classified:1
34797,"bendiocarb (ISO);2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate;2,2-dimethyl-1,3-benzodioxol-4-yl methylcarbamate",245-216-8,22781-23-3,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H410:0;H400:0;H331:0;H311:0
34798,Icosyl docosanoate,255-728-3,42233-14-7,Not Classified,Notified C&L,40,Not classified:40
34800,"Fatty acids, C14-18 and C16-22-unsatd., reaction products with triethanolamine",285-545-4,85116-92-3,Not Classified,Notified C&L,27,Not classified:23;H319:4;H315:4
34803,"Sodium [4-[(hexahydro-2,4,6-trioxopyrimidin-5-yl)azo]phenyl]-6-methylbenzothiazole-7-sulphonate",252-493-9,35294-62-3,Not Classified,Notified C&L,5,Not classified:5
34806,"9-Octadecenoic acid (Z)-, isooctyl ester, reaction products with glycerol trioleate and sulfur",306-111-3,96152-40-8,Not Classified,REACH registration C&L,2,Not classified:1;H412:1
34808,cobalt,231-158-0,7440-48-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Aquatic Chronic 4;Repr. 1B,Harmonised C&L,0,H360:0;H317:0;H334:0;H341:0;H350:0;H413:0
34811,"1,5-diphenylcarbazone",208-698-0,538-62-5,Not Classified,Notified C&L,6,Not classified:3;H302:1;H335:2;H319:3;H315:3
34817,Cianidanol,205-825-1,154-23-4,,Notified C&L,43,Not classified:38;H335:4;H319:5;H315:5
34818,4-hydroxycinnamic acid,231-000-0,7400-08-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Skin Sens. 1;STOT SE 3,REACH registration C&L,16,H335:15;H317:2;H314:2;H302:2;H311:2;H301:2;H319:14;H315:14;Not classified:2;H410:1;H400:1
34827,"(15α)-3,17-Dioxoandrost-4-en-15-yl acetate",613-793-9,65429-29-0,Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H373:2;H401:2;H317:2;H411:2
34828,"Butylidenebis[2-tert-butyl-5-methyl-p-phenylene]-P,P,P',P'-tetratridecylbis(phosphine)",235-841-4,13003-12-8,Not Classified,REACH registration C&L,7,Not classified:7
34829,"Tridecylamine, branched and linear",289-185-9,86089-17-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,120,H335:1;H410:119;H400:36;H314:119;H302:120;H318:119
34830,"(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)",418-960-8,,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H317:0;H411:0
34831,"2-Propenoic acid, homopolymer, sodium salt",619-104-8,95077-68-2,Skin Mild Irrit. 3;Eye Irrit. 2,Notified C&L,1,H320:1;H316:1
34832,"2-Propen-1-aminium, N-methyl-N,N-di-2-propen-1-yl-, chloride",608-008-1,26848-70-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,28,H319:28;H317:28;H315:28
34833,"2,4,4-trimethyl-7-methoxy-isoquinolinedione-(1,3)",606-257-0,191988-38-2,Aquatic Chronic 3,Notified C&L,1,H412:1
34835,2-tert-butylcyclohexanone,217-043-8,1728-46-7,Not Classified,Notified C&L,121,Not classified:120;H335:1;H319:1;H227:1;H315:1
34836,Disodium [6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]-N-methylnaphthalene-2-sulphonamidato(2-)][6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-2-sulphonato(3-)]cobaltate(2-),278-189-6,75314-27-1,Aquatic Chronic 3,REACH registration C&L,28,H412:26;Not classified:2
34838,"Naphtha (petroleum), full-range reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",272-895-8,68919-37-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
34839,2-iodoethanol,210-861-6,624-76-0,Acute Tox. 2;Muta. 2,REACH registration C&L,49,H341:7;H300:49;H310:6
34843,Naproxen,244-838-7,22204-53-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,REACH registration C&L,126,H335:62;H319:65;H302:68;H361:60;H315:65;H301:58;H373:5;H360:3;H411:4;H332:6;H351:2;H312:2;Not classified:1;H371:1;H412:2;H362:1
34844,"5-amino-3-phenyl-1,2,4-oxadiazole",222-918-2,3663-37-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
34845,"(8α,9R)-6'-methoxycinchonan-9-ol monohydrochloride",205-001-1,130-89-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1408,H332:1289;H302:1407;H312:1289;H317:57;H334:56;H304:1;H335:1;H319:1;H315:1
34846,"2,2'-[(4-methylphenyl)imino]bisethanol",221-359-1,3077-12-1,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,373,H302:216;H318:164;H317:140;H412:142;H319:148;Not classified:53;H335:41;H315:67
34848,"(2,4-dichlorophenyl)[1,3-dimethyl-5-[[(4-methylphenyl)sulfonyl]oxy]-1H-pyrazol-4-yl]methanone",611-609-1,58011-68-0,Acute Tox. 4,Notified C&L,38,H332:38
34849,Methyldiphenylphosphine oxide,218-346-8,2129-89-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H335:43;H319:44;H312:38;H332:39;H302:44;H315:44
34853,Caesium sulphate,233-662-6,10294-54-9,Acute Tox. 4;Repr. 2;STOT RE 2,REACH registration C&L,184,H302:67;H361:67;H373:4;H412:83;Not classified:34
34854,"Copper trifluoromethanesulphonate, compound with benzene (2:1)",255-686-6,42152-46-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40;H225:39;H228:1
34856,2-(trifluoromethyl)-9H-thioxanthen-9-one,216-893-7,1693-28-3,Acute Tox. 4,Notified C&L,162,H302:158;Not classified:4
34857,1-(vinyloxy)propane,212-123-9,764-47-6,Flam. Liq. 2;Skin Irrit. 2,REACH registration C&L,45,H315:45;H225:45;H335:40;H319:41
34864,"1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzimidazole",604-866-6,152628-02-9,Aquatic Chronic 2,REACH registration C&L,6,H411:2;Not classified:2;H335:1;H319:1;H315:1;H302:1
34866,"4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine",410-470-2,137796-06-6,Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H314:0;H317:0
34867,"Guaiacum officinale, ext., reaction products with acetic acid and sulfuric acid",309-448-4,100298-95-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,207,H319:198;H315:207
34868,Chromium disilicide,234-633-0,12018-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,215,H335:172;H319:172;H315:172;H332:38;H302:38;H317:43;H312:38;H334:5;Not classified:1
34871,"9-Octadecenedioic acid, 1,18-dimethyl ester",603-876-8,13481-97-5,Not Classified,REACH registration C&L,3,Not classified:3
34874,5-Bromo-2-ethoxypyridine,611-323-7,55849-30-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,44,H335:42;H317:38;H302:43;H318:42;H315:43;H319:1;H332:1;H312:1
34875,Dicobalt trioxide,215-156-7,1308-04-9,Acute Tox. 4;Skin Sens. 1;Carc. 2,Notified C&L,110,H302:75;H351:75;H317:77;Not classified:33;H400:2;H410:2
34876,Methyl (Z)-octadec-11-enoate,217-714-5,1937-63-9,Not Classified,Notified C&L,2,Not classified:1;H335:1;H319:1;H315:1
34881,HEC-5725 Cumeranonacetat,449-680-4,,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H410:1
34882,"1,3-Propanediamine, N-[3-(tridecyloxy)propyl]-, branched and linear, diacetate",270-849-1,68479-01-6,Acute Tox. 4;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H314:1;H302:1;H372:1
34883,"Glycerides, palm-oil mono- and di-, hydrogenated",267-057-3,67784-87-6,Not Classified,REACH registration C&L,131,Not classified:131
34885,1L-chiro-inositol,209-000-7,551-72-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34891,"12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine",432-840-2,220926-97-6,Acute Tox. 4;Aquatic Chronic 4,Harmonised C&L,0,H332:0;H413:0
34892,"Artemisia arborescens, ext.",295-614-0,92113-09-2,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Acute Tox. 4;STOT SE 2;Aquatic Chronic 2,Notified C&L,2,H317:2;H226:2;H302:2;H332:2;H371:2;H304:2;H411:2
34893,Diethyl allylphosphonate,619-646-5,1067-87-4,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,46,H302:1;H319:46;H335:44;H315:45
34894,"4-Butyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(4-trans-pentylcyclohexyl)ester",600-338-4,102714-86-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
34897,"4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2,6-diiodophenol] S,S-dioxide",224-621-3,4430-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
34898,"Plantain, Plantago major, ext.",284-526-8,84929-43-1,Not Classified,Notified C&L,4,Not classified:4
34900,Glyoxal dioxime,209-168-1,557-30-2,,Notified C&L,4,H335:4;H319:4;H312:4;H228:4;H301:4;H315:4
34903,7-amino-heptanoic acid hydrochlorate,608-419-6,29840-65-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H319:2;H315:2;H302:2
34906,p-acetoxystyrene,434-600-2,2628-16-2,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 1;STOT SE 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,35,H373:34;H335:34;H319:35;H317:35;H302:35;H330:2;H412:2;H310:2;H315:35;H320:1
34907,"(3S)-3-Hydroxypyrrolidine, N-BOC protected",600-216-0,101469-92-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48,H301:40;H318:39;H335:47;H315:48;H319:9;H312:2;H332:2;H302:3;H331:1;H311:1
34909,"3,5-Dibromobenzaldehyde",611-441-9,56990-02-4,Skin Corr. 1B,Notified C&L,44,H314:38;H335:4;H319:5;H315:5;H332:1;H302:1;H312:1
34910,Tetraethylammonium tetrahydroborate,241-140-4,17083-85-1,Water-react. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H319:38;H315:38;H261:43;H314:5;H302:4;H318:1
34911,Menthyl isovalerate,240-460-1,16409-46-4,Not Classified,Notified C&L,179,Not classified:141;H335:38;H319:38;H315:38
34912,Ethyl methyl(phenyl)carbamate,220-065-0,2621-79-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:39;H319:39;H312:39;H332:39;H302:39;H315:39
34913,"1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione",229-222-8,6440-58-0,Acute Tox. 4,REACH registration C&L,617,H302:384;H319:216;H334:101;Not classified:80;H335:54;H315:82;H317:104;H351:3;H314:3;H331:3;H340:3;H311:3;H301:3;H412:5
34914,"Triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane",257-473-3,51851-37-7,STOT RE 2,REACH registration C&L,101,H373:2;H335:61;H319:66;H315:66;Not classified:33
34915,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, coupled with 3-aminophenol, diazotized 5-amino-2-[(4-aminophenyl)amino]benzenesulfonic acid and diazotized benzenamine, sodium salts",297-025-4,93281-13-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,29,H412:26;H319:26;Not classified:3
34919,ammonium chloride,235-186-4,12125-02-9,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H302:0;H319:0
34922,Cetylpyridinium chloride,204-593-9,123-03-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;STOT SE 3;Aquatic Acute 1,REACH registration C&L,173,H335:133;H400:135;H302:20;H330:136;H318:122;H315:137;H410:78;H301:115;Not classified:37;H319:15;H411:2
34923,"Cyclohexanol, 4-methyl-1-phenyl-",613-134-5,63007-45-4,Not Classified,Notified C&L,1,Not classified:1
34924,Mephentermine,202-901-6,100-92-5,STOT SE 3,Notified C&L,1,H336:1
34927,2-hydroxy-4'-hydroxyethoxy-2-methylpropiophenone,402-670-3,106797-53-9,Not Classified,REACH registration C&L,92,Not classified:88;H412:4
34932,Methyl hydrogen adipate,211-019-0,627-91-8,Not Classified,REACH registration C&L,5,Not classified:3;H319:2;H315:2;H335:1
34933,carbon tetrachloride;tetrachloromethane,200-262-8,56-23-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 1;Aquatic Chronic 3;Ozone 1,Harmonised C&L,0,H351:0;H331:0;H372:0;H311:0;H301:0;H412:0;H420:0
34937,Ethyl 3-methyl-4-oxo-2-butenoate,255-575-2,41891-38-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H315:1
34938,Potassium propyl 4-oxidobenzoate,284-597-5,84930-16-5,Not Classified,Notified C&L,3,Not classified:3
34941,7-methyl-1H-indole-3-ethylamine,238-498-9,14490-05-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
34942,Cadmium selenide sulfide,235-724-8,12626-36-7,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,18,H373:13;H300:13;H410:13;H400:13;H330:13;Not classified:5
34944,Cyclohexene,203-807-8,110-83-8,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,95,H302:95;H304:90;H411:53;H225:95;H311:39;H336:2;H312:2;H319:1;H310:2;Not classified:1
34945,"(R)-α,α,4-trimethylcyclohex-3-ene-1-methanol",232-081-5,7785-53-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,175,H319:175;H315:175;H335:38
34947,(E)-5-decenol,260-267-6,56578-18-8,Skin Irrit. 2,Notified C&L,90,H315:90;H400:7
34949,3-(Triethoxysilyl)propyl carbamoylamino ethylamino ethylamino propyl trimethoxysilane,922-970-2,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H317:1;H411:1
34952,N-methyl-N-nitrosotoluene-4-sulphonamide,201-252-6,80-11-5,Self-react. C;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H319:42;H317:38;H242:39;H315:42;H312:4;H332:4;H350:3;H302:1
34957,Ajmaline,224-439-4,4360-12-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H332:39;H302:40;H312:38;H335:1;H319:1;H315:1
34958,4-chloro-2-phenylquinazoline,229-346-2,6484-25-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
34964,"5-(phenylethynyl)-2-benzofuran-1,3-dione",601-604-2,119389-05-8,,Notified C&L,6,H335:5;H319:6;H315:6
34966,2-(2-butoxyethoxy)ethanol;diethylene glycol monobutyl ether,203-961-6,112-34-5,Eye Irrit. 2,Harmonised C&L,0,H319:0
34969,Lormetazepam,212-700-5,848-75-9,Eye Irrit. 2;Repr. 1B;Lact.,Notified C&L,3,H362:3;H360:2;H319:2;H336:1;H361:1
34970,Clopidol,221-008-2,2971-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:39;H319:39;H315:39;Not classified:4
34971,"Cyclohexane, oxidized, aq. ext.",272-810-4,68915-38-8,Met. Corr. 1;Eye Dam. 1,REACH registration C&L,90,H318:90;H290:90;H304:83;H225:83
34972,Diethyldithiocarbamic acid,205-701-7,147-84-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H315:38
34973,Calcium bis[6-chloro-4-[(2-hydroxy-1-naphthyl)azo]toluene-3-sulphonate],267-123-1,67801-02-9,Not Classified,Notified C&L,83,Not classified:83
34976,"Pyridine-3,5-dicarboxylic acid",207-893-8,499-81-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:48;H319:49;H315:49;H312:2;H332:2;H302:2;Not classified:2
34977,"Trisodium bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonato(3-)]ferrate(3-)",276-677-3,72479-30-2,Not Classified,REACH registration C&L,41,Not classified:41
34978,"Acetic acid, C11-14-isoalkyl esters, C13-rich",283-740-9,84712-50-5,Not Classified,REACH registration C&L,128,Not classified:128
34979,"Poly(oxy-1,2-ethanediyl), a-[2-[(1-oxotetradecyl)amino]ethyl]-w-hydroxy-",620-274-0,32993-46-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:4;H315:4
34980,"Disodium 2-(2,4-dinitrophenylazo)-1-hydroxynaphthalene-3,6-disulphonate",226-549-8,5423-07-4,Not Classified,Notified C&L,2,Not classified:1;H315:1
34981,"Monarda didyma, ext.",294-492-6,91722-89-3,Not Classified,Notified C&L,1,Not classified:1
34982,"3-methyl-1,5-pentanediyl diacrylate",264-727-7,64194-22-5,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,40,H335:4;H319:27;H317:26;H332:4;H412:26;H315:27;Not classified:13
34985,7-chloro-p-cymene,218-114-6,2051-18-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H314:44;H318:39;H290:1
34986,Ethyltriphenylfosfonium bromide,216-223-3,1530-32-1,Acute Tox. 3;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,452,H301:140;H373:7;H318:7;H411:145;H335:230;H319:348;H312:338;H332:193;H302:305;H412:235;H315:287;H410:16;Not classified:7;H300:1;H311:2;H331:1
34988,"N,N'-[1,3-Phenylenebis(methylene)bis[12-hydroxyoctadecanamide]",603-282-9,128554-52-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,22,H332:22;H413:22
34990,"Disodium 8-[[3,3'-dimethoxy-4'-[[4-[[(p-tolyl)sulphonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-7-hydroxynaphthalene-1,3-disulphonate",229-469-1,6548-30-7,Not Classified,Notified C&L,8,Not classified:8
34995,trifenmorph (ISO);4-tritylmorpholine,215-812-2,1420-06-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
35000,"2-[(5A,7A)-17-(CYCLOPROPYLMETHYL)-3,6-DIMETHOXY-18,19-DIHYDRO-4,5-EPOXY-6,14-ETHENOMORPHINAN-7-YL]-3,3-DIMETHYLBUTAN-2-OL",605-398-5,16524-65-5,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,1,H317:1;H413:1
35002,Dibutylbis(octanoyloxy)stannane,225-236-3,4731-77-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,25,H319:24;H331:24;H311:24;H301:24;H315:24;H412:7;H360:1;H410:1;H400:1;H341:1;H372:1
35003,"3-OXAZOLIDINEETHANOL, 2-(1-METHYLETHYL)-, CARBONATE (2:1) (ESTER)",604-497-0,145899-78-1,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,231,H412:206;H318:206;H317:149;Not classified:25
35008,[No public or meaningful name is available],456-300-0,,Skin Sens. 1,Notified C&L,441,H317:441
35009,4-(4-chloro-3-nitro-phenyl)-3-methyl-4-oxo-butanoic acid,918-019-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H302:2;H335:2;H319:2;H315:2
35013,"tris(η5-cyclopenta-2,4-dien-1-yl)erbium",254-416-4,39330-74-0,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H261:38;H228:42
35015,"3,5-dimethylbenzenethiol",253-901-8,38360-81-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H302:44;H335:43;H319:45;H315:45;H312:6;H331:4;H311:1;H330:1;H301:1;Not classified:1;H332:2
35017,"2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene",412-250-1,102387-48-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
35029,SENSANOV WR,922-551-4,,Eye Irrit. 2,Notified C&L,1,H319:1
35030,4-methoxybenzenesulphonyl chloride,202-692-1,98-68-0,Skin Corr. 1B,Notified C&L,47,H314:47;H318:1;H290:1
35035,[No public or meaningful name is available],682-414-7,129893-21-6,Flam. Liq. 1;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 2;Aquatic Chronic 2,Notified C&L,39,H224:12;H336:36;H340:21;H350:21;H304:39;H361:18;H411:36;H315:36;H226:12;H225:12
35040,"2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane 2,4-disulphide",242-855-4,19172-47-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,53,H332:12;H302:12;H312:7;H261:45;H335:4;H319:5;H361:4;H315:5
35045,Potassium xylenesulphonate,250-140-3,30346-73-7,Not Classified,Notified C&L,9,Not classified:9
35047,Glycerol trihexanoate,210-701-5,621-70-5,Not Classified,Notified C&L,10,Not classified:10
35048,Phenethylamine,200-574-4,64-04-0,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,1525,H301:164;H290:8;H314:1500;H302:1361;H332:1343;H312:1349;H318:121;Not classified:3;H335:1
35055,Tricosafluorododecanoic acid,206-203-2,307-55-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H319:39;H315:39;H314:5;H410:1;H400:1;H290:1;H318:1;H312:1;H332:1;H302:1
35061,"3,7-diamino-2,8-dimethyl-5-phenylphenazinium chloride",207-518-8,477-73-6,Eye Dam. 1,Notified C&L,67,H318:52;H319:11;H315:10;H335:5;H314:2;H302:2;H341:2;H412:2;Not classified:2
35062,N-(2-hydroxyethyl)ethylenediaminetriacetic acid,205-759-3,150-39-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,175,H302:4;H318:3;H315:175;H335:171;H319:172;H312:1;H332:1
35063,"[(2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl]methyl benzoate",618-021-4,874638-80-9,Not Classified,REACH registration C&L,2,Not classified:1;H335:1;H319:1;H315:1
35068,"D-Glucitol, ethoxylated, hexaesters with fatty acids, C8-18 and C18-unsatd.",500-369-2,157707-61-4,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H320:8;H303:8;H315:8
35069,Didecyldimethylammonium bromide,219-234-1,2390-68-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:38;H319:44;H315:44;H301:1;H400:1;H314:1
35070,"α-D-Glucopyranose, hydrate (1:1)",604-408-5,14431-43-7,,Notified C&L,102,Not classified:102
35071,Decyl methyl sulphide,244-997-2,22438-39-7,Aquatic Chronic 4,Notified C&L,38,H413:38
35073,"1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate",406-990-4,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
35074,2-bromopalmitic acid,242-137-0,18263-25-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,41,H335:41;H319:41;H315:41
35075,Glycerol tridecanoate,210-702-0,621-71-6,Not Classified,Notified C&L,8,Not classified:8
35076,"(4E)-N-hydroxy-1,2-benzoxathiin-4(3H)-imine 2,2-dioxide",611-875-9,597563-86-5,Not Classified,REACH registration C&L,2,Not classified:2
35077,"1-Propanol, 3-chloro-, acetate",613-086-5,628-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
35079,Bis(tert-butyl)dodecylphenol,268-192-0,68025-37-6,Aquatic Chronic 3,Notified C&L,461,H412:461
35080,Sodium pentadecyl sulphate,236-475-8,13393-71-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,38,H412:38;H318:38;H315:38
35083,2-amino-4-nitrophenol,202-767-9,99-57-0,Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2192,H351:2052;H410:4;H317:19;H400:4;H335:2088;H319:2179;H312:2047;H332:2049;H302:2147;H315:2088;H412:1;H341:1;H411:1;Not classified:1
35084,"Fatty acids, C12-22 and C16-18-unsatd., Me esters, mixed with C12-24 and C12-24-unsatd. glycerides and C12-24-unsatd. hydrocarbons, sulfurized",292-819-7,91001-49-9,Not Classified,Notified C&L,1,Not classified:1
35092,Quinoline-3-carbonitrile,252-248-6,34846-64-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:39;H319:39;H312:39;H332:39;H302:39;H315:39
35100,D-octan-2-ol,228-213-6,6169-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:40;H319:44;H315:39;Not classified:1;H318:1;H227:1
35110,N-(2-hydroxyethyl)prop-2-enamide,700-169-7,,Eye Dam. 1;STOT RE 2,Notified C&L,1,H373:1;H318:1
35115,"dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-",418-010-2,136897-58-0,Aquatic Chronic 4,Harmonised C&L,0,H413:0
35117,Tetrahydrofuran-3-ol,207-219-2,453-20-3,,Notified C&L,42,Not classified:38;H319:4;H315:4;H335:3;H312:1;H332:1;H302:1
35118,Cesium dichloroiodate,239-686-3,15605-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H335:63;H319:63;H315:63
35122,Cardanol,609-405-2,37330-39-5,Not Classified,Notified C&L,22,Not classified:22
35128,"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris[4-[(4-isocyanatocyclohexyl)methyl]cyclohexyl]-",614-963-5,69409-26-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,25,H334:25;H317:25
35135,"Hydrogen [29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cobaltate(1-)",250-265-3,30638-08-5,Eye Dam. 1,Notified C&L,2,H318:2
35136,"dinoterb (ISO);2-tert-butyl-4,6-dinitrophenol",215-813-8,1420-07-1,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H360:0;H300:0;H410:0;H400:0;H311:0
35142,abamectin (combination of avermectin B1a and avermectin B1b) (ISO),615-339-5,71751-41-2,Acute Tox. 2;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H300:0;H410:0;H400:0;H330:0;H372:0;H361:0
35143,2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl hydrogen maleate,266-156-9,66104-67-4,Eye Irrit. 2,Notified C&L,10,H319:10;H315:1
35146,"5-(4-Propylcyclohexen-1-yl)-1,3-difluorbenzol",604-627-6,148151-00-2,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H225:1;Not classified:1;H400:1;H318:1;H315:1
35147,4'-hydroxyoctanophenone,219-979-2,2589-73-3,,Notified C&L,4,H335:4;H319:4;H315:4
35152,"Disodium 7-[[2-(acetylamino)-4-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]phenyl]azo]naphthalene-1,3-disulphonate",268-974-1,68155-62-4,Skin Sens. 1B,REACH registration C&L,41,H317:41
35153,"Fatty acids, palm-oil, hydrogenated, reaction products with tetraethylenepentamine, acetates",617-618-7,847401-97-2,Not Classified,Notified C&L,1,Not classified:1
35154,(2-acetoxyethyl)trimethylammonium perchlorate,213-166-6,927-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H315:39;H272:1
35155,3-benzyl-1-methylthiourea,220-369-3,2740-94-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35157,methyl 4-(acetylamino)-5-(ethylsulfonyl)-2-methoxybenzoate,923-799-6,,Not Classified,Notified C&L,1,Not classified:1
35158,"5-AMINO-N,N’-BIS(2,3-DIHYDROXYPROPYL)-2,4,6-TRIIODO-1,3-BENZENEDICARBOXIMIDE",616-386-4,76801-93-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H302:1;H335:1;H319:1;H315:1;Not classified:1
35160,"Calcines, lead-zinc ore conc.",305-411-1,94551-62-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Carc. 1B;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H373:1;H360:1;H410:1;H400:1;H332:1;H302:1;H350:1;H318:1;H315:1
35162,"Alcohols, C9-11, branched and linear, ethoxylated",500-446-0,160901-09-7,Eye Dam. 1,REACH registration C&L,219,H318:217;H302:26;Not classified:1;H319:1;H315:1
35164,"Benzenesulfonic acid, dodecyl-, branched, compd. with 2-propanamine",290-709-3,90218-35-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,481,H318:217;H411:217;H315:474;H335:257;H319:257;H302:258;H412:206;Not classified:6;H312:1
35165,N-(carboxymethyl)anthranilic acid,210-311-5,612-42-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
35167,"3-(N,N-diisopropylamino)propane-1,2-diol",288-442-2,85721-30-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
35172,"(3,4-dichlorophenyl)thiourea",242-919-1,19250-09-0,,Notified C&L,5,H301:4;H332:1;H302:1;H312:1
35173,"Pentahydrogen bis[4-[[2,4-dihydroxy-5-[(2-methoxyphenyl)azo]-3-[[4-(phenylamino)-3-sulphophenyl]azo]phenyl]azo]-3-hydroxy-7-nitronaphthalene-1-sulphonato(4-)]ferrate(5-)",276-829-9,72779-11-4,Not Classified,Notified C&L,8,Not classified:8
35174,Methyl vanillate,223-525-9,3943-74-6,Not Classified,Notified C&L,280,Not classified:234;H335:44;H319:46;H315:45
35175,2-thienyllithium,220-504-6,2786-07-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,64,H312:38;H314:64;H302:38;H332:38;H318:38;H250:26
35177,"(1R,2R)-cyclohexane-1,2-diamine (2R,3R)-2,3-dihydroxybutanedioic acid",609-759-8,39961-95-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H302:42;H335:41;H319:42;H315:42;H312:40;H332:40
35179,Bicyclo[2.2.1]hept-5-ene-2-methanol,202-392-0,95-12-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H332:39;H302:40;H312:39;H319:1;H315:1
35182,"Octahydro-4,7-methano-1H-indenedimethylamine",272-573-7,68889-71-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C,Notified C&L,89,H314:89;H302:85;H311:35;H317:56;H312:54;H318:20;H332:4
35185,2-dimethylaminoethyl acetate,215-827-4,1421-89-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
35187,"3,3'-iminodi(propylamine);dipropylenetriamine",200-261-2,56-18-8,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 2,Harmonised C&L,0,H317:0;H314:0;H302:0;H311:0;H330:0
35189,Acid Violet 48,602-080-8,12220-51-8,Eye Irrit. 2,Notified C&L,2044,H412:2039;H319:2043;Not classified:1
35190,3-(chloromethyl)heptane,204-594-4,123-04-6,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,157,H410:118;H400:118;H317:118;H226:157;H315:157;H413:38;H319:1
35192,(2H3)methanol,217-435-9,1849-29-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Notified C&L,43,H370:40;H331:40;H311:40;H301:43;H225:40;H224:3;H330:3;Not classified:1
35193,6-methoxy-2-methylquinoline,214-080-1,1078-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H319:44;H315:44
35196,"1,4-bis(methylamino)anthraquinone",219-602-1,2475-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,120,H335:107;H319:108;H315:108;H412:9;Not classified:4
35197,Titanium(4+) cresolate,249-057-5,28503-70-0,,Notified C&L,7,H335:4;H319:4;H315:4;Not classified:3
35200,"cis-3a,4,9,9a-tetrahydro-2,2-dimethylnaphtho[2,3-d]-1,3-dioxol-5-ol",257-722-6,52187-19-6,Aquatic Chronic 3,REACH registration C&L,4,H412:4
35201,2-deoxy-D-ribose,208-573-0,533-67-5,Not Classified,Notified C&L,5,Not classified:4;H335:1
35202,Amitriptyline hydrochloride,208-964-6,549-18-8,Acute Tox. 3;Repr. 2;STOT SE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,118,H370:38;H410:81;H400:80;H301:79;H361:35;H319:48;H362:36;H302:38;H318:37;H335:6;H317:5;H334:5;H311:5;H330:4;H315:6;H350:2;H413:1;H336:1;Not classified:1;H360:1;H411:1;H331:1
35204,"Pine, Pinus maritima, ext.",284-525-2,84929-42-0,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95,H410:94;H400:93;H317:94;H226:94;H304:94;Not classified:1;H315:1
35206,Chlorphoxim,238-888-9,14816-20-7,Acute Tox. 3,Notified C&L,38,H311:38
35207,"Formaldehyde, reaction products with sulfonated naphthalene and sulfonated 2-naphthalenol, ammonium sodium salts",308-061-8,97862-18-5,Not Classified,Notified C&L,67,Not classified:67
35209,"3,5-diamino-4-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-2-[[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]benzoic acid sodium salt",480-890-9,906532-68-1,Eye Irrit. 2,REACH registration C&L,17,H319:17
35210,Ethyl 3-mercaptopropionate,226-771-5,5466-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1439,H335:1428;H319:1429;H315:1429;Not classified:10;H227:1
35211,Allyl ethyl ether,209-169-7,557-31-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:38;H319:39;H315:39;H225:44;H332:4;H302:4;H331:1;H311:1;H301:1
35213,"4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride",256-071-5,43064-12-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,131,H301:130;H351:129;H311:130;H331:129;H310:1;H300:1;H330:1
35217,1-ethoxyethyl acetate,216-537-0,1608-72-6,Flam. Liq. 3,Notified C&L,113,H226:113
35220,4-methyl-5-nitro-1H-imidazole,237-809-5,14003-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39
35224,"3,7-dimethylnona-1,6-dien-3-ol",233-732-6,10339-55-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1719,H319:1526;H317:54;H315:1519;Not classified:189;H412:1
35226,"4-nitro-2,5-xylidine",222-405-3,3460-29-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
35229,Citalopram,261-891-1,59729-33-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 1,REACH registration C&L,4,H302:2;H317:2;H410:2;Not classified:1;H361:1;H335:1;H319:1
35230,"cis-1,2-dimethylcyclohexane",218-621-2,2207-01-4,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,60,H304:47;H225:55;H336:8;Not classified:5
35233,3-[4-(oxiranylmethoxy)phenyl]- acrylic acid methyl ester,919-210-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
35236,"Octadecen-1-ol, phosphate, potassium salt",294-277-7,91697-15-3,Not Classified,Notified C&L,8,Not classified:8
35237,Tetrahydrofurfurylamine,225-351-9,4795-29-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,48,H226:48;H319:47;H315:47;H335:44
35238,Thiophene-3-methanol,275-741-8,71637-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40
35243,ammonium bifluoride;ammonium hydrogen difluoride,215-676-4,1341-49-7,Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H301:0;H314:0
35244,Copper dichromium tetraoxide,234-634-6,12018-10-9,Not Classified,REACH registration C&L,129,Not classified:35;H400:83;H411:84;H331:10;H302:11;H350:11;H373:1;H335:1;H351:1;H317:1;H334:1;H340:1;H311:1;H330:1;H318:1;H361:1;H315:1
35247,"3,4-Difluorobenzeneboronic acid",605-510-2,168267-41-2,,Notified C&L,10,H335:8;H319:9;H315:9;H312:2;H332:2;H302:2;Not classified:1
35250,"1H-pyrrole, potassium salt",240-327-8,16199-06-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
35251,Tricobalt tetraoxide,215-157-2,1308-06-1,Resp. Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1434,H334:1067;H412:499;H350:594;H317:867;H411:323;H410:249;H400:247;H373:32;H351:280;Not classified:113;H370:25;H371:25;H302:1;H318:1;H335:1;H319:1;H315:1;H413:1
35253,Sodium 2-(4-aminophenyl)-6-methylbenzothiazolesulphonate,301-293-0,93983-05-2,Not Classified,Notified C&L,1,Not classified:1
35258,C.I. Basic Red 18:1,602-888-0,12271-12-4,Not Classified,Notified C&L,1,Not classified:1
35259,Titanium oxide,235-236-5,12137-20-1,Not Classified,Notified C&L,37,Not classified:36;H413:1
35260,"2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane",219-154-7,2374-14-3,Repr. 2;STOT RE 1;STOT RE 2,REACH registration C&L,76,H372:65;H373:65;H361:65;H301:8;H319:10;H315:10;H335:2;Not classified:1;H312:2;H410:2;H400:2;H332:2;H302:2
35261,Nonylcyclohexane,220-739-4,2883-02-5,Asp. Tox. 1,Notified C&L,1,H304:1
35263,p-methylpropiophenone,226-267-5,5337-93-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2A;Aquatic Acute 2,REACH registration C&L,4,H319:4;H317:4;H302:4;H401:3;H315:4
35266,Tetrabromopyrocatechol,207-678-9,488-47-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42;H315:42
35267,2-Fluor-4-pentylphenol,616-604-8,78322-87-9,Acute Tox. 2,Notified C&L,1,Not classified:1;H300:1
35269,"4-[3-(3-carboxy-5-hydroxy-1-(tetrahydro-3-thienyl)-1H-pyrazol-4-yl)allylidene]-4,5-dihydro-5-oxo-1-(tetrahydro-3-thienyl)-1H-pyrazole-3-carboxylic acid S,S,S',S'-tetraoxide",262-220-5,60404-77-5,Not Classified,Notified C&L,1,Not classified:1
35273,4-Butylbenzoic acid-(4-cyano-3-fluorphenylester),617-918-8,86776-52-5,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H319:1;H312:1;H332:1;H302:1;H315:1
35279,Asafetida,232-522-1,9000-04-8,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1454,H226:1428;H304:1287;H317:1325;H411:1286;H302:158;H315:158;H319:26;H400:11;H410:11
35280,N-bromosuccinimide,204-877-2,128-08-5,Ox. Sol. 3;Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,157,H319:94;H400:52;H272:43;H290:43;H315:60;H317:10;H314:64;H302:102;H335:50;H312:10;H332:6;Not classified:2;H341:3;H318:3;H410:1
35286,"Gases (petroleum), C6-8 catalytic reformer recycle;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-761-3,68477-80-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H220:0;H350:0
35287,"Tetrafluoroethylene, oxidized, oligomers, reduced, methyl esters, reduced",500-272-5,88645-29-8,Not Classified,Notified C&L,2,Not classified:2
35289,3-(Ethoxydimethylsilyl)propylamine,605-989-8,18306-79-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H226:39;H335:40;H319:39;H315:40;H318:1
35290,Pentaerythritol tetraacetate,209-907-8,597-71-7,Not Classified,Notified C&L,1,Not classified:1
35291,Oxyfenamate,200-017-5,50-19-1,,Notified C&L,1,H400:1
35294,"1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoroethane-1,1-diol hydrochloride",606-764-7,214353-17-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,11,H314:11;H302:11;H411:11
35306,Dec-1-ene,212-819-2,872-05-9,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,805,H226:778;H304:773;H410:684;H400:684;H335:50;H336:34;H411:27;H315:54;H319:18;Not classified:13;H332:5;H318:5;H412:1;H413:1
35310,Lithium neodecanoate,248-372-5,27253-30-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,277,H318:17;H315:234;H302:5;H412:216;Not classified:23;H413:20
35311,(,227-633-7,5912-86-7,Skin Sens. 1A,Harmonised C&L,0,H317:0
35312,5-(hydroxymethyl)-2-furaldehyde,200-654-9,67-47-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,302,H412:218;H335:202;H319:205;H315:204;Not classified:6;H300:1;H317:1
35313,"1,2,3,5-tetrachloro-4,6-bis(chloromethyl)benzene",214-479-0,1133-57-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H302:38;H410:38;H319:38;H400:38;H314:1;H318:1;H290:1
35316,"3-cyano-3,5,5-trimethylcyclohexanone",411-490-4,7027-11-4,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0;H317:0;H373:0
35318,"Caseins, sodium complexes",618-419-8,9005-46-3,,Notified C&L,40,Not classified:40
35322,"β,4-dimethylcyclohex-3-ene-1-propionic acid",265-036-3,64740-38-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35326,"2,3-dihydro-1,4-benzodioxin-6-methylamine",241-440-5,17413-10-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
35327,Hydroxyoctyloxostannane,236-408-2,13356-20-2,,Notified C&L,15,H413:15
35329,Thiophene-2-methanol,211-264-3,636-72-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,89,H332:88;H302:88;H312:88;H335:1;H319:1;H315:1
35331,α-bromo-4-nitrotoluene,202-820-6,100-11-8,Skin Corr. 1B,Notified C&L,53,H314:53;H335:2;H302:2;H317:1;H318:2;H312:1;H290:1;H332:1
35337,4'-hydroxybutyranilide,202-988-0,101-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
35338,"Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-soya acyl derivs., chlorides",290-621-5,90194-13-1,Skin Corr. 1C;Eye Dam. 1,Notified C&L,441,H314:441;H318:441
35346,"1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate",424-070-0,94346-09-5,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
35349,"Potassium 2,4,5-trichlorobenzenesulphonate",263-649-0,62625-17-6,,Notified C&L,5,H335:4;H319:5;H315:5
35352,ammonium fluoride,235-185-9,12125-01-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H301:0;H311:0;H331:0
35353,3-(4-pyridyl)acrylic acid,226-265-4,5337-79-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H335:1;H319:2;H312:1;H332:1;H302:1;H315:2
35355,Trifluridine,200-722-8,70-00-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,43,H332:42;H302:42;H351:43;H312:42;H341:1;H361:1
35360,Coenzyme Q-10,206-147-9,303-98-0,Not Classified,Notified C&L,84,Not classified:84
35363,Sodium 2-hydroxy-3-[(2-hydroxyethyl)[2-[(1-oxo-9-octadecenyl)amino]ethyl]amino]propanesulphonate,268-732-5,68134-15-6,Aquatic Chronic 3,REACH registration C&L,12,H412:12
35364,Tetrafluoroterephthalonitrile,217-397-3,1835-49-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H301:42;H335:40;H319:42;H315:42;H331:1;H311:1
35366,3-methyl-6-(1-methylethylidene)cyclohex-2-en-1-one,207-729-5,491-09-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,2,H412:1;H335:1;H319:1;H315:1;Not classified:1
35368,Ethyl 2-oxopiperidine-3-carboxylate,223-086-3,3731-16-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35373,1-(2-chloroethoxy)propane,255-685-0,42149-74-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,158,H226:157;H301:156;H331:156;H335:1;H319:2;H312:2;H332:2;H302:2;H315:2
35376,Uridine,200-407-5,58-96-8,Not Classified,REACH registration C&L,13,Not classified:12;H335:1;H319:1;H315:1
35377,2-methylpent-2-enal,210-789-5,623-36-9,Flam. Liq. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,1551,H317:1460;H226:1551;H331:1465;H412:1460;H318:1465;H319:83;H315:84;H335:4
35383,"2-(1-ethylpentyl)-1,3-dioxolane",224-436-8,4359-47-1,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1529,H412:14;H317:14;Not classified:1515
35387,Chromium,231-157-5,7440-47-3,Not Classified,REACH registration C&L,2276,Not classified:1007;H334:487;H317:498;H319:446;H400:233;H410:178;H413:84;H351:9;H228:8;H371:6;H272:2;H315:4;H341:2;H335:2;H350:1;H373:1
35393,"Benzene-1,2,4-triol",208-575-1,533-73-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,51,H302:47;H318:45;H335:44;H315:51;H319:6;H317:5
35394,"2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylphenol",616-488-9,77712-29-9,Aquatic Chronic 2,REACH registration C&L,2,H411:2
35396,"Pyridazino[1,2-b]phthalazine-1-carboxylic acid, 1,2,3,4,6,11-hexahydro-6,11-dioxo-, (S)-",604-761-5,150971-61-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35398,Pentahydrogen bis[6-acetamido-4-hydroxy-3-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]naphthalene-2-sulphonato(4-)]chromate(5-),269-234-0,68201-74-1,Not Classified,Notified C&L,1,Not classified:1
35407,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono(C16 (even numbered, C18 unsaturated) alkyl) ethers, phosphates",618-724-6,91254-26-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,30,H314:29;H318:29;H315:1
35409,"Hexamethylene diisocyanate, trimers, reaction products with 2-hydroxyethyl acrylate",500-734-6,162492-01-5,Skin Sens. 1A;Aquatic Chronic 4,REACH registration C&L,85,H317:84;H413:1;H412:83;H319:1;H315:1
35411,401N,618-493-1,9016-00-6,Not Classified,Notified C&L,427,Not classified:243;H413:126;H319:54;H226:4
35413,Tridodecyl phosphite,221-356-5,3076-63-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H335:56;H319:62;H315:69;H400:6;H410:6;H318:7;Not classified:2
35414,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers, reaction products with 3,5-dimethyl-1H-pyrazole",606-423-2,200295-52-9,STOT RE 1,REACH registration C&L,6,H372:6
35417,"Fatty acids, soya, Me esters",272-898-4,68919-53-9,Not Classified,Notified C&L,130,Not classified:79;H319:51;H315:51
35418,Furfuryl octanoate,254-381-5,39252-03-4,Not Classified,Notified C&L,88,Not classified:88
35419,"Benzene, 1,1'-oxybis[methyl-, sulfonated, ammonium salts",278-188-0,75314-26-0,Aquatic Chronic 3,REACH registration C&L,39,H412:1;Not classified:38
35420,Lithium dodecyl sulphate,218-058-2,2044-56-6,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,245,H335:157;H332:85;H302:197;H228:144;H412:187;H318:225;H315:245;H319:20
35421,Disodium 1-isodecyl 2-sulphonatosuccinate,265-669-5,65277-50-1,,Notified C&L,1,H318:1
35424,3-Bromo-2-methyl-1-propene,604-496-5,1458-98-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,43,H314:43;H332:43;H302:43;H411:39;H225:43;H318:3;H312:1;H341:1
35427,Ethyl 4-ethoxybenzoate,245-818-0,23676-09-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,66,H302:66;H335:58;H319:61;H315:61
35430,N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide,618-536-4,90357-51-0,Skin Sens. 1B;Muta. 2;Carc. 2;Repr. 1B,REACH registration C&L,5,H351:3;H341:3;H360:3;H317:2;H319:2;H312:1;H332:1;H302:2;H315:2
35434,"2,7-Naphthalenedisulfonic acid, 4-hydroxy-5-[[4-[[4-[(2-hydroxyethyl)amino]-6-[[5-hydroxy-6-[(2-methoxy-5-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-methoxy-2-methylphenyl]azo]-, tetrasodium salt",277-449-6,73398-51-3,Not Classified,Notified C&L,13,Not classified:13
35436,Barium dilactate,259-425-7,54983-89-0,Not Classified,Notified C&L,1,Not classified:1
35442,"5-ethyldihydro-2-thioxo-5-(p-tolyl)pyrimidine-4,6(1H,5H)-dione",281-782-2,84030-12-6,Eye Irrit. 2,Notified C&L,38,H319:38
35444,Cyclooctanol,211-800-6,696-71-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,13,H302:13;H319:11;H315:12;H335:2;H312:1;H332:1;H318:1;H227:1
35448,Sodium methyl 2-sulphooctadecanoate,223-770-1,4062-78-6,,Notified C&L,8,H304:6;H319:6;Not classified:1;H302:1;H318:1;H412:1
35449,"Narcissus poeticus, ext.",290-087-3,90064-26-9,Aquatic Chronic 3,Notified C&L,1424,H412:1288;Not classified:136;H317:1;H315:1
35451,Butyl cinnamate,208-699-6,538-65-8,Not Classified,Notified C&L,325,Not classified:232;H319:93;H315:93
35452,"Potassium 1,2-bis(2-ethylhexyloxycarbonyl)ethanesulphonate",231-308-5,7491-09-0,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,850,H318:844;H315:850;H319:6
35456,4'-chloroacetoacetanilide,202-989-6,101-92-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
35458,"3H-2,1-benzoxathiole 1,1-dioxide",224-620-8,4430-23-3,Acute Tox. 4,Notified C&L,38,H302:38
35460,"Ptychopetalum olacoides, ext.",284-529-4,84929-46-4,Flam. Liq. 3,Notified C&L,1,H226:1
35462,Tri-o-tolyl phosphite,220-068-7,2622-08-4,,Notified C&L,5,H319:5;H315:5
35464,Potassium hexafluorophosphate,241-143-0,17084-13-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,154,H312:11;H314:119;H302:15;H332:11;H318:64;H319:29;Not classified:5;H335:1;H315:1;H290:1
35467,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl propionate",241-514-7,17511-60-3,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1769,H319:1318;H411:1769;Not classified:1;H400:1
35469,Ethyl (Z)hex-3-enoate,264-724-0,64187-83-3,Not Classified,Notified C&L,89,Not classified:88;H226:1
35470,4-Cyano-3-fluorophenyl 4-Ethylbenzoate,617-916-7,86776-50-3,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H319:1;H312:1;H332:1;H302:1;H315:1
35471,"1-Octanesulfonamide, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-N-(2-hydroxyethyl)-N-methyl-",610-711-3,51619-73-9,Acute Tox. 4,Notified C&L,47,H302:47
35472,Samarium(3+) perchlorate,236-986-6,13569-60-3,,Notified C&L,4,H335:4;H272:4;H319:4;H315:4
35474,3'-methylpropiophenone,257-405-2,51772-30-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
35475,1-dimethoxymethyl-2-nitro-benzene,423-830-9,20627-73-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
35477,Tetraéthylène pentamine acrylonitrile,614-459-5,68412-45-3,Eye Irrit. 2,Notified C&L,2,H319:2
35478,Ethyl undecanoate,211-018-5,627-90-7,Not Classified,Notified C&L,135,Not classified:135
35479,"3,5-bis-tert-butyl-4-hydroxybenzoic acid",215-823-2,1421-49-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:44;H335:44;H319:45;H315:45
35480,"Tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione",261-490-1,58909-39-0,Eye Irrit. 2,REACH registration C&L,45,H319:44;Not classified:1;H335:1;H315:1
35488,"Nona-3,6-dienyl acetate",278-519-9,76649-26-8,Not Classified,Notified C&L,89,Not classified:89
35492,E-ethyl-4-oxo-4-phenylcrotonate,408-040-4,15121-89-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H410:0;H400:0;H317:0;H302:0;H318:0;H315:0
35494,"(S)-2,2-dimethyl-1,3-dioxolane-4-methanol",244-910-8,22323-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H335:4;H319:4;H315:4;Not classified:1;H227:1
35498,"1,5-dimethyl-3-[(2-methyl-1H-indol-3-yl)azo]-2-phenyl-1H-pyrazolium methyl sulphate",249-671-3,29508-48-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H335:1;H319:1;H315:1
35499,Zinc azelate,238-495-2,14488-60-9,Not Classified,Notified C&L,2,Not classified:2
35500,Norborn-5-en-2-yl acetate,228-144-1,6143-29-9,Aquatic Chronic 3,Notified C&L,1,H412:1
35503,Pentasodium bis[6-amino-4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]naphthalene-2-sulphonato(4-)]chromate(5-),276-825-7,72765-46-9,,Notified C&L,35,Not classified:35
35507,"Ethane-1,2-diylbis(oxyethane-1,2-diyl) distearate",246-593-1,25062-49-1,Not Classified,Notified C&L,40,Not classified:40
35509,Ethyl 4-bromobutyrate,221-005-6,2969-81-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,166,H335:164;H319:165;H315:166;H302:2;H226:1;H317:1
35512,"[29H,31H-phthalocyaninato-N29,N30,N31,N32]cobalt",222-012-7,3317-67-7,Not Classified,REACH registration C&L,68,Not classified:23;H351:41;H341:4;H317:4
35513,"Alkanes, C14-17",292-449-6,90622-47-2,Not Classified,Notified C&L,75,Not classified:75
35515,"Pyridine-2,4-dicarboxylic acid",207-892-2,499-80-9,Not Classified,REACH registration C&L,56,Not classified:6;H335:49;H319:50;H315:50
35517,[No public or meaningful name is available],804-496-7,9009-62-5,Skin Irrit. 2,Notified C&L,38,H315:38
35518,Diammonium hexachloropalladate,242-854-9,19168-23-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H410:84;H400:84;H317:84;H302:43;H318:88;H315:130;H301:83;H319:42;H335:4
35519,Altrenogest,212-703-1,850-52-2,Acute Tox. 3;Repr. 1B;STOT RE 2;Aquatic Chronic 1,Notified C&L,57,H301:53;H373:52;H360:53;H410:52;H361:4;H400:1;H351:1
35521,"4-(acetylamino)-3-bromo-2-(2-bromoethoxy)-5-chloro-, methyl ester",616-157-9,748788-39-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H302:2;H335:2;H319:2;H315:2
35523,Sodium bis[1-[[2-hydroxy-3-nitro-5-tert-pentylphenyl]azo]-2-naphtholato(2-)]chromate(1-),260-617-8,57206-83-4,Aquatic Chronic 2,Notified C&L,9,H411:7;H360:2;Not classified:2
35524,"2,5-diphenyl-1,3,4-oxadiazole",211-968-0,725-12-2,,Notified C&L,5,H302:5
35526,Lincomycin,205-824-6,154-21-2,Not Classified,Notified C&L,12,Not classified:11;H335:1;H319:1;H315:1
35532,"1,4-Bis(acryloyl)piperazine",613-215-5,6342-17-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:52;H319:52;H315:52
35535,"Cuprate(6-), [2-[[[[3-[[4-chloro-6-[[4-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,5-disulfophenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-5-sulfobenzoato(8-)]-, sodium",294-106-6,91672-94-5,Not Classified,Notified C&L,13,Not classified:13
35537,Oxydipropyl dibenzoate,248-258-5,27138-31-4,Aquatic Chronic 3,REACH registration C&L,969,H412:348;Not classified:375;H411:229;H319:56;H361:16;H302:1;H410:1;H315:1
35539,Allyl chloroformate,220-916-6,2937-50-0,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1,REACH registration C&L,43,H226:43;H301:41;H314:42;H330:42;H302:2;H318:1;H319:1;H315:1
35541,Quinine formate,205-002-7,130-90-5,,Notified C&L,1,H302:1;H317:1
35542,"Dihydrogen bis(nitrito-N)[sulphato(2-)-O,O']platinate(2-)",234-794-7,12033-81-7,,Notified C&L,6,H314:6;H312:1;H302:1;H290:1;H332:1;H318:1
35543,Allylmagnesium bromide,217-046-4,1730-25-2,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,67,H314:67;H250:41;H260:42;H225:26;H224:1;H302:2;H336:2;H318:1
35545,"Tar acids, cresylic;Distillate Phenols;[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200°C to 230°C (392°F to 446°F). It contains chiefly phenols and pyridine bases.]",295-540-9,92062-26-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
35546,"Dihydronicotinamide-adenine dinucleotide, disodium salt",210-123-3,606-68-8,Not Classified,REACH registration C&L,8,Not classified:8
35548,"(2S)-1,2-Azetidinedicarboxylic acid, 1-(1,1-dimethylethyl) ester",619-530-4,51077-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:38;H319:38;H315:38;H318:3
35553,"2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol",416-380-1,146925-83-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
35565,"7-methoxy-3,7-dimethyloctan-2-ol",255-574-7,41890-92-0,Not Classified,Notified C&L,1583,Not classified:1572;H319:10;H315:11
35572,"Glycerides, mixed coco, decanoyl and octanoyl",271-729-1,68606-18-8,Not Classified,REACH registration C&L,90,Not classified:90
35573,"2,4,6-tribromoaniline",205-700-1,147-82-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT RE 2,Notified C&L,55,H373:39;H331:40;H311:40;H301:40;H318:39;H315:44;Not classified:10;H335:4;H319:5;H312:5;H332:5;H302:5
35576,"1,4-bis(4-chlorophenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-3,6-dione",401-540-3,,Not Classified,REACH registration C&L,177,Not classified:177
35578,Methyldiphenylsilane,212-281-9,776-76-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
35584,"(4S,4aS,5aR,12aS)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide",617-177-0,808-26-4,Lact.,REACH registration C&L,4,H362:4
35585,α-bromo-p-xylene,203-240-6,104-81-4,Skin Corr. 1B,Notified C&L,45,H314:45;H330:4;H331:1;H311:1;H301:1;H318:1;H302:1;H312:1
35586,"Fatty acids, coco, reaction products with 2-[(2-aminoethyl)amino]ethanol",267-058-9,67784-90-1,,Notified C&L,2,H314:2;H312:1;H302:1;H410:1;H400:1
35588,Sodium borate silicate,610-575-5,50815-87-7,Not Classified,Notified C&L,10,Not classified:10
35590,"2',5-dichloro-4'-nitrosalicylanilide",215-811-7,1420-04-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H319:1;H410:1
35591,"2-Propenoic acid, sodium salt (1:1), polymer with 2-propenamide",607-529-1,25085-02-3,Not Classified,Notified C&L,193,Not classified:191;H319:1;H302:1
35592,2-chloro-6-nitrobenzothiazole,219-302-0,2407-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H319:41;H315:41;H312:2;H332:2;H302:3
35596,"Fatty acids, C12-20 and C12-20-unsatd., compds. with ethanolamine",277-287-6,73138-37-1,Not Classified,Notified C&L,3,Not classified:3
35597,METHYL INDOLE-6-CARBOXYLATE,610-576-0,50820-65-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H319:41;H315:41
35601,Phenethyl acrylate,222-562-8,3530-36-7,,Notified C&L,2,H335:2;H319:2;H315:2
35602,"Poly(oxy-1,2-ethanediyl), a-[2-[(1-oxohexadecyl)amino]ethyl]-w-hydroxy-",620-276-1,32993-45-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:4;H315:4
35603,m-tolylurea,200-571-8,63-99-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,43,H302:43;H319:38
35606,Potassium trihydrogen dioxalate,204-874-6,127-96-8,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,12,H302:12;H312:12
35607,"3,6-bis(diethylamino)-9-[2-(ethoxycarbonyl)phenyl]xanthylium chloride",219-233-6,2390-63-8,Acute Tox. 3;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,14,H410:3;H400:3;H332:12;H301:3;H318:10;H302:8;H412:7;Not classified:2;H319:1
35610,"Fatty acids, coco, esters with 1,3-butanediol",277-288-1,73138-39-3,Aquatic Chronic 3,REACH registration C&L,94,H412:4;Not classified:89;H400:1;H410:1
35614,"Sodium 9,10-dimethoxyanthracene-2-sulphonate",266-720-4,67580-39-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
35616,4-(4-trans-Pentylcyclohexyl)-benzoic acid-[4-cyano-3-fluorphenyl]ester,618-821-3,92118-84-8,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
35617,"Amines, C12-14-alkyl, isooctyl phosphates",269-119-5,68187-67-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,500,H312:16;H400:17;H314:30;H302:30;H318:31;H411:30;H315:470
35619,"N,N-bis(2-hydroxyethyl)glycine",205-755-1,150-25-4,Not Classified,REACH registration C&L,125,Not classified:123;H335:1;H319:2;H315:2
35621,"Elastins, cartilage, hydrolyzates",309-148-3,100085-10-7,Not Classified,Notified C&L,37,Not classified:37
35623,"Trihydrogen [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-)",250-266-9,30638-09-6,Not Classified,Notified C&L,1,Not classified:1
35626,Tripentylamine,210-705-7,621-77-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,41,H314:40;H302:40;H318:1;Not classified:1;H411:1
35627,Aluminium tris(hydroxybenzenesulphonate),215-083-0,1300-35-2,Eye Irrit. 2,Notified C&L,67,H319:38;H301:21;H302:8
35629,Ethylenebis(oxyethylenenitrilo)tetra(acetic acid),200-651-2,67-42-5,Not Classified,Notified C&L,10,Not classified:8;H315:2;H335:1;H319:1
35630,"Fatty acids, cocoa-butter",287-399-7,85507-77-3,Not Classified,Notified C&L,1,Not classified:1
35631,"Tetradecahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methanol",236-476-3,13393-93-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,326,H317:321;H411:240;H413:38;Not classified:37
35633,6-hydroxy-7-methoxy-2-benzopyrone,212-282-4,776-86-3,Not Classified,Notified C&L,2,Not classified:2
35634,Phenylethylene di(acetate),228-445-8,6270-03-7,Not Classified,Notified C&L,88,Not classified:88
35640,"2-methyl-m-phenylene diisocyanate;toluene-2,6-di-isocyanate;toluene-2,4-di-isocyanate",202-039-0,91-08-7,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;Resp. Sens. 1;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H335:0;H319:0;H351:0;H317:0;H334:0;H330:0;H412:0;H315:0
35641,"(R*,R*)-(+)-9,9',10,10'-tetrahydro-4,4',5,5'-tetrahydroxy-10,10'-dioxo[9,9'-bianthracene]-2,2'-dicarboxylic acid",211-371-5,641-12-3,Acute Tox. 4,Notified C&L,3,H302:3
35642,"Fatty acids, tallow, compds. with ethanolamine",268-891-0,68153-63-9,Not Classified,Notified C&L,9,Not classified:9
35644,"Bis(2-ethylhexyl) cyclohexane-1,4-dicarboxylate",283-829-2,84731-70-4,Not Classified,REACH registration C&L,13,Not classified:13
35648,o-[(trimethylsilyl)oxy]benzaldehyde,214-081-7,1078-31-5,,Notified C&L,4,H319:4;H315:4
35650,Hex-3-enoic acid,224-157-1,4219-24-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,115,H314:115;H318:86;H290:1
35660,Tetraphenylarsonium bromide,208-069-0,507-27-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H400:38;H410:38;H331:38
35663,"Vacuum distillate (shale oil), middle",917-782-2,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1
35666,Triphosphorus pentanitride,235-233-9,12136-91-3,Not Classified,Notified C&L,2,Not classified:2
35667,"2,2-dimethylglutaric acid",211-655-9,681-57-2,Not Classified,Notified C&L,16,Not classified:11;H335:4;H319:5;H315:5
35670,"2,2'-dithiodi(ethylammonium) dichloride",200-260-7,56-17-7,Acute Tox. 4,Notified C&L,52,H302:52;H335:5;H319:5;H315:5;H312:1;H332:1
35671,Indene,202-393-6,95-13-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,283,H319:25;H226:281;H304:210;H411:20;H315:24;H351:4;Not classified:2;H335:4;H312:1;H317:3;H371:3;H332:1;H311:1;H370:1
35673,Sodium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),260-616-2,57206-81-2,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,141,H319:95;H317:8;H412:87;Not classified:40;H411:6
35674,Succinamide,203-739-9,110-14-5,Skin Sens. 1,Notified C&L,43,H317:39;H335:4;H319:4;H315:4
35676,Nitric (2H)acid,237-024-8,13587-52-5,Ox. Liq. 3;Skin Corr. 1A,Notified C&L,38,H314:38;H272:38
35680,(17β)-hydroxyandrost-4-en-3-one acetate,213-876-6,1045-69-8,Acute Tox. 4;Carc. 1B;Repr. 2,Notified C&L,39,H302:39;H361:38;H350:38;H334:1
35685,Silicon orthophosphate,234-858-4,12037-47-7,Eye Dam. 1,REACH registration C&L,39,H318:38;Not classified:1
35686,"Hexanedioic acid, polymer with 1,3-butanediol, 2-ethylhexyl ester",613-159-1,63149-79-1,,Notified C&L,45,Not classified:45
35688,"Amides, tall-oil fatty, n-(hydroxylethyl), ethoxylated",610-501-1,501019-85-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H315:1
35693,(chloromethyl)cyclopropane,227-632-1,5911-08-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:44;H319:46;H315:45;H225:47;H302:6;H312:1;H332:1
35694,"6,7,8,8a-tetrahydro-2,5,5,8a-tetramethyl-5H-1-benzopyran",226-916-2,5552-30-7,Not Classified,Notified C&L,88,Not classified:88
35695,Potassium hydrogen butynedioate,213-169-2,928-04-1,Acute Tox. 3;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H335:40;H319:41;H301:42;H310:41;H315:41;H331:39;H311:1
35698,Dihexyl sulphide,228-556-1,6294-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H319:39;H315:39;H302:1
35699,4-nitro-o-phenylenediamine,202-766-3,99-56-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,84,H302:84;H317:75;H341:4;H335:5;H319:7;H334:3;Not classified:2;H315:2;H332:1;H312:1
35702,"Amines, soya alkyl",263-112-0,61790-18-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,316,H302:275;H410:176;H400:275;H314:99;Not classified:41
35704,"Neodecanoic acid, cobalt salt",248-373-0,27253-31-2,Acute Tox. 4;Skin Sens. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,467,H372:30;H302:423;H412:40;H317:460;H411:281;H315:246;H350:83;H319:84;H410:32;H400:32;H301:20;Not classified:6;H361:10;H335:1;H334:1;H332:1
35705,Trimethylsilylmethyl acetate,220-849-2,2917-65-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H225:1
35706,"Butanedioic acid, 2-sulfo-, 1(or 4)-C18-32-alkyl esters, disodium salts",606-924-6,220680-63-7,Not Classified,Notified C&L,3,Not classified:3
35709,"Fatty acids, tallow, iso-Bu esters",271-207-3,68526-50-1,Not Classified,Notified C&L,38,Not classified:38
35711,Dimethylmethylenammonium chloride,250-142-4,30354-18-8,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38;H228:38
35715,"Tributyl prop-1-ene-1,2,3-tricarboxylate",231-468-6,7568-58-3,,Notified C&L,33,Not classified:33
35718,"Laminaria hyperborea, ext.",289-981-6,90046-13-2,Not Classified,Notified C&L,1,Not classified:1
35721,"Willemite, white",305-410-6,94551-61-8,Not Classified,Notified C&L,1,Not classified:1
35722,"L-Glutamic acid, N-[(phenylmethoxy)carbonyl]-, 5-(phenylmethyl) ester",611-426-7,5680-86-4,Not Classified,Notified C&L,1,Not classified:1
35723,"2,5-dimethoxybenzoic acid",220-503-0,2785-98-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
35724,"9-[2-carboxy-5(or 6)-isothiocyanatophenyl]-3,6-bis(diethylamino)xanthylium chloride",253-248-9,36877-69-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H335:38;H319:38;H312:38;H332:38;H302:38;H334:38;H315:38
35729,"Fatty acids, tall-oil, oligomeric reaction products with diethylenetriamine and fumaric acid",500-443-4,160901-07-5,Not Classified,Notified C&L,59,Not classified:59
35730,Ethoxymethylenemalononitrile,204-597-0,123-06-8,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,53,H302:42;H317:53;H334:53;H301:11;H311:9;H330:2;H331:1;H315:1
35732,"2,2'-[[4-[(2,6-dibromo-4-nitrophenyl)azo]phenyl]imino]bisethyl diacetate",259-725-8,55619-18-6,Not Classified,Notified C&L,3,Not classified:3
35734,(E)-m-(trifluoromethyl)cinnamic acid,267-126-8,67801-07-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35738,Ethyl (R)-2-oxiranylacetate,601-155-2,112083-64-4,Acute Tox. 4,Notified C&L,38,H302:38
35740,Benzenesulphonohydrazide,201-255-2,80-17-1,Self-react. D;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,47,H301:3;H242:41;H412:2;H302:5;H228:5;Not classified:1
35742,Chrysen-6-ylamine,220-149-7,2642-98-0,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H319:1;H351:1;H341:1;H315:1
35743,4-nitrobenzenethiol,217-436-4,1849-36-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:41;H319:42;H315:42;H312:1;H332:1;H302:1;H314:1
35745,"Citrus bergamia communis, ext.",297-821-1,93763-04-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,61,H410:61;H317:61;H226:61;H304:61;H315:61;H319:25;H400:25
35747,N-Hydroxysuccinimido biotin,609-055-0,35013-72-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35748,4-Ethoxy-4'-fluor-diphenylacetylene,603-239-4,127727-79-1,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
35751,Hafnium tetrachloride,236-826-5,13499-05-3,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,123,H314:123;H290:2;H317:22;H302:2
35752,"2',4',5'-trihydroxybutyrophenone",215-824-8,1421-63-2,Skin Sens. 1,Notified C&L,128,H317:128
35756,Laccase,617-092-9,80498-15-3,Resp. Sens. 1,Notified C&L,39,H334:39
35757,4-Cyano-3-fluorophenyl 4-Propylbenzoate,617-917-2,86776-51-4,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H319:1;H312:1;H332:1;H302:1;H315:1
35758,"Benzenamine, N,N-diethyl-3-methyl-4-[(5-nitro-2-thiazolyl)azo]-",615-144-5,70693-64-0,Skin Sens. 1A,Notified C&L,38,H317:36;H335:2;H319:2;H315:2;Not classified:1;H413:1;H228:3
35766,tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-),404-860-1,116810-46-9,Flam. Sol. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H318:0;H410:0;H228:0
35769,2-[2-[4-[2-(3-cyanophenyl)vinyl]phenyl]vinyl]benzonitrile,279-038-7,79026-03-2,Not Classified,Notified C&L,2,Not classified:2
35770,Dibrompropamidine isetionate,210-399-5,614-87-9,Not Classified,Notified C&L,1,Not classified:1
35771,Quinine hydrobromide,208-967-2,549-49-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H335:38;H319:38;H312:38;H317:39;H302:39;H332:38;H334:38;H315:38
35772,"Cyclosiloxanes, Me hydrogen",614-220-5,68037-53-6,Not Classified,Notified C&L,75,Not classified:33;H226:42;H413:22
35775,Lithium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),280-659-0,83733-06-6,Not Classified,Notified C&L,1,Not classified:1
35778,2-nitrobenzoic acid,209-004-9,552-16-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,68,H335:67;H319:68;H315:68;H341:4
35779,α-methylenebenzyl acetate,218-620-7,2206-94-2,Aquatic Chronic 3,REACH registration C&L,3,H412:3
35780,Cyclopropyltriphenylphosphonium bromide,237-970-1,14114-05-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H319:43;H315:43
35785,Potassium manganate,233-665-2,10294-64-1,Ox. Sol. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H272:42;H319:38;H315:38
35786,Ethylene Glycol Bis(2-aminophenyl) Ether,610-833-7,52411-34-4,Aquatic Chronic 2,Notified C&L,2,H411:1;H319:1;H315:1
35790,"4,6-dimethyl-2-benzopyrone",237-806-9,14002-89-2,Eye Irrit. 2,Notified C&L,38,H319:38
35795,"2,2',2''-nitrilotrisethyl triacetate",221-089-4,3002-18-4,Not Classified,Notified C&L,1,Not classified:1
35796,"2,6-dichloropyrimidin-4-amine",233-369-3,10132-07-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H302:40;H335:45;H319:46;H315:46
35799,"188627-10-3 Dimethyl siloxane, (ethanediamino-2-methylpropyl)methoxymethylsilyl)oxy- and C13-15-alkoxy-term.",606-148-8,188627-10-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,122,H412:58;H319:86;H315:86;Not classified:36
35800,"Fatty acids, C16-18, esters with pentaerythritol",285-547-5,85116-93-4,Not Classified,REACH registration C&L,295,Not classified:275;H413:20
35802,1-ethyl-4-nitrobenzene,202-821-1,100-12-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
35808,Propylphosphonic anhydride (50% solution in Ethyl acetate),614-857-9,68957-94-8,Met. Corr. 1;Skin Corr. 1B,Notified C&L,45,H314:45;H290:39;H302:1;H332:1;H312:1;H336:2;H225:2
35809,Decene,246-870-7,25339-53-1,Flam. Liq. 3;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H226:3;H304:3;H410:2;H400:2
35814,4-amidino-N'-nitroso-1-tetrazene-1-carboximidohydrazide,203-659-4,109-27-3,Unst. Expl.,REACH registration C&L,14,H200:14;H319:1;H315:1
35815,"2',5'-dichloroacetophenone",219-605-8,2476-37-1,,Notified C&L,6,H319:6;H315:6;H335:2
35816,"Perhydrodioxino[2,3-b][1,4]dioxin-2,3,6,7-tetraol",224-551-3,4405-13-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H319:40;H315:40
35817,Fumaronitrile,212-122-3,764-42-1,Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:44;H331:40;H319:1;H311:1;H315:1
35818,Ethyl 2-bromobutyrate,208-574-6,533-68-6,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1,REACH registration C&L,49,H226:47;H302:43;H317:4;H335:43;H318:39;H315:44;H319:5;H314:1
35822,"Gases (petroleum), C6-8 catalytic reformer;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]",270-762-9,68477-81-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H220:0;H350:0
35829,"m-(1,1,2,2-tetrafluoroethoxy)benzaldehyde",252-496-5,35295-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38
35830,"Petroleum products, hydrofiner-powerformer reformates;Low boiling point cat-reformed naphtha;[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27°C to 210°C (80°F to 410°F).]",271-058-4,68514-79-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
35834,"1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide",261-890-6,59729-32-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,114,H302:110;H411:60;H362:3;H412:2;H301:1;H361:4;H335:2;H319:3;H315:2;H341:1;H410:1;H400:1;H332:2;H312:2;H360:1;H351:3;H371:1;H336:1
35836,phoxim (ISO);α-(diethoxyphosphinothioylimino) phenylacetonitrile,238-887-3,14816-18-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H400:0;H317:0;H302:0;H361:0
35837,"8,8-dimethoxy-2,6-dimethyloctan-2-ol",205-510-9,141-92-4,Not Classified,Notified C&L,1587,Not classified:1548;H335:38;H319:38;H315:38;H411:1
35838,"2-Propenenitrile, polymer with 1,3-butadiene, hydrogenated",927-840-9,88254-10-8,,Notified C&L,33,Not classified:33
35842,"L-Ascorbic acid, 2-[(3β)-cholest-5-en-3-yl hydrogen phosphate], monosodium salt",606-043-7,185018-43-3,Not Classified,Notified C&L,1,Not classified:1
35844,Acarbose,260-030-7,56180-94-0,Acute Tox. 4,Notified C&L,1,H302:1
35849,4-Fluoro-3-methylphenol,610-234-0,452-70-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:40;H319:41;H315:41;H314:5;H302:6;H312:6;H301:1;H311:1;H331:1;H332:1
35850,"Sodium 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-acetate",212-652-5,837-27-4,Not Classified,Notified C&L,1,Not classified:1
35851,N6-(1-oxododecyl)-L-lysine,257-843-4,52315-75-0,Not Classified,REACH registration C&L,127,Not classified:127
35852,Potassium 4-hydroxybenzoate,240-830-2,16782-08-4,Not Classified,Notified C&L,3,Not classified:3
35855,"1-[(5α,7α)-4,5-epoxy-18,19-dihydro-3,6-dimethoxy-17-methyl-6,14-ethenomorphinan-7-yl]ethanone",240-326-2,16196-82-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,167,H319:128;H317:5;H332:5;H302:129;H334:5;H315:129;H412:124;H301:38
35862,Triethylammonium bromide,211-263-8,636-70-4,Eye Irrit. 2,REACH registration C&L,121,H319:121;H335:56;H315:56;H302:5;H312:1;H332:1
35864,2-(4-methylthiazol-5-yl)ethyl butyrate,303-209-8,94159-31-6,Not Classified,Notified C&L,91,Not classified:89;H319:2;H315:2;H335:1
35866,"(R)-dimethyl(1-methyl-4-oxo-3,3-diphenylhexyl)ammonium chloride",227-756-6,5967-73-7,Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,2,H336:2;H412:2;H300:2
35870,Chromium (III) hydroxide,215-158-8,1308-14-1,Not Classified,REACH registration C&L,190,Not classified:188;H318:2
35871,"Gasoline, C",297-458-9,93572-29-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H350:0;H340:0
35872,"Sulfonic acids, lard-oil, polymd., oxidized, sodium salts",614-472-6,68424-75-9,,Notified C&L,34,Not classified:34
35873,"1-(3,5-dichlorophenyl)piperazine",259-841-9,55827-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35874,Copper molybdenum tetraoxide,237-378-3,13767-34-5,Not Classified,Notified C&L,69,Not classified:37;H373:29;H335:29;H319:29;H400:3
35878,3-(2-ethylhexyloxy)propylamine,226-420-6,5397-31-9,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2222,H335:87;H314:2221;H302:2222;H311:2199;H318:95;H411:2132;H410:23;H319:1;H315:1
35880,Quinuclidin-3-one,223-087-9,3731-38-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,4,H332:4;H302:4;H411:4;H312:4
35881,"4-bromo-2,6-xylenol",219-153-1,2374-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H319:45;H315:45;H312:6;H302:6;H332:2
35882,"1,3-difluoropropan-2-ol",207-216-6,453-13-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:45;H335:45;H319:45;H315:45;H312:5;H302:5;H332:5
35883,"Oleic acid, compound with triethylamine",233-281-5,10103-17-0,Not Classified,Notified C&L,1,Not classified:1
35884,2-methoxy-5-methylpyrazine,220-738-9,2882-22-6,Flam. Liq. 3,Notified C&L,1,H226:1
35885,"trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione",444-750-0,211387-26-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
35887,"2-methylpentane-2,4-diol",203-489-0,107-41-5,Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H315:0
35888,pyridine,203-809-9,110-86-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H312:0;H225:0
35890,Ammonium hydrogensulphide,235-184-3,12124-99-1,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,114,H314:114;H400:104;H310:10;H300:10;H330:10
35891,Acetic Acid Ethenyl Ester co-Polymer with Ethenol,607-648-9,25213-24-5,Eye Irrit. 2,Notified C&L,712,H319:467;Not classified:216;H332:29;H302:29;H371:29;H312:29
35894,"Amides, from C8-10-fatty acids and tetraethylenepentamine",285-080-7,85029-55-6,Skin Corr. 1C;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,33,H314:2;H400:2;H317:2;H410:2;Not classified:31
35896,Tri-tert-butylphosphonium Tetraphenylborate,603-474-2,131322-08-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H301:1;H311:1;H331:1
35898,Sucrose dimyristate,250-302-3,30701-38-3,Not Classified,Notified C&L,1,Not classified:1
35899,"Malic acid, compound with 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methylpiperidine (1:1)",225-970-4,5189-11-7,Acute Tox. 4,Notified C&L,7,H302:6;Not classified:1
35902,benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;flurazole,276-942-3,72850-64-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
35903,3-phenylsalicylic acid,206-148-4,304-06-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H302:39;H319:40;H315:2;H335:1
35904,"1,5-Naphthalenedisulfonic acid, 3,3-(2,2-disulfo1,1-biphenyl-4,4-diyl)bisimino(6-chloro-1,3,5-triazine-4,2-diyl)imino(1-hydroxy-3-sulfo-6,2-naphthalenediyl)azobis-, octasodium salt",618-726-7,91261-29-9,Not Classified,Notified C&L,2,Not classified:1;H334:1
35909,"Trisodium 1-amino-4-[[3-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",277-040-2,72927-99-2,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,85,H318:34;H317:37;Not classified:45;H412:3;H319:3
35912,2-methoxybenzhydryl alcohol,245-218-9,22788-49-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1
35913,glufosinate ammonium (ISO);ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate,278-636-5,77182-82-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2;Repr. 1B,Harmonised C&L,0,H373:0;H360:0;H312:0;H332:0;H302:0
35916,"Alcohols, C14-16",269-790-4,68333-80-2,Not Classified,Notified C&L,214,Not classified:178;H400:36
35918,Clopamide,211-261-7,636-54-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,42,H334:39;H317:39;H412:3
35920,Enoxolone,207-444-6,471-53-4,Not Classified,REACH registration C&L,67,Not classified:21;H302:46;H319:45
35924,Methyl 19α-methyl-2-oxoformosanan-16-carboxylate,208-106-0,509-80-8,Acute Tox. 2,Notified C&L,1,H300:1
35925,D-glucitol monolaurate,247-888-8,26657-97-6,Not Classified,REACH registration C&L,2,Not classified:2
35930,ALKYL-(C12-C14) ALCOHOL ETHOXYLATED PROPOXYLATED,614-901-7,69013-18-9,Eye Irrit. 2,Notified C&L,94,H319:83;Not classified:9;H412:2;H318:1;H302:1;H315:2
35933,"Phosphoric acid, mono- and bis(branched and linear pentyl) esters",282-784-6,84418-71-3,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H314:2;H402:1;H318:1;H412:2;H290:1
35936,"Sodium 4-chloro-3-[4-[[5-chloro-2-(2-chlorophenoxy)phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",276-675-2,72479-28-8,Aquatic Chronic 3,REACH registration C&L,22,H412:12;Not classified:10;H334:1;H317:1
35937,4-(trans-4-Ethylcyclohexyl)-2-fluorphenylboronic acid,600-125-6,1007223-52-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,Not classified:1;H400:1;H317:1;H410:1
35947,2-[(4-chloro-3-nitrophenyl)sulphonyl]anthranilic acid,268-121-3,68003-38-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H319:1;H312:1;H332:1;H302:1;H315:1
35948,"(trans,trans)-4-{(4'-Ethyl[1,1'-bicyclohexyl]-4-yl)-difluormethoxy}-1,2-difluorbenzen",609-017-3,346708-60-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
35951,"Trisodium 5-[[(2,3-dichloro-6-quinoxalinyl)carbonyl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",219-303-6,2407-13-8,,Notified C&L,1,Not classified:1
35952,"dazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione",208-576-7,533-74-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H319:0;H400:0
35953,"dialuminium manganese tetraoxide, spinel type",927-806-3,1302-69-8,Not Classified,REACH registration C&L,1,Not classified:1
35957,"amidosulfuron (ISO);3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea",407-380-0,120923-37-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
35961,"5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one",230-423-8,7120-86-7,,Notified C&L,1,H302:1
35963,Isocyanoethane,210-863-7,624-79-3,,Notified C&L,2,H332:1;H302:1;H312:1;H225:2;H301:1;H311:1;H331:1
35964,2-(phenylmethoxy)naphthalene,405-490-3,613-62-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
35966,"Imidazolium compounds, 1-[2-(2-carboxyethoxy)ethyl]-1(or 3)-(2-carboxyethyl)-4,5-dihydro-2-norcoco alkyl",272-897-9,68919-40-4,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,4,H318:4;H317:2;H411:2;H315:2
35969,"2,6-dimethylcyclohexan-1-ol",226-264-9,5337-72-4,Flam. Liq. 3,Notified C&L,39,H226:39
35971,4’-(2-Propyl-4-methyl-6-(1-methylbenzimidazolyl-2-yl)-benzimidazol-1-ylmethyl)biphenyl-2-carbonsäure Hydrochlorid,485-140-4,,Aquatic Chronic 2,Notified C&L,1,H411:1
35972,"reaction mass of: (E)-2,12-tridecadiennitrile;(E)-3,12-tridecadiennitrile;(Z)-3,12-tridecadiennitrile",422-190-8,124071-40-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
